Single nucleotide polymorphisms in genes

ABSTRACT

The invention provides nucleic acid segments of the human genome, particularly nucleic acid segments from a gene, including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking or containing these sites are also provided. The nucleic acids, primers and probes are used in applications such as phenotype correlations, forensics, paternity testing, medicine and genetic analysis. A role for the thrombospondin gene(s) in vascular disease is also disclosed. Use of single nucleotide polymorphisms in the thrombospondin gene(s) for diagnosis, prediction of clinical course and treatment response, development of therapeutics and development of cell-culture-based and animal models for research and treatment are disclosed.

RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application Serial No. 60/153,357, filed Sep. 10, 2000, U.S. Provisional Application Serial No. 60/220,947, filed Jul. 26, 2000, and U.S. Provisional Application Serial No. 60/225,724, filed Aug. 16, 2000, the entire teachings of all of which are incorporated herein by reference.

BACKGROUND OF THE INVENTION

The genomes of all organisms undergo spontaneous mutation in the course of their continuing evolution, generating variant forms of progenitor nucleic acid sequences (Gusella, Ann. Rev. Biochem. 55, 831-854 (1986)). The variant form may confer an evolutionary advantage or disadvantage relative to a progenitor form, or may be neutral. In some instances, a variant form confers a lethal disadvantage and is not transmitted to subsequent generations of the organism. In other instances, a variant form confers an evolutionary advantage to the species and is eventually incorporated into the DNA of many or most members of the species and effectively becomes the progenitor form. In many instances, both progenitor and variant form(s) survive and co-exist in a species population. The coexistence of multiple forms of a sequence gives rise to polymorphisms.

Several different types of polymorphism have been reported. A restriction fragment length polymorphism (RFLP) is a variation in DNA sequence that alters the length of a restriction fragment (Botstein et al., Am. J. Hum. Genet. 32, 314-331 (1980)). The restriction fragment length polymorphism may create or delete a restriction site, thus changing the length of the restriction fragment. RFLPs have been widely used in human and animal genetic analyses (see WO 90/13668; WO90/11369; Donis-Keller, Cell 51, 319-337 (1987); Lander et al., Genetics 121, 85-99 (1989)). When a heritable trait can be linked to a particular RFLP, the presence of the RFLP in an individual can be used to predict the likelihood that the animal will also exhibit the trait.

Other polymorphisms take the form of short tandem repeats (STRs) that include tandem di-, tri- and tetra-nucleotide repeated motifs. These tandem repeats are also referred to as variable number tandem repeat (VNTR) polymorphisms. VNTRs have been used in identity and paternity analysis (U.S. Pat. No. 5,075,217; Armour et al., FEBS Lett. 307, 113-115 (1992); Horn et al., WO 91/14003; Jeffreys, EP 370,719), and in a large number of genetic mapping studies.

Other polymorphisms take the form of single nucleotide variations between individuals of the same species. Such polymorphisms are far more frequent than RFLPs, STRs and VNTRs. Some single nucleotide polymorphisms (SNP) occur in protein-coding nucleic acid sequences (coding sequence SNP (cSNP)), in which case, one of the polymorphic forms may give rise to the expression of a defective or otherwise variant protein and, potentially, a genetic disease. Examples of genes in which polymorphisms within coding sequences give rise to genetic disease include β-globin (sickle cell anemia), apoE4 (Alzheimer's Disease), Factor V Leiden (thrombosis), and CFTR (cystic fibrosis). cSNPs can alter the codon sequence of the gene and therefore specify an alternative amino acid. Such changes are called “missense” when another amino acid is substituted, and “nonsense” when the alternative codon specifies a stop signal in protein translation. When the cSNP does not alter the amino acid specified the cSNP is called “silent”.

Other single nucleotide polymorphisms occur in noncoding regions. Some of these polymorphisms may also result in defective protein expression (e.g., as a result of defective splicing). Other single nucleotide polymorphisms have no phenotypic effects.

Single nucleotide polymorphisms can be used in the same manner as RFLPs and VNTRs, but offer several advantages. Single nucleotide polymorphisms occur with greater frequency and are spaced more uniformly throughout the genome than other forms of polymorphism. The greater frequency and uniformity of single nucleotide polymorphisms means that there is a greater probability that such a polymorphism will be found in close proximity to a genetic locus of interest than would be the case for other polymorphisms. The different forms of characterized single nucleotide polymorphisms are often easier to distinguish than other types of polymorphism (e.g., by use of assays employing allele-specific hybridization probes or primers).

Only a small percentage of the total repository of polymorphisms in humans and other organisms has been identified. The limited number of polymorphisms identified to date is due to the large amount of work required for their detection by conventional methods. For example, a conventional approach to identifying polymorphisms might be to sequence the same stretch of DNA in a population of individuals by dideoxy sequencing. In this type of approach, the amount of work increases in proportion to both the length of sequence and the number of individuals in a population and becomes impractical for large stretches of DNA or large numbers of persons.

SUMMARY OF THE INVENTION

Work described herein pertains to the identification of polymorphisms which can predispose individuals to disease, by resequencing large numbers of genes in a large number of individuals. Various genes from a number of individuals have been resequenced as described herein, and SNPs in these genes have been discovered (see the Table and FIG. 3). Some of these SNPs are cSNPs which specify a different amino acid sequence, some of the SNPs are silent cSNPs and some of these cSNPs specify a stop signal in protein translation. Some of the identified SNPs were located in non-coding regions.

The invention relates to a gene which comprises a single nucleotide polymorphism at a specific location. In a particular embodiment the invention relates to the variant allele of a gene having a single nucleotide polymorphism, which variant allele differs from a reference allele by one nucleotide at the site(s) identified in the Table and FIG. 3. Complements of these nucleic acid sequences are also included. The nucleic acid molecules can be DNA or RNA, and can be double- or single-stranded. Nucleic acid molecules can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30, 10-50 or 10-100 bases long.

The invention further provides allele-specific oligonucleotides that hybridize to the reference or variant allele of a gene comprising a single nucleotide polymorphism or to the complement thereof. These oligonucleotides can be probes or primers.

The invention further provides a method of analyzing a nucleic acid from an individual. The method determines which base is present at any one of the polymorphic sites shown in the Table and/or FIG. 3. Optionally, a set of bases occupying a set of the polymorphic sites shown in the Table and/or FIG. 3 is determined. This type of analysis can be performed on a number of individuals, who are tested for the presence of a disease phenotype. The presence or absence of disease phenotype is then correlated with a base or set of bases present at the polymorphic site or sites in the individuals tested.

Thus, the invention further relates to a method of predicting the presence, absence, likelihood of the presence or absence, or severity of a particular phenotype or disorder associated with a particular genotype. The method comprises obtaining a nucleic acid sample from an individual and determining the identity of one or more bases (nucleotides) at polymorphic sites of genes described herein, wherein the presence of a particular base is correlated with a specified phenotype or disorder, thereby predicting the presence, absence, likelihood of the presence or absence, or severity of the phenotype or disorder in the individual.

The thrombospondins are a family of extracellular matrix (ECM) glycoproteins that modulate many cell behaviors including adhesion, migration, and proliferation. Thrombospondins (also known as thrombin sensitive proteins or TSPs) are large molecular weight glycoproteins composed of three identical disulfide-linked polypeptide chains. The results described herein also reveal an important association between alterations, particularly SNPs, in TSP genes, particularly TSP-1 and TSP-4, and vascular disease. In particular, SNPs in these genes which are associated with premature coronary artery disease (CAD)(or coronary heart disease) and myocardial infarction (MI) have been identified and represent a potentially vital marker of upstream biology influencing the complex process of atherosclerotic plaque generation and vulnerability.

Thus, the invention relates to the TSP gene SNPs identified as described herein, both singly and in combination, as well as to the use of these SNPs, and others in TSP genes, particularly those nearby in linkage disequilibrium with these SNPs, for diagnosis, prediction of clinical course and treatment response for vascular disease, development of new treatments for vascular disease based upon comparison of the variant and normal versions of the gene or gene product, and development of cell-culture based and animal models for research and treatment of vascular disease. The invention further relates to novel compounds and pharmaceutical compositions for use in the diagnosis and treatment of such disorders. In preferred embodiments, the vascular disease is CAD or MI.

The invention relates to isolated nucleic acid molecules comprising all or a portion of the variant allele of TSP-1 (e.g., as exemplified by SEQ ID NO: 1), and to isolated nucleic acid molecules comprising all or a portion of the variant allele of TSP-4 (e.g., as exemplified by SEQ ID NO: 3). Preferred portions are at least 10 contiguous nucleotides and comprise the polymorphic site, e.g., a portion of SEQ ID NO: 1 which is at least 10 contiguous nucleotides and comprises the “G” at position 2210, or a portion of SEQ ID NO: 3 which is at least 10 contiguous nucleotides and comprises the “C” at position 1186. The invention further relates to isolated gene products, e.g., polypeptides or proteins, which are encoded by a nucleic acid molecule comprising all or a portion of the variant allele of TSP-1 or TSP-4 (e.g., SEQ ID NO: 1 or SEQ ID NO: 3, respectively). The invention also relates to nucleic acid molecules which hybridize to and/or share identity with the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site.

The invention further relates to isolated proteins or polypeptides comprising all or a portion of the variant amino acid-sequence of TSP-1 (e.g., as exemplified by SEQ ID NO: 2), and to isolated proteins or polypeptides comprising all or a portion of the variant amino acid sequence of TSP-4 (e.g., as exemplified by SEQ ID NO: 4). Preferred polypeptides are at least 10 contiguous amino acids and comprise the polymorphic amino acid, e.g., a portion of SEQ ID NO: 2 which is at least 10 contiguous amino acids and comprises the serine at residue 700, or a portion of SEQ ID NO: 4 which is at least 10 contiguous amino acids and comprises the proline at residue 387. The invention further relates to isolated nucleic acid molecules encoding such proteins and polypeptides, as well as to antibodies which bind, e.g., specifically, to such proteins and polypeptides.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with the presence of one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 in an individual. The method comprises obtaining a nucleic acid sample from the individual and determining the nucleotide present at one or more of the indicated nucleotide positions, wherein presence of one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 is indicative of increased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the reference nucleotide at one or more of said positions. In a particular embodiment the disorder is a vascular disease selected from the group consisting of atherosclerosis, coronary heart or artery disease, MI, stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In a preferred embodiment, the vascular disease is selected from the group consisting of CAD and M.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 in an individual. The method comprises obtaining a nucleic acid sample from the individual and determining the nucleotide present at one or more of the indicated nucleotide positions, wherein presence of one or more of (a) an A at nucleotide position 2210 of SEQ ID NO: 1; or (b) a G at nucleotide position 1186 of SEQ ID NO: 3 is indicative of decreased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the variant nucleotide at said position. In a particular embodiment the disorder is a vascular disease selected from the group consisting of atherosclerosis, coronary heart or artery disease, MI, stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In a preferred embodiment, the vascular disease is selected from the group consisting of CAD and MI.

In one embodiment, the invention relates to a method for predicting the likelihood that an individual will have a vascular disease (or aiding in the diagnosis of a vascular disease), comprising the steps of obtaining a DNA sample from an individual to be assessed and determining the nucleotide present at one or more of nucleotide positions 2210 of SEQ ID NO: 1 or 1186 of SEQ ID NO: 3. The presence of the reference nucleotide at one or more of these positions indicates that the individual has a lower likelihood of having a vascular disease than an individual having the variant nucleotide at one or more of these positions, or a lower likelihood of having severe symptomology. In a particular embodiment, the individual is an individual at risk for development of a vascular disease.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with the presence of one or more of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4 in an individual. The method comprises obtaining a biological sample containing the TSP-1 and/or TSP-4 protein or relevant portion thereof from the individual and determining the amino acid present at one or more of the indicated amino acid positions, wherein presence of one or more of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4 is indicative of increased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the reference amino acid at one or more of said positions.

The invention further relates to a method of diagnosing or aiding in the diagnosis of a disorder associated with one or more of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4 in an individual. The method comprises obtaining a biological sample containing the TSP-1 and/or TSP-4 protein or relevant portion thereof from the individual and determining the amino acid present at one or more of the indicated amino acid positions, wherein presence of one or more of (a) an asparagine at amino acid position 700 of SEQ ID NO: 2; or (b) an alanine at amino acid position 387 of SEQ ID NO: 4 is indicative of decreased likelihood of said disorder in the individual as compared with an appropriate control, e.g., an individual having the variant amino acid at one or more of said positions.

In one embodiment, the invention relates to a method for predicting the likelihood that an individual will have a vascular disease (or aiding in the diagnosis of a vascular disease), comprising the steps of obtaining a biological sample comprising the TSP-1 and/or TSP-4 protein or relevant portion thereof from an individual to be assessed and determining the amino acid present at one or more of amino acid positions 700 of SEQ ID NO: 2 or 387 of SEQ ID NO: 4. The presence of the reference amino acid at one or more of these positions indicates that the individual has a lower likelihood of having a vascular disease than an individual having the variant amino acid at one or more of these positions, or a lower likelihood of having severe symptomology. In a particular embodiment, the individual is an individual at risk for development of a vascular disease.

In another embodiment, the invention relates to pharmaceutical compositions comprising a reference TSP-1 and/or TSP-4 gene or gene product, or active portion thereof, for use in the treatment of vascular diseases. The invention further relates to the use of agonists and antagonists of TSP-1 and TSP-4 activity for use in the treatment of vascular diseases. In a particular embodiment the vascular disease is selected from the group consisting of atherosclerosis, coronary heart or artery disease, MI, stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In a preferred embodiment, the vascular disease is selected from the group consisting of CAD and MI.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-1D show the reference nucleotide (SEQ ID NO: 1) and amino acid (SEQ ID NO: 2) sequences for TSP-1.

FIGS. 2A-2C show the reference nucleotide (SEQ ID NO: 3) and amino acid (SEQ ID NO: 4) sequences for TSP4.

FIG. 3 shows a table providing detailed information about the SNPs identified herein. Column one shows the internal polymorphism identifier. Column two shows the accession number for the reference sequence in the TIGR database which can be found on the world wide web at tigr.org/tdb/hgi/searching/hgi_reports.html. Column three shows the nucleotide position for the SNP site. Column four shows the gene in which the polymorphism was identified. Column five shows the polymorphic site and additional flanking sequence on each side of the polymorphism. Column six shows the type of mutation produced by the polymorphism. Columns seven and eight show the reference and alternate (variant) nucleotides, respectively, for the SNP. Columns nine and ten show the reference and alternate (variant) amino acids, respectively, encoded by the alleles of the gene.

DETAILED DESCRIPTION OF THE INVENTION

The present invention relates to a gene which comprises a single nucleotide polymorphism (SNP) at a specific location. The gene which includes the SNP has at least two alleles, referred to herein as the reference allele and the variant allele. The reference allele (prototypical or wild type allele) has been designated arbitrarily and typically corresponds to the nucleotide sequence of the gene which has been deposited with GenBank or TIGR under a given Accession number. The variant allele differs from the reference allele by one nucleotide at the site(s) identified in the Table. The present invention also relates to variant alleles of the described genes and to complements of the variant alleles. The invention also relates to nucleic acid molecules which hybridize to and/or share identity with the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site.

The invention further relates to portions of the variant alleles and portions of complements of the variant alleles which comprise (encompass) the site of the SNP and are at least 5 nucleotides in length. Portions can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30, 10-50 or 10-100 bases long. For example, a portion of a variant allele which is 21 nucleotides in length includes the single nucleotide polymorphism (the nucleotide which differs from the reference allele at that site) and twenty additional nucleotides which flank the site in the variant allele. These nucleotides can be on one or both sides of the polymorphism. Polymorphisms which are the subject of this invention are defined in the Table with respect to the reference sequence deposited in GenBank or TIGR under the Accession number indicated. For example, the invention relates to a portion of a gene (e.g., AT3) having a nucleotide sequence as deposited in GenBank (e.g., U11270) comprising a single nucleotide polymorphism at a specific position (e.g., nucleotide 11918). The reference nucleotide for AT3 is shown in column 8, and the variant nucleotide is shown in column 9 of the Table. The nucleotide sequences of the invention can be double- or single-stranded.

The invention further provides allele-specific oligonucleotides that hybridize to the reference or variant allele of a gene comprising a single nucleotide polymorphism or to the complement thereof. These oligonucleotides can be probes or primers.

The invention further provides a method of analyzing a nucleic acid from an individual. The method determines which base is present at any one of the polymorphic sites shown in the Table and/or FIG. 3. Optionally, a set of bases occupying a set of the polymorphic sites shown in the Table and/or FIG. 3 is determined. This type of analysis can be performed on a number of individuals, who are tested for the presence of a disease phenotype. The presence or absence of disease phenotype is then correlated with a base or set of bases present at the polymorphic site or sites in the individuals tested.

Thus, the invention further relates to a method of predicting the presence, absence, likelihood of the presence or absence, or severity of a particular phenotype or disorder associated with a particular genotype. The method comprises obtaining a nucleic acid sample from an individual and determining the identity of one or more bases (nucleotides) at polymorphic sites of genes described herein, wherein the presence of a particular base is correlated with a specified phenotype or disorder, thereby predicting the presence, absence, likelihood of the presence or absence, or severity of the phenotype or disorder in the individual.

DEFINITIONS

A nucleic acid molecule or oligonucleotide can be DNA or RNA, and single- or double-stranded. Nucleic acid molecules and oligonucleotides can be naturally occurring or synthetic, but are typically prepared by synthetic means. Preferred nucleic acid molecules and oligonucleotides of the invention include segments of DNA, or their complements, which include any one of the polymorphic sites shown in the Table. The segments can be between 5 and 250 bases, and, in specific embodiments, are between 5-10, 5-20, 10-20, 10-50, 20-50 or 10-100bases. For example, the segment can be 21 bases. The polymorphic site can occur within any position of the segment. The segments can be from any of the allelic forms of DNA shown in the Table.

As used herein, the terms “nucleotide”, “base” and “nucleic acid” are intended to be equivalent. The terms “nucleotide sequence”, “nucleic acid sequence”, “nucleic acid molecule” and “segment” are intended to be equivalent.

Hybridization probes are oligonucleotides which bind in a base-specific manner to a complementary strand of nucleic acid. Such probes include peptide nucleic acids, as described in Nielsen et al., Science 254, 1497-1500 (1991). Probes can be any length suitable for specific hybridization to the target nucleic acid sequence. The most appropriate length of the probe may vary depending upon the hybridization method in which it is being used; for example, particular lengths may be more appropriate for use in microfabricated arrays, while other lengths may be more suitable for use in classical hybridization methods. Such optimizations are known to the skilled artisan. Suitable probes and primers can range from about 5 nucleotides to about 30 nucleotides in length. For example, probes and primers can be 5, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 25, 26, 28 or 30 nucleotides in length. The probe or primer preferably overlaps at least one polymorphic site occupied by any of the possible variant nucleotides. The nucleotide sequence can correspond to the coding sequence of the allele or to the complement of the coding sequence of the allele.

As used herein, the term “primer” refers to a single-stranded oligonucleotide which acts as a point of initiation of template-directed DNA synthesis under appropriate conditions (e.g., in the presence of four different nucleoside triphosphates and an agent for polymerization, such as DNA or RNA polymerase or reverse transcriptase) in an appropriate buffer and at a suitable temperature. The appropriate length of a primer depends on the intended use of the primer, but typically ranges from 15 to 30 nucleotides. Short primer molecules generally require cooler temperatures to form sufficiently stable hybrid complexes with the template. A primer need not reflect the exact sequence of the template, but must be sufficiently complementary to hybridize with a template. The term primer site refers to the area of the target DNA to which a primer hybridizes. The term primer pair refers to a set of primers including a 5′ (upstream) primer that hybridizes with the 5′ end of the DNA sequence to be amplified and a 3′ (downstream) primer that hybridizes with the complement of the 3′ end of the sequence to be amplified.

As used herein, linkage describes the tendency of genes, alleles, loci or genetic markers to be inherited together as a result of their location on the same chromosome. It can be measured by percent recombination between the two genes, alleles, loci or genetic markers.

As used herein, polymorphism refers to the occurrence of two or more genetically determined alternative sequences or alleles in a population. A polymorphic marker or site is the locus at which divergence occurs. Preferred markers have at least two alleles, each occurring at frequency of greater than 1%, and more preferably greater than 10% or 20% of a selected population. A polymorphic locus may be as small as one base pair. Polymorphic markers include restriction fragment length polymorphisms, variable number of tandem repeats (VNTR's), hypervariable regions, minisatellites, dinucleotide repeats, trinucleotide repeats, tetranucleotide repeats, simple sequence repeats, and insertion elements such as Alu. The first identified allelic form is arbitrarily designated as the reference form and other allelic forms are designated as alternative or variant alleles. The allelic form occurring most frequently in a selected population is sometimes referred to as the wildtype form. Diploid organisms may be homozygous or heterozygous for allelic forms. A dialleic or biallelic polymorphism has two forms. A triallelic polymorphism has three forms.

Work described herein pertains to the resequencing of large numbers of genes in a large number of individuals to identify polymorphisms which can predispose individuals to disease. For example, polymorphisms in genes which are expressed in liver may predispose individuals to disorders of the liver. By altering amino acid sequence, SNPs may alter the function of the encoded proteins. The discovery of the SNP facilitates biochemical analysis of the variants and the development of assays to characterize the variants and to screen for pharmaceutical that would interact directly with on or another form of the protein. SNPs (including silent SNPs) also enable the development of specific DNA, RNA, or protein-based diagnostics that detect the presence or absence of the polymorphism in particular conditions.

A single nucleotide polymorphism occurs at a polymorphic site occupied by a single nucleotide, which is the site of variation between allelic sequences. The site is usually preceded by and followed by highly conserved sequences of the allele (e.g., sequences that vary in less than 1/100 or 1/1000 members of the populations).

A single nucleotide polymorphism usually arises due to substitution of one nucleotide for another at the polymorphic site. A transition is the replacement of one purine by another purine or one pyrimidine by another pyrimidine. A transversion is the replacement of a purine by a pyrimidine or vice versa. Single nucleotide polymorphisms can also arise from a deletion of a nucleotide or an insertion of a nucleotide relative to a reference allele. Typically the polymorphic site is occupied by a base other than the reference base. For example, where the reference allele contains the base “T” at the polymorphic site, the altered allele can contain a “C”, “G” or “A” at the polymorphic site.

The invention also relates to nucleic acid molecules which hybridize to the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site. Hybridizations are usually performed under stringent conditions, for example, at a salt concentration of no more than 1 M and a temperature of at least 25° C. For example, conditions of 5×SSPE (750 mM NaCl, 50 mM NaPhosphate, 5 mM EDTA, pH 7.4) and a temperature of 25-30° C., or equivalent conditions, are suitable for allele-specific probe hybridizations. Equivalent conditions can be determined by varying one or more of the parameters given as an example, as known in the art, while maintaining a similar degree of identity or similarity between the target nucleotide sequence and the primer or probe used.

The invention also relates to nucleic acid molecules which share substantial sequence identity to the variant alleles identified herein (or their complements) and which also comprise the variant nucleotide at the SNP site. Particularly preferred are nucleic acid molecules and fragments which have at least about 60%, preferably at least about 70, 80 or 85%, more preferably at least about 90%, even more preferably at least about 95%, and most preferably at least about 98% identity with nucleic acid molecules described herein. The percent identity of two nucleotide or amino acid sequences can be determined by aligning the sequences for optimal comparison purposes (e.g., can be introduced in the sequence of a first sequence). The nucleotides or amino acids at corresponding positions are then compared, and the percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e., % identity=# of identical positions/total # of positions×100). In certain embodiments, the length of a sequence aligned for comparison purposes is at least 30%, preferably at least 40%, more preferably at least 60%, and even more preferably at least 70%, 80% or 90% of the length of the reference sequence. The actual comparison of the two sequences can be accomplished by well-known methods, for example, using a mathematical algorithm. A preferred, non-limiting example of such a mathematical algorithm is described in Karlin et al., Proc. Natl. Acad. Sci. USA, 90:5873-5877 (1993). Such an algorithm is incorporated into the NBLAST and XBLAST programs (version 2.0) as described in Altschul et al., Nucleic Acids Res., 25:389-3402 (1997). When utilizing BLAST and Gapped BLAST programs, the default parameters of the respective programs (e.g., NBLAST) can be used. See the world wide web at ncbi.nlm.nih.gov. In one embodiment, parameters for sequence comparison can be set at score=100, wordlength=12, or can be varied (e.g., W=5 or W=20).

The term “isolated” is used herein to indicate that the material in question exists in a physical milieu distinct from that in which it occurs in nature. For example, an isolated nucleic acid of the invention may be substantially isolated with respect to the complex cellular milieu in which it naturally occurs. In some instances, the isolated material will form part of a composition (for example, a crude extract containing other substances), buffer system or reagent mix. In other circumstance, the material may be purified to essential homogeneity, for example as determined by PAGE or column chromatography such as HPLC. Preferably, an isolated nucleic acid comprises at least about 50, 80 or 90 percent (on a molar basis) of all macromolecular species present.

I. Novel Polymorphisms of the Invention

Some of the novel polymorphisms of the invention are shown in the Table. Columns one and two show designations for the indicated polymorphism. Column three shows the Genbank or TIGR Accession number for the wild type (or reference) allele. Column four shows the location of the polymorphic site in the nucleic acid sequence with reference to the Genbank or TIGR sequence shown in column three. Column five shows common names for the gene in which the polymorphism is located. Column six shows the polymorphism and a portion of the 3′ and 5′ flanking sequence of the gene. Column seven shows the type of mutation; N, non-sense, S, silent, M, missense. Columns eight and nine show the reference and alternate nucleotides, respectively, at the polymorphic site. Columns ten and eleven show the reference and alternate amino acids, respectively, encoded by the reference and variant, respectively, alleles. Other novel polymorphisms of the invention are shown in FIG. 3.

II. Analysis of Polymorphisms

A. Preparation of Samples

Polymorphisms are detected in a target nucleic acid from an individual being analyzed. For assay of genomic DNA, virtually any biological sample (other than pure red blood cells) is suitable. For example, convenient tissue samples include whole blood, semen, saliva, tears, urine, fecal material, sweat, buccal, skin and hair. For assay of cDNA or mRNA, the tissue sample must be obtained from an organ in which the target nucleic acid is expressed. For example, if the target nucleic acid is a cytochrome P450, the liver is a suitable source.

Many of the methods described below require amplification of DNA from target samples. This can be accomplished by e.g., PCR. See generally PCR Technology: Principles and Applications for DNA Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992); PCR Protocols: A Guide to Methods and Applications (eds. Innis, et al., Academic Press, San Diego, Calif., 1990); Mattila et al., Nucleic Acids Res. 19, 4967 (1991); Eckert et a., PCR Methods and Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press, Oxford); and U.S. Pat. No. 4,683,202.

Other suitable amplification methods include the ligase chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989), Landegren et al., Science 241, 1077 (1988), transcription amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173 (1989)), and self-sustained sequence replication (Guatelli et al., Proc. Nat. Acad. Sci. USA, 87, 1874 (1990)) and nucleic acid based sequence amplification (NASBA). The latter two amplification methods involve isothermal reactions based on isothermal transcription, which produce both single stranded RNA (ssRNA) and double stranded DNA (dsDNA) as the amplification products in a ratio of about 30 or 100 to 1, respectively.

B. Detection of Polymorphisms in Target DNA

There are two distinct types of analysis of target DNA for detecting polymorphisms. The first type of analysis, sometimes referred to as de novo characterization, is carried out to identify polymorphic sites not previously characterized (i.e., to identify new polymorphisms). This analysis compares target sequences in different individuals to identify points of variation, i.e., polymorphic sites. By analyzing groups of individuals representing the greatest ethnic diversity among humans and greatest breed and species variety in plants and animals, patterns characteristic of the most common alleles/haplotypes of the locus can be identified, and the frequencies of such alleles/haplotypes in the population can be determined. Additional allelic frequencies can be determined for subpopulations characterized by criteria such as geography, race, or gender. The de novo identification of polymorphisms of the invention is described in the Examples section. The second type of analysis determines which form(s) of a characterized (known) polymorphism are present in individuals under test. There are a variety of suitable procedures, which are discussed in turn.

1. Allele-Specific Probes

The design and use of allele-specific probes for analyzing polymorphisms is described by e.g., Saiki et al., Nature 324, 163-166 (1986); Dattagupta, EP 235,726, Saiki, WO 89/11548. Allele-specific probes can be designed that hybridize to a segment of target DNA from one individual but do not hybridize to the corresponding segment from another individual due to the presence of different polymorphic forms in the respective segments from the two individuals. Hybridization conditions should be sufficiently stringent that there is a significant difference in hybridization intensity between alleles, and preferably an essentially binary response, whereby a probe hybridizes to only one of the alleles. Some probes are designed to hybridize to a segment of target DNA such that the polymorphic site aligns with a central position (e.g., in a 15-mer at the 7 position; in a 16-mer, at either the 8 or 9 position) of the probe. This design of probe achieves good discrimination in hybridization between different allelic forms.

Allele-specific probes are often used in pairs, one member of a pair showing a perfect match to a reference form of a target sequence and the other member showing a perfect match to a variant form. Several pairs of probes can then be immobilized on the same support for simultaneous analysis of multiple polymorphisms within the same target sequence.

2. Tiling Arrays

The polymorphisms can also be identified by hybridization to nucleic acid arrays, some examples of which are described in WO 95/11995. One form of such arrays is described in the Examples section in connection with de novo identification of polymorphisms. The same array or a different array can be used for analysis of characterized polymorphisms. WO 95/11995 also describes subarrays that are optimized for detection of a variant form of a precharacterized polymorphism. Such a subarray contains probes designed to be complementary to a second reference sequence, which is an allelic variant of the first reference sequence. The second group of probes is designed by the same principles as described in the Examples, except that the probes exhibit complementarity to the second reference sequence. The inclusion of a second group (or further groups) can be particularly useful for analyzing short subsequences of the primary reference sequence in which multiple mutations are expected to occur within a short distance commensurate with the length of the probes (e.g., two or more mutations within 9 to 21 bases).

3. Allele-Specific Primers

An allele-specific primer hybridizes to a site on target DNA overlapping a polymorphism and only primes amplification of an allelic form to which the primer exhibits perfect complementarity. See Gibbs, Nucleic Acid Res. 17, 2427-2448 (1989). This primer is used in conjunction with a second primer which hybridizes at a distal site. Amplification proceeds from the two primers, resulting in a detectable product which indicates the particular allelic form is present. A control is usually performed with a second pair of primers, one of which shows a single base mismatch at the polymorphic site and the other of which exhibits perfect complementarity to a distal site. The single-base mismatch prevents amplification and no detectable product is formed. The method works best when the mismatch is included in the 3′-most position of the oligonucleotide aligned with the polymorphism because this position is most destabilizing to elongation from the primer (see, e.g., WO 93/22456).

4. Direct-Sequencing

The direct analysis of the sequence of polymorphisms of the present invention can be accomplished using either the dideoxy chain termination method or the Maxam—Gilbert method (see Sambrook et al., Molecular Cloning, A Laboratory Manual (2nd Ed., CSHP, New York 1989); Zyskind et al., Recombinant DNA Laboratory Manual, (Acad. Press, 1988)).

5. Denaturing Gradient Gel Electrophoresis

Amplification products generated using the polymerase chain reaction can be analyzed by the use of denaturing gradient gel electrophoresis. Different alleles can be identified based on the different sequence-dependent melting properties and electrophoretic migration of DNA in solution. Erlich, ed., PCR Technology, Principles and Applications for DNA Amplification, (W. H. Freeman and Co, New York, 1992), Chapter 7.

6. Single-Strand Conformation Polymorphism Analysis Alleles of target sequences can be differentiated using single-strand conformation polymorphism analysis, which identifies base differences by alteration in electrophoretic migration of single stranded PCR products, as described in Orita et at., Proc. Nat. Acad. Sci. 86, 2766-2770 (1989). Amplified PCR products can be generated as described above, and heated or otherwise denatured, to form single stranded amplification products. Single-stranded nucleic acids may refold or form secondary structures which are partially dependent on the base sequence. The different electrophoretic mobilities of single-stranded amplification products can be related to base-sequence differences between alleles of target sequences.

7. Single-Base Extension

An alternative method for identifying and analyzing polymorphisms is based on single-base extension (SBE) of a fluorescently-labeled primer coupled with fluorescence resonance energy transfer (FRET) between the label of the added base and the label of the primer. Typically, the method, such as that described by Chen et al., (PNAS 94:10756-61 (1997), incorporated herein by reference) uses a locus-specific oligonucleotide primer labeled on the 5′ terminus with 5-carboxyfluorescein (FAM). This labeled primer is designed so that the 3′ end is immediately adjacent to the polymorphic site of interest. The labeled primer is hybridized to the locus, and single base extension of the labeled primer is performed with fluorescently labeled dideoxyribonucleotides (ddNTPs) in dye-terminator sequencing fashion, except that no deoxyribonucleotides are present. An increase in fluorescence of the added ddNTP in response to excitation at the wavelength of the labeled primer is used to infer the identity of the added nucleotide.

III. Methods of Use

After determining polymorphic form(s) present in an individual at one or more polymorphic sites, this information can be used in a number of methods.

A. Forensics

Determination of which polymorphic forms occupy a set of polymorphic sites in an individual identifies a set of polymorphic forms that distinguishes the individual. See generally National Research Council, The Evaluation of Forensic DNA Evidence (Eds. Pollard et al., National Academy Press, DC, t996). The more sites that are analyzed, the lower the probability that the set of polymorphic forms in one individual is the same as that in an unrelated individual. Preferably, if multiple sites are analyzed, the sites are unlinked. Thus, polymorphisms of the invention are often used in conjunction with polymorphisms in distal genes. Preferred polymorphisms for use in forensics are biallelic because the population frequencies of two polymorphic forms can usually be determined with greater accuracy than those of multiple polymorphic forms at multi-allelic loci.

The capacity to identify a distinguishing or unique set of forensic markers in an individual is useful for forensic analysis. For example, one can determine whether a blood sample from a suspect matches a blood or other tissue sample from a crime scene by determining whether the set of polymorphic forms occupying selected polymorphic sites is the same in the suspect and the sample. If the set of polymorphic markers does not match between a suspect and a sample, it can be concluded (barring experimental error) that the suspect was not the source of the sample. If the set of markers does match, one can conclude that the DNA from the suspect is consistent with that found at the crime scene. If frequencies of the polymorphic forms at the loci tested have been determined (e.g., by analysis of a suitable population of individuals), one can perform a statistical analysis to determine the probability that a match of suspect and crime scene sample would occur by chance.

p(ID) is the probability that two random individuals have the same polymorphic or allelic form at a given polymorphic site. In biallelic loci, four genotypes are possible: AA, AB, BA, and BB. If alleles A and B occur in a haploid genome of the organism with frequencies x and y, the probability of each genotype in a diploid organism is (see WO 95/12607):

Homozygote: p(AA)=x²

Homozygote: p(BB)=y²=(1−x)²

Single Heterozygote: p(AB)=p(BA)=xy=x(1−x)

Both Heterozygotes: p(AB+BA)=2xy=2x(1−x)

The probability of identity at one locus (i.e, the probability that two individuals, picked at random from a population will have identical polymorphic forms at a given locus) is given by the equation:

p(ID)=(x ²)²+(2xy)²+(y ²)².

These calculations can be extended for any number of polymorphic forms at a given locus. For example, the probability of identity p(ID) for a 3-allele system where the alleles have the frequencies in the population of x, y and z, respectively, is equal to the sum of the squares of the genotype frequencies:

p(ID)=x⁴+(2xy)²+(2yz)²+(2yz)² +z ⁴ +y ⁴

In a locus of n alleles, the appropriate binomial expansion is used to calculate p(ID) and p(exc).

The cumulative probability of identity (cum p(ID)) for each of multiple unlinked loci is determined by multiplying the probabilities provided by each locus.

cum p(ID)=p(ID1)p(ID2)p(ID3) . . . p(IDn)

The cumulative probability of non-identity for n loci (i.e. the probability that two random individuals will be different at 1 or more loci) is given by the equation:

cum p(nonID)=1−cum p(ID).

If several polymorphic loci are tested, the cumulative probability of non-identity for random individuals becomes very high (e.g., one billion to one). Such probabilities can be taken into account together with other evidence in determining the guilt or innocence of the suspect.

B. Paternity Testing

The object of paternity testing is usually to determine whether a male is the father of a child. In most cases, the mother of the child is known and thus, the mother's contribution to the child's genotype can be traced. Paternity testing investigates whether the part of the child's genotype not attributable to the mother is consistent with that of the putative father. Paternity testing can be performed by analyzing sets of polymorphisms in the putative father and the child.

If the set of polymorphisms in the child attributable to the father does not match the set of polymorphisms of the putative father, it can be concluded, barring experimental error, that the putative father is not the real father. If the set of polymorphisms in the child attributable to the father does match the set of polymorphisms of the putative father, a statistical calculation can be performed to determine the probability of coincidental match.

The probability of parentage exclusion (representing the probability that a random male will have a polymorphic form at a given polymorphic site that makes him incompatible as the father) is given by the equation (see WO 95/12607):

p(exc)=xy(1−xy)

where x and y are the population frequencies of alleles A and B of a biallelic polymorphic site.

(At a triallelic site p(exc)=xy(1−xy)+yz(1−yz)+xz(1−xz)+3xyz(1−xyz))), where x, y and z and the respective population frequencies of alleles A, B and C).

The probability of non-exclusion is

p(non-exc)=1−p(exc)

The cumulative probability of non-exclusion (representing the value obtained when n loci are used) is thus:

cum p(non-exc)=p(non-exc1)p(non-exc2)p(non-exc3) . . . p(non-excn)

The cumulative probability of exclusion for n loci (representing the probability that a random male will be excluded) cum p(exc)=1−cum p(non-exc).

If several polymorphic loci are included in the analysis, the cumulative probability of exclusion of a random male is very high. This probability can be taken into account in assessing the liability of a putative father whose polymorphic marker set matches the child's polymorphic marker set attributable to his/her father.

C. Correlation of Polymorphisms with Phenotypic Traits

The polymorphisms of the invention may contribute to the phenotype of an organism in different ways. Some polymorphisms occur within a protein coding sequence and contribute to phenotype by affecting protein structure. The effect may be neutral, beneficial or detrimental, or both beneficial and detrimental, depending on the circumstances. For example, a heterozygous sickle cell mutation confers resistance to malaria, but a homozygous sickle cell mutation is usually lethal. Other polymorphisms occur in noncoding regions but may exert phenotypic effects indirectly via influence on replication, transcription, and translation. A single polymorphism may affect more than one phenotypic trait. Likewise, a single phenotypic trait may be affected by polymorphisms in different genes. Further, some polymorphisms predispose an individual to a distinct mutation that is causally related to a certain phenotype.

Phenotypic traits include diseases that have known but hitherto unmapped genetic components (e.g., agammaglobulimenia, diabetes insipidus, Lesch-Nyhan syndrome, muscular dystrophy, Wiskott-Aldrich syndrome, Fabry's disease, familial hypercholesterolemia, polycystic kidney disease, hereditary spherocytosis, von Willebrand's disease, tuberous sclerosis, hereditary hemorrhagic telangiectasia, familial colonic polyposis, Ehlers-Danlos syndrome, osteogenesis imperfecta, and acute intermittent porphyria). Phenotypic traits also include symptoms of, or susceptibility to, multifactorial diseases of which a component is or may be genetic, such as autoimmune diseases, inflammation, cancer, diseases of the nervous system, and infection by pathogenic microorganisms. Some examples of autoimmune diseases include rheumatoid arthritis, multiple sclerosis, diabetes (insulin-dependent and non-independent), systemic lupus erythematosus and Graves disease. Some examples of cancers include cancers of the bladder, brain, breast, colon, esophagus, kidney, leukemia, liver, lung, oral cavity, ovary, pancreas, prostate, skin, stomach and uterus. Phenotypic traits also include characteristics such as longevity, appearance (e.g., baldness, obesity), strength, speed, endurance, fertility, and susceptibility or receptivity to particular drugs or therapeutic treatments.

The correlation of one or more polymorphisms with phenotypic traits can be facilitated by knowledge of the gene product of the wild type (reference) gene. The genes in which cSNPs of the present invention have been identified are genes which have been previously sequenced and characterized in one of their allelic forms.

Correlation is performed for a population of individuals who have been tested for the presence or absence of a phenotypic trait of interest and for polymorphic markers sets. To perform such analysis, the presence or absence of a set of polymorphisms (i.e. a polymorphic set) is determined for a set of the individuals, some of whom exhibit a particular trait, and some of which exhibit lack of the trait. The alleles of each polymorphism of the set are then reviewed to determine whether the presence or absence of a particular allele is associated with the trait of interest. Correlation can be performed by standard statistical methods such as a U-squared test and statistically significant correlations between polymorphic form(s) and phenotypic characteristics are noted. For example, it might be found that the presence of allele A1 at polymorphism A correlates with heart disease. As a further example, it might be found that the combined presence of allele A1 at polymorphism A and allele B1 at polymorphism B correlates with increased milk production of a farm animal.

Such correlations can be exploited in several ways. In the case of a strong correlation between a set of one or more polymorphic forms and a disease for which treatment is available, detection of the polymorphic form set in a human or animal patient may justify immediate administration of treatment, or at least the institution of regular monitoring of the patient. Detection of a polymorphic form correlated with serious disease in a couple contemplating a family may also be valuable to the couple in their reproductive decisions. For example, the female partner might elect to undergo in vitro fertilization to avoid the possibility of transmitting such a polymorphism from her husband to her offspring. In the case of a weaker, but still statistically significant correlation between a polymorphic set and human disease, immediate therapeutic intervention or monitoring may not be justified. Nevertheless, the patient can be motivated to begin simple life-style changes (e.g., diet, exercise) that can be accomplished at little cost to the patient but confer potential benefits in reducing the risk of conditions to which the patient may have increased susceptibility by virtue of variant alleles. Identification of a polymorphic set in a patient correlated with enhanced receptiveness to one of several treatment regimes for a disease indicates that this treatment regime should be followed.

For animals and plants, correlations between characteristics and phenotype are useful for breeding for desired characteristics. For example, Beitz et al., U.S. Pat. No. 5,292,639 discuss use of bovine mitochondrial polymorphisms in a breeding program to improve milk production in cows. To evaluate the effect of mtDNA D-loop sequence polymorphism on milk production, each cow was assigned a value of 1 if variant or 0 if wildtype with respect to a prototypical mitochondrial DNA sequence at each of 17 locations considered. Each production trait was analyzed individually with the following animal model:

Y _(ijkpn) =μ+YS _(i) +P _(j) +X _(k)β_(l)+ . . . β₁₇ +PE _(n) +a _(n) +e _(p)

where Y_(ijknp) is the milk, fat, fat percentage, SNF, SNF percentage, energy concentration, or lactation energy record; μ is an overall mean; YS_(i) is the effect common to all cows calving in year-season; X_(k) is the effect common to cows in either the high or average selection line; β₁ to β₁₇ are the binomial regressions of production record on mtDNA D-loop sequence polymorphisms; PE_(n) is permanent environmental effect common to all records of cow n; a_(n) is effect of animal n and is composed of the additive genetic contribution of sire and darn breeding values and a Mendelian sampling effect; and e_(p) is a random residual. It was found that eleven of seventeen polymorphisms tested influenced at least one production trait. Bovines having the best polymorphic forms for milk production at these eleven loci are used as parents for breeding the next generation of the herd.

D. Genetic Mapping of Phenotypic Traits

The previous section concerns identifying correlations between phenotypic traits and polymorphisms that directly or indirectly contribute to those traits. The present section describes identification of a physical linkage between a genetic locus associated with a trait of interest and polymorphic markers that are not associated with the trait, but are in physical proximity with the genetic locus responsible for the trait and co-segregate with it. Such analysis is useful for mapping a genetic locus associated with a phenotypic trait to a chromosomal position, and thereby cloning gene(s) responsible for the trait. See Lander et al., Proc. Natl. Acad. Sci. (USA) 83, 7353-7357 (1986); Lander et al., Proc. Natl. Acad. Sci. (USA) 84, 2363-2367 (1987); Donis-Keller et al., Cell 51, 319-337 (1987); Lander et al., Genetics 121, 185-199 (1989)). Genes localized by linkage can be cloned by a process known as directional cloning. See Wainwright, Med. J. Australia 159, 170-174 (1993); Collins, Nature Genetics 1,3-6 (1992).

Linkage studies are typically performed on members of a family. Available members of the family are characterized for the presence or absence of a phenotypic trait and for a set of polymorphic markers. The distribution of polymorphic markers in an informative meiosis is then analyzed to determine which polymorphic markers co-segregate with a phenotypic trait. See, e.g., Kerem et al., Science 245, 1073-1080 (1989); Monaco et al., Nature 316, 842 (1985); Yamoka et al., Neurology 40, 222-226 (1990); Rossiter et al., FASEB Journal 5, 21-27 (1991).

Linkage is analyzed by calculation of LOD (log of the odds) values. A lod value is the relative likelihood of obtaining observed segregation data for a marker and a genetic locus when the two are located at a recombination fraction θ, versus the situation in which the two are not linked, and thus segregating independently (Thompson & Thompson, Genetics in Medicine (5th ed, W. B. Saunders Company, Philadelphia, 1991); Strachan, “Mapping the human genome” in The Human Genome (BIOS Scientific Publishers Ltd, Oxford), Chapter 4). A series of likelihood ratios are calculated at various recombination fractions (θ), ranging from θ=0.0 (coincident loci) to θ=0.50 (unlinked). Thus, the likelihood at a given value of θ is: probability of data if loci linked at θ to probability of data if loci unlinked. The computed likelihoods are usually expressed as the log₁₀ of this ratio (i.e., a lod score). For example, a lod score of 3 indicates 1000:1 odds against an apparent observed linkage being a coincidence. The use of logarithms allows data collected from different families to be combined by simple addition. Computer programs are available for the calculation of lod scores for differing values of θ (e.g., LIPED, MLINK (Lathrop, Proc. Nat. Acad. Sci. (USA) 81, 3443-3446 (1984)). For any particular lod score, a recombination fraction may be determined from mathematical tables. See Smith et al., Mathematical tables for research workers in human genetics (Churchill, London, 1961); Smith, Ann. Hum. Genet. 32, 127-150(1968). The value of θ at which the lod score is the highest is considered to be the best estimate of the recombination fraction.

Positive lod score values suggest that the two loci are linked, whereas negative values suggest that linkage is less likely (at that value of θ) than the possibility that the two loci are unlinked. By convention, a combined lod score of +3 or greater (equivalent to greater than 1000:1 odds in favor of linkage) is considered definitive evidence that two loci are linked. Similarly, by convention, a negative lod score of −2 or less is taken as definitive evidence against linkage of the two loci being compared. Negative linkage data are useful in excluding a chromosome or a segment thereof from consideration. The search focuses on the remaining non-excluded chromosomal locations.

IV. Modified Polypeptides and Gene Sequences

The invention further provides variant forms of nucleic acids and corresponding proteins. The nucleic acids comprise one of the sequences described in the Table, column 5, in which the polymorphic position is occupied by one of the alternative bases for that position. Some nucleic acids encode full-length variant forms of proteins. Similarly, variant proteins have the prototypical amino acid sequences encoded by nucleic acid sequences shown in the Table, column 5, (read so as to be in-frame with the full-length coding sequence of which it is a component) except at an amino acid encoded by a codon including one of the polymorphic positions shown in the Table. That position is occupied by the amino acid coded by the corresponding codon in any of the alternative forms shown in the Table.

Variant genes can be expressed in an expression vector in which a variant gene is operably linked to a native or other promoter. Usually, the promoter is a eucaryotic promoter for expression in a mammalian cell. The transcription regulation sequences typically include a heterologous promoter and optionally an enhancer which is recognized by the host. The selection of an appropriate promoter, for example trp, lac, phage promoters, glycolytic enzyme promoters and tRNA promoters, depends on the host selected. Commercially available expression vectors can be used. Vectors can include host-recognized replication systems, amplifiable genes, selectable markers, host sequences useful for insertion into the host genome, and the like.

The means of introducing the expression construct into a host cell varies depending upon the particular construction and the target host. Suitable means include fusion, conjugation, transfection, transduction, electroporation or injection, as described in Sambrook, supra. A wide variety of host cells can be employed for expression of the variant gene, both prokaryotic and eukaryotic. Suitable host cells include bacteria such as E. coli, yeast, filamentous fungi, insect cells, mammalian cells, typically immortalized, e.g., mouse, CHO, human and monkey cell lines and derivatives thereof Preferred host cells are able to process the variant gene product to produce an appropriate mature polypeptide. Processing includes glycosylation, ubiquitination, disulfide bond formation, general post-translational modification, and the like. As used herein, “gene product” includes mRNA, peptide and protein products.

The protein may be isolated by conventional means of protein biochemistry and purification to obtain a substantially pure product, i.e., 80, 95 or 99% free of cell component contaminants, as described in Jacoby, Methods in Enzymology Volume 104, Academic Press, New York (1984); Scopes, Protein Purification, Principles and Practice, 2nd Edition, Springer-Verlag, New York (1987); and Deutscher (ed), Guide to Protein Purification, Methods in Enzymology, Vol. 182 (1990). If the protein is secreted, it can be isolated from the supernatant in which the host cell is grown. If not secreted, the protein can be isolated from a lysate of the host cells.

The invention further provides transgenic nonhuman animals capable of expressing an exogenous variant gene and/or having one or both alleles of an endogenous variant gene inactivated. Expression of an exogenous variant gene is usually achieved by operably linking the gene to a promoter and optionally an enhancer, and microinjecting the construct into a zygote. See Hogan et al., “Manipulating the Mouse Embryo, A Laboratory Manual,” Cold Spring Harbor Laboratory. Inactivation of endogenous variant genes can be achieved by forming a transgene in which a cloned variant gene is inactivated by insertion of a positive selection marker. See Capecchi, Science 244, 1288-1292 (1989). The transgene is then introduced into an embryonic stem cell, where it undergoes homologous recombination with an endogenous variant gene. Mice and other rodents are preferred animals. Such animals provide useful drug screening systems.

In addition to substantially full-length polypeptides expressed by variant genes, the present invention includes biologically active fragments of the polypeptides, or analogs thereof, including organic molecules which simulate the interactions of the peptides. Biologically active fragments include any portion of the full-length polypeptide which confers a biological function on the variant gene product, including ligand binding, and antibody binding. Ligand binding includes binding by nucleic acids, proteins or polypeptides, small biologically active molecules, or large cellular structures.

Polyclonal and/or monoclonal antibodies that specifically bind to variant gene products but not to corresponding prototypical gene products are also provided. Antibodies can be made by injecting mice or other animals with the variant gene product or synthetic peptide fragments thereof Monoclonal antibodies are screened as are described, for example, in Harlow & Lane, Antibodies, A Laboratory Manual, Cold Spring Harbor Press, New York (1988); Goding, Monoclonal antibodies, Principles and Practice (2d ed.) Academic Press, New York (1986). Monoclonal antibodies are tested for specific immunoreactivity with a variant gene product and lack of immunoreactivity to the corresponding prototypical gene product. These antibodies are useful in diagnostic assays for detection of the variant form, or as an active ingredient in a pharmaceutical composition.

V. Kits

The invention further provides kits comprising at least one allele-specific oligonucleotide as described herein. Often, the kits contain one or more pairs of allele-specific oligonucleotides hybridizing to different forms of a polymorphism. In some kits, the allele-specific oligonucleotides are provided immobilized to a substrate. For example, the same substrate can comprise allele-specific oligonucleotide probes for detecting at least 10, 100 or all of the polymorphisms shown in the Table. Optional additional components of the kit include, for example, restriction enzymes, reverse-transcriptase or polymerase, the substrate nucleoside triphosphates, means used to label (for example, an avidin-enzyme conjugate and enzyme substrate and chromogen if the label is biotin), and the appropriate buffers for reverse transcription, PCR, or hybridization reactions. Usually, the kit also contains instructions for carrying out the methods.

The thrombospondins are a family of extracellular matrix (ECM) glycoproteins that modulate many cell behaviors including adhesion, migration, and proliferation. Thrombospondins (also known as thrombin sensitive proteins or TSPs) are large molecular weight glycoproteins composed of three identical disulfide-linked polypeptide chains. TSPs are stored in the alpha-granules of platelets and secreted by a variety of mesenchymal and epithelial cells (Majack et al., Cell Membrane 3:57-77 (1987)). Platelets secrete TSPs when activated in the blood by such physiological agonists such as thrombin. TSPs have lectin properties and a broad function in the regulation of fibrinolysis and as a component of the ECM, and are one of a group of ECM proteins which have adhesive properties. TSPs bind to fibronectin and fibrinogen (Lahav et al., Eur J Biochem 145:151-6 (1984)), and these proteins are known to be involved in platelet adhesion to substratum and platelet aggregation (Leung, J Clin Invest 74:1764-1772 (1986)).

Recent work has implicated TSPs in response of cells to growth factors. Submitogenic doses of PDGF induce a rapid but transitory, increase in TSP synthesis and secretion by rat aortic smooth muscle cells (Majack et al., J Biol Chem 101:1059-70 (1985)). PDGF responsiveness to TSP synthesis in glial cells has also been shown (Asch et al, Proc Natl Acad Sci 83:2904-8 (1986)). TSP mRNA levels rise rapidly in response to PDGF (Majack et al., J Biol Chem 262:8821-5 (1987)). TSPs act synergistically with epidermal growth factor to increase DNA synthesis in smooth muscle cells (Majack et al., Proc Natl Acad Sci 83:9050-4 (1986)), and monoclonal antibodies to TSPs inhibit smooth muscle cell proliferation (Majack et al., J Biol Chem 106:415-22 (1988)). TSPs modulate local adhesions in endothelial cells, and TSPs, particularly TSP-1 primarily derived from platelet granules, are known to be an important activator of transforming growth factor beta-1 (TGFB-1) (Crawford et al., Cell 93:1159 (1998)) and appear to be a potential link between platelet-thrombosis and development of atherosclerosis.

To determine pivotal genes associated with premature coronary artery disease, we analyzed DNA from 347 patients with MI or coronary revascularization before age 40 (men) or 45 (women) and 422 general population controls. Cases were drawn (one per family) from a retrospective collection of sibling pairs with premature CAD. Controls were ascertained through random-digit dialing. Both cases and controls were Caucasian. A complete database of phenotypic and laboratory variables for the affected patients afforded logistic regression to control for age, diabetes, body mass index, gender.

Thrombospondin (TSP) 4 and 1 emerged as important SNPs associated with premature CAD and MI. For CAD, 148 of 347 patients carried at least one copy of the TSP-4 variant compared with 142 of 422 control subjects; adjusted odds ratio 1.47, p=0.01. For premature MI, the association was even stronger: 91 of 187 cases vs. 142 of 422 controls had the variant; adjusted odds ratio 2.08, p=0.0003. The TSP-1 SNP was rare. Nonetheless, homozygosity for the variant allele gave an adjusted odds ratio of 9.5, p=0.04.

Specific reference nucleotide (SEQ ID NO: 1) and amino acid (SEQ ID NO: 2) sequences for TSP-1 are shown in FIGS. 1A-1D. Specific reference nucleotide (SEQ ID NO: 3) and amino acid (SEQ ID NO: 4) sequences for TSP-4 are shown in FIGS. 2A-2C. It is understood that the invention is not limited by these exemplified reference sequences, as variants of these sequences which differ at locations other than the SNP sites identified herein can also be utilized. The skilled artisan can readily determine the SNP sites in these other reference sequences which correspond to the SNP sites identified herein by aligning the sequence of interest with the reference sequences specifically disclosed herein, and programs for performing such alignments are commercially available. For example, the ALIGN program in the GCG software package can be used, utilizing a PAM120 weight residue table, a gap length penalty of 12 and a gap penalty of 4, for example.

Two SNPs have been specifically studied as described herein. The first (G334u4) is a change from A (reference nucleotide) to G (alternate or variant nucleotide) at nucleotide position 2210 of the nucleic acid sequence of TSP-1 (FIGS. 1A-1D), resulting in a missense amino acid mutation from asparagine (reference) to serine (alternate) at amino acid 700. The second SNP (G355u2) is a change from G (reference) to C (alternate) at nucleotide position 1186 of the nucleic acid sequence of TSP-4 (FIGS. 2A-2C), resulting in a missense amino acid alteration from alanine (reference) to proline (alternate) at amino acid 387. With respect to the G355u2 SNP, individuals with CAD carried at least one copy of the variant “C” allele more frequently than control individuals (43% as compared with 34%). With respect to the G355u2 SNP, individuals with MI carried at least one copy of the variant “C” allele more frequently than control individuals (49% as compared with 34%). With respect to the G334u4 SNP, individuals with CAD carried two copies of the variant “G” allele more frequently than control individuals (1.7% as compared with 0.2%). With respect to the G334u4 SNP, individuals with MI carried two copies of the variant “G” allele more frequently than control individuals (2% as compared with 0.2%).

As used herein, the term “polymorphism” refers to the occurrence of two or more genetically determined alternative sequences or alleles in a population. A polymorphic marker or site is the locus at which divergence occurs. Preferred markers have at least two alleles, each occurring at frequency of greater than 1%, and more preferably greater than 10% or 20% of a selected population. A polymorphic locus may be as small as one base pair, in which case it is referred to as a single nucleotide polymorphism (SNP).

Thus, the invention relates to a method for predicting the likelihood that an individual will have a vascular disease, or for aiding in the diagnosis of a vascular disease, or predicting the likelihood of having altered symptomology associated with a vascular disease, comprising the steps of obtaining a DNA sample from an individual to be assessed and determining the nucleotide present at one or more of nucleotide positions 2210 of the TSP-1 gene or 1186 of the TSP-4 gene. In a preferred embodiment, the nucleotides present at both of these nucleotide positions are determined. In one embodiment the TSP-1 gene has the nucleotide sequence of SEQ ID NO: 1 and the TSP-4 gene has the nucleotide sequence of SEQ ID NO: 3. The presence of one or more of a G (the variant nucleotide) at position 2210 of SEQ ID NO: 1 or a C (the variant nucleotide) at position 1186 of SEQ ID NO: 1186 indicates that the individual has a greater likelihood of having a vascular disease, or a greater likelihood of having severe symptomology associated with a vascular disease, than if that individual had the reference nucleotide at one or more of these positions. Conversely, the presence of one or more of an A (the reference nucleotide) at position 2210 of SEQ ID NO: 1 or a G (the reference nucleotide) at position 1186 of SEQ ID NO: 3 indicates that the individual has a reduced likelihood of having a vascular disease or a likelihood of having reduced symptomology associated with a vascular disease than if that individual had the variant nucleotide at one or more of these positions.

In a particular embodiment, the individual is an individual at risk for development of a vascular disease. In another embodiment the individual exhibits clinical symptomology associated with a vascular disease. In one embodiment, the individual has been clinically diagnosed as having a vascular disease. Vascular diseases include, but are not limited to, atherosclerosis, coronary heart disease, myocardial infarction (MI), stroke, peripheral vascular diseases, venous thromboembolism and pulmonary embolism. In preferred embodiments, the vascular disease is CAD or MI.

The genetic material to be assessed can be obtained from any nucleated cell from the individual. For assay of genomic DNA, virtually any biological sample (other than pure red blood cells) is suitable. For example, convenient tissue samples include whole blood, semen, saliva, tears, urine, fecal material, sweat, skin and hair. For assay of cDNA or mRNA, the tissue sample must be obtained from a tissue or organ in which the target nucleic acid is expressed.

Many of the methods described herein require amplification of DNA from target samples. This can be accomplished by e.g., PCR. See generally PCR Technology: Principles and Applications for DNA Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992); PCR Protocols: A Guide to Methods and Applications (eds. Innis, et al., Academic Press, San Diego, Calif., 1990); Mattila et al., Nucleic Acids Res. 19, 4967 (1991); Eckert et al., PCR Methods and Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press, Oxford); and U.S. Pat. No. 4,683,202.

Other suitable amplification methods include the ligase chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989), Landegren et al., Science 241, 1077 (1988), transcription amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173 (1989)), and self-sustained sequence replication (Guatelli et al., Proc. Nat. Acad. Sci. USA, 87, 1874 (1990)) and nucleic acid based sequence amplification (NASBA). The latter two amplification methods involve isothermal reactions based on isothermal transcription, which produce both single stranded RNA (ssRNA) and double stranded DNA (dsDNA) as the amplification products in a ratio of about 30 or 100 to 1, respectively.

The nucleotide which occupies the polymorphic site of interest (e.g., nucleotide position 2210 in TSP-1 and/or nucleotide position 1186 in TSP-4) can be identified by a variety of methods, such as Southern analysis of genomic DNA; direct mutation analysis by restriction enzyme digestion; Northern analysis of RNA; denaturing high pressure liquid chromatography (DHPLC); gene isolation and sequencing; hybridization of an allele-specific oligonucleotide with amplified gene products; single base extension (SBE). In a preferred embodiment, determination of the allelic form of TSP is carried out using SBE-FRET methods as described herein, or using chip-based oligonucleotide arrays as described herein.

The invention also relates to a method for predicting the likelihood that an individual will have a vascular disease, or for aiding in the diagnosis of a vascular disease, or predicting the likelihood of having altered symptomology associated with a vascular disease, comprising the steps of obtaining a biological sample comprising TSP-1 and/or TSP-4 protein or relevant portion thereof from an individual to be assessed and determining the amino acid present at one or more of amino acid positions 700 of the TSP-1 gene product (e.g., as exemplified by SEQ ID NO: 2) or 387 of the TSP-4 gene product (e.g., as exemplified by SEQ ID NO: 4). In a preferred embodiment, the amino acids present at both of these amino acid positions are determined. As used herein, the term “relevant portion” of the TSP-1 and TSP-4 proteins is intended to encompass any portion of the protein which comprises the polymorphic amino acid positions. The presence of one or more of a serine (the variant amino acid) at position 700 of SEQ ID NO: 2, or a proline (the variant amino acid) at position 387 of SEQ ID NO: 4 indicates that the individual has a greater likelihood of having a vascular disease, or a greater likelihood of having severe symptomology associated with a vascular disease, than if that individual had the reference amino acid at one or more of these positions. Conversely, the presence of one or more of an asparagine (the reference amino acid) at position 700 of SEQ ID NO: 2, or an alanine (the reference amino acid) at position 387 of SEQ ID NO: 4 indicates that the individual has a reduced likelihood of having a vascular disease or a likelihood of having reduced symptomology associated with a vascular disease, than if that individual had the varaint amino acid at one or more of these positions.

In a particular embodiment, the individual is an individual at risk for development of a vascular disease. In another embodiment the individual exhibits clinical symptomology associated with a vascular disease. In one embodiment, the individual has been clinically diagnosed as having a vascular disease.

In this embodiment of the invention, the biological sample contains protein molecules from the test subject. In vitro techniques for detection of protein include enzyme linked immunosorbent assays (ELISAs), Western blots, immunoprecipitations and immunofluorescence. Furthermore, in vivo techniques for detection of protein include introducing into a subject a labeled anti-protein antibody. For example, the antibody can be labeled with a radioactive marker whose presence and location in a subject can be detected by standard imaging techniques. Polyclonal and/or monoclonal antibodies that specifically bind to variant gene products but not to corresponding reference gene products, and vice versa, are also provided. Antibodies can be made by injecting mice or other animals with the variant gene product or synthetic peptide fragments thereof comprising the variant portion. Monoclonal antibodies are screened as are described, for example, in Harlow & Lane, Antibodies, A Laboratory Manual, Cold Spring Harbor Press, New York (1988); Goding, Monoclonal antibodies, Principles and Practice (2d ed.) Academic Press, New York (1986). Monoclonal antibodies are tested for specific immunoreactivity with a variant gene product and lack of immunoreactivity to the corresponding prototypical gene product. These antibodies are useful in diagnostic assays for detection of the variant form, or as an active ingredient in a pharmaceutical composition.

The polymorphisms of the invention may be associated with vascular disease in different ways. The polymorphisms may exert phenotypic effects indirectly via influence on replication, transcription, and translation. Additionally, the described polymorphisms may predispose an individual to a distinct mutation that is causally related to a certain phenotype, such as susceptibility or resistance to vascular disease and related disorders. The discovery of the polymorphisms and their correlation with CAD and MI facilitates biochemical analysis of the variant and reference forms and the development of assays to characterize the variant and reference forms and to screen for pharmaceutical agents that interact directly with one or another form of the protein.

Alternatively, these particular polymorphisms may belong to a group of two or more polymorphisms in the TSP gene(s) which contributes to the presence, absence or severity of vascular disease. An assessment of other polymorphisms within the TSP gene(s) can be undertaken, and the separate and combined effects of these polymorphisms, as well as alternations in other, distinct genes, on the vascular disease phenotype can be assessed.

Correlation between a particular phenotype, e.g., the CAD or MI phenotype, and the presence or absence of a particular allele is performed for a population of individuals who have been tested for the presence or absence of the phenotype. Correlation can be performed by standard statistical methods such as a Chi-squared test and statistically significant correlations between polymorphic form(s) and phenotypic characteristics are noted. This correlation can be exploited in several ways. In the case of a strong correlation between a particular polymorphic form, e.g., the variant allele for TSP-1 and/or TSP-4, and a disease for which treatment is available, detection of the polymorphic form in an individual may justify immediate administration of treatment, or at least the institution of regular monitoring of the individual. Detection of a polymorphic form correlated with a disorder in a couple contemplating a family may also be valuable to the couple in their reproductive decisions. For example, the female partner might elect to undergo in vitro fertilization to avoid the possibility of transmitting such a polymorphism from her husband to her offspring. In the case of a weaker, but still statistically significant correlation between a polymorphic form and a particular disorder, immediate therapeutic intervention or monitoring may not be justified. Nevertheless, the individual can be motivated to begin simple life-style changes (e.g., diet modification, therapy or counseling) that can be accomplished at little cost to the individual but confer potential benefits in reducing the risk of conditions to which the individual may have increased susceptibility by virtue of the particular allele. Furthermore, identification of a polymorphic form correlated with enhanced receptiveness to one of several treatment regimes for a disorder indicates that this treatment regimen should be followed for the individual in question.

Furthermore, it may be possible to identify a physical linkage between a genetic locus associated with a trait of interest (e.g., CAD or MI) and polymorphic markers that are or are not associated with the trait, but are in physical proximity with the genetic locus responsible for the trait and co-segregate with it. Such analysis is useful for mapping a genetic locus associated with a phenotypic trait to a chromosomal position, and thereby cloning gene(s) responsible for the trait. See Lander et al., Proc. Natl. Acad. Sci. (USA) 83, 7353-7357 (1986); Lander et al., Proc. Natl. Acad. Sci. (USA) 84, 2363-2367 (1987); Donis-Keller et al., Cell 51, 319-337 (1987); Lander et al., Genetics 121, 185-199 (1989)). Genes localized by linkage can be cloned by a process known as directional cloning. See Wainwright, Med. J Australia 159, 170-174 (1993); Collins, Nature Genetics 1,3-6 (1992). Linkage studies are discussed in more detail above.

In another embodiment, the invention relates to pharmaceutical compositions comprising a reference TSP-1 and/or TSP-4 gene or gene product for use in the treatment of vascular disease, e.g., CAD and MI. As used herein, a reference TSP gene product is intended to mean gene products which are encoded by the reference allele of the TSP gene. In addition to substantially full-length polypeptides expressed by the genes, the present invention includes biologically active fragments of the polypeptides, or analogs thereof, including organic molecules which simulate the interactions of the peptides. Biologically active fragments include any portion of the full-length polypeptide which confers a biological function on the variant gene product, including ligand binding, and antibody binding. Ligand binding includes binding by nucleic acids, proteins or polypeptides, small biologically active molecules, or large cellular structures.

For instance, the polypeptide or protein, or fragment thereof, of the present invention can be formulated with a physiologically acceptable medium to prepare a pharmaceutical composition. The particular physiological medium may include, but is not limited to, water, buffered saline, polyols (e.g., glycerol, propylene glycol, liquid polyethylene glycol) and dextrose solutions. The optimum concentration of the active ingredient(s) in the chosen medium can be determined empirically, according to procedures well known to medicinal chemists, and will depend on the ultimate pharmaceutical formulation desired. Methods of introduction of exogenous peptides at the site of treatment include, but are not limited to, intradermal, intramuscular, intraperitoneal, intravenous, subcutaneous, oral and intranasal. Other suitable methods of introduction can also include rechargeable or biodegradable devices and slow release polymeric devices. The pharmaceutical compositions of this invention can also be administered as part of a combinatorial therapy with other agents and treatment regimens.

The invention further pertains to compositions, e.g., vectors, comprising a nucleotide sequence encoding reference or variant TSP-1 and/or TSP-4 gene products. For example, reference genes can be expressed in an expression vector in which a reference gene is operably linked to a native or other promoter. Usually, the promoter is a eukaryotic promoter for expression in a mammalian cell. The transcription regulation sequences typically include a heterologous promoter and optionally an enhancer which is recognized by the host. The selection of an appropriate promoter, for example trp, lac, phage promoters, glycolytic enzyme promoters and tRNA promoters, depends on the host selected. Commercially available expression vectors can be used. Vectors can include host-recognized replication systems, amplifiable genes, selectable markers, host sequences useful for insertion into the host genome, and the like.

The means of introducing the expression construct into a host cell varies depending upon the particular construction and the target host. Suitable means include fusion, conjugation, transfection, transduction, electroporation or injection, as described in Sambrook, supra. A wide variety of host cells can be employed for expression of the variant gene, both prokaryotic and eukaryotic. Suitable host cells include bacteria such as E. coli, yeast, filamentous fungi, insect cells, mammalian cells, typically immortalized, e.g., mouse, CHO, human and monkey cell lines and derivatives thereof Preferred host cells are able to process the variant gene product to produce an appropriate mature polypeptide. Processing includes glycosylation, ubiquitination, disulfide bond formation, general post-translational modification, and the like.

It is also contemplated that cells can be engineered to express the reference allele of the invention by gene therapy methods. For example, DNA encoding the reference TSP gene product, or an active fragment or derivative thereof, can be introduced into an expression vector, such as a viral vector, and the vector can be introduced into appropriate cells in an animal. In such a method, the cell population can be engineered to inducibly or constitutively express active reference TSP gene product. In a preferred embodiment, the vector is delivered to the bone marrow, for example as described in Corey et al. (Science 244:1275-1281(1989)).

The invention further relates to the use of compositions (i.e., agonists) which enhance or increase the activity of the reference (or variant) TSP (e.g., TSP-1 or TSP-4) gene product, or a functional portion thereof, for use in the treatment of vascular disease. The invention also relates to the use of compositions (i.e., antagonists) which reduce or decrease the activity of the variant (or reference) TSP (e.g., TSP-1 or TSP-4) gene product, or a functional portion thereof, for use in the treatment of vascular disease.

The invention also relates to constructs which comprise a vector into which a sequence of the invention has been inserted in a sense or antisense orientation. For example, a vector comprising a nucleotide sequence which is antisense to the variant TSP-1 or TSP-4 allele may be used as an antagonist of the activity of the TSP-1 or TSP-4 variant allele. Alternatively, a vector comprising a nucleotide sequence of the TSP-1 or TSP-4 reference allele may be used therapeutically to treat vascular diseases. As used herein, the term “vector” refers to a nucleic acid molecule capable of transporting another nucleic acid to which it has been linked. One type of vector is a “plasmid”, which refers to a circular double stranded DNA loop into which additional DNA segments can be ligated. Another type of vector is a viral vector, wherein additional DNA segments can be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell into which they are introduced (e.g., bacterial vectors having a bacterial origin of replication and episomal mammalian vectors). Other vectors (e.g., non-episomal mammalian vectors) are integrated into the genome of a host cell upon introduction into the host cell, and thereby are replicated along with the host genome. Moreover, certain vectors, expression vectors, are capable of directing the expression of genes to which they are operably linked. In general, expression vectors of utility in recombinant DNA techniques are often in the form of plasmids (vectors). However, the invention is intended to include such other forms of expression vectors, such as viral vectors (e.g., replication defective retroviruses, adenoviruses and adeno-associated viruses) that serve equivalent functions.

Preferred recombinant expression vectors of the invention comprise a nucleic acid of the invention in a form suitable for expression of the nucleic acid in a host cell. This means that the recombinant expression vectors include one or more regulatory sequences, selected on the basis of the host cells to be used for expression, which is operably linked to the nucleic acid sequence to be expressed. Within a recombinant expression vector, “operably linked” is intended to mean that the nucleotide sequence of interest is linked to the regulatory sequence(s) in a manner which allows for expression of the nucleotide sequence (e.g., in an in vitro transcription/translation system or in a host cell when the vector is introduced into the host cell). The term “regulatory sequence” is intended to include promoters, enhancers and other expression control elements (e.g., polyadenylation signals). Such regulatory sequences are described, for example, in Goeddel, Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, Calif. (1990). Regulatory sequences include those which direct constitutive expression of a nucleotide sequence in many types of host cell and those which direct expression of the nucleotide sequence only in certain host cells (e.g., tissue-specific regulatory sequences). It will be appreciated by those skilled in the art that the design of the expression vector can depend on such factors as the choice of the host cell to be transformed, the level of expression of protein desired, etc.

The expression vectors of the invention can be introduced into host cells to thereby produce proteins or peptides, including fusion proteins or peptides, encoded by nucleic acids as described herein. The recombinant expression vectors of the invention can be designed for expression of a polypeptide of the invention in prokaryotic or eukaryotic cells, e.g., bacterial cells such as E. coli, insect cells (using baculovirus expression vectors), yeast cells or mammalian cells. Suitable host cells are discussed further in Goeddel, supra. Alternatively, the recombinant expression vector can be transcribed and translated in vitro, for example using T7 promoter regulatory sequences and T7 polymerase.

Another aspect of the invention pertains to host cells into which a recombinant expression vector of the invention has been introduced. The terms “host cell” and “recombinant host cell” are used interchangeably herein. It is understood that such terms refer not only to the particular subject cell but also to the progeny or potential progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein. A host cell can be any prokaryotic or eukaryotic cell. For example, a nucleic acid of the invention can be expressed in bacterial cells (e.g., E. coli), insect cells, yeast or mammalian cells (such as Chinese hamster ovary cells (CHO) or COS cells). Other suitable host cells are known to those skilled in the art.

Vector DNA can be introduced into prokaryotic or eukaryotic cells via conventional transformation or transfection techniques. As used herein, the terms “transformation” and “transfection” are intended to refer to a variety of art-recognized techniques for introducing foreign nucleic acid (e.g., DNA) into a host cell, including calcium phosphate or calcium chloride co-precipitation, DEAB-dextran-mediated transfection, lipofection, or electroporation. Suitable methods for transforming or transfecting host cells can be found in Sambrook, et al (supra), and other laboratory manuals.

A host cell of the invention, such as a prokaryotic or eukaryotic host cell in culture, can be used to produce (i.e., express) a polypeptide of the invention. Accordingly, the invention further provides methods for producing a polypeptide using the host cells of the invention. In one embodiment, the method comprises culturing the host cell of the invention (into which a recombinant expression vector encoding a polypeptide of the invention has been introduced) in a suitable medium such that the polypeptide is produced. In another embodiment, the method further comprises isolating the polypeptide from the medium or the host cell.

The host cells of the invention can also be used to produce nonhuman transgenic animals. For example, in one embodiment, a host cell of the invention is a fertilized oocyte or an embryonic stem cell into which a nucleic acid of the invention has been introduced. Such host cells can then be used to create non-human transgenic animals in which exogenous nucleotide sequences have been introduced into their genome or homologous recombinant animals in which endogenous nucleotide sequences have been altered. Such animals are useful for studying the function and/or activity of the nucleotide sequence and polypeptide encoded by the sequence and for identifying and/or evaluating modulators of their activity. As used herein, a “transgenic animal” is a non-human animal, preferably a mammal, more preferably a rodent such as a rat or mouse, in which one or more of the cells of the animal includes a transgene. Other examples of transgenic animals include non-human primates, sheep, dogs, cows, goats, chickens, amphibians, etc. A transgene is exogenous DNA which is integrated into the genome of a cell from which a transgenic animal develops and which remains in the genome of the mature animal, thereby directing the expression of an encoded gene product in one or more cell types or tissues of the transgenic animal. As used herein, an “homologous recombinant animal” is a non-human animal, preferably a mammal, more preferably a mouse, in which an endogenous gene has been altered by homologous recombination between the endogenous gene and an exogenous DNA molecule introduced into a cell of the animal, e.g., an embryonic cell of the animal, prior to development of the animal.

A transgenic animal of the invention can be created by introducing a nucleic acid of the invention into the male pronuclei of a fertilized oocyte, e.g., by microinjection, retroviral infection, and allowing the oocyte to develop in a pseudopregnant female foster animal. The sequence can be introduced as a transgene into the genome of a non-human animal. Intronic sequences and polyadenylation signals can also be included in the transgene to increase the efficiency of expression of the transgene. A tissue-specific regulatory sequence(s) can be operably linked to the transgene to direct expression of a polypeptide in particular cells. Methods for generating transgenic animals via embryo manipulation and microinjection, particularly animals such as mice, have become conventional in the art and are described, for example, in U.S. Pat. Nos. 4,736,866 and 4,870,009, U.S. Pat. No. 4,873,191 and in Hogan, Manipulating the Mouse Embryo (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1986). Similar methods are used for production of other transgenic animals. A transgenic founder animal can be identified based upon the presence of the transgene in its genome and/or expression of mRNA in tissues or cells of the animals. A transgenic founder animal can then be used to breed additional animals carrying the transgene. Moreover, transgenic animals carrying a transgene encoding the transgene can further be bred to other transgenic animals carrying other transgenes.

The invention also relates to the use of the variant and reference gene products to guide efforts to identify the causative mutation for vascular diseases or to identify or synthesize agents useful in the treatment of vascular diseases, e.g., CAD and MI. Amino acids that are essential for function can be identified by methods known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham et al., Science, 244:1081-1085 (1989)). The latter procedure introduces single alanine mutations at every residue in the molecule. The resulting mutant molecules are then tested for biological activity in vitro, or in vitro activity. Sites that are critical for polypeptide activity can also be determined by structural analysis such as crystallization, nuclear magnetic resonance or photoaffinity labeling (Smith et al, J Mol. Biol., 224:899-904 (1992); de Vos et al. Science, 255:306-312 (1992)).

Another aspect of the invention pertains to monitoring the influence of agents (e.g., drugs, compounds) on the expression or activity of proteins of the invention in clinical trials. An exemplary method for detecting the presence or absence of proteins or nucleic acids of the invention in a biological sample involves obtaining a biological sample from a test subject and contacting the biological sample with a compound or an agent capable of detecting the protein, or nucleic acid (e.g., mRNA, genomic DNA) that encodes the protein, such that the presence of the protein or nucleic acid is detected in the biological sample. A preferred agent for detecting mRNA or genomic DNA is a labeled nucleic acid probe capable of hybridizing to mRNA or genomic DNA sequences described herein, preferably in an allele-specific manner. The nucleic acid probe can be, for example, a full-length nucleic acid, or a portion thereof, such as an oligonucleotide of at least 15, 30, 50, 100, 250 or 500 nucleotides in length and sufficient to specifically hybridize under stringent conditions to appropriate mRNA or genomic DNA. Other suitable probes for use in the diagnostic assays of the invention are described herein.

The invention also encompasses kits for detecting the presence of proteins or nucleic acid molecules of the invention in a biological sample. For example, the kit can comprise a labeled compound or agent (e.g., nucleic acid probe) capable of detecting protein or mRNA in a biological sample; means for determining the amount of protein or mRNA in the sample; and means for comparing the amount of protein or mRNA in the sample with a standard. The compound or agent can be packaged in a suitable container. The kit can further comprise instructions for using the kit to detect protein or nucleic acid.

The following Examples are offered for the purpose of illustrating the present invention and are not to be construed to limit the scope of this invention. The teachings of all references cited herein are hereby incorporated herein by reference.

EXAMPLES

Identification of Single Nucleotide Polymorphisms

The polymorphisms shown in the Table were identified by resequencing of target sequences from individuals of diverse ethnic and geographic backgrounds by hybridization to probes immobilized to microfabricated arrays. The strategy and principles for design and use of such arrays are generally described in WO 95/11995.

A typical probe array used in this analysis has two groups of four sets of probes that respectively tile both strands of a reference sequence. A first probe set comprises a plurality of probes exhibiting perfect complementarily with one of the reference sequences. Each probe in the first probe set has an interrogation position that corresponds to a nucleotide in the reference sequence. That is, the interrogation position is aligned with the corresponding nucleotide in the reference sequence, when the probe and reference sequence are aligned to maximize complementarily between the two. For each probe in the first set, there are three corresponding probes from three additional probe sets. Thus, there are four probes corresponding to each nucleotide in the reference sequence. The probes from the three additional probe sets are identical to the corresponding probe from the first probe set except at the interrogation position, which occurs in the same position in each of the four corresponding probes from the four probe sets, and is occupied by a different nucleotide in the four probe sets. In the present analysis, probes were 25 nucleotides long. Arrays tiled for multiple different references sequences were included on the same substrate.

Publicly available sequences for a given gene were assembled into Gap4, which can be found on the world wide web at biozentrum.unibas.ch/˜biocomp/staden/Overview.html. PCR primers covering each exon were designed using Primer 3, which can be found on the world wide web at genome.wi.mit.edu/cgi-bin/primer/primer3.cgi. Primers were not designed in regions where there were sequence discrepancies between reads. Genomic DNA was amplified in at least 50 individuals using 2.5 pmol each primer, 1.5 mM MgCl₂, 100 μM dNTPs, 0.75 μM AmpliTaq GOLD polymerase, and 19 ng DNA in a 15 μl reaction. Reactions were assembled using a PACKARD MultiPROBE robotic pipetting station and then put in MJ 96-well tetrad thermocyclers (96° C. for 10 minutes, followed by 35 cycles of 96° C. for 30 seconds, 59° C. for 2 minutes, and 72° C. for 2 minutes). A subset of the PCR assays for each individual were run on 3% NuSieve gels in 0.5× TBE to confirm that the reaction worked.

For a given DNA, 5 μl (about 50 ng) of each PCR or RT-PCR product were pooled (Final volume=150-200 1 μl). The products were purified using QiaQuick PCR purification from Qiagen. The samples were eluted once in 35 μl sterile water and 4 μl 10× One-Phor-All buffer (Pharmacia). The pooled samples were digested with 0.2 μ DNaseI (Promega)for 10 minutes at 37° C. and then labeled with 0.5 nmols biotin-N6-ddATP and 15μ Terminal Transferase (GibcoBRL Life Technology) for 60 minutes at 37° C. Both fragmentation and labeling reactions were terminated by incubating the pooled sample for 15 minutes at 100° C.

Low-density DNA chips (Affymetrix,CA) were hybridized following the manufacturer's instructions. Briefly, the hybridization cocktail consisted of 3M TMACl, 10 mM Tris pH 7.8,0.01% Triton X-100, 100 mg/ml herring sperm DNA (Gibco BRL), 200 pM control biotin-labeled oligo. The processed PCR products were denatured for 7 minutes at 100° C. and then added to prewarmed (37° C.) hybridization solution. The chips were hybridized overnight at 44° C. Chips were washed in 1×SSPET and 6×SSPET followed by staining with 2 μg/ml SARPE and 0.5 mg/ml acetylated BSA in 200 μl of 6×SSPET for 8 minutes at room temperature. Chips were scanned using a Molecular Dynamics scanner.

Chip image files were analyzed using Ulysses (Affymetrix, Calif.) which uses four algorithms to identify potential polymorphisms. Candidate polymorphisms were visually inspected and assigned a confidence value: high confidence candidates displayed all three genotypes, while likely candidates showed only two genotypes (homozygous for reference sequence and heterozygdus for reference and variant). Some of the candidate polymorphisms were confirmed by ABI sequencing. Identified polymorphisms were compared to several databases to determine if they were novel. Results arc shown in the Table.

Association of Thrombospondin Gene Polymorphisms with Vascular Disease To determine pivotal genes associated with premature coronary artery disease, we analyzed DNA from 347 patients with MI or coronary revascularization before age 40 (men) or 45 (women) and 422 general population controls. Cases were drawn (one per family) from a retrospective collection of sibling pairs with premature CAD. Controls were ascertained through random-digit dialing. Both cases and controls were Caucasian. A complete database of phenotypic and laboratory variables for the affected patients afforded logistic regression to control for age, diabetes, body mass index, gender.

Thrombospondin (TSP) 4 and 1 emerged as important SNPs associated with premature CAD and MI. For CAD, 148 of 347 patients carried at least one copy of the TSP4 variant compared with 142 of 422 control subjects; adjusted odds ratio 1.47, p=0.01. For premature MI, the association was even stronger: 91 of 187 cases vs. 142 of 422 controls had the variant; adjusted odds ratio 2.08, p=0.0003. The TSP-1 SNP was rare. Nonetheless, homozygosity for the variant allele gave an adjusted odds ratio of 9.5, p=0.04.

Genbank or TIGR Position in Mutation Poly ID WIAF ID Accession Number Sequence Gene Description Flanking Seq Type Ref NT Alt NT Ref AA Alt AA AT3a7 WIAF-13246 U11270 11918 AT3, antithrombin III CTGCAGGAGT[G/A]GCTGGATGAA N G A W * DRD5u22 WIAF-12913 M67439 310 DRD1, dopamine receptor D1 CATCTGGACC[C/T]TGCTGGGCAA S C T L L DRD5u23 WIAF-12914 M67439 332 DRD1, dopamine receptor D1 GTGCTGGTGT[G/C]CGCAGCCATC M G C C S DRD5u24 WIAF-12915 M67439 369 DRD1, dopamine receptor D1 TGCGCGCCAA[C/G]ATGACCAACG M C G N K DRD5u25 WIAF-12916 M67439 522 DRD1, dopamine receptor D1 TGTGCTCCAC[T/C]GCCTCCATCC S T C T T DRD5u26 WIAF-12917 M67439 953 DRD1, dopamine receptor D1 GCAGAGCACG[C/T]GCAGAGCTGC M C T A V DRD5u27 WIAF-12918 M67439 635 DRD1, dopamine receptor D1 ATGGTCGGCC[T/C]GGCATGGACC M T C L P DRD5u28 WIAF-12919 M67439 606 DRD1, dopamine receptor D1 GCAAGATGAC[T/C]CAGCGCATGG S T C T T DRD5u29 WIAF-12920 M67439 845 DRD1, dopamine receptor D1 TCGCTCATCA[G/A]CTTCTACATC M G A S N DRD5u30 WIAF-12921 M67439 720 DRD1, dopamine receptor D1 GGGGCGGGCT[G/T]GACCTGCCAA S G T L L DRD5u31 WIAF-12922 M67439 1044 DRD1, dopamine receptor D1 AGACCCTGTC[G/A]GTGATCATGG S G A S S DRD5u32 WIAF-12923 M67439 766 DRD1, dopamine receptor D1 GGAGGAGGAC[T/G]TTTGGGAGCC M T G F V DRD5u33 WIAF-12924 M67439 777 DRD1, dopamine receptor D1 TTTGGGAGCC[C/T]GACGTGAATG S C T P P DRD5u34 WIAF-12925 M67439 786 DRD1, dopamine receptor D1 CCGACGTGAA[T/G]GCAGAGAACT M T G N K DRD5u35 WIAF-12926 M67439 887 DRD1, dopamine receptor D1 ACCTACACGC[G/A]CATCTACCGC M G A R H DRD5u36 WIAF-12927 M67439 1279 DRD1, dopamine receptor D1 GTGCAGCCAC[T/G]TCTGCTCCCG M T G F V DRD5u37 WIAF-12928 M67439 1370 DRD1, dopamine receptor D1 GAAATCGCAG[C/T]TGCCTACATC M C T A V DRD5u38 WIAF-12929 M67439 1500 DRD1, dopamine receptor D1 ACCCTGTTGC[T/A]GAGTCTGTCT S T A A A DRD5u39 WIAF-12930 M67439 1338 DRD1, dopamine receptor D1 TCTCCTACAA[C/T]CAAGACATCG S C T N N DRD5u40 WIAF-12931 M67439 1215 DRD1, dopamine receptor D1 CACTCAACCC[C/A]GTCATCTATG S C A P P DRD5u41 WIAF-12932 M67439 1242 DRD1, dopamine receptor D1 ACGCCGACTT[T/C]CAGAAGGTGT S T C F F DRD5u42 WIAF-12933 M67439 1441 DRD1, dopamine receptor D1 CGAGGAGGAG[G/A]GTCCTTTCGA M G A G S DRD5u43 WIAF-12934 M67439 1460 DRD1, dopamine receptor D1 GATCGCATGT[T/C]CCAGATCTAT M T C F S DRD5u44 WIAF-12960 M67439 399 DRD1, dopamine receptor D1 TGTCTCTGGC[C/T]GTGTCTGACC S C T A A DRD5u45 WIAF-12961 M67439 162 DRD1, dopamine receptor D1 TGCCGCCAGG[C/G]AGCAACGGCA S C G G G DRD5u46 WIAF-12962 M67439 195 DRD1, dopamine receptor D1 GGCAGTTCGC[T/G]CTATACCAGC S T G A A DRD5u47 WIAF-12963 M67439 264 DRD1, dopamine receptor D1 TGGGGCCCTC[A/G]CAGGTGGTCA S A G S S DRD5u48 WIAF-12964 M67439 465 DRD1, dopamine receptor D1 TGGCCGGTTA[C/T]TGGCCCTTTG S C T Y Y DRD5u49 WIAF-12965 M67439 511 DRD1, dopamine receptor D1 CTTCGACATC[A/T]TGTGCTCCAC M A T M L DRD5u50 WIAF-12966 M67439 557 DRD1, dopamine receptor D1 ATCAGCGTGG[A/G]CCGCTACTGG M A G D G DRD5u51 WIAF-12967 M67439 476 DRD1, dopamine receptor D1 TGGCCCTTTG[G/A]AGCGTTCTGC M G A G E DRD5u52 WIAF-12968 M67439 1004 DRD1, dopamine receptor D1 AGCCTGCGCG[C/T]TTCCATCAAG M C T A V DRD5u53 WIAF-12969 M67439 1036 DRD1, dopamine receptor D1 GGTTCTCAAG[A/C]CCCTGTCGGT M A C T P DRD5u54 WIAF-12970 M67439 859 DRD1, dopamine receptor D1 CTACATCCCC[G/A]TTGCCATCAT M G A V I DRD5u55 WIAF-12971 M67439 931 DRD1, dopamine receptor D1 GATTTCCTCC[C/T]TGGAGAGGGC S C T L L G10u1 WIAF-10234 J04111 1308 JUN, v-jun avian sarcoma virus 17 CCCTCAACGC[C/T]TCGTTCCTCC S C T A A oncogene homolog G10u2 WIAF-10235 J04111 1471 JUN, v-jun avian sarcoma virus 17 GCTGCTCAAG[C/T]TGGCGTCGCC S C T L L oncogene homolog G10u3 WIAF-10253 J04111 2010 JUN, v-jun avian sarcoma virus 17 TGGAGTCCCA[G/A]GAGCGGATCA S G A Q Q oncogene homolog G1001u1 WIAF-13746 D26135 993 DGKG, diacylglycerol kinase, CCCCAGTGGT[G/A]TACCTGAAGG S G A V V gamma (90 kD) G1001u2 WIAF-13764 D26135 2313 DGKG, diacylglycerol kinase, ATGTGATGAG[A/T]GAGAAACATC M A T R S gamma (90 kD) G1002u1 WIAF-13918 X57206 334 ITPKB, inositol 1,4,5- CCCCAAGATC[A/C]GGACAAGCCT M A C Q P trisphosphate 3-kinase B G1002u2 WIAF-13925 X57206 575 ITPKB, inositol 1,4,5- CCAACTCAGC[T/C]TTCCTGCATA S T C A A trisphosphate 3-kinase B G1004u1 WIAF-13567 L36151 1854 PIK4CA, phosphatidylinositol 4- GCCGCTCAGA[C/T]TCCGAGGATG S C T D D kinase, catalytic, alpha polypeptide G1006u1 WIAF-12375 HT2690 858 PRKCA, protein kinase C, alpha GGTACAAGTT[G/A]CTTAACCAAG S G A L L G1008u1 WIAF-12397 HT2136 300 PRKCZ, protein kinase C, zeta CTGGCCTGCC[A/G]TGTCCGGGAG S A G P P G1008u2 WIAF-12398 HT2136 246 PRKCZ, protein kinase C, zeta AGTGCAGGGA[T/C]GAAGGCCTCA S T C D D G1008u3 WIAF-12399 HT2136 504 PRKCZ, protein kinase C, zeta GCTGCCACGG[C/T]CTCGTCCCGC S C T G G G1008u4 WIAF-12403 HT2136 807 PRKCZ, protein kinase C, zeta AGAAGAATGA[C/T]CAAATTTACG S C T D D G1008u5 WIAF-12404 HT2136 1514 PRKCZ, protein kinase C, zeta GGATTTTCTG[A/T]CATCAAGTCC M A T D V G1008u6 WIAF-12412 HT2136 166 PRKCZ, protein kinase C, zeta CAAGTGGGTG[G/A]ACAGCGAAGG M G A D N G1008u7 WIAF-12418 HT2136 560 PRKCZ, protein kinase C, zeta TCCCAAGAGC[C/T]TCCAGTAGAC M C T P L G1009u1 WIAF-12396 L05186 2495 PTK2, PTK2 protein tyrosine TCATCAACAA[G/A]ATGAAACTGG S G A K K kinase 2 G1011u1 WIAF-11988 X07876 1250 WNT2, wingless-type MMTV TCCCATGTCA[C/A]CCGGATGACC M C A T N integration site family member 2 G1011u2 WIAF-11997 X07876 788 WNT2, wingless-type MMTV GACTATGGGA[T/C]CAAATTTGCC M T C I T integration site family member 2 G1011u3 WIAF-12014 X07876 1338 WNT2, wingless-type MMTV TGCACACATG[C/A]AAGGCCCCCA N C A C * integration site family member 2 G1011u4 WIAF-13475 X07876 856 WNT2, wingless-type MMTV CCTGATGAAT[C/T]TTCACAACAA M C T L F integration site family member 2 G1011u5 WIAF-13476 X07876 958 WNT2, wingless-type MMTV GACATGCTGG[C/T]TGGCCATGGC S C T L L integration site family member 2 G1011u6 WIAF-13477 X07876 789 WNT2, wingless-type MMTV ACTATGGGAT[C/T]AAATTTGCCC S C T I I integration site family member 2 G1011u7 WIAF-13478 X07876 823 WNT2, wingless-type MMTV TGCAAAGGAA[A/G]GGAAAGGAAA M A G R G integration site family member 2 G1012u1 WIAF-12408 HT48910 1574 WNT2B, wingless-type MMTV ATACTTGCAA[A/G]GCCCCCAAGA S A G K K integration site family, member 2B G1016a1 WIAF-12125 Z22534 793 ACVR1, activin A receptor, type I GGCAAGGGGA[A/G]AATGTTGCCG S A G E E G1016u2 WIAF-12392 Z22534 373 ACVR1, activin A receptor, type I CTGGCCAAGC[T/C]GTGGAGTGCT S T C A A G1018u1 WIAF-12413 X74210 1150 ADCY2, adenylate cyclase 2 CAAATTGCGA[G/T]TGGGTATTAA M G T V L (brain) G1019u1 WIAF-12394 U83867 5475 SPTAN1, spectrin, alpha, non- GGGACCTAAC[T/C]GGCGTGCAGA S T C T T erythrocytic 1 (alpha-fodrin) G1019u2 WIAF-12406 U83867 1223 SPTAN1, spectrin, alpha, non- GCCCTCATCA[A/G]TGCAGATGAG M A G N S erythrocytic 1 (alpha-fodrin) G1019u3 WIAF-12409 U83867 3555 SPTAN1, spectrin, alpha, non- CTGAAGGTCT[T/C]ATGGCAGAGG S T C L L erythrocytic 1 (alpha-fodrin) G1019u4 WIAF-12415 U83867 3369 SPTAN1, spectrin, alpha, non- TCCGTGAAGC[G/A]AATGAACTAC S G A A A erythrocytic 1 (alpha-fodrin) G1019u5 WIAF-12417 U83867 5839 SPTAN1, spectrin, alpha, non- TGAGACAGAC[T/A]TCACCGTCCA M T A F I erythrocytic 1 (alpha-fodrin) G1022u1 WIAF-12393 U45945 631 ATP1B2, ATPase, Na+/Ka+ CATGAATGTT[A/G]CCTGTGCTGG M A G T A transporting, beta 2 polypeptide G1022u2 WIAF-12400 U45945 432 ATP182, ATPase, Na+/K+ GCCGCCCTGG[G/A]CGCTATTACG S G A G G transporting, beta 2 polypeptide G1023u1 WIAF-12401 D89722 395 ARNTL, aryl hydrocarbon receptor AACATTAAGA[G/C]GTGCCACCAA M G C G R nuclear translocator-like G1023u2 WIAF-12407 D89722 681 ARNTL, aryl hydrocarbon receptor CTCATACATG[C/T]AAAAACTGGA M C T A V nuclear translocator-like G1024u1 WIAF-12410 U85946 731 Homo sapiens brain secretory GATAGATTTT[C/T]AGAAGTTAAA M C T S L protein hSec10p (HSEC10) mRNA, complete cds. G1027u1 WIAF-12402 L47647 1135 CKB, creatine kinase, brain TCGAGATGGA[A/G]CAGCGGCTGG S A G E E G1027u2 WIAF-12405 L47647 499 CKB, creatine kinase, brain GGGAGCGCCG[A/C]GCCATCGAGA S A C R R G103u1 WIAF-10427 HT2269 335 ERCC5, excision repair cross- GGGATCGCCA[T/C]GGGAACTCAA S T C H H complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u2 WIAF-10429 HT2269 1221 ERCC5, excision repair cross- CCCTCCTTCT[C/T]CAAGAACTTT M C T P S complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u3 WIAF-10431 HT2269 1783 ERCC5, excision repair cross- TCTCCAACTT[G/C]TACAAATTCT M G C C S complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u4 WIAF-10432 HT2269 2077 ERCC5, excision repair cross- ACTGAATCTG[C/A]AGGCCAGGAT M C A A E complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u5 WIAF-10446 HT2269 3338 ERCC5, excision repair cross- AATTTGAGCT[A/T]CTTGATAAGG S A T L L complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u6 WIAF-10447 HT2269 3487 ERCC5, excision repair cross- TCAGAATCAT[C/T]TGATGGATCT M C T S F complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u7 WIAF-10448 HT2269 3507 ERCC5, excision repair cross- TTCAAGTGAA[C/G]ATGCTGAAAG M C G H D complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u8 WIAF-10457 HT2269 1388 ERCC5, excision repair cross- CTCTTGACGA[T/G]GACGAAGATG M T G D E complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u9 WIAF-10458 HT2269 1362 ERCC5, excision repair cross- CCGGACTCTT[T/C]CAGCCATTAA M T C S P complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u10 WIAF-10459 HT2269 2357 ERCC5, excision repair cross- CTGAGAAAGA[T/C]GCGGAAGATT S T C D D complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u11 WIAF-10462 HT2269 3109 ERCC5, excision repair cross- TGGAACAGAA[C/T]GAAGACAGAT M C T T M complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u12 WIAF-10463 HT2269 3138 ERCC5, excision repair cross- GTTTCCTGTA[T/C]TAAAGCAACT S T C L L complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u14 WIAF-10484 HT2269 3553 ERCC5, excision repair cross- AGAACAGCTG[C/T]GAAAGAGCCA M C T A V complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103u15 WIAF-10485 HT2269 1429 ERCC5, excision repair cross- GATGTGCAGA[C/T]GGGAGGGCCA M C T T M complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G103a16 WIAF-12097 HT2269 3335 ERCC5, excision repair cross- AAGAATTTGA[G/T]CTACTTGATA M G T E D complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)) G1030u1 WIAF-12411 U07358 203 ZPK, zipper (leucine) protein ACACTTCTGA[C/T]TGCACTCCCG S C T D D kinase G1030u2 WIAF-12416 U07358 1806 ZPK, zipper (leucine) protein GCCACCCCAT[G/T]AACCTGGAGG N G T E * kinase G1031a1 WIAF-12124 U87460 2825 GPR37, G protein-coupled receptor GAGTCACCAC[C/T]TTCACCTTAT S C T T T 37 (endothelin receptor type B- like) G1032u1 WIAF-12381 U57911 926 C11ORF8, chromosome 11 open ACGTACATCA[A/C]TGCCTCGACG M A C N T reading frame 8 G1033u1 WIAF-12437 M65188 431 GJA1, gap junction protein, alpha TCTGTACCCA[C/T]ACTCTTGTAC M C T T I 1, 43 kD (connexin 43) G1033u2 WIAF-12438 M65188 169 GJA1, gap junction protein, alpha AGGCAACATG[G/C]GTGACTGGAG M G C G R 1, 43 kD (connexin 43) G1033u3 WIAF-12439 M65188 467 GJA1, gap junctiono protein, alpha TATGTGATGC[G/A]AAAGGAAGAG M G A R Q 1, 43 kD (connexin 43) G1033u4 WIAF-12440 M65188 263 GJA1, gap junction protein, alpha TTCATTTTCC[G/A]AATCCTGCTG M G A R Q 1, 43 kD (connexin 43) G1033u5 WIAF-12441 M65188 218 GJA1, gap junction protein, alpha CAAGCCTACT[C/T]AACTGCTGGA M C T S L 1, 43 kD (connexin 43) G1033u6 WIAF-12442 M65188 498 GJA1, gap junction protein, alpha AGAAAGAGGA[A/G]GAACTCAAGG S A G E E 1, 43 kD (connexin 43) G1033u7 WIAF-12465 M65188 550 GJA1, gap junction protein, alpha GCACTTGAAG[C/A]AGATTGAGAT M C A Q K 1, 43 kD (connexin 43) G1033u8 WIAF-12466 M65188 548 GJA1, gap junction protein, alpha ATGCACTTGA[A/G]GCAGATTGAG M A G K R 1, 43 kD (connexin 43) G1033u9 WIAF-12486 M65188 933 GJA1, gap junction protein, alpha CGCTGAGCCC[T/C]GCCAAAGACT S T C P P 1, 43 kD (connexin 43) G1033u10 WIAF-12487 M65188 990 GJA1, gap junction protein, alpha CCTCACCAAC[C/T]GCTCCCCTCT S C T T T 1, 43 kD (connexin 43) G1033u11 WIAF-12488 M65188 1034 GJA1, gap junction protein, alpha AAGCTGGTTA[C/A]TGGCGACAGA M C A T N 1, 43 kD (connexin 43) G1033u12 WIAF-12489 M65188 1158 GJA1, gap junction protein, alpha CTAACTCCCA[T/C]GCACAGCCTT S T C H H 1, 43 kD (connexin 43) G1033u13 WIAF-12490 M65188 1222 GJA1, gap junction protein, alpha TGGACATGAA[T/C]TACAGCCACT S T C L L 1, 43 kD (connexin 43) G1033u14 WIAF-12491 M65188 1069 GJA1, gap junction protein, alpha CCGCAATTAC[A/G]ACAAGCAAGC M A G N D 1, 43 kD (connexin 43) G1033u15 WIAF-12492 M65188 1250 GJA1, gap junction protein, alpha TATTTGTGTC[T/C]GTACCCACAC M T C S S 1, 43 kD (connexin 43) G1033u16 WIAF-12496 M65188 423 GJA1, gap junction protein, alpha TATTTGTGTC[T/C]GTACCCACAC S T C S S 1, 43 kD (connexin 43) G1033u17 WIAF-12503 M65188 880 GJA1, gap junction protein, alpha CGTTAAGGAT[C/T]GGGTTAAGGG M C T R W 1, 43 kD (connexin 43) G1033u18 WIAF-12504 M65188 855 GJA1, gap junction protein, alpha AACTCTTCTA[T/C]GTTTTCTTCA S T C Y Y 1, 43 kD (connexin 43) G1033u19 WIAF-12505 M65188 576 GJA1, gap junction protein, alpha AGTTCAAGTA[C/T]GGTATTGAAG S C T Y Y 1, 43 kD (connexin 43) G1033u20 WIAF-12512 M65188 1255 GJA1, gap junction protein, alpha CCAGCGACCT[T/G]CAAGCAGAGC M T G S A 1, 43 kD (connexin 43) G1033u21 WIAF-12513 M65188 1078 GJA1, gap junction protein, alpha CAACAAGCAA[G/A]CAAGTGAGCA M G A A T 1, 43 kD (connexin 43) G1033u22 WIAF-12514 M65188 1097 GJA1, gap junction protein, alpha CAAAACTGGG[C/G]TAATTACAGT M C G A G 1, 43 kD (connexin 43) G1034u1 WIAF-12443 J03544 1201 PYGB, phosphorylase, glycogen; AGACCTGTGC[A/G]TACACCAACC S A G A A brain G1034u2 WIAF-12469 J03544 771 PYGB, phosphorylase, glycogen; GACACCCCAG[T/C]GCCCGGCTAC M T C V A brain G1034u3 WIAF-12470 J03544 1465 PYGB, phosphorylase, glycogen; TCCACTCGGA[G/C]ATCGTGAAAC M G C E D brain G1034u4 WIAF-12471 J03544 1583 PYGB, phosphorylase, glycogen; GGGGCTGGCC[G/A]ATACCATCGT M G A D N brain G1034u5 WIAF-12472 J03544 1774 PYGB, phosphorylase, glycogen; CCATGTTCGA[T/C]GTGCATGTGA S T C D D brain G1034u6 WIAF-12474 J03544 2449 PYGB, phosphorylase, glycogen; AGGTGGACCA[G/A]CTGTACCGGA S G A Q Q brain G1034u7 WIAF-12508 J03544 718 PYGB, phosphorylase, glycogen; CCCCCGACGG[C/T]GTGAAGTGGC S C T G G brain G1035u1 WIAF-12484 U97105 1962 DPYSL2, dihydropyrimidinase-like GCAGAGGAGC[A/G]GCAGAGGATC M A G Q R 2 G1035u2 WIAF-12485 U97105 2842 DPYSL2, dihydropyrimidinase-like ATGACGGACC[T/C]GTGTGTGAAG S T C P P 2 G1035u3 WIAF-12511 U97105 2062 DPYSL2, dihydropyrimidinase-like CCATCACCAT[C/T]GCCAACCAGA S C T I I 2 G1036u1 WIAF-12444 D88460 311 WASL, Wiskott-Aldrich syndrome- ACGTGGGGTC[C/T]CTGTTGCTCA S C T S S like G1038u1 WIAF-12445 HT2746 994 PCTK2, PCTAIRE protein kinase 2 TAGAAGAAAG[G/A]TATTGCATCG M G A V I G1039u1 WIAF-12429 HT2747 955 serine/threonine kinase, PCTAIRE-3 ATCCAAGAGT[C/T]GCATGTCAGC M C T R C G1039u2 WIAF-12458 HT2747 808 serine/threonine kinase, PCTAIRE-3 CACAGAAGAG[A/T]CGTGGCCCGG M A T T S G1041u1 WIAF-12459 X72886 544 H. sapiens TYRO3 mRNA. CAAGTGGCTG[G/C]CCCTGGAGAG M G C A P G1041u2 WIAF-12460 X72886 693 H. sapiens TYRO3 mRNA. TTGGCGGGAA[C/T]CGCCTGAAAC S C T N N G1041u3 WIAF-12502 X72886 561 H. sapiens TYRO3 mRNA. AGAGCCTGGC[C/T]GACAACCTGT S C T A A G1043u1 WIAF-12448 M94055 5481 Human voltage-gated sodium channel CTCTGAGTGA[G/A]GATGACTTTG S G A E E mRNA, complete cds. G1043u2 WIAF-12449 M94055 5205 Human voltage-gated sodium channel TTGAGACCTT[T/C]GGCAACAGCA S T C F F mRNA, complete cds. G1043u3 WIAF-12450 M94055 5224 Human voltage-gated sodium channel CATGATCTGC[C/T]TGTTCCAAAT S C T L L mRNA, complete cds. G1043u4 WIAF-12451 M94055 5514 Human voltage-gated sodium channel AGGTTTGGGA[G/A]AAGTTTGATC S G A E E mRNA, complete cds. G1043u5 WIAF-12452 M94055 5217 Human voltage-gated sodium channel GCAACAGCAT[G/C]ATCTGCCTGT M G C M I mRNA, complete cds. G1043u6 WIAF-12453 M94055 5334 Human voltage-gated sodium channel GCTCAGTTAA[A/G]GGAGACTGTG S A G K K mRNA, complete cds. G1043u7 WIAF-12454 M94055 5424 Human voltage-gated sodium channel TGTACATCGC[G/C]GTCATCCTGG S G C A A mRNA, complete cds. G1043u8 WIAF-12455 M94055 5322 Human voltage-gated sodium channel ATCACCCTGG[A/C]AGCTCAGTTA S A C G G mRNA, complete cds. G1043u9 WIAF-12456 M94055 1200 Human voltage-gated sodium channel ATGGCTACAG[G/A]AGCTTTGACA S G A T T mRNA, complete cds. G1043u10 WIAF-12499 M94055 1170 Human voltage-gated sodium channel TCTGTGTGAA[G/T]GCTGGTAGAA M G T K N mRNA, complete cds. G1046a1 WIAF-13187 U50352 267 ACCN1, amiloride-sensitive cation TCCCAGCTGT[G/A]ACCCTCTGTA S G A V V channel 1, neuronal (degenerin) G1046a2 WIAF-13188 U50352 282 ACCN1, amiloride-sensitive cation TCTGTAACCT[C/g]AATGGCTTCC S C g L L channel 1, neuronal (degenerin) G1046a3 WIAF-13189 U50352 315 ACCN1, amiloride-sensitive cation TCACCACCAA[C/t]GACCTGTACC S C t N N channel 1, neuronal (degenerin) G1046a4 WIAF-13190 U50352 386 ACCN1, amiloride-sensitive cation CCCCATCTGG[C/a]TGACCCCTCC M C a A D channel 1, neuronal (degenerin) G1046a5 WIAF-13191 U50352 417 ACCN1, amiloride-sensitive cation CCCTGCGGCA[G/A]AAGGCCAACT S G A Q Q channel 1, neuronal (degenerin) G1048u1 WIAF-12641 HT5174S 3214 REST, RE1-silencing transcription CAGTCAAAGC[G/A]GCTAAGGGAG S G A A A factor G1048u2 WIAF-12642 HT5174S 3199 REST, RE1-silencing transcription CAAAGGAAGC[C/G]TTGGCAGTCA S C G A A factor G1048u3 WIAF-12657 HT5174S 2125 REST, RE1-silencing transcription CTCCCATGGA[G/T]ACTGCTCAGA M G T S D factor G1048u4 WIAF-12660 HT5174S 2333 REST, RE1-silencing transcription GGAACCTGTT[A/C]AGATAGAGCT M A C K Q factor G1051u1 WIAF-12431 HT28321 658 SCNN1G, sodium channel, ATGACACCTC[C/T]GACTGTGCCA S C T S S nonvoltge-gated 1, gamma G1051u2 WIAF-12434 HT28321 1735 SCNN1G, sodium channel, AAGCCAAGGA[G/A]TGGTGCGCCT S G A E S nonvoltage-gated 1, gamma G1051u3 WIAF-12473 HT28321 409 SCNN1G, sodium channel, AGTCCCTGTA[T/C]GGCTTTCCAG S T C Y Y nonvoltage-gated 1, gamma G1051u4 WIAF-12475 HT28321 953 SCNN1G, sodium channel, AGTCATTTTG[T/C]ACATAAACGA M T C Y H nonvoltage-gated 1, gamma G1051u5 WIAF-12476 HT28321 975 SCNN1G, sodium channel, GAGGAATACA[A/G]CCCATTCCTC M A G N S nonvoltage-gated 1, gamma G1051u6 WIAF-12477 HT28321 1192 SCNN1G, sodium channel, CTGCCTACTC[G/A]CTCCAGATCT S G A S S nonvoltage-gated 1, gamma G1053a1 WIAF-13192 HT2201 4085 SCN5A, sodium channel, voltage- CGTCCTCTGA[G/A]AGCTCTGTCA N G A R K gated, type V, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1053a2 WIAF-13193 HT2201 5607 SCN5A, sodium channel, voltage- ACTTTGCCGA[C/T]GCCCTGTCTG S C T D D gated, type v, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1053a3 WIAF-13194 HT2201 5828 SCN5A, sodium channel, voltage- GAGCCCATCA[C/T]CACCACACTC M C T T I gated, type v, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1053a4 WIAF-13202 HT2201 713 SCN5A, sodium channel, voltage- GCGTTCACTT[T/A]CCTTCGGGAC M T A F Y gated, type v, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1053a5 WIAF-13203 HT2201 6148 SCN5A, sodium channel, voltage- CCACAGTGAA[G/T]ATCTCGCCGA M G T D Y gated, type v, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1053a6 WIAF-13204 HT2201 6217 SCN5A, sodium channel, voltage- GGCCTGGCTG[G/T]CCAGGACACA — G T — — gated, type v, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1053a7 WIAF-13205 HT2201 6324 SCN5A, sodium channel, voltage- AATGGGCCTC[G/A]GCCCCGCGGA — G A — — gated, type v, alpha polypeptide (long (electrocardiographic) QT syndrome 3) G1054u1 WIAF-12419 HT2202 2252 SCN5A, sodium channel, voltage- TTGGGAAGAG[C/T]TACAAGGAGT S C T S S gated, type IV, alpha polypeptide G1054u2 WIAF-12423 HT2202 4559 SCN4A, sodium channel, voltage- TGGTCATGTT[C/T]ATCTACTCCA S C T F F gated, type IV, alpha polypeptide G1054u3 WIAF-12424 HT2202 4856 SCN4A, sodium channel, voltage- TGAACATGTA[C/G]ATCGCCATCA N C G Y * gated, type IV, alpha polypeptide G1054u4 WIAF-12425 HT2202 4777 SCN4A, sodium channel, voltage- GTGAAGGGTG[A/G]CTGCGGGAAC M A G D G gated, type IV, alpha polypeptide G1054u5 WIAF-12426 HT2202 4863 SCN4A, sodium channel, voltage- GTACATCGCC[A/G]TCATCCTGGA M A G I V gated, type IV, alpha polypeptide G1054u6 WIAF-12427 HT2202 4566 SCN4A, sodium channel, voltage- GTTCATCTAC[T/G]CCATCTTCGG M T G S A gated, type IV, alpha polypeptide G1054u7 WIAF-12428 HT2202 4923 SCN4A, sodium channel, voltage- TGGTGAAGAT[G/T]ACTTTGAGAT M G T D Y gated, type IV, alpha polypeptide G1054u8 WIAF-12446 HT2202 3595 SCN4A, sodium channel, voltage- TTCTGGCTGA[T/C]CTTCAGCATC M T C I T gated, type IV, alpha polypeptide G1054u9 WIAF-12447 HT2202 4203 SCN4A, sodium channel, voltage- GGAGACAGAC[G/A]ACCAGAGCCA M G A D N gated, type IV, alpha polypeptide G1054u10 WIAF-12495 HT2202 4811 SCN4A, sodium channel, voltage- TCTGCTTCTT[C/A]TGCAGCTATA N C A F L gated, type IV, alpha polypeptide G1054u11 WIAF-12497 HT2202 5555 SCN4A, sodium channel, voltage- CAGGGCAGAC[T/G]GTGCGCCCAG S T G T T gated, type IV, alpha polypeptide G1054u12 WIAF-12498 HT2202 5480 SCN4A, sodium channel, voltage- CAGGGGACGC[C/T]GGACCCACTA S C T A A gated, type IV, alpha polypeptide G1059u1 WIAF-12432 HT33704 112 APLP1, amyloid beta (A4) CGCTGCTGCT[G/A]CCACTATTGC S G A L L precursor-like protein 1 G1059u2 WIAF-12433 HT33704 140 APLP1, amyloid beta (A4) TCTGCGCGCG[C/T]AGCCCGCCAT N C T Q * precursor-like protein 1 G1059u3 WIAF-12435 HT33704 1344 APLP1, amyloid beta (A4) CAGCATGTGG[C/T]CGCCGTGGAT M C T A V precursor-like protein 1 G1059u4 WIAF-12457 HT33704 1687 APLP1, amyloid beta (A4) ATGAGCGAAA[G/A]GTGAATGCGT S G A K K precursor-like protein 1 G1059u5 WIAF-12500 HT33704 976 APLP1, amyloid beta (A4) GGTTCCTGAG[A/G]GCCAAGATGG S A G R R precursor-like protein 1 G1059u6 WIAF-12501 HT33704 1786 APLP1, amyloid beta (A4) GTGAGGCTGT[A/G]TCGGGTCTGC S A G V V precursor-like protein 1 G1060u1 WIAF-12436 HT1418 1744 APLP2, amyloid beta (A4) CGAAGAAATT[C/G]AAGAGGAAAT M C G Q E precursor-like protein 2 G1060u2 WIAF-12467 HT1418 2213 APLP2, anyloid beta (A4) ATCAGCCTGG[T/G]GATGCTGAGG M T G V G precursor-like protein 2 G1060u3 WIAF-12468 HT1418 2256 APLP2, anyloid beta (A4) GCCACGGGAT[C/T]GTGGAGGTTG S C T I I precursor-like protein 2 G1066a1 WIAF-13195 HT3538 566 CCKBR, cholecystokinin B receptor CTTTGGCACC[G/A]TCATCTGCAA M G A V I G1066a2 WIAF-13196 HT3538 607 CCKBR, cholecystokinin B receptor GGGTGTCTGT[G/A]AGTGTGTCCA S G A V V G1066a3 WIAF-13206 HT3538 864 CCKBR, cholecystokinin B receptor CTGCTGCTTC[T/A]GCTCTTGTTC M T A L Q G1067u1 WIAF-12478 HT0830 684 KCNA1, potassium voltage-gated AAACGCTGTG[C/T]ATCATCTGGT S C T C C channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) G1067u2 WIAF-12479 HT0830 722 KCNA1, potassium voltage-gated GTGCGCTTCT[T/C]CGCCTGCCCC M T C F S channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) G1067u3 WIAF-12480 HT0830 804 KCNA1, potassium voltage-gated ATTTCATCAC[C/G]CTGGGCACCG S C G T T channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) G1067u4 WIAF-12509 HT0830 690 KCNA1, potassium voltage-gated TGTGCATCAT[C/T]TGGTTCTCCT S C T I I channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) G1068u1 WIAF-12493 HT0831 774 KCNA2, potassium voltage-gated TGAACATCAT[T/A]GACATTGTGG S T A I I channel, shaker-related subfamily, member 2 G1070a1 WIAF-13197 HT27728 522 KCNJ6, potassium inwardly- CACAGTGACC[T/C]GGCTCTTTTT M T C W R rectifying channel, subfamily J. member 6 G1070a2 WIAF-13201 HT27728 1244 KCNJ6, potassium inwardly- CCCTGGAGGA[T/C]GGGTTCTACG S T C D D rectifying channel, subfamily J. member 6 G1070a3 WIAF-13207 HT27728 707 KCNJ6, potassium inwardly- ATAAATGCCC[G/A]GAGGGAATTA S G A P P rectifying channel, subfamily J. member 6 G1071u1 WIAF-12422 HT38672 1534 KCNJ3, potassium inwardly- TTCCGGGCAA[C/T]TCAGAAGAAA S C T N N rectifying channel, subfamily J. member 3 G1073u1 WIAF-12461 HT4556 1127 KCNJ1, potassium inwardly- CACTGTGCCA[T/C]GTGCCTTTAT M T C M T rectifying channel, subfamily J. member 1 G1074u1 WIAF-12462 HT27804 289 KCNAB2, potassium voltage-gated ACCTCTTCGA[T/C]ACAGCAGAAG S T C D D channel, shaker-related subfamily, beta member 2 G1079u1 WIAF-12463 HT27383 1130 potassium channel, inwardly ACCTGGCCGA[T/A]GAGATCCTGT M T A D E rectifing (GB:D50582) G1079u2 WIAF-12464 HT27383 1192 potassium channel, inwardly CGTTACTCTG[T/G]GGACTACTCC M T G V G rectifing (GB:D50582) G1079u3 WIAF-12481 HT27383 708 potassium channel, inwardly GCTTGGCTAC[A/G]TCTTCATGAA M A G I V rectifing (GB:D50582) G1079u4 WIAF-12482 HT27383 779 potassium channel, inwardly CGGTGATCGC[T/C]CTGCGCCACG S T C A A rectifing (GB:D50582) G1079u5 WIAF-12483 HT27383 276 potassium channel, inwardly GGACCCTGCC[G/A]AGCCCAGGTA M G A E K rectifing (GB:D50582) G1079u6 WIAF-12510 HT27383 489 potassium channel, inwardly GTGGCTCATC[G/A]CCTTCGCCCA M G A A T rectifing (GB:D50582) G1080u1 WIAF-12536 HT4412 1099 KCNJ4, potassium inwardly- TGGACTACTC[A/G]CGTTTTCACA S A G S S rectifying channel, subfamily J. member 4 G1080u2 WIAF-12537 HT4412 1050 KCNJ4, potassium inwardly- GGCCACCGCT[T/A]TGAGCCTGTG M T A F Y rectifying channel, subfamily J. member 4 G1081u1 WIAF-12538 HT27724 1090 KCNJ2, potassium inwardly- GGCCACCGCT[A/T]TGAGCCTGTG M A T Y F rectifying channel, subfamily J. member 2 G1082u1 WIAF-12662 HT28319 768 potassium channel, inwardly CGCGGGTCAC[C/T]GAGGAGGGCT S C T T T rectifying, high conductance, alpha subunit G1082u2 WIAF-12663 HT28319 854 potassium channel, inwardly CTGGTGTCGC[C/T]CATCACCATC M C T P L rectifying, high conductance, alpha subunit G1082u3 WIAF-12679 HT28319 471 potassium channel, inwardly TCTCCATCGA[G/C]ACGCAGACCA M G C E D rectifying, high conductance, alpha subunit G1084a1 WIAF-13198 HT0383 2028 KCNB1, potassium voltage-gated CACTCCCCAG[C/A]AAGACTGGGG M C A S R channel, Shab-related subfamily, member 1 G1084a2 WIAF-13199 HT0383 2033 KCNB1, potassiuim voltage-gated CCCAGCAAGA[C/G]TGGGGGCAGC M C G T S channel, Shab-related subfamily, member 1 G1084a3 WIAF-13200 HT0383 2321 KCNB1, potassium voltage-gated GAGTGTGCCA[C/A]GCTTTTGGAC M C A T K channel, Shab-related subfamily, member 1 G1084a4 WIAF-13208 HT0383 870 KCNB1, potassium voltage-gated ACAACCCCCA[G/A]CTGGCCCACG S G A Q Q channel, Shab-related subfamily, member 1 G1088u1 WIAF-12516 HT0522 1503 KCNA5, potassium voltage-gated TCCTGGGCAA[G/A]ACCTTGCAGG S G A K K channel, shaker-related subfamily, member 5 G1088u2 WIAF-12519 HT0522 1249 KCNA5, potassium voltage-gated CGAGCTGCTC[G/A]TGCGGTTCTT M G A V M channel, shaker-related subfamily, member 5 G1088u3 WIAF-12520 HT0522 973 KCNA5, potassium voltage-gated CTCTGGGTCC[G/A]CGCGGGCCAT M G A A T channel, shaker-related subfamily, member 5 G1088u4 WIAF-12521 HT0522 1013 KCNA5, potassium voltage-gated GTTATCCTCA[T/C]CTCCATCATC M T C I T channel, shaker-related subfamily, member 5 G1090u1 WIAF-12651 HT1497 1836 KCNA6, potassium voltage-gated CAACCAGCCA[G/A]TGGAGGAGGC M G A S N channel, shaker-related subfamily, member 6 G1091u1 WIAF-12714 HT0222 843 KCNA3, potassium voltage-gated CATCATCTGG[T/C]TCTCCTTCGA M T C F L channel, shaker-related subfamily, member 3 G1094a1 WIAF-13218 HT27381 1280 KCNJ8, potassium inwardly- GTGTATTCTG[G/a]GGATTACTCC M T a V E rectifying channel, subfamily J. member 8 G1095u1 WIAF-12532 HT2629 765 KCNMA1, potassium large TTCTCTACTT[C/T]GGCTTGCGGT S C T F F conductance calcium-activated channel, subfamily M, alpha member 1 G1095u2 WIAF-12533 HT2629 2441 KCNMA1, potassium large GTGGTCTGCA[T/C]CTTTGGCGAC M T C I T conductance calcium-activated channel, subfamily M, alpha member 1 G1095u3 WIAF-12534 HT2629 2714 KCNMA1, potassium large GATGATACTT[C/G]GCTGCAGGAC M C G S W conductance calcium-activated channel, subfamily M, alpha member 1 G1095u4 WIAF-12535 HT2629 2439 KCNMA1, potassium large TCGTGGTCTG[C/T]ATCTTGGGCG S C T C C conductance calcium-activated channel, subfamily M, alpha member 1 G1095u5 WIAF-12539 HT2629 3048 KCNMA1, potassium large CACTCATGAG[C/T]GCGACCTACT S C T S S conductance calcium-activated channel, subfamily M, alpha member 1 G1095u6 WIAF-12544 HT2629 2352 KCNMA1, potassium large GGATGTTTCA[C/T]TGGTGTGCAC S C T H H conductance calcium-activated channel, subfamily M, alpha member 1 G1095u7 WIAF-12545 HT2629 2392 KCNMA1, potassium large CATCCTGACT[C/T]GAAGTGAAGC N C T R * conductance calcium-activated channel, subfamily M, alpha member 1 G1095u8 WIAF-12546 HT2629 2295 KCNMA1, potassium large CTGGCAATGA[T/C]CAGATTGACA S T C D D conductance calcium-activated channel, subfamily M, alpha member 1 G1095u9 WIAF-12548 HT2629 2949 KCNMA1, potassium large AGTTTTTGGA[C/T]CAAGACGATG S C T D D conductance calcium-activated channel, subfamily M, alpha member 1 G1095u10 WIAF-12549 HT2629 2865 KCNMA1, potassium large TGCACGGGAT[G/A]TTACGTCAAC M G A M I conductance calcium-activated channel, subfamily M, alpha member 1 G1096u1 WIAF-12547 L26318 930 PRKM8, protein kinase mitogen- TGCTGGTAAT[A/T]GATGCATCTA S A T I I activated 8 (MAP kinase) G1098u1 WIAF-12515 L19711 2650 DAG1, dystroglycan 1 (dystrophin- TCTACCTGCA[C/T]ACAGTCATTC S C T H H associated glycoprotein 1) G110u1 WIAF-10385 HT27392 230 meiosis-specific recA homolog, CAAAGGTATA[C/T]AGATGACAAC N T C Q * HsLim15 G110u2 WIAF-10397 HT27392 1050 meiosis-specific recA homolog, CCTGAAAATG[A/G]AGCCACCTTC M A G E G HsLim15 G110u3 WIAF-10399 HT27392 674 meiosis-specific recA homolog, TGAACATCAG[A/G]TGGAGCTACT M A G M V HsLim15 G1106u1 WIAF-12647 HT5073 5781 MAP1B, microtubule-associated ACTATGAGAA[G/A]ATAGAGAGAA S G A K K protein 1B G1106u2 WIAF-12648 HT5073 5916 MAP1B, microtubule-associated CTGAAGAGGG[C/T]GGGTACTCAT S C T G G protein 1B G1106u3 WIAF-12650 HT5073 1837 MAP1B, microtubule-associated AGACAAGCCA[G/A]TAAAAACAGA M G A V I protein 1B G1106u4 WIAF-12653 HT5073 2476 MAP1B, microtubule-associated CACCACAGCA[G/A]CTGTCATGGC M G A A T protein 1B G1106u5 WIAF-12656 HT5073 3913 MAP1B, microtubule-associated GCCCAATGAG[A/G]TTAAAGTCTC M A G I V protein 1B G1106u6 WIAF-12667 HT5073 559 MAP1B, microtubule-associated GATTTTCACC[G/A]ATCAAGAGAT M G A D N protein 1B G1106u7 WIAF-12668 HT5073 570 MAP1B, microtubule-associated ATCAAGAGAT[C/T]GGGGAGTTAC S C T I I protein 1B G1106u8 WIAF-12669 HT5073 6175 MAP1B, microtubule-associated TACTTCCACA[T/C]ACTGTTACGA M T C Y H protein 1B G1106u9 WIAF-12670 HT5073 1215 MAP1B, microtubule-associated TCACTCTCCA[G/C]TACCTAAACA M G C Q H protein 1B G1106u10 WIAF-12672 HT5073 1821 MAP1B, microtubule-associated AGGTAATGGT[G/A]AAAAAAGACA S G A V V protein 1B G1106u11 WIAF-12673 HT5073 2727 MAP1B, microtubule-associated GTCGTGCCGA[G/T]TCCCCTGATG M G T E D protein 1B G1106u12 WIAF-12674 HT5073 2739 MAP1B, microtubule-associated CCCCTGATGA[G/A]GGAATCACTA S G A E E protein 1B G1106u13 WIAF-12676 HT5073 3643 MAP1B, microtubule-associated AGATGCCACT[G/A]ATGGCAAGGA M G A D N protein 1B G1106u14 WIAF-12677 HT5073 3609 MAP1B, microtubule-associated CACCGCTCAA[C/T]GGATTTTCTG S C T N N protein 1B G1106u15 WIAF-12682 HT5073 4752 MAP1B, microtubule-associated TTCCAGAGCC[A/T]ACAACAGATG S A T P P protein 1B G1110u1 WIAF-12517 HT1096 1527 myelin aesociated glycoprotein GCGGCCTCGT[G/C]CTCACCAGCA S G C V V G1110u2 WIAF-12518 HT1096 1678 myelin aseociated glycoprotein TGTGGGCGCC[G/T]TGGTCGCCTT M G T V L G1110u3 WIAF-12522 HT1096 1271 myelin associated glycoprotein GCCGTGTCAC[C/T]CGAGGATGAT M C T P L G1113u1 WIAF-12523 HT2242 353 myelin transcription factor 1 AATTCCGATC[G/T]GATCCTCAGG M G T R L G1116a1 WIAF-13217 HT28451 417 myelin oligodendrocyte CAAGCTTATC[G/A]AGACCCTCTC S G A S S glycoprotein (MOG) G1116a2 WIAF-13219 HT28451 913 myelin oligodendrocyte GCAGATCACT[C/G]TTGGCCTCGT M C G L V glycoprotein (MOG) G1116a3 WIAF-13220 HT28451 922 myelin oligodendrocyte TCTTGGCCTC[G/A]TCTTCCTCTG M G A V I glycoprotein (MOG) G1120u1 WIAF-12525 HT3695 1200 neurofilament, subunit H TAGAGATAGC[T/C]GCTTACAGAA S T C A A G1123u1 WIAF-12542 HT2569 2269 OMG, oligodendrocyte myelin CAGCTGCAAC[T/C]CTAACTATTC S T C T T glycoprotein G1126u1 WIAF-12526 HT28354 626 PSEN2, presenilin 2 (Alzheimer GAGCGAAGCA[T/C]GTGATCATGC S T C H H disease 4) G1126u2 WIAF-12527 HT28354 494 PSEN2, presenilin 2 (Alzheimer ATGGAGAGAA[T/C]ACTGCCCAGT S T C N N disease 4) G1126u3 WIAF-12528 HT28354 434 PSEN2, presenilin 2 (Alzheimer TAATGTCGGC[C/T]GAGAGcCCCA S C T A A disease 4) G1126u4 WIAF-12543 HT28354 550 PSEN2, presenilin 2 (Alzheimer GACCCTGACC[G/A]CTATGTCTGT M G A R H disease 4) G117u1 WIAF-10391 HT27765 156 GTBP, G/T mismatch-binding ACTTCTCACC[A/G]GGAGATTTGG S A G P P protein G117u2 WIAF-10392 HT27765 420 GTBP, G/T mismatch-binding AACGTGCAGA[T/C]GAAGCCTTAA S T C D D protein G117u3 WIAF-10407 HT27765 939 GTBP, G/T mismatch-binding CCCACGTTAG[T/C]GGAGGTGGTG S T C S S protein G117u4 WIAF-10411 HT27765 1622 GTBP, G/T mismatch-binding CATTGTTCGA[G/A]ATTTAGGACT M G A R K protein G117u5 WIAF-10412 HT27765 2405 GTBP, G/T mismatch-binding GACAGCAGGG[C/T]TATAATGTAT M C T A V protein G117u6 WIAF-10413 HT27765 2387 GTBP, G/T mismatch-binding AAGAGTCAGA[A/T]CCACCCAGAC M A T N I protein G125u1 WIAF-10371 HT28632 1999 ATM, ataxia telangiectasia CAGTAATTTT[C/T]CTCATCTTGT M C T P S mutated (includes complementation groups A, C and D) G125u2 WIAF-10372 HT28632 2631 ATM, ataxia telangiectasia TAATGAATGA[C/A]ATTGCAGATA M C A D E mutated (includes complementation groups A, C and D) G125u3 WIAF-10373 HT28632 3084 ATM, ataxia telangiectasia CAATGGAAGA[T/C]GTTCTTGAAC M T G D E mutated (includes complementation groups A, C and D) G125u5 WIAF-10375 HT28632 4767 ATM, ataxia telangiectasia CACTTATACC[C/T]CTTGTGTATG S C T P P mutated (includes complementation groups A, C and D) G125u6 WIAF-10383 HT28632 8713 ATM, ataxia telangiectasia ATTCTTGGAT[C/T]CAGCTATTTG M C T P S mutated (includes complementation groups A, C and D) G125u7 WIAF-10396 HT28632 1825 ATM, ataxia telangiectasia GACTTTGGCA[C/G]TGACCACCAG M C G L V mutated (includes complementation groups A, C and D) G125u8 WIAF-10398 HT28632 2924 ATM, ataxia telangiectasia ACTACTGCTC[A/G]CACCAATACT M A G Q R mutated (includes complementation groups A, C and D) G125u9 WIAF-10405 HT28632 8967 ATM, ataxia telangiectasia TTGAAGGTGT[C/T]TTCAGAAGAT S C T V V mutated (includes complementation groups A, C and D) G125u10 WIAF-10408 HT28632 6954 ATM, ataxia telangiectasia CCAAACACCT[T/C]GTAGAACTCT S T C L L mutated (includes complementation groups A, C and D) G125u11 WIAF-10409 HT28632 6855 ATM, ataxia telangiectasia TTCAGGAGCC[T/C]ATCATGGCTC S T C P P mutated (includes complementation groups A, C and D) G125u12 WIAF-10410 HT28632 6801 ATM, ataxia telangiectasia TATATATTAA[G/T]TGGCAGAAAC M G T K N mutated (includes complementation groups A, C and D) G125u13 WIAF-10421 HT28632 335 ATM, ataxia telangiectasia CATTCAGATT[C/G]CAAACAAGGA M C G S C mutated (includes complementation groups A, C and D) G125u14 WIAF-11607 HT28632 3966 ATM, ataxia telangiectasia TTCCACATCT[G/A]GTGATTAGAA S G A L L mutated (includes complementation groups A, C and D) G125a15 WIAF-13130 HT28632 8642 ATM, ataxia telangiectasia GAGAAATATG[A/C]AGTCTTCATG M A C E A mutated (includes complementation groups A, C and D) G136u1 WIAF-10388 HT3337 535 MLH1, mutL (E. coli) homolog 1 AGGAGAAAAG[C/T]TTTAAAAAAT M C T A V (colon cancer, nonpolyposis type 2) G136u2 WIAF-10389 HT3337 769 MLH1, mutL (E. coli) homolog 1 TTCAAAATGA[A/G]TGGTTACATA M A G N S (colon cancer, nonpolyposis type 2) G144u1 WIAF-11638 HT3625 1129 FOS, v-fos FBJ murine CCTGTGCACT[C/T]CGGTGGTCAC M C T P S osteosarcoma viral oncogene homolog G1461u1 WIAF-12562 HT0329 684 pRB-binding protein TTGCCAAGAA[G/A]TCCAAGAACC S G A K K G1466u1 WIAF-12571 HT27849 2128 API2, apoptosis inhibitor 2 ATGATCCATG[G/C]GTAGAACATG M G C W C G1468u1 WIAF-12563 HT4986 1928 apoptosis inhibitor, neuronal CCACCAGACC[A/T]GACGAGGGGC S A T P P G1468u2 WIAF-12564 HT4986 3057 apoptosis inhibitor, neuronal TTTGCAATTC[C/G]TTCAAGGGAG M C G L V G1472u1 WIAF-12565 HT28478 242 BAK1, BCL2-antagonist/killer 1 GGCAGGAGTG[C/T]GGAGAGCCTG S C T C C G1472u2 WIAF-12572 HT28478 509 BAK1, BCL2-antagonist/killer 1 TGCAGCCCAC[G/A]GCAGAGAATG S G A T T G1473u1 WIAF-12568 HT28606 394 CASP6, caspase 6, apoptosis- GGTGTCAAGT[G/C]TTAGCCACGG M G C V L related cysteine protease G1473u2 WIAF-12576 HT28606 411 CASP6, caspase 6, apoptosis- ACGCAGATGC[C/T]GATTGCTTTG S C T A A related cysteine protease G1479u1 WIAF-12550 Y09077 711 ATR, ataxia telangiectastia and AGTTTATTAA[T/C]GGTTCTTACT M T C M T Rad3 related G1479u2 WIAF-12551 Y09077 4303 ATR, ataxia telangiectastia and TTGCGTATGC[T/C]GATAATAGCC S T C A A Rad3 related G1479u3 WIAF-12552 Y09077 1894 ATR, ataxia telangiectastia and ATTCTGATGA[T/C]GGCTGTTTAA S T C D D Rad3 related G1479u4 WIAF-12553 Y09077 1855 ATR, ataxia telangiectastia and ATTTATGTGG[T/A]ATGCTCTCAC S T A G G Rad3 related G1479u5 WIAF-12558 Y09077 5287 ATR, ataxia telangiectastia and TCATTGATTA[T/C]CATGGTGTAG S T C Y Y Rad3 related G1479u6 WIAF-12559 Y09077 5539 ATR, ataxia telangiectastia and CAGCTTTTTA[T/C]GACTCACTGA S T C Y Y Rad3 related G1479u7 WIAF-12569 Y09077 1540 ATR, ataxia telangiectastia and ATCCTGTTAT[T/C]GAGATGTTAG S T C I I Rad3 related G1479u8 WIAF-12570 Y09077 2521 ATR, ataxia telangiectastia and ATTTAATGGA[A/G]GATCCAGACA S A G E E Rad3 related G1482u1 WIAF-12560 HT27870 3176 BLM, Bloom syndrome AAAATATAAC[G/A]GAATGCAGGA S G A T T G1482u2 WIAF-12561 HT27870 3605 BLM, Bloom syndrome GAAATAAAGC[C/A]CAAACTGTAC S C A A A G1482u3 WIAF-12573 HT27870 2677 BLM, Bloom syndrome TATGTATTAC[C/T]GAAAAAGCCT M C T P L G1483u1 WIAF-12597 HT1470 1910 MYBL2, v-myb avian myeloblastosis GGATGAGGAT[G/A]TGAAGCTGAT M G A V M viral oncogene homolog-like 2 G1483u2 WIAF-12610 HT1470 244 MYBL2, v-myb avian myeloblastosis ATGAGGAGGA[C/T]GAGCAGCTGA S C T D D viral oncogene homolog-like 2 G1483u3 WIAF-12611 HT1470 1406 MYBL2, v-myb avian myeloblastosis CACTGAGAAT[A/G]GCACCAGTCT M A G S G viral oncogene homolog-like 2 G1485u1 WIAF-12581 HT1432 1941 BCR, breakpoint cluster region TGGAGATGAG[A/G]AAATGGGTCC S A G R R G1485u2 WIAF-12582 HT1432 3144 BCR, breakpoint cluster region TGACCATCAA[T/C]AAGGAAGATG S T C N N G1485u3 WIAF-12583 HT1432 3777 BCR, breakpoint cluster region ATAACAAGGA[T/C]GTGTCGGTGA S T C D D G1485u4 WIAF-12603 HT1432 2831 BCR, breakpoint cluster region CAGATCAAGA[G/A]TGACATCCAG M G A S N G1485u5 WIAF-12608 HT1432 4217 BCR, breakpoint cluster region ATCCCTGCCC[C/T]GGACAGCAAG M C T P L G1486u1 WIAF-12578 HT33770 1909 BRCA2, breast cancer 2, early ATTGATAATG[G/A]AAGCTGGCCA M G A G E onset G1486u2 WIAF-12579 HT33770 3623 BRCA2, breast cancer 2, early AGTTTAGAAA[A/G]CCAAGCTACA S A G K K onset G1486u3 WIAF-12586 HT33770 1341 BRCA2, breast cancer 2, early AAATGTAGCA[A/C]ATCAGAAGCC M A C N H onset G1486u4 WIAF-12594 HT33770 446 BRCA2, breast cancer 2, early CTTATAATCA[G/A]CTGGCTTCAA S G A Q Q onset G1486u5 WIAF-12598 HT33770 3013 BRCA2, breast cancer 2, early ACCATGGTTT[T/C]ATATGGAGAC M T C L S onset G1486u6 WIAF-12599 HT33770 3187 BRCA2, breast cancer 2, early CAAAAAAATA[A/T]TGATTACATG M A T N I onset G1486u7 WIAF-12604 HT33770 4971 BRCA2, breast cancer 2, early AGCATGTGAG[A/C]CCATTGAGAT M A C T P onset G1486u8 WIAF-12607 HT33770 4034 BRCA2, breast cancer 2, early ATGATTCTGT[C/T]GTTTCAATGT S C T V V onset G1487u1 WIAF-12584 HT27632 2536 BRCA1, breast cancer 1, early AGTCAGTGTG[C/G]AGCATTTGAA M C G A G onset G1487u2 WIAF-12587 HT27632 4697 BRCA1, breast cancer 1, early CATCTCAAGA[G/C]GAGCTCATTA M G C E D onset G1487u3 WIAF-12595 HT27632 469 BRCA1, breast cancer 1, early TCTCCTGAAC[A/G]TCTAAAAGAT M A G H R onset G1487u4 WIAF-12600 HT27632 3667 BRCA1, breast cancer 1, early AGCGTCCACA[A/G]AGGAGAGCTT M A G K R onset G1487u5 WIAF-12601 HT27632 3537 BRCA1, breast cancer 1, early TATGGGAAGT[A/G]GTCATGCATC M A G S G onset G1487u6 WIAF-12602 HT27632 4956 BRCA1, breast cancer 1, early ATCTGCCCAG[A/G]GTCCAGCTGC M A G S G onset G1487u7 WIAF-12605 HT27632 2090 BRCA1, breast cancer 1, early AGTACAACCA[A/G]ATGCCAGTCA S A G Q Q onset G1487u8 WIAF-12614 HT27632 233 BRCA1, breast cancer 1, early TCTCCACAAA[G/A]TGTGACCACA S G A K K onset G1492u1 WIAF-12585 HT3506 3912 cell death-associated kinase TCCAGGTCCG[T/C]GGCCTGGAGA S T C R R G1492u2 WIAF-12593 HT3506 4352 cell death-associated kinase TACAACACCA[A/G]TAACGGGGCT M A G N S G1492u3 WIAF-12606 HT3506 2127 cell death-associated kinase GCAATTTGGA[C/T]ATCTCCAACA S C T D D G1492u4 WIAF-12612 HT3506 1605 cell death-associated kinase TGAAATTTCT[C/T]AGTGAGAACA S C T L L G1494u1 WIAF-12589 HT28507 366 cell death-inducing protein Bik TTCACCACAC[T/C]TAAGGAGAAC M T C L P G1495u1 WIAF-12580 HT27803 759 CSE1L, chromosome segregation 1 TTTCTTCCCT[G/C]ATCCTGATCT S G C L L (yeast homolog)-like G1501u1 WIAF-13502 HT1949 1181 MCC, mutated in colorectal CAGCAATGAC[A/C]TTCCCATCGC M A C I L cancers G1501u2 WIAF-13503 HT1949 1753 MCC, mutated in colorectal CAGCTGAGAA[C/T]GCTGCCAAGG S C T N N cancers G1501u3 WIAF-13504 HT1949 2344 MCC, mutated in colorectal TGTCCCTAGC[T/C]GAACTCAGGA S T C A A cancers G1501u4 WIAF-13521 HT1949 445 MCC, mutated in colorectal AGCGAACGAC[G/A]CTTCGCTATG S G A T T cancers G1501u5 WIAF-13522 HT1949 1504 MCC, mutated in colorectal AAAGCAATGC[T/C]GAGAGGATGA S T C A A cancers G1501u6 WIAF-13527 MT1949 2511 MCC, mutated in colorectal TTCGTGAATG[A/G]TCTAAAGCGG M A G D G cancers G1502u1 WIAF-12633 HT1547 870 CCND1, cyclin D1 (PRAD1: AGTGTGACCC[A/G]GACTGCCTCC S A G P P parathyroid adenomatosis 1) G1503u1 WIAF-13741 U37022 1151 CDK4, cyclin-dependent kinase 4 CATGCCAATT[G/A]CATCGTTCAC M G A C Y G1503u2 WIAF-13742 U37022 1410 CDK4, cyclin-dependent kinase 4 CTGAAGCCGA[C/T]CAGTGGGGCA S C T D D G1503u3 WIAF-13743 U37022 1328 CDK4, cyclin-dependent kinase 4 TATGCAACAC[C/T]TGTGGACATG M C T P L G1503u4 WIAF-13780 U37022 1194 CDK4, cyclin-dependent kinase 4 TTCTGGTGAC[A/G]AGTGGTGGAA S A G T T G1503u5 WIAF-13781 U37022 1443 CDK4, cyclin-dependent kinase 4 TGATTGGGCT[G/A]CCTCCAGAGG S G A L L G1503u6 WIAF-13787 U37022 1633 CDK4, cyclin-dependent kinase 4 CTCTTATCTA[C/T]ATAAGGATGA M C T H Y G1517u1 WIAF-12618 HT1132 3894 ERBB3, v-erb-b2 avian CAGACCTCAG[T/C]GCCTCTCTGG S T C S S erythroblastic leukemia viral oncogene homolog 3 G152u1 WIAF-11608 HT3854 1673 HSPA1L, heat shock 70 kD protein- GTGAGTGATG[A/C]AGGTTTGAAG M A C E A like 1 G152u2 WIAF-11629 HT3854 1683 HSPA1L, heat shock 70 kD protein- AAGGTTTGAA[G/A]GGCAAGATTA S G A K K like 1 G152u3 WIAF-11609 HT3854 1478 HSPA1L, heat shock 70 kD protein- GTCACAGCCA[C/T]GGACAAGAGC M C T T M like 1 G152u4 WIAF-11610 HT3854 1443 HSPA1L, heat shock 70 kD protein- TGACGTTTGA[C/T]ATTGATGCCA S C T D D like 1 G1520u1 WIAF-12162 HT1175 2211 DNA excision repair protein ERCC2, TGACCGTGGA[C/T]GAGGGTGTCC S C T D D 5′ end G1520u2 WIAF-12166 HT1175 546 DNA excision repair protein ERCC2, CCCACTGCCG[A/C]TTCTATGAGG S A C R R 5′ end G1527u1 WIAF-12168 HT0086 577 GSTM2, glutathione S-transferase TCATCTCCCG[A/C]TTTGAGGGCT S A C R R M2 (muscle) G1527u2 WIAF-12169 HT0086 644 GSTM2, glutathione S-transferase ACCTGTGTTC[A/T]CAAAGATGGC M A T T S M2 (muscle) G1527u3 WIAF-12171 HT0086 100 GSTM2, glutathione S-transferase ACTCAAGCTA[C/T]GAGGAAAAGA S C T Y Y M2 (muscle) G1527u4 WIAF-12172 HT0086 41 GSTM2, glutathione S-transferase CGGGTACTGG[A/G]ACATCCGCGG M A G N D M2 (muscle) G1527u5 WIAF-12173 HT0086 215 GSTM2, glutathione S-transferase GATTGATGGG[A/G]CTGAGAAGAT M A G T A M2 (muscle) G1527u6 WIAF-12194 HT0086 238 GSTM2, glutathione S-transferase CCGAGAGCAA[T/C]GCCATCGTGC S T C N N M2 (muscle) G1528u1 WIAF-11950 HT1811 529 GSTM3, glutathione S-transferase GTATATTTGA[C/G]CCCAAGTGCC M C G D E M3 (brain) G1528u2 WIAF-11951 HT1811 674 GSTM3, glutathione S-transferase CAACAAGCCT[G/A]TATGCTGAGC M G A V I M3 (brain) G1528u3 WIAF-11989 HT1811 572 GSTM3, glutathione S-transferase GGCTTTGATG[T/G]GCCGTTTTGA M T G C G M3 (brain) G1528u4 WIAF-13470 HT1811 240 GSTM3, glutathione S-transferase GAGAGGAATG[C/A]CATCTTGCGC M C A A D M3 (brain) G1529u1 WIAF-14146 HT2006 797 GSTM4, glutathione S-transferase TGGACGCCTT[C/T]CCAAATGTGA S C T F F M4 G153u1 WIAF-12163 HT3856 1212 HSPA1B, heat shock 70 kD protein 1 TGGGGCTGGA[G/A]ACGGCCGGAG S G A E E G153u2 WIAF-12182 HT3856 676 HSPA1B, heat shock 70 kD protein 1 GGCCGGGGAC[A/G]CCCACCTGGG M A G T A G153u3 WIAF-12183 HT3856 1695 HSPA1B, heat shock 70 kD protein 1 TCAGCGAGGC[C/G]GACAAGAAGA S C G A A G153u4 WIAF-12189 HT3856 330 HSPA1B, heat shock 70 kD protein 1 AGAAGGGGGA[G/C]ACCAAGGCAT M G C E D G153u5 MIAF-12190 HT3856 1053 HSPA1B, heat shock 70 kD protein 1 AGCTGCTGGA[A/G]GACTTCTTGA S A G Q Q G1530u1 WIAF-11964 HT3010 673 GSTM5, glutathione S-transferase ATTCCTCCGA[G/A]GTCTTTTGTT M G A G S M5 G1530u2 WIAF-11995 HT3010 593 GSTM5, glutathione S-transferase GACGCCTTCC[T/C]AAACTTGAAG M T C L P M5 G1530u3 WIAF-13473 HT3010 693 GSTM5, glutathione S-transferase TTGGAAAGTC[A/G]GCTACATGGA S A G S S M5 G1533u1 WIAF-13458 HT27460 543 GSTT2, glutathione S-transferase CTCTCGGCTA[C/T]GAACTGTTTG S C T Y Y theta 2 G1533u2 WIAF-13460 HT27460 417 GSTT2, glutathione S-transferase GGACTGCGAT[G/A]GACCAGGCCC M G A M I theta 2 G1533u3 WIAF-13461 HT27460 359 GSTT2, glutathione S-transferase CAGGTGTTGG[G/A]GCCACTCATT M G A G E theta 2 G1533u4 WIAF-13462 HT27460 363 GSTT2, glutathione S-transferase TGTTGGGGCC[A/C]CTGATTGGGG S A C P P theta 2 G1533u5 WIAF-13463 HT27460 385 GSTT2, glutathione S-transferase CCAGGTGCCC[G/A]AGGAGAAGGT M G A E K theta 2 G1535u1 WIAF-11952 HT0436 517 HCK, hemopoietic cell kinase CCGCGTTGAC[T/C]CTCTGGAGAC M T C S P G1535u2 WIAF-12013 HT0436 783 HCK, hemopoietic cell kinase TGGACCACTA[C/T]AAGAAGGGGA S C T Y Y G1535u3 WIAF-13464 HT0436 357 HCK, hemopoietic cell kinase TCATCGTGGT[T/C]GCCCTGTATG S T C V V G1535u4 WIAF-13465 HT0436 387 HCK, hemopoietic cell kinase CCATTCACCA[C/T]GAAGACCTCA S C T H H G1535u5 WIAF-13466 HT0436 471 HCK, hemopoietic cell kinase CCCTGGCCAC[C/G]CGGAAGGAGG S C G T T G1535u6 WIAF-13467 HT0436 240 HCK, hemopoietic cell kinase CCAGCGCCAG[C/T]CCACACTGTC S C T S S G1535u7 WIAF-13468 HT0436 394 HCK, hemopoietic cell kinase CCACGAAGAC[C/T]TCAGCTTCCA M C T L F G1537u1 WIAF-12020 U04045 1514 MSH2, mutS (E. coli) homolog 2 GTGAATTAAG[A/G]GAAATAATGA S A G R R (colon cancer, nonpolyposis type 1) G1537u2 WIAF-12044 U04045 599 MSH2, mutS (E. coli) homolog 2 GACTGTGTGA[A/T]TTCCCTGATA M A T E D (colon cancer, nonpolyposis type 1) G1537u3 WIAF-12045 U04045 1452 MSH2, mutS (E. coli) homolog 2 AGATATGGAT[C/T]AGGTGGAAAA N C T Q * (colon cancer, nonpolyposis type 1) G1537u4 WIAF-12076 U04045 938 MSH2, mutS (E. coli) homolog 2 GACAGTTTGA[A/T]CTGACTACTT M A T E D (colon cancer, nonpolyposis type 1) G1537u5 WIAF-12077 U04045 1878 MSH2, mutS (E. coli) homolog 2 TCAGCTAGAT[G/A]CTGTTGTCAG M G A A T (colon cancer, nonpolyposis type 1) G1543u1 WIAF-13856 J00119 553 MOS, v-mos Moloney murine sarcoma GAGTTTCTGG[G/T]CTGAGCTCAA M G T A S viral oncogene homolog G1543u2 WIAF-13857 J00119 621 MOS, v-mos Moloney murine sarcoma GCACGCGCAC[G/A]CCCGCAGGOT S G A T T viral oncogene homolog G1544u1 WIAF-12018 U59464 3821 PTCH, patched (Drosophila) CATCCCGAAT[C/T]CAGGCATCAC M C T S F homolog G1544u2 WIAF-12019 U59464 3618 PTCH, patched (Drosophila) GCGTGGTCCG[C/T]TTCGCCATGC S C T R R homolog G1544u3 WIAF-12027 U59464 1761 PTCH, patched (Drosophila) ATTTTGCCAT[G/T]GTTCTGCTCA M G T M I homolog G1544u4 WIAF-12029 U59464 4074 PTCH, patched (Drosophila) CTGCCATGGG[C/T]AGCTCCGTGC S C T G G homolog G1544u5 WIAF-12043 U59464 3845 PTCH, patched (Drosophila) CCCTCGAACC[C/T]GAGACAGCAG M C T P L homolog G1544u6 WIAF-12056 U59464 1433 PTCH, patched (Drosophila) CTGCTGGTTG[C/T]ACTGTCAGTG M C T A V homolog G1544u7 WIAF-12058 U59464 3298 PTCH, patched (Drosophila) CACCGTTCAC[G/C]TTGCTTTGGC M G C V L homolog G1544u8 WIAF-12062 U59464 3986 PTCH, patched (Drosophila) TCTACTGAAG[G/A]GCATTCTGGC M G A G E homolog G1544u9 WIAF-13489 U59464 1665 PTCH, patched (Drosophila) CCATCAGCAA[T/C]GTCACAGCCT S T C N N homolog G1544u10 WIAF-13490 U59464 2396 PTCH, patched (Drosophila) AAATACTTTT[C/T]TTTCTACAAC M C T S F homolog G1544u11 WIAF-13491 U59464 2199 PTCH, patched (Drosophila) GGACACTCTC[A/G]TCTTTTGCTG S A G S S homolog G1544u12 WIAF-13492 U59464 2222 PTCH, patched (Drosophila) AAGCACTATG[C/T]TCCTTTCCTC M C T A V homolog G1544u13 WIAF-13500 U59464 1686 PTCH, patched (Drosophila) TCTTCATGGC[C/T]GCGTTAATCC S C T A A homolog G1545u1 WIAF-12032 HT0473 1835 RAG1, recombination activating GGACATGGAA[G/A]AAGACATCTT M G A E K gene 1 G1545u2 WIAF-12035 HT0473 2519 RAG1, recombination activating TGACATTGGC[A/G]ATGCAGCTGA M A G N D gene 1 G1545u3 WIAF-12046 HT0473 3045 RAG1, recombination activating CGGAAAATGA[A/G]TGCCAGGCAG M A G N S gene 1 G1545u4 WIAF-12047 HT0473 3146 RAG1, recombination activating TCATAATGCA[T/C]TAAAAACCTC S T C L L gene 1 G1545u5 WIAF-12075 HT0473 2513 RAG1, recombination activating CCACTGTGAC[A/T]TTGGCAATGC M A T I F gene 1 G1545u6 WIAF-13484 HT0473 1322 RAG1, recombination activating GTCGCTGACT[C/T]GGAGAGCTCA M C T R W gene 1 G1545u7 WIAF-13494 HT0473 2571 RAG1, recombination activating GAAGTGTATA[A/G]GAATCCCAAT M A G K R gene 1 G1545u8 WIAF-13498 HT0473 1018 RAG1, recombination activating TTCTGGCTGA[C/A]CCTGTGGAGA M C A D E gene 1 G1545u9 WIAF-13499 HT0473 2782 RAG1, recombination activating ATCTTTACCT[G/C]AAGATGAAAC S G C L L gene 1 G1548u1 WIAF-12015 HT4999 133 IFI27, interferon, alpha- CTCTGCCGTA[G/A]TTTTGCCCCT M G A V I inducible protein 27 G1548u2 WIAF-13482 HT4999 380 IFI27, interferon, alpha- ATCCTGGGCT[C/T]CATTGGGTCT M C T S F inducible protein 27 G1548u3 WIAF-13483 HT4999 135 IFI27, interferon, alpha- CTGCCGTAGT[T/C]TTGCCCCTGG S T C V V inducible protein 27 G155u1 WIAF-11634 HT3962 991 CHC1, chromosome condensation 1 AGCTGGATGT[G/A]CCTGTGGTAA S G A V V G155u2 WIAF-11635 HT3962 1271 CHC1, chromosome condensation 1 CGGGTTCGGC[C/T]TCTCCAACTA M C T L F G155u3 WIAF-11636 HT3962 1192 CHC1, chromosome condensation 1 GCCGGGGCCA[C/T]GTGAGATTCC S C T H H G155u4 WIAF-11637 HT3962 1267 CHC1, chromosome condensation 1 TGTACGGCTT[C/T]GGCCTCTCCA S C T F F G155u5 WIAF-11649 HT3962 1657 CHC1, chromosome condensation 1 TGATGGGCAA[A/G]CAGCTGGAGA S A G K K G1550u1 WIAF-12057 M16038 611 LYN, v-yes-1 Yamaguchi sarcoma GCAAAGTCCC[T/G]TTTAACAAAA M T G L R viral related oncogene homolog G1550u2 WIAF-12061 M16038 1371 LYN, v-yes-1 Yamaguchi sarcoma TGGCATACAT[C/T]GAGCGGAAGA S C T I I viral related oncogene homolog G1550u3 WIAF-12080 M16038 1059 LYN, v-yes-1 Yamaguchi sarcoma AAAGGCTTGG[C/T]GCTGGGCAGT S C T G G viral related oncogene homolog G1550u4 WIAF-12081 M16038 996 LYN, v-yes-1 Yamaguchi sarcoma AGCCACAGAA[G/A]CCATGGGATA S G A K K viral related oncogene homolog G1552u1 WIAF-12030 HT4578 2355 PMS1, postmeiotic segregation CCTGCTATTT[A/T]AAAGACTTCT N A T K * increased (S. cerevisiae) 1 G1552u2 WIAF-12031 HT4578 2231 PMS1, postmeiotic segregation ACAAAGTTGA[C/T]TTAGAAGAGA S C T D D increased (S. cerevisiae) 1 G1552u3 WIAF-12040 HT4578 617 PMS1, postmeiotic segregation TCATGAGCTT[T/C]GGTATCCTTA S T C F F increased (S. cerevisiae) 1 G1552u4 WIAF-12063 HT4578 1723 PMS1, postmeiotic segregation TCATGTAACA[A/G]AAAATCAAAT M A G K R increased (S. cerevisiae) 1 G1552u5 WIAF-12064 HT4578 1732 PMS1, postmeiotic segregation AAAAAATCAA[A/G]TGTAATAGAT M A G N S increased (S. cerevisiae) 1 G1552u6 WIAF-12065 HT4578 1660 PMS1, postmeiotic segregation TTACCATGTA[A/G]AGTAAGTAAT M A G K R increased (S. cerevisiae) 1 G1552u7 WIAF-12066 HT4578 1975 PMS1, postmeiotic segregation GAACGATACA[A/G]TAGTCAAATG M A G N S increased (S. cerevisiae) 1 G1552u8 WIAF-12067 HT4578 1881 PMS1, postmeiotic segregation TTTAGAGGAT[G/T]CAACACTACA M G T A S increased (S. cerevisiae) 1 G1552u9 WIAF-12068 HT4578 2454 PMS1, postmeiotic segregation TTTAGACGTT[T/A]TATATAAAAT M T A L I increased (S. cerevisiae) 1 G1552u10 WIAF-12069 HT4578 2457 PMS1, postmeiotic segregation AGACGTTTTA[T/C]ATAAAATGAC M T C Y H increased (S. cerevisiae) 1 G1552u11 WIAF-12082 HT4578 2557 PMS1, postmeiotic segregation ATACCAGGAG[T/C]TTCAATTACT M T C V A increased (S. cerevisiae) 1 G1552u12 WIAF-12083 HT4578 971 PMS1, postmeiotic segregation TTTTCTTTCT[G/T]AAAATCGATG S G T L L increased (S. cerevisiae) 1 G1554u1 WIAF-12028 HT4161 1500 ELK3, ELK3, ETS-domain protein CTCAGAAATC[C/T]TGATGACGTC S C T S S (SRF accessory protein 2) NOTE: Symbol and name provisional. G1554u2 WIAF-12059 HT4161 1380 ELK3, ELK3, ETS-domain protein CTGCCAGGCT[G/A]CAAGGGCCAA S G A L L (SRF accessory protein 2) NOTE: Symbol and name provisional. G1554u3 WIAF-12060 HT4161 1436 ELK3, ELK3, ETS-domain protein CACATGCCAG[T/C]GCCAATCCCC M T C V A (SRF accessory protein 2) NOTE: Symbol and name provisional. G1562u1 WIAF-12024 HT28220 804 PDCD1, programmed cell death 1 GGGGCTCAGC[T/C]GACGGCCCTC S T C A A G1562u2 WIAF-13488 HT28220 644 PDCD1, programmed cell death 1 GACCCCTCAG[C/T]CGTGCCTGTG M C T A V G1563u1 WIAF-13493 HT1187 1748 EGFR, epidermal growth factor CCGGAGCCCA[G/A]GGACTGCGTC M G A R K receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog) G1563u2 WIAF-13497 HT1187 2073 EGFR, epidermal growth factor ACGGATGCAC[T/A]GGGCCAGGTC S T A T T receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene homolog) G1566u1 WIAF-12016 HT27594 235 PDCD2, programmed cell death 2 GCGCCGCCTGC[C/G]TGGCCGCCCG M C G P R G1566u2 WIAF-12033 HT27594 904 PDCD2, programmed cell death 2 TTGGAATTCC[A/G]GGTCATGCCT M A G Q R G1566u3 WIAF-12041 HT27594 331 PDCD2, programmed cell death 2 AATCAACTAC[C/T]CAGGAAAAAC M C T P L G1566u4 WIAF-12071 HT27594 649 PDCD2, programmed cell death 2 CCTGAGGTTG[T/C]GGAAAAGGAA M T C V A G1566u5 WIAF-12072 HT27594 633 PDCD2, programmed cell death 2 AGAAGATGAG[A/T]TTATGCCTGA M A T I F G1567u1 WIAF-12042 M95936 293 AKT2, v-akt murine thymoma viral GAGAGGCCGC[G/A]ACCCAACACC M G A R Q oncogene homolog 2 G1572u1 WIAF-12212 HT3998 1894 proto-oncogene c-abl, tyrosine TGTTCCAGGA[A/G]TCCAGTATCT S A G E E protein kinase, alt. transcript 2 G1572u2 WIAF-12233 HT3998 3694 proto-oncogene c-abl, tyrosine AGCTTCAGAT[C/T]TGCCCGGCGA S C T I I protein kinase, alt. transcript 2 G1572u3 WIAF-12234 HT3998 3721 proto-oncogene c-abl, tyrosine GCAGTGGTCC[G/A]GCGGCCACTC S G A P P protein kinase, alt. transcript 2 G1573u1 WIAF-12021 HT0642 343 CBL, Cas-Br-M (murine) ecotropic TCATGGACAA[G/C]GTGGTGCGGT M G C K N retroviral transforming sequence G1573u2 WIAF-12022 HT0642 363 CBL, Cas-Br-M (murine) ecotropic TTGTGTCAGA[A/T]CCCAAAGCTG M A T N I retroviral transforming sequence G1573u3 WIAF-12034 HT0642 2364 CBL, Cas-Br-M (murine) ecotropic AATATTCAGT[C/T]CCAGGCGCCA M C T S F retroviral transforming sequence G1573u4 WIAF-12049 HT0642 387 CBL, Cas-Br-M (murine) ecotropic CTAAAGAATA[G/A]CCCACCTTAT M G A S N retroviral transforming sequence G1573u5 WIAF-12050 HT0642 947 CBL, Cas-Br-M (murine) ecotropic AACTCATCCT[G/A]GCTACATGGC M G A G S retroviral transforming sequence G1573u6 WIAF-12070 HT0642 2740 CBL, Cas-Br-M (murine) ecotropic TCGAGAACCT[C/T]ATGAGTCAGG S C T L L retroviral transforming sequence G1573u7 WIAF-12073 HT0642 661 CBL, Cas-Br-M (murine) ecotropic TCTTTCCAAG[T/C]GGACTCTTTC S T C S S retroviral transforming sequence G1573u8 WIAF-12074 HT0642 2569 CBL, Cas-Br-M (murine) ecotropic CTCTGGATGG[T/C]GATCCTACAA S T C G G retroviral transforming sequence G1573u9 WIAF-13486 HT0642 2006 CBL, Cas-Br-M (murine) ecotropic CCGGCACTCA[C/T]TTCCATTTTC M C T L F retroviral transforming sequence G1574u1 WIAF-12037 HT1508 2493 FES, feline sarcoma (Snyder- AGCGGCCCAG[C/T]TTCAGCACCA S C T S S Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u2 WIAF-12051 HT1508 189 FES, feline sarcoma (Snyder- CCCAGCGGCT[C/T]AAGAGTGACA S C T V V Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u3 WIAF-12052 HT1508 1441 FES, feline sarcoma (Snyder- GAAGCCCCTG[C/T]ATGAGCAGCT M C T H Y Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u4 WIAF-12053 HT1508 2202 FES, feline sarcoma (Snyder- GAGAGGAAGC[C/T]GATGGGGTCT S C T A A Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u5 WIAF-12054 HT1508 2088 FES, feline sarcoma (Snyder- CTGCTGGCAT[G/T]GAGTACCTGG M G T M I Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u6 WIAF-12078 HT1508 1577 FES, feline sarcoma (Snyder- GATGGTCTGC[C/T]CCGGCACTTC M C T P L Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u7 WIAF-13495 HT1508 579 FES, feline sarcoma (Snyder- GTGACAAGGC[T/C]AAGGACAAGT S T C A A Theilen) viral (v-fes)/Fujinami avian sarcoma (PRCII) viral (v- fps) oncogene homolog G1575u1 WIAF-12079 HT1052 963 FGR, Gardner-Rasheed feline TGGGCACCGG[C/T]TGCTTCGGGG S C T G G sarcoma viral (v-fgr) oncogene homolog G1575u2 WIAF-13487 HT1052 232 FGR, Gardner-Rasheed feline CAGAAGCTAC[G/A]GGGCAGCAGA M G A G R sarcoma viral (v-fgr) oncogene homolog G1585u1 WIAF-12017 HT1675 996 CRK, v-crk avian sarcoma virus TGGATCAACA[G/A]AATCCCGATG S G A Q Q CT10 oncogene homolog G1585u2 WIAF-12036 HT1675 446 CRK, v-crk avian sarcoma virus ACTACAACGT[T/C]GATAGAACCA M T C L S CT10 oncogene homolog G1587u1 WIAF-12023 HT0590 1473 proto-oncogene dbl GGCCAATCCA[A/G]TTTGTGGTAC S A G Q Q G1587u2 WIAF-12025 HT0590 2549 proto-oncogene dbl GTCCAGGCTT[C/T]TAATGTAGAT M C T S F G1587u3 WIAF-12026 HT0590 2828 proto-oncogene dbl GCATCACAAT[C/T]TGCAGAAATC M C T S F G1587u4 WIAF-12038 HT0590 982 proto-oncogene dbl AAATTCTCAG[G/C]AGCTATTATC M G C E Q G1587u5 WIAF-12039 HT0590 2343 proto-oncogene dbl AACCAATGCA[G/T]CGACACCTTT M G T Q H G1587u6 WIAF-12048 HT0590 683 proto-oncogene dbl GACACTGAAG[G/A]AGCTGTCAGT M G A G E G1587u7 WIAF-12055 HT0590 2686 proto-oncogene dbl TTCTCTTCAG[C/T]AGAATGATGA N C T Q * G1587u8 WIAF-13485 HT0590 2136 proto-oncogene dbl ACTGTGAAGG[T/A]TCTGCTCTGT S T A G G G1587u9 WIAF-13496 HT0590 1566 proto-oncogene dbl AAAATCAGAG[C/T]AACTTAAAAA S C T S S G159u1 WIAF-11616 HT4209 1059 RAD23B, RAD23 (S. cerevisiae) AGTACTGGGG[C/T]TCCTCAGTCT M C T A V homolog B G1590u1 WIAF-13897 HT2455 1257 ETS2, v-ets avian GCCAGTCTCT[G/C]TGCCTCAATA S C G L L erythroblastosis virus E26 oncogene homolog 2 G1590u2 WIAF-13913 HT2455 1107 ETS2, v-ets avian ATTCTGGGAC[T/G]CCCAAAGACC S T G T T erythroblastosis virus E26 oncogene homolog 2 G1590u3 WIAF-13914 HT2455 1314 ETS2, v-ets avian GGAGTGACCC[A/G]GTGGAGCAAG S A G P P erythroblastosis virus E26 oncogene homolog 2 G1591u1 WIAF-13924 HT2333 417 HRAS, v-Ha-ras Harvey rat sarcoma TCCAGAACCA[T/C]TTTGTGGACG S T C H H viral oncogene homolog G1595u1 WIAF-12262 HT33778 1302 proto-oncogene 1-myc, alt. GCATACCTCA[G/C]TGGCTACTAA M G C S T transcript 1 G1597u1 WIAF-12243 HT0410 900 MAS1, MAS1 oncogene CCATCTTGGT[C/T]GTGAAGATCC S C T V V G160u1 WIAF-11630 HT4247 690 RAD23A, RAD23 (S. cerevisiae) AGAGCCAGGT[A/G]TCGGAGCAGC S A G V V homolog A G1602u1 WIAF-14180 HT1903 1321 proto-oncogene pim-1 GTCGCCGGGG[C/A]CCAGCAAATA M C A P T G1604u1 WIAF-12319 HT2788 1182 REL, v-rel avian CCTCCCAAAG[T/C]GCTGGGATTA S T C S S reticuloendotheliosis viral oncogene homolog G1609u1 WIAF-12358 HT33646 348 RIPK1, receptor (TNFRSF)- GACGCAGGGT[C/T]TCCCATGACC S C T V V interacting serine-threonine kinase 1 G161u1 WIAF-11654 HT4251 1522 DNA repair and recombination TATGATCCAT[C/T]TTAACTGAGG M C T S F homolog RAD52 G1610a1 WIAF-12101 HT27727 501 replication protein Rpa4, 30 kDa TGCAACTCCT[G/A]CTATTAAGAC M G A A T G1610a2 WIAF-12102 HT27727 554 replication protein Rpa4, 30 kDa TACCGTGTAA[C/T]GTGAACCAGC S C T N N G1610u3 WIAF-12307 HT27727 450 replication protein Rpa4, 30 kDa TTCTGCTGCT[G/A]ATGGAGCGAG M G A D N G1610u4 WIAF-12320 HT27727 1037 replication protein Rpa4, 30 kDa TGATTCATGA[G/C]TGTCCTCATC M G C E D G1610u5 WIAF-12321 HT27727 857 replication protein Rpa4, 30 kDa TAGAGGACAT[G/A]AACGAGTTCA M G A M I G1610u6 WIAF-12343 HT27727 539 replication protein Rpa4, 30 kDa GAATTCAGGA[C/T]GTTGTACCGT S C T D D G1630u1 WIAF-12302 HT3563 4312 DCC, deleted in colorectal ACTCATGAAG[C/T]AGCTTAATGC N C T Q * carcinoma G1632u1 WIAF-13572 HT27355 742 tumor suppressor, PDGF receptor TTTATGACAT[G/C]AAGCGGGGCT M G C M I beta-like G1632u2 WIAF-13584 HT27355 1102 tumor suppressor, PDGF receptor TGGAAGACTT[C/T]GAGACCATTG S C T F F beta-like G1632u3 WIAF-13601 HT27355 258 tumor suppressor, PDGF receptor AAGACGCAGT[C/T]TATCATGATG M C T S F beta-like G1633u1 WIAF-13957 HT1778 1263 FER, fer (fpa/fes related) TTCAGGCAAA[T/C]GAGATCATGT S T C N N tyrosine kinase (phosphoprotein NCP94) G1633u2 WIAF-13958 HT1778 2407 FER, fer (fpa/fes related) TATGTTGTAT[C/T]TCGAGAGTAA M C T L F tyrosine kinase (phosphoprotein NCP94) G1634u1 WIAF-13505 HT3216 1569 ELK1, ELK1, member of ETS TCTCGACCCC[C/T]GTGGTGCTCT S C T P P oncogene family G1634u2 WIAF-13858 HT3216 456 ELK1, ELK1, member of ETS GGCTGTGGGG[A/G]CTACGCAAGA S A G G G oncogene family G1634u3 WIAF-13859 HT3216 745 ELK1, ELK1, member of ETS AGGCCCAGGC[G/A]GTTTGGCACG M G A G S oncogene family G1638u1 WIAF-14172 HT1224 98 uracil-DNA glycosylase GCTGGGACCT[G/C]TTCCACAAAT — G C — — G1643u1 WIAF-13517 HT3751 629 DXS648E, DNA segment on TACATCCCCA[G/A]TCGTGGCCCT M G A S N chromosome X (unique) 648 expressed sequence G1645u1 WIAF-14087 D21089 363 XPC, xeroderma pigmentosum, AAAACCTCAA[G/A]GTTATAAAGG S G A K K complementation group C G1645u2 WIAF-14088 D21089 2166 XPC, xeroderma pigmentosum, TGCATTCCAG[G/A]GACACGTGGC S G A R R complementation group C G1645u3 WIAF-14089 D21089 1580 XPC, xeroderma pigmentosum, GGGAGCCATC[G/A]TAAGGACCCA M G A R H complementation group C G1645u4 WIAF-14090 D21089 1601 XPC, xeroderma pigmentosum, AGCTTGCCAG[T/C]GGCATCCTCA M T C V A complementation group C G1645u5 WIAF-14091 D21089 2920 XPC, xeroderma pigmentosum, CCCATTTGAG[A/C]AGCTGTGAGC M A C K Q complementation group C G1645u6 WIAF-14103 D21089 405 XPC, xeroderma pigmentosum, ATGACCTCAG[G/A]GACTTTCCAA S G A R R complementation group C G1645u7 WIAF-14104 D21089 151 XPC, xeroderma pigmentosum, GGGACGCGAA[C/G]TGCGCAGCCA M C G L V complementation group C G1645u8 WIAF-14105 D21089 2133 XPC, xeroderma pigmentosum, AAGCGGTCTA[C/T]TCCAGGGATT S C T Y Y complementation group C G167u1 WIAF-11632 HT4579 83 PMS2L8, postmeiotic segregation CCTATTGATC[G/A]GAAGTCAGTC M G A R Q increased 2-like 8 G167u2 WIAF-11633 HT4579 219 PMS2L8, postmeiotic segregation GAGTGGATCT[T/C]ATTGAAGTTT S T C L L increased 2-like 8 G167u3 WIAF-11644 HT4579 768 PMS2L8, postmeiotic segregation TGCCCCCTAG[T/C]GACTCCGTGT S T C S S increased 2-like 8 G167u4 WIAF-11622 HT4579 1645 PMS2L8, postmeiotic segregation GAAAGCGCCT[G/A]AAACTGACGA M G A E K increased 2-like 8 G167u5 WIAF-11645 HT4579 1512 PMS2L8, postmeiotic segregation ACTCGGGGCA[C/T]GGCAGCACTT S C T H H increased 2-like 8 G167u6 WIAF-11646 HT4579 1619 PMS2L8, postmeiotic segregation TCGCAGGAAC[A/G]TGTGGACTCT M A G H R increased 2-like 8 G167u7 WIAF-11647 HT4579 1432 PMS2L8, postmeiotic segregation CGTCCTGAGA[C/T]CTCAGAAAGA M C T P S increased 2-like 8 G167u8 WIAF-11625 HT4579 2490 PMS2L8, postmeiotic segregation GGACTGCTCT[T/C]AACACAAGCG S T C L L increased 2-like 8 G167u9 WIAF-11619 HT4579 804 PMS2L8, postmeiotic segregation TGAGCTGTTC[G/C]GATGCTCTGC S G C S S increased 2-like 8 G167u10 WIAF-11623 HT4579 1555 PMS2L8, postmeiotic segregation CATCCCAGAC[A/G]CGGGCAGTCA M A G T A increased 2-like 8 G167u11 WIAF-11624 HT4579 2364 PMS2L8, postmeiotic segregation CCTTCGGACC[C/T]CAGGACGTCG S C T P P increased 2-like 8 G167u12 WIAF-11626 HT4579 2348 PMS2L8, postmeiotic segregation ACTAGTAAAA[A/G]CTGGACCTTC M A G N S increased 2-like 8 G181u1 WIAF-11697 HT48793 311 ERCC4, excision repair cross- ATATTTGCGA[C/T]AAGTAGGATA M C T T I complementing rodent repair deficiency, complementation group 4 G181u2 WIAF-11698 HT48793 295 ERCC4, excision repair cross- CACACAAGGT[G/C]GTGTTATATT M G C G R complementing rodent repair deficiency, complementation group 4 G181u3 WIAF-11699 HT48793 234 ERCC4, excision repair cross- TTGAACACCT[C/T]CCTCGCCGTG S C T L L complementing rodent repair deficiency, complementation group 4 G181u4 WIAF-11704 HT48793 808 ERCC4, excision repair cross- TTTGTGGCAC[C/T]AGCTTGGACC N C T Q * complementing rodent repair deficiency, complementation group 4 G181u5 WIAF-11705 HT48793 640 ERCC4, excision repair cross- TTCTATGACA[C/T]CTACCATGCT M C T P S complementing rodent repair deficiency, complementation group 4 G181u6 WIAF-11670 HT48793 1117 ERCC4, excision repair cross- AGAAAGCAAC[C/T]CAAAGTGGGA M C T P S complementing rodent repair deficiency, complementation group 4 G185u1 WIAF-11668 HT5122 319 ACVR2B, activin A receptor, type TCTGCAACGA[G/A]CGCTTCACTC S G A E E IIB G185u2 WIAF-11707 HT5122 70 ACVR2B, activin A receptor, type AGACACGGGA[G/C]TGCATCTACT M G C E D IIB G185u3 WIAF-11672 HT5122 812 ACVR2B, activin A receptor, type CCTCACGGAT[T/C]ACCTCAAGGG M T C Y H IIB G185u4 WIAF-13542 X77533 1109 ACVR2B, activin A receptor, type GGCTCCTGAG[G/A]TGCTCGAGGG M G A V M IIB G185u5 WIAF-13558 X77533 997 ACVR2B, activin A receptor, type TGCTGAAGAG[C/T]GACCTCACAG S C T S S IIB G187u1 WIAF-11669 HT97400 183 androgen CCAGAGACAG[C/T]GCGACCCGGA M C T R C G191u1 WIAF-10176 AF025375 414 CXCR4, chemokine (C-X-C motif), ACCTGGCCAT[C/T]GTCCACGCCA S C T I I receptor 4 (fusin) G193u1 WIAF-10178 D29984 231 CCR2, chemokine (C-C motif) AGTGCTTGAC[T/A]GACATTTACC S T A T T receptor 2 G193u2 WIAF-10179 D29984 190 CCR2, chemokine (C-C motif) CATGCTGGTC[G/A]TCCTCATCTT M G A V I receptor 2 G194u1 WIAF-10211 D43767 121 SCYA17, small inducible cytokine ACATCCACGC[A/C]GCTCGAGGGA S A C A A subfamily A (Cys-Cys), member 17 G197u1 WIAF-10167 D50403 1515 NRAMP1, natural resistance- GGTGCTAGTC[T/C]GCGCCATCAA M T C C R associated macrophage protein 1 (might include Leishmaniasis) G197u2 WIAF-10173 D50403 1629 NRAMP1, natural resistance- CACCTACCTG[G/C]TCTGGACCTG M G C V L associated macrophage protein 1 (might include Leishmaniasis) G20u1 WIAF-10249 U14722 896 ACVR1B, activin A receptor, type CGGTACACAG[T/C]GACAATTGAG M T C V A IB G20u2 WIAF-10250 U14722 866 ACVR1B, activin A receptor, type GAGCACGGGT[C/T]CCTGTTTGAT M C T S F IB G20u3 WIAF-10251 U14722 1391 ACVR1B, activin A receptor, type CAGAGTTATG[A/T]GGCACTGCGG M A T E V IB G20u4 WIAF-10252 U14722 1236 ACVR1B, activin A receptor, type TATATTGGGA[G/C]ATTGCTCGAA M G C E D IB G20u5 WIAF-10261 U14722 518 ACVR1B, activin A receptor, type GAGATGTGTC[T/C]CTCCAAAGAC M T C L P IB G207a1 WIAF-10516 L25259 866 Human CTLA4 counter-receptor (B7- AGCTGTACTT[C/T]CAACAGTTAT M C T P S 2) mRNA, complete cds. G208u1 WIAF-10204 L31581 85 CCR7, chemokine (C-C motif) GGGGAAACCA[A/G]TGAAAAGCGT M A G M V receptor 7 G211u1 WIAF-10213 M24545 174 SCYA2, small inducible cytokine TCACCTGCTG[T/C]TATAACTTCA S T C C C A2 (monocyte chemotactic protein 1, homologous to mouse Sig-je) G214u1 WIAF-10191 M27533 452 CD80, CD80 antigen (CD28 antigen TGAAAGAAGT[G/A]GCAACGCTGT S G A V V ligand 1, B7-1 antigen) G215u1 WIAF-11659 M28393 822 PRF1, perforin 1 (preforming GCATCTCTGC[C/T]GAAGCCAAGG S C T A A protein) G215u2 WIAF-11723 M28393 159 PRF1, perforin 1 (preforming TGACCAGCCT[C/T]CGCCGCTCCG S C T L L protein) G215u3 WIAF-11724 M28393 96 PRF1, perforin 1 (preforming CAGAGTGCAA[G/A]CGCAGCCACA S G A K K protein) G215u4 WIAF-11725 M28393 1377 PRF1, perforin 1 (preforming ATAACAACCC[C/T]ATCTGGTCAG S C T P P protein) G215u5 WIAF-11726 M28393 1326 PRF1, perforin 1 (preforming TGAAGCTCTT[C/T]TTTGGTGGCC S C T F F protein) G215u6 WIAF-11727 M28393 1076 PRF1, perforin 1 (preforming CGGCGGGAGG[C/T]ACTGAGGAGG M C T A V protein) G217u1 WIAF-11691 M31932 649 FCGR2B, Fc fragment of IgG, low GCAGCTCTTC[A/G]CCAATGGGGA S A G S S affinity IIb, receptor for (CD32) G217u2 WIAF-11692 M31932 625 FCGR2B, Fc fragment of IgG, low TCACTGTCCA[A/G]GTGCCCAGCA S A G Q Q affinity IIb, receptor for (CD32) G217u3 WIAF-11712 M31932 332 FCGR2B, Fc fragment of IgG, low GACTGGCCAG[A/C]CCAGCCTCAG M A C T P affinity IIb, receptor for (CD32) G217u4 WIAF-11713 M31932 101 FCGR2B, Fc fragment of IgG, low GGCTTCTGCA[G/T]ACAGTCAAGC M G T D Y affinity IIb, receptor for (CD32) G218u1 WIAF-10184 M36712 677 CD8B1, CD8 antigen, beta TTTTACAAAT[A/G]AGCAGAGAAT N A G * * polypeptide 1 (p37) G218u2 WIAF-10188 M36712 326 CD8B1, CD8 antigen, beta GCTGTGTTTC[G/C]GGATGCAAGC M G C R P polypeptide 1 (p37) G218u3 WIAF-10189 M36712 196 CD8B1, CD8 antigen, beta CAGTAACATG[C/T]GCATCTACTG M C T R C polypeptide 1 (p37) G218u4 WIAF-10190 M36712 225 CD8B1, CD8 antigen, beta AGCGCCAGGC[A/C]CCGAGCAGTG S A C A A polypeptide 1 (p37) G218u5 WIAF-10194 M36712 583 CD8B1, CD8 antigen, beta GGTGGCTGGC[G/A]TCCTGGTTCT M G A V I polypeptide 1 (p37) G218u6 WIAF-10208 M36712 372 CD8B1, CD8 antigen, beta TGAAGCCGGA[A/G]GACAGTGGCA S A G E E polypeptide 1 (p37) G218u7 WIAF-10209 M36712 400 CD8B1, CD8 antigen, beta CTGCATGATC[G/T]TCGGGAGCCC M G T V F polypeptide 1 (p37) G218u8 WIAF-10210 M36712 270 CD8B1, CD8 antigen, beta TCTGGGATTC[C/T]GCAAAAGGGA S C T S S polypeptide 1 (p37) G218a9 WIAF-10518 M36712 618 CD8B1, CD8 antigen, beta GAGTGGCCAT[C/G]CACCTGTGCT M C G I M polypeptide 1 (p37) G218a10 WIAF-13223 M36712 556 CD8B1, CD8 antigen, beta TTGTAGCCCC[A/G]TCACCCTTGG M A G I V polypeptide 1 (p37) G218a11 WIAF-13224 M36712 836 CD8B1, CD8 antigen, beta CTGTGTGTGA[T/C]GTGCATGGGA — T C — — polypeptide 1 (p37) G22u1 WIAF-10301 U86136 6719 Human telomerase-associated GGTGGTAACC[G/A]TCGGGCTAGA M G A V I protein TP-1 mRNA, complete cds. G22u2 WIAF-10302 U86136 7537 Human telomerase-associated CTGATGGGAT[C/G]CTATGGAACC M C G I M protein TP-1 mRNA, complete cds. G22u3 WIAF-10311 U86136 1798 Human telomerase-associated ATGATGCCAT[T/C]GATGCCCTCG S T C I I protein TP-1 mRNA, complete cds. G22u4 WIAF-10312 U86136 2397 Human telomerase-associated CTGTCTCTGG[C/T]TGGCCAAAGG M C T A V protein TP-1 mRNA, complete cds. G22u5 WIAF-10313 U86136 3289 Human telomerase-associated AGAAAGGGAT[A/C]ACCTGCCGCA S A C I I protein TP-1 mRNA, complete cds. G22u6 WIAF-10314 U86136 3242 Human telomerase-associated AGAGGCCGCA[T/C]GTCGGATCTC M T C C R protein TP-1 mRNA, complete cds. G22u7 WIAF-10315 U86136 4482 Human telomerase-associated CCGTTTGCCT[G/A]CCTCGTCCAG M G A C Y protein TP-1 mRNA, complete cds. G22u8 WIAF-10316 U86136 4363 Human telomerase-associated GTTTGACTGT[G/A]GACCAGCTGC S G A V V protein TP-1 mRNA, complete cds. G22u9 WIAF-10317 U86136 4230 Human telomerase-associated GTGTCTGAGA[G/A]ACTCCGGACC M G A R K protein TP-1 mRNA, complete cds. G22u10 WIAF-10318 U86136 4419 Human telomerase-associated GGGACTAAGA[G/C]CTGGGAAGAA M G C S T protein TP-1 mRNA, complete cds. G22u11 WIAF-10319 U86136 5269 Human telomerase-associated TCTCCGATGA[T/C]ACACTCTTTC S T C D D protein TP-1 mRNA, complete cds. G22u12 WIAF-10320 U86136 5015 Human telomerase-associated GCTGCTCTCC[C/T]GGAGATGGCA M C T R W protein TP-1 mRNA, complete cds. G22u13 WIAF-10321 U86136 5133 Human telomerase-associated GTGGCCTTCT[C/T]CACCAATGGG M C T S F protein TP-1 mRNA, complete cds. G22u14 WIAF-10322 U86136 7764 Human telomerase-associated ACAGCCCTCC[A/G]TGTGCTACCT M A G H R protein TP-1 mRNA, complete cds. G22u15 WIAF-10323 U86136 7884 Human telomerase-associated TGCCTGGAAC[C/T]TTGGCTGGGC M C T P L protein TP-1 mRNA, complete cds. G22u16 WIAF-10324 U86136 7744 Human telomerase-associated AGATTCACTC[G/A]GGCTCTGTCA S G A S S protein TP-1 mRNA, complete cds. G22u17 WIAF-10337 U86136 1018 Human telomerase-associated CCATTGCTGC[T/C]TTCTTGCCGG S T C A A protein TP-1 mRNA, complete cds. G22u18 WIAF-10338 U86136 1000 Human telomerase-associated TGGCCAATAA[C/A]ATCTTGGCCA M C A N K protein TP-1 mRNA, complete cds G22u19 WIAF-10339 U86136 1182 Human telomerase-associated ATGACGGACA[A/G]ATTTGCCCAG M A G K R protein TP-1 mRNA, complete cds. G22u20 WIAF-10340 U86136 1939 Human telomerase-associated AGCAGCTTCG[T/G]ATGGCAATGA S T G R R protein TP-1 mRNA, complete cds. G22u21 WIAF-10341 U86136 2227 Human telomerase-associated TCACGAGGGC[G/A]GAGCAGGTGG S G A A A protein TP-1 mRNA, complete cds. G22u22 WIAF-10342 U86136 2776 Human telomerase-associated GGCGCAGCAT[C/T]CGGCTTTTCA S C T I I protein TP-1 mRNA, complete cds. G22u23 WIAF-10343 U86136 2877 Human telomerase-associated GCCCCTCACC[G/A]TATCAGCCTT M G A R H protein TP-1 mRNA, complete cds. G22u24 WIAF-10344 U86136 3087 Human telomerase-associated TCAGGGCGCT[C/T]TGTGACAGAG M C T S F protein TP-1 mRNA, complete cds. G22u25 WIAF-10345 U86136 3662 Human telomerase-associated CAAGGTGGCA[C/T]CATTAGTCTT M C T P S protein TP-1 mRNA, complete cds. G22u26 WIAF-10346 U86136 4762 Human telomerase-associated TTTCGAAGTT[C/T]CTTACCAACC S C T F F protein TP-1 mRNA, complete cds. G22u27 WIAF-10351 U86136 1737 Human telomerase-associated CTCCAGCATG[G/C]GAAGTCGGTG M G C G A protein TP-1 mRNA, complete cds. G22u28 WIAF-10352 U86136 3543 Human telomerase-associated ACAGTGCAAC[A/G]GCTGATGCTG M A G Q R protein TP-1 mRNA, complete cds. G22u29 WIAF-10353 U86136 4232 Human telomerase-associated GTCTGAGAGA[C/T]TCCGGACCCT M C T L F protein TP-1 mRNA, complete cds. G22u30 WIAF-10354 U86136 4523 Human telomerase-associated GGAGGGCCCT[C/T]TGGAGCGCCC S C T L L protein TP-1 mRNA, complete cds. G22u31 WIAF-10355 U86136 5333 Human telomerase-associated TGGTTGTCGG[G/T]TGCTGCAGAC M G T V L protein TP-1 mRNA, complete cds. G22u32 WIAF-10356 U86136 6208 Human telomerase-associated AGCTGCTGAC[G/A]CGGCCACACA S G A T T protein TP-1 mRNA, complete cds. G22u33 WIAF-10357 U86136 7703 Human telomerase-associated TAGTGAGCCA[A/G]CACCACATCT M A G T A protein TP-1 mRNA, complete cds. G22u34 WIAF-10360 U86136 3881 Human telomerase-associated CATCGATGGG[G/A]CTGATAGGTT M G A A T protein TP-1 mRNA, complete cds. G222u1 WIAF-11700 M57230 697 IL6ST, interleukin 6 signal TGAGTGGGAT[G/C]GTGGAAGGGA M G C G R transducer (gp130, oncostatin M receptor) G222u2 WIAF-11701 M57230 708 IL6ST, interleukin 6 signal GTGGAAGGGA[A/G]ACACACTTGG S A G E E transducer (gp130, oncostatin M receptor) G222u3 WIAF-11702 M57230 677 IL6ST, interleukin 6 signal GAGGGGAAGA[A/G]AATGAGGTGT M A G K R transducer (gp130, oncostatin M receptor) G222u4 WIAF-11706 M57230 1616 IL6ST, interleukin 6 signal AAGAAATATA[T/C]ACTTGAGTGG M T C I T transducer (gp130, oncostatin M receptor) G222u5 WIAF-11667 M57230 1444 IL6ST, interleukin 6 signal TGATCGCTAT[C/G]TAGCAACCCT M C G L V transducer (gp130, oncostatin M receptor) G222u6 WIAF-11708 M57230 981 IL6ST, interleukin 6 signal TCTTAAAATT[G/C]ACATGGACCA M G C L F transducer (gp130, oncostatin M receptor) G226u1 WIAF-11714 M85079 869 TGFBR2, transforming growth CACTGGGAGT[T/C]GCCATATCTG S T C V V factor, beta receptor II (70-80 kD) G226u2 WIAF-11715 M85079 1749 TGFBR2, transforming growth AGATTATGAG[C/T]CTCCATTTGG M C T P S factor, beta receptor II (70-80 kD) G226u3 WIAF-11716 M85079 1601 TGFBR2, transforming growth TGGGAACTGC[A/G]AGATACATGG S A G A A factor, beta receptor II (70-80 kD) G226u4 WIAF-11721 M85079 1256 TGFBR2, transforming growth TACTCCAGTT[C/G]CTGACGGCTG M C G F L factor, beta receptor II (70-80 kD) G226u5 WIAF-11722 M85079 1502 TGFBR2, transforming growth TCGTGAAGAA[C/T]GACCTAACCT S C T N N factor, beta receptor II (70-80 kD) G226u6 WIAF-11671 M85079 888 TGFBR2, transforming growth TGTCATCATC[A/C]TCTTCTACTG M A C I L factor, beta receptor II (70-80 kD) G226u7 WIAF-11674 M85079 1425 TGFBR2, transforming growth CCTCCACAGT[G/A]ATCACACTCC M G A D N factor, beta receptor II (70-80 kD) G227u1 WIAF-10197 M86511 685 CD14, CD14 antigen CCTGTCTGAC[A/G]ATCCTGGACT M A G N D G227u2 WIAF-10212 M86511 497 CD14, CD14 antigen GAAGCCACAG[G/A]ACTTGCACTT M G A G E G2278u1 WIAF-14117 AF034611 959 CUBN, cubilin (intrinsic factor- AGATAAATAA[T/C]GGCGGCTGTT S T C N N cobalamin receptor) G2278u2 WIAF-14118 AF034611 781 CUBN, cubilin (intrinsic factor- GGGTGGATGT[C/T]TTCACCCAAC M C T S F cobalamin receptor) G2278u3 WIAF-14119 AF034611 641 CUBN, cubilin (intrinsic factor- CTGAGACGTA[C/T]GGACCCCAGT S C T Y Y cobalamin receptor) G2278u4 WIAF-14121 AF034611 1185 CUBN, cubilin (intrinsic factor- TGGTTATGGG[C/A]CAAATGGATG M C A P T cobalamin receptor) G2278u5 WIAF-14133 AF034611 1532 CUBN, cubilin (intrinsic factor- TCTGGGTTAT[C/G]AAAACTGAAA M C G I M cobalamin receptor) G2278u6 WIAF-14134 AF034611 2208 CUBN, cubilin (intrinsic factor- GCCTTTCACT[C/T]ACACCAGGCA M C T H Y cobalamin receptor) G228u1 WIAF-10199 U00672 586 IL10RA, interleukin 10 receptor, GCAAGGTGCC[G/A]GGAAACTTCA S G A P P alpha G228u2 WIAF-10200 U00672 731 IL10RA, interleukin 10 receptor, AGAGGAGTGC[A/G]TCTCCCTCAC M A G I V alpha G2280u1 WIAF-13970 AJ001515 1747 RYR3, ryanodine receptor 3 CAGGTATCTT[G/A]GAAGTTTTGC S G A L L G2280u2 WIAF-13974 AJ001515 8593 RYR3, ryanodine receptor 3 TAGAAGCCAT[T/C]GTCAGCAGTG S T C I I G2282u1 WIAF-12694 D00726 263 FECH, ferrochelatase ACATGGGAGG[C/T]CCTGAAACTC S C T G G (protoporphyria) G2282u2 WIAF-12695 D00726 514 FECH, ferrochelatase TACTATATTG[G/A]ATTTCGGTAC M G A G E (protoporphyria) G2285u1 WIAF-12688 D16611 673 CPO, coproporphyrinogen oxidase AGAAGACGCT[G/A]TCCATTTTCA M G A V I (coproporphyria, harderoporphyria) G2285u2 WIAF-12689 D16611 783 CPO, coproporphyrinogen oxidase ATCGTGGAGA[G/A]CGGCGGGGCA S G A E E (coproporphyria, harderoporphyria) G2287u1 WIAF-12687 D28472 502 PTGER4, prostaglandin E receptor GGGCCTCACG[C/T]TCTTTGCAGT M C T L F 4 (subtype EP4) G2287u2 WIAF-12691 D28472 1309 PTGER4, prostaglandin E receptor TGAAAATGGC[C/T]TTGGAGGCAG M C T L F 4 (subtype EP4) G2287u3 WIAF-12707 D28472 243 PTGER4, prostaglandin E receptor AGGAGACGAC[C/T]TTCTACACGC S C T T T 4 (subtype EP4) G2287u4 WIAF-12710 D28472 1343 PTGER4, prostaglandin E receptor GGTGTGCCTG[G/A]CATGGGCCTG M G A G D 4 (subtype EP4) G229u1 WIAF-10185 U16752 202 SDF1, stromal cell-derived factor CATGTTGCCA[G/A]AGCCAACGTC M G A R K 1 G2295u1 WIAF-12727 D89079 613 LTB4R, leukotriene b4 receptor CTATGTCTGC[G/C]GAGTCAGCAT M G C G R (chemokine receptor-like 1) G2295u2 WIAF-12728 D89079 1248 LTB4R, leukotriene b4 receptor AGGGCACGGG[T/C]TCCGAGGCGT S T C G G (chemokine receptor-like 1) G2295u3 WIAF-12753 D89079 1348 LTB4R, leukotriene b4 receptor CCTCACTGCC[T/G]CCAGCCCTCT M T G S A (chemokine receptor-like 1) G230u1 WIAF-10201 U31628 627 IL15RA, interleukin 15 receptor, ACAGCCAAGA[A/C]CTGGGAACTC M A C N T alpha G2300u1 WIAF-12735 J02959 102 LTA4H, leukotriene A4 hydrolase ACCTGCACCT[G/T]CGCTGCAGCG S G T L L G2300u2 WIAF-12738 J02959 1380 LTA4H, leukotriene A4 hydrolase CCTGGCTCTA[C/T]TCTCCTGGAC S C T Y Y G2302u1 WIAF-12741 J03037 627 CA2, carbonic anhydrase II TCCTGAATCC[C/T]TGGATTACTG S C T L L G2302u2 WIAF-12742 J03037 819 CA2, carbonic anhydrase II GCCACTGAAG[A/G]ACAGGCAAAT M A G N D G2303u1 WIAF-12751 J03571 304 ALOX5, arachidonate 5- CGCTGAAGAC[G/A]CCCCACGGGG S G A T T lipoxygenase G2303u2 WIAF-12752 J03571 794 ALOX5, arachidonate 5- AGAGCTGCCC[G/A]AGAAGCTCCC M G A E K lipoxygenase G2304u1 WIAF-12772 J03575 840 PDHA1, pyruvate dehydrogenase TCCGAGAGGC[A/G]ACAAGGTTTG S A G A A (lipoamide) alpha 1 G2304u2 WIAF-12779 J03575 1044 PDHA1, pyruvate dehydrogenase CCAGTGTGGA[A/C]GAACTAAAGG M A C E D (lipoamide) alpha 1 G2305u1 WIAF-12763 J03576 456 PDHB, pyruvate dehydrogenase TCTTCAGGGG[A/G]CCCAATGGTG S A G G G (lipoamide) beta G2305u2 WIAF-12764 J03576 650 PDHB, pyruvate dehydrogenase GTTCCTTTTG[A/C]ATTTCTCCCG M A C E A (lipoamide) beta G231u1 WIAF-10202 U32324 734 IL11RA, interleukin 11 receptor, CCAGGGCCTG[C/T]GGGTAGAGTC M C T R W alpha G2312u1 WIAF-12762 J05096 3726 ATP1A2, ATPase, Na+/K+ TCAAGAACCA[C/T]ACAGAGATCG S C T H H transporting, alpha 2 (+) polypeptide G2313u1 WIAF-12760 J05200 6141 RYR1, ryanodine receptor 1 TGCAATTCAA[A/G]GATGGTACAG S A G K K (skeletal) G2313u2 WIAF-12767 J05200 3048 RYR1, ryanodine receptor 1 CGGCGCAGAC[A/G]ACACTGGTGG S A G T T (skeletal) G2313u3 WIAF-12768 J05200 3084 RYR1, ryanodine receptor 1 ATGGGCACAA[C/T]CTGTGGGCCC S C T N N (skeletal) G2313u4 WIAF-12777 J05200 5667 RYR1, ryanodine receptor 1 GCATCTTTGG[C/T]GATGAGGATG S C T G G (skeletal) G2313u5 WIAF-12780 J05200 6600 RYR1, ryanodine receptor 1 GCTCGCTGCT[C/T]ATCGTGCAGA S C T L L (skeletal) G2313u6 WIAF-12781 J05200 7191 RYR1, ryanodine receptor 1 AGCCTGAGTG[C/T]TTCGGACCCG S C T C C (skeletal) G2313u7 WIAF-12782 J05200 7602 RYR1, ryanodine receptor 1 ACCACAAGGC[G/A]TCCATGGTGC S G A A A (skeletal) G2313u8 WIAF-12784 J05200 9288 RYR1, ryanodine receptor 1 CAGACGCCCC[A/G]GCTGTGGTCA S A G P P (skeletal) G2313u9 WIAF-12786 J05200 13690 RYR1, ryanodine receptor 1 TCCAAAGAAG[G/A]AGGAAGCTGG M G A E K (skeletal) G2313u10 WIAF-12789 J05200 3147 RYR1, ryanodine receptor 1 ACATCCCAGC[G/A]CGCCGAAACC S C A A A (skeletal) G2314u1 WIAF-12771 J05272 1920 IMPDH1, IMP (inosine TGAAGATCGC[A/G]CAGGGTGTCT S A G A A monophosphate) dehydrogenase 1 G2319u1 WIAF-12814 K03191 651 CYP1A1, cytochrome P450, CCCCTACAGG[T/C]ATGTGGTGGT M T C Y H subfamily I (aromatic compound- inducible), polypeptide 1 G232u1 WIAF-11657 U58917 1490 Homo sapiens IL-17 receptor mRNA, TGAACATGAT[C/T]CTCCCGGACT S C T I I complete cds. G232u2 WIAF-11677 U58917 1293 Homo sapiens IL-17 receptor mRNA, GCAGGCCATC[T/C]CGGAGGCAGG M T C S P complete cds. G232u3 WIAF-11658 U58917 1132 Homo sapiens IL-17 receptor mRNA, GGCCTGCCTG[C/T]GGCTGACCTG M C T A V complete cds. G232u4 WIAF-11679 U58917 905 Homo sapiens IL-17 receptor mRNA, GCAGCTGCCT[C/T]AATGACTGCC S C T L L complete cds. G232u5 WIAF-11682 U58917 1794 Homo sapiens IL-17 receptor mRNA, GTTCGAATGT[G/T]AGAACCTCTA N G T E * complete cds. G232u7 WIAF-11660 U58917 743 Homo sapiens IL-17 receptor mRNA, TGACCAGTTT[T/C]CCGCACATGG S T C F F complete cds. G2322u1 WIAF-12853 L01406 1316 GHRHR, growth hormone releasing CTGACATCTA[T/C]GTGCTAGGCT M T C M T hormone receptor G2328u1 WIAF-12845 L20316 1285 GCGR, glucagon receptor TGCGGGCACG[G/C]CAGATGCACC S G C R R G2329u1 WIAF-12850 L22214 713 ADORA1, adenosine A1 receptor TGCTGGCAAT[T/C]GCTGTGGACC S T C I I G2329u2 WIAF-12851 L22214 716 ADORA1, adenosine A1 receptor TGGCAATTGC[T/G]GTGGACCGCT S T G A A G2335a1 WIAF-12136 L32961 265 ABAT, 4-aminobutyrate CCTAGATCTC[A/G]GGAGTTAATG M A G Q R aminotransferase G2335a2 WIAF-12137 L32961 407 ABAT, 4-aminobutyrate TCTCCTCTGT[T/C]CCCATAGGTT S T C V V aminotransferase G2335u3 WIAF-12838 L32961 365 ABAT, 4-aminobutyrate TTGATGTGGA[C/T]GGCAACCGAA S C T D D aminotransferase G2335u4 WIAF-12839 L32961 583 ABAT, 4-aminobutyrate ATCACCATGG[C/T]CTGCGGCTCC M C T A V aminotransferase G2335u5 WIAF-12841 L32961 1082 ABAT, 4-aminobutyrate TGGACGAGGT[C/A]CAGACCGGAG S C A V V aminotransferase G2335u6 WIAF-12852 L32961 227 ABAT, 4-aminobutyrate ATTATGATGG[G/A]CCTCTGATGA S G A G G aminotransferase G2337u1 WIAF-13577 L34820 149 ALDH5A1, aldehyde dehydrogenase 5 TGTTCTCGAA[A/G]GAATGCCAAG M A G K R family, member A1 (succinate- semialdehyde dehydrogenase) G2342a1 WIAF-12138 M12530 1602 TF, transferrin GCCTAAACCT[G/C]TGTGAACCCA S G C L L G2342a2 WIAF-12139 M12530 1795 TF, transferrin TACCAGGAAA[C/T]CTGTGGAGGA M C T P S G2346u1 WIAF-12829 M13928 234 ALAD, aminolevulinate, delta-, TGGCCAGGTA[T/C]GGTGTGAAGC S T C Y Y dehydratase G2346u2 WIAF-12830 M13928 529 ALAD, aminolevulinate, delta-, TGAGGTGGCA[T/C]TGGCGTATGC S T C L L dehydratase G2346u3 WIAF-12843 M13928 480 ALAD, aminolevulinate, delta-, TGAGTGAAAA[C/T]GGAGCATTCC S C T N N dehydratase G2348u1 WIAF-12835 M14016 621 UROD, uroporphyrinogen CTCTGGTCCC[A/G]TATCTGGTAG S A G P P decarboxylase G235u1 WIAF-11678 U83171 100 SCYA22, small inducible cytokine CAGGCCCCTA[C/T]GGCGCCAACA S C T Y Y subfamily A (Cys—Cys), member 22 G2363a1 WIAF-10519 M37435 596 CSF1, colony stimulating factor 1 GACAAGGACT[G/T]GAATATTTTC M G T W L (macrophage) G2363a2 WIAF-13225 M37435 498 CSF1, colony stimulating factor 1 AAGAGCATGA[C/T]AAGGCCTGCG S C T D D (macrophage) G2363a3 WIAF-13226 M37435 712 CSF1, colony stimulating factor 1 CAGTGACCCG[G/T]CCTCTGTCTC M G T A S (macrophage) G2369u1 WIAF-12854 M30773 857 PPP3R1, protein phosphatase 3 TTGATTTGGA[C/T]AATTCTGGTT S C T D D (formerly 2B), regulatory subunit B (19 kD), alpha isoform (calcineurin B, type I) G2369u2 WIAF-12855 M30773 1274 PPP3R1, protein phosphatase 3 ATGTGTGACT[C/T]TTATCAGAGA — C T — — (formerly 2B), regulatory subunit B (19 kD), alpha isoform (calcineurin B, type I) G237u1 WIAF-11662 U86358 311 SCYA25, small inducible cytokine CACCACAACA[T/C]GCAGACCTTC M T C M T subfamily A (Cys—Cys), member 25 G237u2 WIAF-11680 U86358 134 SCYA25, small inducible cytokine GTGCTCCGGC[G/A]CGCCTGGACT M G A R H subfamily A (Cys—Cys), member 25 G237u3 WIAF-11681 U86358 133 SCYA25, small inducible cytokine TGTGCTCCGG[C/T]GCGCCTGGAC M C T R C subfamily A (Cys—Cys), member 25 G237u5 WIAF-11661 U86358 302 SCYA25, small inducible cytokine GCAAAGCTCC[A/G]CCACAACATG M A G H R subfamily A (Cys—Cys), member 25 G237u6 WIAF-11663 U86358 378 SCYA25, small inducible cytokine AGTTATCATC[A/G]TCCAAGTTTA S A G S S subfamily A (Cys—Cys), member 25 G2373u1 WIAF-12870 M36035 500 BZRP, benzodiazapine receptor GCTGGCCTTC[G/A]CGACCACACT M G A A T (peripheral) G2376u1 WIAF-13025 M57414 979 TACR2, tachykinin receptor 2 CTGCTGCCCA[T/C]GGGTCACACC M T C W R G238u1 WIAF-10177 X01394 239 TNF, tumor necrosis factor (TNF GCTCCAGGCG[G/T]TGCTTGTTCC S G T R R superfamily, member 2) G2381u1 WIAF-12894 M59941 730 CSF2RB, colony stimulating factor CAGAGGTTTG[C/T]TGGGACTCCC S C T C C 2 receptor, beta, low-affinity (granulocyte-macrophage) G2381u2 WIAF-12896 M59941 1306 CSF2RB, colony stimulating factor GGATCTGGAG[C/T]GAGTGGAGTG S C T S S 2 receptor, beta, low-affinity (granulocyte-macrophage) G2381u3 WIAF-12900 M59941 1972 CSF2RB, colony stimulating factor CGATGGGACC[G/A]GGACAGGCCG S G A P P 2 receptor, beta, low-affinity (granulocyte-macrophage) G2381u4 WIAF-12901 M59941 1982 CSF2RB, colony stimulating factor GGGACAGGCC[G/A]TGGAAGTGGA M G A V M 2 receptor, beta, low-affinity (granulocyte-macrophage) G2381u5 WIAF-12942 M59941 773 CSF2RB, colony stimulating factor CCAGAACCTG[G/C]AGTGCTTCTT M G C E Q 2 receptor, beta, low-affinity (granulocyte-macrophage) G2381u6 WIAF-12946 M59941 2458 CSF2RB, colony stimulating factor CCCCACAGCC[C/A]GAGGGCCTCC S C A P P 2 receptor, beta, low-affinity (granulocyte-macrophage) G2384u1 WIAF-12908 M61831 1000 AHCY, S-adenosylhomocysteine GCCGTGGAGA[A/C]GGTGAACATC M A C K T hydrolase G2387u1 WIAF-12910 M63967 2585 ALDH5, aldehyde dehydrogenase 5 CTGCTGAACC[T/G]CCTGGCAGAC M T G L R G2387u2 WIAF-12911 M63967 2996 ALDH5, aldehyde dehydrogenase 5 TATGGCCCAA[C/G]AGCAGGTGCG M C G T R G2387u3 WIAF-12954 M63967 2522 ALDH5, aldehyde dehydrogenase 5 GCCCGGGAAG[C/T]CTTCCGCCTG M C T A V G2387u4 WIAF-12955 M63967 2448 ALDH5, aldehyde dehydrogenase 5 ACCCTACCAC[C/T]GGGGAGGTCA S C T T T G2387u5 WIAF-12956 M63967 2460 ALDH5, aldehyde dehydrogenase 5 GGGAGGTCAT[C/T]GGGCACGTGG S C T I I G2387u6 WIAF-12957 M63967 2991 ALDH5, aldehyde dehydrogenase 5 CGGGGTATGG[C/T]CCAACAGCAG S C T G G G2387u7 WIAF-12958 M63967 3022 ALDH5, aldehyde dehydrogenase 5 CGCCCAGCAC[A/G]TGGATGTTGA M A G M V G2387u8 WIAF-12959 M63967 2943 ALDH5, aldehyde dehydrogenase 5 CCCTCATCAA[G/C]GAGGCAGGCT M G C K N G2388u1 WIAF-12888 M64590 588 GLDC, glycine dehydrogenase TGCCACAGAC[G/A]ATTTTGCGGA S G A T T (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u2 WIAF-12889 M64590 651 GLDC, glycine dehydrogenase ACCAGCCTGA[G/A]GTGTCTCAGG S G A E E (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u3 WIAF-12890 M64590 698 GLDC, glycine dehydrogenase CAGACCATGG[T/C]GTGTGACATC M T C V A (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u4 WIAF-12891 M64590 557 GLDC, glycine dehydrogenase TATATTGGCA[T/C]GGGCTATTAT M T C M T (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u5 WIAF-12938 M64590 587 GLDC, glycine dehydrogenase GTGCCACAGA[C/G]GATTTTGCGG M C G T R (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u6 WIAF-12939 M64590 518 GLDC, glycine dehydrogenase CTGCATGCCA[T/C]TTCAAGCAAA M T C I T (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u7 WIAF-12940 M64590 810 GLDC, glycine dehydrogenase GGAAATTTCT[C/T]GTTGATCCCC S C T L L (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u8 WIAF-12941 M64590 1481 GLDC, glycine dehydrogenase CATTGTGGCT[G/A]CTCAGTGAAG M G A C Y (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u9 WIAF-12947 M64590 1841 GLDC, glycine dehydrogenase AAACTGAACA[G/A]TTCGTCTGAA M G A S N (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u10 WIAF-12948 M64590 2325 GLDC, glycine dehydrogenase GACAGGTCTA[C/T]CTAGACGGGG S C T Y Y (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u11 WIAF-12949 M64590 2362 GLDC, glycine dehydrogenase GGTGGGAATC[T/A]GTCGCCCTGG M T A C S (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2388u12 WIAF-12950 M64590 3220 GLDC, glycine dehydrogenase TTAGTCCTCT[C/G]TCCCTAAGTT — C G — — (decarboxylating; glycine decarboxylase, glycine cleavage system protein P) G2391u1 WIAF-12998 M69238 623 ARNT, aryl hydrocarbon receptor TGGTGTATGT[G/C]TCTGACTCCG S G C V V nuclear translocator G2391u2 WIAF-13002 M69238 1072 ARNT, aryl hydrocarbon receptor TGCCTAGTGG[C/T]CATTGGCAGA M C T A V nuclear translocator G2391u3 WIAF-13021 M69238 966 ARNT, aryl hydrocarbon receptor ACCTCACTTC[G/A]TGGTGGTCCA M G A V M nuclear translocator G2394u1 WIAF-13003 M73747 2061 TSHR, thyroid stimulating hormone TTGCTGGTAC[T/A]CTTCTATCCA M T A L H receptor G2394u2 WIAF-13004 M73747 2248 TSHR, thyroid stimulating hormone TTACCCACGA[C/G]ATGAGGCAGG M C G D E receptor G2396u1 WIAF-12995 M74542 1027 ALDH3, aldehyde dehydrogenase 3 CCCCCAGTCC[C/G]CGGTGATGCA M C G P A G2396u2 WIAF-13019 M74542 1295 ALDH3, aldehyde dehydrogenase 3 GGCAAGAAGA[G/A]CTTCGAGACT M G A S N G2403u1 WIAF-13583 M83670 280 CA4, carbonic anhydrase IV TACGATAAGA[A/T]GCAAACGTGG M A T K M G2409u1 WIAF-10010 HT2156 1268 AGTR1, angiotensin receptor 1 CCACTCAAAC[C/T]TTTCAACAAA M C T L F G2411u1 WIAF-13541 M97759 210 ADORA2B, adenosine A2b receptor TGGCGGGCAA[C/T]GTGCTGGTGT S C T N N G2422u1 WIAF-14077 S90469 375 POR, P450 (cytochrome) GCAGCCTGCC[A/G]GAGATCGACA S A G P P oxidoreductase G2422u2 WIAF-14078 S90469 852 POR, P450 (cytochrome) TCCTGGCTGC[A/G]GTCACCACCA S A G A A oxidoreductase G2422u3 WIAF-14082 S90469 1496 POR, P450 (cytochrome) AAGGAGCCTG[T/C]CGGGGAGAAC M T C V A oxidoreductase G2422u4 WIAF-14099 S90469 1443 POR, P450 (cytochrome) AGACCAAGGC[C/T]GGCCGCATCA S C T A A oxidoreductase G2422u5 WIAF-14100 S90469 1704 POR, P450 (cytochrome) GCCGCCGCTC[G/A]GATGAGGACT S G A S S oxidoreductase G2427u1 WIAF-14079 U07919 1369 ALDH6, aldehyde dehydrogenase 6 ACTATGGACT[C/T]ACAGCAGCCG S C T L L G2427u2 WIAF-14096 U07919 1347 ALDH6, aldehyde dehydrogenase 6 ATAAAAAGAG[C/T]GAATAGCACC M C T A V G243u1 WIAF-11684 X57522 926 TAP1, transporter 1, ABC (ATP ATAGCCAGTG[C/G]AGTGCTGGAG M C G A G binding cassette) G243u2 WIAF-11685 X57522 627 TAP1, transporter 1, ABC (ATP ACCCTACCGC[C/T]TTCGTTGTCA S C T A A binding cassette) G243u3 WIAF-11686 X57522 538 TAP1, transporter 1, ABC (ATP CCTGCCGGGA[C/G]TTGCCTTGTT M C G L V binding cassette) G243u4 WIAF-11687 X57522 798 TAP1, transporter 1, ABC (ATP TGGTGGTCCT[C/G]TCCTCTCTTG S C G L L binding cassette) G243u5 WIAF-11689 X57522 1465 TAP1, transporter 1, ABC (ATP TAGTATTTCA[G/T]GTATGCTGCT M G T G C binding cassette) G243u6 WIAF-11690 X57522 177 TAP1, transporter 1, ABC (ATP AGAGTCCCAG[A/G]CCCGGCCGGG S A G R R binding cassette) G243u7 WIAF-11693 X57522 1067 TAP1, transporter 1, ABC (ATP AACATCATGT[C/T]TCGGGTAACA M C T S F binding cassette) G243u8 WIAF-11665 X57522 1207 TAP1, transporter 1, ABC (ATP GGTCACCCTG[A/G]TCACCCTGCC M A G I V binding cassette) G243u9 WIAF-11664 X57522 1757 TAP1, transporter 1, ABC (ATP CCAAACCGCC[C/T]AGATGTCTTA M C T P L binding cassette) G244u1 WIAF-10174 X60592 239 TNFRSF5, tumor necrosis factor CTTGCGGTGA[A/G]AGCGAATTCC S A G E E receptor superfamily, member 5 G2441u1 WIAF-13682 U30246 1355 SLC12A2, solute carrier family 12 TGCTTAAGGA[A/G]CATTCCATAC S A G E E (sodium/potassium/chloride transporters), member 2 G2441u2 WIAF-13714 U30246 2691 SLC12A2, solute carrier family 12 AGCCAAATAT[C/G]AGCGATGGCT M C G Q E (sodium/potassium/chloride transporters), member 2 G2443u1 WIAF-14004 U37143 1456 CYP2J2, cytochrome P450, CTGAAGTTTA[G/A]AATGGGTATC M G A R K subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2 G2443u2 WIAF-14032 U37143 376 CYP2J2, cytochrome P450, TTTAAGAAAA[A/G]TGGATTGATT M A G N S subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2 G2443u3 WIAF-14033 U37143 1502 CYP2J2, cytochrome P450, TCTGCGCTGT[T/A]CCTCAGGTGT S T A V V subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2 G2444u1 WIAF-14065 U37519 771 ALDH3, aldehyde dehydrogenase 3 CCCGCAGGGA[A/G]TTGCGTGGTG M A G N S G2444u2 WIAF-14066 U37519 1698 ALDH3, aldehyde dehydrogenase 3 AAGGAGATCC[G/A]CTACCCACCC M G A R H G2445u1 WIAF-14114 U38178 236 CNP, 2′,3′-cyclic nucleotide 3′ TGCCGGGCGC[G/A]CCTCTCGCTG M G A R H phosphodiesterase G2445u2 WIAF-14115 U38178 849 CNP, 2′,3′-cyclic nucleotide 3′ GTGCCGCCGA[A/G]GAAAAAGTGC S A G E E phosphodiesterase G2445u3 WIAF-14122 U38178 1655 CNP, 2′,3′-cyclic nucleotide 3′ GTTATCTTGC[A/T]GAGATCTCTG M A T Q L phosphodiesterase G2445u4 WIAF-14241 X95520 941 CNP, 2′,3′-cyclic nucleotide 3′ TGCAAAATAT[T/C]CAGGAGACCG ? T C ? ? phosphodiesterase G2445u5 WIAF-14242 X95520 1057 CNP, 2′,3′-cyclic nucleotide 3′ TGGAGTTGAT[C/T]TTTCAGTGCT ? C T ? ? phosphodiesterase G2445u6 WIAF-14243 X95520 1583 CNP, 2′,3′-cyclic nucleotide 3′ TCTACTGGCT[C/G]TCTAACTAAT ? C G ? ? phosphodiesterase G2448u1 WIAF-13973 U46689 1895 ALDH10, aldehyde dehydrogenase 10 TTGTCAAGGC[A/T]GAATATTACT S A T A A (fatty aldehyde dehydrogenase) G2457u1 WIAF-13898 U90277 1304 GRIN2A, glutamate receptor, GGTCCCGATG[C/T]ACACCTTGCA M C T H Y ionotropic, N-methyl D-aspartate 2A G2457u2 WIAF-13899 U90277 1934 GRIN2A, glutamate receptor, AAGAAGTAAT[G/T]GCACCGTCTC M G T G C ionotropic, N-methyl D-aspartate 2A G2457u3 WIAF-13900 U90277 2230 GRIN2A, glutamate receptor, TCGCTGTCAT[A/G]TTCCTGGCTA M A G I M ionotropic, N-methyl D-aspartate 2A G2457u4 WIAF-13902 U90277 2916 GRIN2A, glutamate receptor, GGCATCTACA[G/A]CTGCATTCAT M G A S N ionotropic, N-methyl D-aspartate 2A G2457u5 WIAF-13903 U90277 3251 GRIN2A, glutamate receptor, CTATGTATTC[C/T]AGGGACAACA N C T Q * ionotropic, N-methyl D-aspartate 2A G2457u6 WIAF-13917 U90277 2756 GRIN2A, glutamate receptor, GGACATTGAC[A/G]ACATGGCGGG M A G N D ionotropic, N-methyl D-aspartate 2A G2468u1 WIAF-13642 X04011 1017 CYBB, cytochrome b-245, beta AGGTGTCCAA[G/A]CTGGAGTGGC S G A K K polypeptide (chronic granulomatous disease) G2473u1 WIAF-13670 X06990 1417 ICAM1, intercellular adhesion GGTCACCCGC[G/A]AGGTGACCGT M G A E K molecule 1 (CD54), human rhinovirus receptor G2473u2 WIAF-13695 X06990 179 ICAM1, intercellular adhesion GACCAGCCCA[A/T]GTTGTTGGGC M A T K M molecule 1 (CD54), human rhinovirus receptor G2480u1 WIAF-14148 X55330 800 AGA, aspartylglucosaminidase TTGGCATGGT[T/G]GTAATCCATA S T G V V G2480u2 WIAF-14149 X55330 852 AGA, aspartylglucosaminidase AAATGGTATA[A/T]AATTCAAAAT N A T K * G2480u3 WIAF-14158 X55330 616 AGA, aspartylglucosaminidase TTATCTACCA[G/C]TGCTTCTCAA M G C S T G2485u1 WIAF-13612 X59543 2301 RRM1, ribonucleotide reductase M1 ATTGATCAAA[G/A]CCAATCTTTG M G A S N polypeptide G2485u2 WIAF-13613 X59543 2410 RRM1, ribonucleotide reductase M1 ATTTAAGGAC[G/A]AGACCAGCAG S G A T T polypeptide G2485u3 WIAF-13651 X59543 548 RRM1, ribonucleotide reductase M1 CAAGTCAACA[T/C]TGGATATTGT S T C L L polypeptide G2485u4 WIAF-13652 X59543 199 RRM1, ribonucleotide reductase M1 TGCATGTGAT[C/T]AAGCGAGATG S C T I I polypeptide G2485u5 WIAF-13653 X59543 1037 RRM1, ribonucleotide reductase M1 CAACACAGCT[C/A]GATATGTGGA S C A R R polypeptide G2485u6 WIAF-13660 X59543 1955 RRM1, ribonucleotide reductase M1 GAAGATTGCA[A/C]AGTATGGTAT M A C K Q polypeptide G2485u7 WIAF-13877 X59543 860 RRM1, ribonucleotide reductase M1 GAGTATGAAA[G/C]ATGACAGCAT M G C D H polypeptide G2486u1 WIAF-14075 X59618 543 RRM2, ribonucleotide reductase M2 TCAGCACTGG[G/C]AATCCCTGAA M G C E Q polypeptide G2486u2 WIAF-14076 X59618 189 RRM2, ribonucleotide reductase M2 TCGCTGCGCC[T/G]CCACTATGCT — T G — — polypeptide G2486u3 WIAF-14092 X59618 524 RRM2, ribonucleotide reductase M2 TTGACCTCTC[C/G]AAGGACATTC S C G S S polypeptide G2488u1 WIAF-13585 X63563 1633 POLR2B, polymerase (RNA) II (DNA CCTTGATGGC[G/A]TATATTTCAG S G A A A directed) polypeptide B (140 kD) G2488u2 WIAF-13586 X63563 2452 POLR2B, polymerase (RNA) II (DNA CTGTAGACCG[C/T]GGCTTCTTCA S C T R R directed) polypeptide B (140 kD) G2488u3 WIAF-13587 X63563 2740 POLR2B, polymerase (RNA) II (DNA TCAGAACTAG[T/C]GAGACGGGCA S T C S S directed) polypeptide B (140 kD) G2488u4 WIAF-13602 X63563 1411 POLR2B, polymerase (RNA) II (DNA GGGGTGATCA[A/G]AAGAAAGCTC S A G Q Q directed) polypeptide B (140 kD) G2488u5 WIAF-13603 X63563 2386 POLR2B, polymerase (RNA) II (DNA CAATTGTGGC[C/T]ATTGCATCAT S C T A A directed) polypeptide B (140 kD) G2489u1 WIAF-14181 X63564 1346 POLR2A, polymerase (RNA) II (DNA TGGTGGACAA[T/C]GAGCTGCCTG S T C N N directed) polypeptide A (220 kD) G2489u2 WIAF-14236 X63564 1847 POLR2A, polymerase (RNA) II (DNA TGAATCTTAG[C/T]GTGACAACTC ? C T ? ? directed) polypeptide A (220 kD) G2489u3 WIAF-14237 X63564 2678 POLR2A, polymerase (RNA) II (DNA CTGAATACAA[C/T]AACTTCAAGT ? C T ? ? directed) polypeptide A (220 kD) G2489u4 WIAF-14238 X63564 3059 POLR2A, polymerase (RNA) II (DNA AGCTGCGCTA[C/T]GGCGAAGACG ? C T ? ? directed) polypeptide A (220 kD) G2489u5 WIAF-14239 X63564 3827 POLR2A, polymerase (RNA) II (DNA TGGGCCAGTC[C/T]GCTCGAGATG ? C T ? ? directed) polypeptide A (220 kD) G2489u6 WIAF-14240 X63564 3992 POLR2A, polymerase (RNA) II (DNA TGCCTGACTT[T/C]GATGTGGCCC ? T C ? ? directed) polypeptide A (220 kD) G2489u7 WIAF-14245 X63564 3938 POLR2A, polymerase (RNA) II (DNA CCCAGAGCAC[G/A]GTGGTGGCAG ? G A ? ? directed) polypeptide A (220 kD) G250u1 WIAF-11696 HT0155 1113 IL3RA, interleukin 3 receptor, CTGTGTCTTC[G/C]TGATCTGCAG M G C V L alpha (low affinity) G251u1 WIAF-11666 HT0240 179 interleukin 1 beta convertase TGGATAAGAC[C/T]CGAGCTTTGA S C T T T G251u2 WIAF-11694 HT0240 973 interleukin 1 beta convertase GATGCTATTA[A/G]GAAAGCCCAC M A G K R G251u3 WIAF-11695 HT0240 783 interleukin 1 beta convertase CCCAGATATA[C/T]TACAACTCAA S C T L L G2513u1 WIAF-13736 HT27365 1721 PLCB3, phospholipase C, beta 3 AACTATCTAT[G/A]AAAAGCCAAA M G A M I (phosphatidylinositol-specific) G2513u2 WIAF-13737 HT27365 1741 PLCB3, phospholipase C, beta 3 AACTATTGGG[A/T]AATGTGTTCA M A T E V (phosphatidylinositol-specific) G2513u3 WIAF-13738 HT27365 1697 PLCB3, phospholipase C, beta 3 AATCTGTTCA[A/G]TACAGGGATT S A G Q Q (phosphatidylinositol-specific) G2513u4 WIAF-13739 HT27365 1908 PLCB3, phospholipase C, beta 3 CTGTCAGATT[G/A]TAGCAATGAA M G A V I (phosphatidylinositol-specific) G2513u5 WIAF-13740 HT27365 2172 PLCB3, phospholipase C, beta 3 TATAGAGATA[C/T]ACGGAATTCC M C T H Y (phosphatidylinositol-specific) G2513u6 WIAF-13744 HT27365 3019 PLCB3, phospholipase C, beta 3 TTGAAGGGCC[A/G]AGGAGATCTG M A G Q R (phosphatidylinositol-specific) G2513u7 WIAF-13745 HT27365 3024 PLCB3, phospholipase C, beta 3 GGGCCAAGGA[G/A]ATCTGTTGAA M G A D N (phosphatidylinositol-specific) G2513u8 WIAF-13771 HT27365 1079 PLCB3, phospholipase C, beta 3 ACATTTTTGA[T/C]CCTGAGCAAA S T C D D (phosphatidylinositol-specific) G2513u9 WIAF-13772 HT27365 1546 PLCB3, phospholipase C, beta 3 AAGTTGCCTT[C/T]TGATCCAGAT M C T S F (phosphatidylinositol-specific) G2513u10 WIAF-13773 HT27365 1514 PLCB3, phospholipase C, beta 3 AATTAAAAAG[A/T]ATGATCATTG M A T R S (phosphatidylinositol-specific) G2513u11 WIAF-13774 HT27365 1445 PLCB3, phospholipase C, beta 3 AGGTCTTTGG[C/T]AATAAACTCT S C T G G (phosphatidylinositol-specific) G2513u12 WIAF-13778 HT27365 2087 PLCB3, phospholipase C, beta 3 TTCATATCAA[G/A]ATCATCAGTG S G A K K (phosphatidylinositol-specific) G2513u13 WIAF-13779 HT27365 2367 PLCB3, phospholipase C, beta 3 TGAATGTTTG[C/T]AGCCTGGATA N C T Q * (phosphatidylinositol-specific) G2513u14 WIAF-13782 HT27365 2719 PLCB3, phospholipase C, beta 3 CTCATCACCA[G/A]TGACAATACT M G A S N (phosphatidylinositol-specific) G2513u15 WIAF-13783 HT27365 2567 PLCB3, phospholipase C, beta 3 TTGATGACAT[C/T]TTTAAAATAG S C T I I (phosphatidylinositol-specific) G2513u16 WIAF-13784 HT27365 2864 PLCB3, phospholipase C, beta 3 TAGAAATGGC[G/A]GACACAGTCC S G A A A (phosphatidylinositol-specific) G2513u17 WIAF-13785 HT27365 2571 PLCB3, phospholipase C, beta 3 TGACATCTTT[A/T]AAATAGCGGT N A T K * (phosphatidylinositol-specific) G2513u18 WIAF-13786 HT27365 2706 PLCB3, phospholipase C, beta 3 TCTGTCATCT[C/T]GGCTCATCAC M C T R W (phosphatidylinositol-specific) G252u1 WIAF-10195 HT0425 397 FCER2, Fc fragment of IgE, low GAGGGCTGCC[C/T]GGAACGTCTC M C T R W affinity II, receptor for (CD23A) G252u2 WIAF-10206 HT0425 930 FCER2, Fc fragment of IgE, low ATGGGAGCCA[T/C]GTGGACTACA S T C H H affinity II, receptor for (CD23A) G253u1 WIAF-10175 HT0573 228 IFNB1, interferon, beta 1, GGCTTGAATA[C/T]TGCCTCAAGG S C T Y Y fibroblast G254u1 WIAF-10196 HT0611 466 IL4R, interleukin 4 receptor TCAGTGCGGA[T/C]AACTATACAC S T C D D G254u2 WIAF-10198 HT0611 1474 IL4R, interleukin 4 receptor CATGCCTTCT[T/C]CCACCTTCGG S T C L L G254u3 WIAF-10207 HT0611 1902 IL4R, interleukin 4 receptor AGTGGCTATC[A/G]GGAGTTTGTA M A G Q R G260u1 WIAF-10186 HT1090 453 IL1R1, interleukin 1 receptor, TGTTATAATG[C/G]ACAAGCCATA M C G A G type I G261u1 WIAF-10187 HT1101 434 IL7R, interleukin 7 receptor CCTGAGTGTC[A/G]TCTATCGGGA M A G I V G261u2 WIAF-10203 HT1101 517 IL7R, interleukin 7 receptor TTTTAATGCA[T/C]GATGTAGCTT S T C H H G267u1 WIAF-11735 HT1877 881 IL2RB, interleukin 2 receptor, TCCTCGTGGG[C/T]CTCAGCGGGG S C T G G beta G267u2 WIAF-11759 HT1877 379 IL2RB, interleukin 2 receptor, AGTCAAGCAT[C/T]CTGGGCCTGC M C T S F beta G268u1 WIAF-11758 HT1985 568 CD19 antigen GCCTCCGTGT[G/C]TCCCACCGAG M G C V L G268u2 WIAF-11734 HT1985 783 CD19 antigen ACGATCGCCC[G/T]GCCAGAGATA S G T P P G270u1 WIAF-11736 HT2415 530 IL6R, interleukin 6 receptor AGGAGGTGGC[A/G]AGAGGCGTGC S A G A A G270u2 WIAF-11760 HT2415 1590 IL6R, interleukin 6 receptor CATTGCCATT[G/A]TTCTGAGGTT M G A V I G270u3 WIAF-11737 HT2415 1510 IL6R, interleukin 6 receptor CCAGTGCAAG[A/C]TTCTTCTTCA M A C D A G270u4 WIAF-11761 HT2415 1451 IL6R, interleukin 6 receptor CTACTAATAA[A/T]GACGATGATA M A T K N G270u5 WIAF-11766 HT2415 1843 IL6R, interleukin 6 receptor TTCCCCAGAT[A/G]GCTGGCTGGG N A G * W G270u6 WIAF-11767 HT2415 1829 IL6R, interleukin 6 receptor ATACAGACTA[C/T]TTCTTCCCCA S C T Y Y G271u1 WIAF-11762 HT2531 577 CD2, CD2 antigen (p50), sheep red TCAGAGGGTC[A/G]TCACACACAA M A G I V blood cell receptor G271u2 WIAF-11739 HT2531 861 CD2, CD2 antigen (p50), sheep red GGAAGCCCCA[A/C]CAAATTCCAG M A C X H blood cell receptor G271u3 WIAF-11768 HT2531 818 CD2, CD2 antigen (p50), sheep red CTGGAGACAA[G/A]AGCCCACAGA M G A R K blood cell receptor G271u4 WIAF-11738 HT2531 736 CD2, CD2 antigen (p50), sheep red CCTCTTGATG[G/A]TCTTTGTGGC M G A V I blood cell receptor G273u1 WIAF-11763 HT3139 667 IL2RA, interleukin 2 receptor, ATCATGGTGC[C/T]TGGCTGCCAG M C T P L alpha G273u2 WIAF-11764 HT3139 956 IL2RA, interleukin 2 receptor, AAAGTCCAAT[G/C]CAGCCAGTGG M G C M I alpha G273u3 WIAF-11765 HT3139 701 IL2RA, interleukin 2 receptor, ACGATGACCC[G/A]CCAGAGATCC S G A P P alpha G273u4 WIAF-11740 HT3139 1133 IL2RA, interleukin 2 receptor, AAATGACCCA[C/T]GGGAAGACAA S C T H H alpha G273u5 WIAF-11769 HT3139 1163 IL2RA, interleukin 2 receptor, AGCCCCAGCT[C/A]ATATGCACAG S C A L L alpha G276u1 WIAF-10192 HT3670 644 CD4 antigen CTGGTAGTAG[C/G]CCCTCAGTGC M C G S R G276u2 WIAF-10193 HT3670 1535 CD4 antigen CCTGCCAGTG[T/C]CCTCACCGGT S T C C C G276u3 WIAF-10205 HT3670 1217 CD4 antigen TGATGCTGAG[T/C]TTGAAACTGG S T C S S G277u1 WIAF-10007 D10232 851 RENBP, renin-binding protein CACGTGATTG[A/G]CAAGTTCCTA M A G D G G277u2 WIAF-10032 D10232 842 RENBP, renin-binding protein CTTCGAGCCC[A/G]CGTGATTGAC M A G H R G277u3 WIAF-10042 D10232 634 RENBP, renin-binding protein GCTGGCGGGC[A/G]AATACGCAGA M A G K E G279u1 WIAF-10047 K01740 1658 F8C, coagulation factor VIIIc, ACTGATGTCC[G/A]TCCTTTGTAT M G A R H procoagulant component (hemophilia A) G279u2 WIAF-10049 K01740 2328 F8C, coagulation factor VIIIc, CCTTACTGAA[G/A]GTTTCTAGTT S G A K K procoagulant component (hemophilia A) G279u3 WIAF-10050 K01740 4650 F8C, coagulation factor VIIIc, CTGTTCTCCC[G/A]AAACCAGACT S G A P P procoagulant component (hemophilia A) G279u4 WIAF-10061 K01740 6919 F8C, coagulation factor VIIIc, CCAGAAGACA[A/G]TGAAAGTCAC M A G M V procoagulant component (hemophilia A) G279u5 WIAF-10080 K01740 480 F8C, coagulation factor VIIIc, TTAAGAACAT[G/A]GCTTCCCATC M G A M I procoagulant component (hemophilia A) G279u6 WIAF-10082 K01740 2129 F8C, coagulation factor VIIIc, TACATTCTAA[G/A]CATTGGAGCA M G A S N procoagulant component (hemophilia A) G279u7 WIAF-10084 K01740 2533 F8C, coagulation factor VIIIc, GTTTGCACAC[A/G]GAACACCTAT M A G R G procoagulant component (hemophilia A) G279u8 WIAF-10086 K01740 6639 F8C, coagulation factor VIIIc, ACCCTCCAAT[T/C]ATTGCTCGAT S T C I I procoagulant component (hemophilia A) G279u9 WIAF-10087 K01740 5957 F8C, coagulation factor VIIIc, GAGAATTATC[G/A]CTTCCATGCA M G A R H procoagulant component (hemophilia A) G279a10 WIAF-10495 K01740 5829 F8C, coagulation factor VIIIc, TGACAGTACA[G/A]GAATTTGCTC S G A Q Q procoagulant component (hemophilia A) G279a11 WIAF-10496 K01740 5852 F8C, coagulation factor VIIIc, TTTTTCACCA[T/G]CTTTGATGAG M T G I S procoagulant component (hemophilia A) G279a12 WIAF-10502 K01740 2492 F8C, coagulation factor VIIIc, ACCACAATTC[C/T]AGAAAATGAC M C T P L procoagulant component (hemophilia A) G279a13 WIAF-10503 K01740 6906 F8C, coagulation factor VIIIc, TGCAAGTGGA[C/T]TTCCAGAAGA S C T D D procoagulant component (hemophilia A) G279a14 WIAF-13120 K01740 1980 F8C, coagulation factor VIIIc, CAGAGAATAT[A/c]CAACGCTTTC S A c I I procoagulant component (hemophilia A) G279a15 WIAF-13121 K01740 1982 F8C, coagulation factor VIIIc, GAGAATATAC[A/c]ACGCTTTCTC M A c Q P procoagulant component (hemophilia A) G282u1 WIAF-10067 L25615 976 AVPR1A, arginine vasopressin CGCCTTTCTT[C/A]ATCATCCAGA M C A F L receptor 1A G282u2 WIAF-10070 L25615 460 AVPR1A, arginine vasopressin TCGGCATGTT[T/C]GCGTCGGCCT S T C F F receptor 1A G282u3 WIAF-10071 L25615 343 AVPR1A, arginine vasopressin GCCTGGCCGA[C/T]CTGGCCGTGG S C T D D receptor 1A G282u4 WIAF-10072 L25615 68 AVPR1A, arginine vasopressin TCTCTCCGCC[G/A]GTCCCGACGC M G A G S receptor 1A G282u5 WIAF-10073 L25615 535 AVPR1A, arginine vasopressin AGACTCTGCA[A/G]CAGCCCGCGC S A G Q Q receptor 1A G282u6 WIAF-10092 L25615 1075 AVPR1A, arginine vasopressin CCTTGAATAG[C/A]TGCTGTAATC M C A S R receptor 1A G282a7 WIAF-10499 L25615 1089 AVPR1A, arginine vasopressin TGTAATCCCT[G/A]GATATACATG N G A W * receptor 1A G284u1 WIAF-10182 M16827 1179 ACADM, acyl-Coenzyme A AATATCCTGT[A/G]GAAAAACTAA S A G V V dehydrogenase, C-4 to C-12 straight chain G284a2 WIAF-10515 M16827 696 ACADM, acyl-Coenzyme A TTGTGGAAGC[A/G]GATACCCCAG S A G A A dehydrogenase, C-4 to C-12 straight chain G285u1 WIAF-10108 M28372 258 ZNF9, zinc finger protein 9 (a CTCTTCCAGA[T/C]ATTTGTTATC S T C D D cellular retroviral nucleic acid binding protein) G289u1 WIAF-10041 M63012 172 PON1, paraoxonase 1 CTCTGAAGAC[A/T]TGGAGATACT M A T M L G290u1 WIAF-10085 M63959 354 LRPAP1, low density lipoprotein- CTCATACGCA[A/G]CCTCAATGTC M A G N S related protein-associated protein 1 (alpha-2-macroglobulin receptor- associated protein 1) G290a2 WIAF-13122 M63959 223 LRPAP1, low density lipoprotein- AGCGACTGCA[T/A]CTTCCTCCCG M T A H Q related protein-associated protein 1 (alpha-2-macroglobulin receptor- associated protein 1) G292u1 WIAF-10180 M74096 1002 ACADL, acyl-Coenzyme A AGTGCAACAT[A/C]AATTAGCAGA M A C K Q dehydrogenase, long chain G293u1 WIAF-10068 M74775 723 LIPA, lipase A, lysosomal acid, AAGGACTTAT[T/C]TGGAGACAAA M T C F S cholesterol esterase (Wolman disease) G293a2 WIAF-10497 M74775 107 LIPA, lipase A, lysosomal acid, TGAGGGGTCT[G/A]GAGGGAAACT M G A G R cholesterol esterase (Wolman disease) G293a3 WIAF-10498 M74775 86 LIPA, lipase A, lysosomal acid, GGTTCTCTGG[C/A]CCCTGCATTC M C A P T cholesterol esterase (Wolman disease) G295u1 WIAF-10057 U04270 1282 KCNH2, potassium voltage-gated AAAGGAGCGA[A/T]CCCACAATGT M A T T S channel, subfamily H, member 2 G295u2 WIAF-10062 U04270 1875 KCNH2, potassium voltage-gated CGCACTGGCT[A/G]GCCTGCATCT S A G L L channel, subfamily H, member 2 G295u3 WIAF-10064 U04270 2040 KCNH2, potassium voltage-gated ACTTCACCTT[C/T]AGCAGCCTCA S C T F F channel, subfamily H, member 2 G295u4 WIAF-10088 U04270 1650 KCNH2, potassium voltage-gated CCGGCCGCAT[C/T]GCCGTCCACT S C T I I channel, subfamily H, member 2 G295u5 WIAF-10090 U04270 2139 KCNH2, potassium voltage-gated CCCTCATGTA[T/C]GCTAGCATCT S T C Y Y channel, subfamily H, member 2 G2951u1 WIAF-14147 HT0030 1334 ZNF42, zinc finger protein 42 CCCTGCTCTG[A/G]TCACCACCCG M A G I V (myeloid-specific retinoic acid- responsive) G2951u2 WIAF-14157 HT0030 1558 ZNF42, zinc finger protein 42 ACCAGCTTAC[G/A]CACACCGAGG S G A T T (myeloid-specific retinoic acid- responsive) G2959u1 WIAF-13501 HT0134 1014 GRLF1, glucocorticoid receptor GTGGAGAGAC[T/C]CTGCATAGCT S T C T T DNA binding factor 1 G2959u2 WIAF-13518 HT0134 1853 GRLF1, glucocorticoid receptor GAGCCATCTT[A/C]CAGCCTGTTT M A C Y S DNA binding factor 1 G296a1 WIAF-10514 U12778 961 ACADSB, acyl-Coenzyme A TATTCCATAT[A/G]TTAAAGAAAG M A G I V dehydrogenase, short/branched chain G2968u1 WIAF-12699 HT0244 1754 SMARCA1, SWI/SNF related, matrix CAGAAGAAAC[C/T]AGTACGTGTA M C T P L associated, actin dependent regulator of chromatin, subfamily a, member 1 G2968u2 WIAF-12716 HT0244 2624 SMARCA1, SWI/SNF related, matrix TGGGAACGTT[G/T]CAATGAATTA M G T C F associated, actin dependent regulator of chromatin, subfamily a, member 1 G297u1 WIAF-10109 U16660 402 ECH1, enoyl Coenzyme A hydratase ACATGGCTTC[G/A]GACATCCTGC S G A S S 1, peroxisomal G297u2 WIAF-10110 U16660 149 ECH1, enoyl Coenzyme A hydratase GCACAAGAGG[A/C]GGCTTCCGGA M A C E A 1, peroxisomal G2970u1 WIAF-12746 HT0281 682 BR140: bromodomain-containing ATGACATGGA[C/T]GAGGAGGACT S C T D D protein, 140 kD (peregrin) G2975u1 WIAF-12729 HT0334 1104 B-cell-specific transcription AGTTTTCCGG[G/A]AGTCCCTACA S G A G G factor G2975u2 WIAF-12730 HT0334 1185 B-cell-specific transcription GCTCCCCCTA[C/T]TATTATAGCG S C T Y Y factor G2976a1 WIAF-12129 HT0340 1600 SATB1, special AT-rich sequence GTCCTGCCCC[C/A]CTCATCAGCA S C A P P binding protein 1 (binds to nuclear matrix/scaffold- associating DNA's) G2976u2 WIAF-12743 HT0340 2116 SATB1, special AT-rich sequence TGGCCTCTCC[A/G]GCAGAGTCAG S A G P P binding protein 1 (binds to nuclear matrix/scaffold- associating DNA's) G2978u1 WIAF-12721 HT0346 1140 MSX1, msh (Drosophila) homeo box CATAGAGGGT[C/T]CCAGGTCCCC — C T — — homolog 1 (formerly homeo box 7) G298u1 WIAF-10048 U33837 8995 Human glycoprotein receptor gp330 CCGGACAGGA[G/A]GTGCATTCCC M G A R K precursor, mRNA, complete cds. G298u2 WIAF-10051 U33837 13217 Human glycoprotein receptor gp330 ATGCAGCCAT[C/T]GAACTGCCTA S C T I I precursor, mRNA, complete cds. G298u3 WIAF-10077 U33837 6298 Human glycoprotein receptor gp330 AACTCTTTCA[T/C]TGTTGTTTCA M T C I T precursor, mRNA, complete cds. G298u4 WIAF-10078 U33837 6371 Human glycoprotein receptor gp330 CCATGGTGCC[G/A]GTGGCAGGCC S G A P P precursor, mRNA, complete cds. G298u5 WIAF-10079 U33837 6914 Human glycoprotein receptor gp330 ACTCTGAAGT[G/A]ATTCGTTATG S G A V V precursor, mRNA, complete cds. G298u6 WIAF-10081 U33837 8718 Human glycoprotein receptor gp330 GTTCCAATGC[G/A]CATCTGGGCG M G A A T precursor, mRNA, complete cds. G298u7 WIAF-10083 U33837 9088 Human glycoprotein receptor gp330 ACTTGCTCTG[A/G]AAATGAATTC M A G E G precursor, mRNA, complete cds. G298u8 WIAF-10096 U33837 6949 Human glycoprotein receptor gp330 ACTCCTTATG[G/C]CATCACTGTT M G C G A precursor, mRNA, complete cds. G298u9 WIAF-10097 U33837 7149 Human glycoprotein receptor gp330 TTGCTTGGAA[A/G]ACAATGGTGG M A G N D precursor, mRNA, complete cds. G298u10 WIAF-10100 U33837 8590 Human glycoprotein receptor gp330 TACACAAAAT[G/A]TCATAATTCA M G A C Y precursor, mRNA, complete cds. G298u11 WIAF-10101 U33837 12948 Human glycoprotein receptor gp330 CATCTTTGAA[G/C]ACCAGTTATA M G C D H precursor, mRNA, complete cds. G2980u1 WIAF-12723 HT0356 437 TLE1, transducin-like enhancer of TCATGGCCAC[G/A]GACCCCCAGT M G A G R split 1, homolog of Drosophila E(sp1) G2980u2 WIAF-12726 HT0356 2044 TLE1, transducin-like enhancer of AGTGGCTGGC[A/G]GTGGGCATGG S A G A A split 1, homolog of Drosophila E(sp1) G2980u3 WIAF-12747 HT0356 379 TLE1, transducin-like enhancer of CCATGGCAGA[G/A]TTGAATGCCA S G A E E split 1, homolog of Drosophila E(sp1) G2980u4 WIAF-12748 HT0356 276 TLE1, transducin-like enhancer of ATCGCCAAGA[G/A]ATTGAATACG M G A R K split 1, homolog of Drosophila E(sp1) G2980u5 WIAF-12749 HT0356 1876 TLE1, transducin-like enhancer of GCCACACAGA[C/T]GGAGCCAGCT S C T D D split 1, homolog of Drosophila E(sp1) G2980u6 WIAF-12750 HT0356 1759 TLE1, transducin-like enhancer of CCGCCTGCTA[C/T]GCCCTGGCCA S C T Y Y split 1, homolog of Drosophila E(sp1) G2981u1 WIAF-12720 HT0357 2206 TLE2, transducin-like enhancer of ACAAATACAT[T/C]GTGACAGGCT S T C I I split 2, homolog of Drosophila E(sp1) G2981u2 WIAF-12737 HT0357 1036 TLE2, transducin-like enhancer of CGGACAGCGT[C/T]GCCCTGAGGA S C T V V split 2, homolog of Drosophila E(sp1) G2981u3 WIAF-12740 HT0357 2181 TLE2, transducin-like enhancer of CTGAGTTGTG[A/T]CATCTCCAGA M A T D V split 2, homolog of Drosophila E(sp1) G2983u1 WIAF-12833 HT0360 636 TLE3, transducin-like enhancer of TGTCACCCTC[G/C]GAAAGCCTCC S G C S S split 3, homolog of Drosophila E(sp1) G2983u2 WIAF-12834 HT0360 1944 TLE3, transducin-like enhancer of TGGACAACAC[G/A]GTGCGCTCCT S G A T T split 3, homolog of Drosophila E(sp1) G2983u3 WIAF-12848 HT0360 1710 TLE3, transducin-like enhancer of ACCTGGCCTC[G/A]CCCACGCCCC S G A S S split 3, homolog of Drosophila E(sp1) G2985u1 WIAF-12724 HT0421 995 homeotic protein D3 GGCTTCGCCA[G/A]CGCCAACCTG M G A S N G2985u2 WIAF-12725 HT0421 1003 homeotic protein D3 CAGCGCCAAC[C/T]TGCAGGGCAG S C T L L G2986u1 WIAF-14124 HT0468 1197 CSDA, cold shock domain protein A GCCGTGGATA[C/T]CGGCGTCCCT S C T Y Y G2987u1 WIAF-12758 HT0474 2068 ZNF7, zinc finger protein 7 (KOX AGTGGTTTTA[C/T]GAATATGGGA S C T Y Y 4, clone HF.16) G2987u2 WIAF-12773 HT0474 985 ZNF7, zinc finger protein 7 (KOX GAGAGAAGCC[G/C]TACGAATGTG S G C P P 4, clone HF.16) G2987u3 WIAF-12775 HT0474 1278 ZNF7, zinc finger protein 7 (KOX AGCCAGCAGT[C/T]GCAGCTGGTT M C T S L 4, clone HF.16) G3005a1 WIAF-12133 HT0735 1441 homeotic protein 5.1 GAGGCAGCGG[C/T]CCCGGGCCTG S C T G G G3008a1 WIAF-12134 HT0753 1850 ATF4, activating transcription TAAAAGAGAG[G/A]GCGGATTCCC S G A R R factor 4 (tax-responsive enhancer element B67) G3008u2 WIAF-12798 HT0753 946 ATF4, activating transcription CCCTTCGACC[C/A]GTCGGGTTTG M C A P Q factor 4 (tax-responsive enhancer element B67) G3008u3 WIAF-12812 HT0753 1482 ATF4, activating transcription CACTGCTTAC[G/A]TTGCCATGAT M G A V I factor 4 (tax-responsive enhancer element B67) G3008u4 WIAF-12813 HT0753 1847 ATF4, activating transcription CTCTAAAAGA[G/C]AGGGCGGATT M G C E D factor 4 (tax-responsive enhancer element B67) G301u1 WIAF-10127 U71285 3639 MTR, 5-methyltetrahydrofolate- TGTGGAGACT[C/T]GCAGACATCG S C T L L homocysteine methyltransferase G3012u1 WIAF-12794 HT0873 402 MAD, MAX dimerization protein TGGTGCCACT[G/T]GGACCCGAAT S G T L L G3014u1 WIAF-14183 HT0899 274 homeotic protein 2, distal-less AAAAGACTCA[G/A]TACTTGGCCT S G A Q Q G3020u1 WIAF-12797 HT0956 852 MLLT3, myeloid/lymphoid or mixed- GTGCCTTCAA[A/G]GAACCTTCCA S A G K K lineage leukemia (trithorax (Drosophila) homolog); translocated to, 3 G3023u1 WIAF-13724 HT0966 381 zinc finger, X-linked, duplicated GCTGCAGCAA[G/A]CAATATGACA S G A K K A G3023u2 WIAF-13725 HT0966 220 zinc finger, X-linked, duplicated GGCCAAACTC[G/A]GCGCCCACCA M G A G S A G3023u3 WIAF-13726 HT0966 69 zinc finger, X-linked, duplicated AGTCGCACGA[T/C]AAACTGCGGC S T C D D A G3023u4 WIAF-13727 HT0966 249 zinc finger, X-linked, duplicated ACTTCGAACC[C/T]GAGAGGCCTT S C T P P A G3023u5 WIAF-13765 HT0966 661 zinc finger, X-linked, duplicated CAGGTTCTCT[G/A]CTCGCAGTAG M G A A T A G3023u6 WIAF-13766 HT0966 1302 zinc finger, X-linked, duplicated TGACTCCTTC[G/T]AGCACCCTTT S G T S S A G3027u1 WIAF-12800 HT1035 124 HOXB7, homeo box B7 TTATGCGAAT[G/A]CTTTATTTTC M G A A T G3027u2 WIAF-12816 HT1035 450 HOXB7, homeo box B7 GGGACTCGGA[C/T]TTGGCGGCCG S C T D D G3028u1 WIAF-12806 HT1037 701 homeotic protein C8 AGACCCTGGA[A/G]CTGGAGAAGG S A G E E G3029u1 WIAF-14153 HT1100 441 zinc finger protein 8 TCAGACTCAG[G/A]GAAAACTGCG S G A R R G3029u2 WIAF-14155 HT1100 1416 zinc finger protein 8 GGCGTGAACA[A/G]TCCTCGAGCA S A G Q Q G303u1 WIAF-10000 X13916 4110 LRP1, low density lipoprotein- ATGGAGCTGG[G/A]GCCCGACAAC M G A G E related protein 1 (alpha-2- macroglobulin receptor) G303u2 WIAF-10001 X13916 4012 LRP1, low density lipoprotein- GCGAGCTCTG[C/T]GACCAGTGCT S C T C C related protein 1 (alpha-2- macroglobulin receptor) G303u3 WIAF-10002 X13916 4702 LRP1, low density lipoprotein- GCCTGCCCCG[C/T]ATTGAGGCAG S C T R R related protein 1 (alpha-2- macroglobulin receptor) G303u4 WIAF-10003 X13916 6395 LRP1, low density lipoprotein- CTGGATCGCA[G/A]GCAACATCTA M G A G S related protein 1 (alpha-2- macroglobulin receptor) G303u5 WIAF-10004 X13916 6937 LRP1, low density lipoprotein- AAGGCACCAA[C/T]GTGTGCCGCGG S C T N N related protein 1 (alpha-2- macroglobulin receptor) G303u6 WIAF-10005 X13916 9391 LRP1, low density lipoprotein- GGCTGAAGGA[T/C]GACGGCCGGA S T C D D related protein 1 (alpha-2- macroglobulin receptor) G303u7 WIAF-10011 X13916 766 LRP1, low density lipoprotein- ACTGCATGGA[C/T]GGCTCAGATG S C T D D related protein 1 (alpha-2- macroglobulin receptor) G303u8 WIAF-10015 X13916 9040 LRP1, low density lipoprotein- ACCCGACCTG[C/T]GGCCCCAGTG S C T C C related protein 1 (alpha-2- macroglobulin receptor) G303u9 WIAF-10019 X13916 11749 LRP1, low density lipoprotein- CCCTGCGCTG[C/T]AACATGTTCG S C T C C related protein 1 (alpha-2- macroglobulin receptor) G303u10 WIAF-10020 X13916 1917 LRP1, low density lipoprotein- GACCAGTATG[G/A]GAAGCCGGGT M G A G E related protein 1 (alpha-2- macroglobulin receptor) G303u11 WIAF-10021 X13916 4810 LRP1, low density lipoprotein- AGAAGCGCAT[C/T]CTTTGGATTG S C T I I related protein 1 (alpha-2- macroglobulin receptor) G303u12 WIAF-10022 X13916 6367 LRP1, low density lipoprotein- TTGGCCGTGT[G/C]GAGGGCATTG S G C V V related protein 1 (alpha-2- macroglobulin receptor) G303u13 WIAF-10023 X13916 6247 LRP1, low density lipoprotein- CTGTCGGCAT[C/T]GACTTCCACG S C T I I related protein 1 (alpha-2- macroglobulin receptor) G303u14 WIAF-10024 X13916 8371 LRP1, low density lipoprotein- ACGCCTCAGA[T/C]GAGATGAACT S T C D D related protein 1 (alpha-2- macroglobulin receptor) G303u15 WIAF-10030 X13916 11395 LRP1, low density lipoprotein- ACGGCAGCGA[C/T]GAGGAGGCCT S C T D D related protein 1 (alpha-2- macroglobulin receptor) G303u16 WIAF-10031 X13916 12763 LRP1, low density lipoprotein- ACGTCTTTGA[G/A]GATTACATCT S G A E E related protein 1 (alpha-2- macroglobulin receptor) G303u17 WIAF-10035 X13916 640 LRP1, low density lipoprotein- ACGGATCTGA[C/T]GAGGCCCCTG S C T D D related protein 1 (alpha-2- macroglobulin receptor) G303u18 WIAF-10037 X13916 1609 LRP1, low density lipoprotein- GCCGCCTTGT[C/T]TACTGGGCAG S C T V V related protein 1 (alpha-2- macroglobulin receptor) G303u19 WIAF-10038 X13916 1629 LRP1, low density lipoprotein- GATGCCTATC[T/G]GGACTATATT M T G L R related protein 1 (alpha-2- macroglobulin receptor) G303u20 WIAF-10039 X13916 2210 LRP1, low density lipoprotein- CACCAGCTAC[C/T]TCATTGGCCG M C T L F related protein 1 (alpha-2- macroglobulin receptor) G303u21 WIAF-10043 X13916 7287 LRP1, low density lipoprotein- GATGGCTCCA[G/A]GAGGATCACC M G A R K related protein 1 (alpha-2- macroglobulin receptor) G303u22 WIAF-10044 X13916 8258 LRP1, low density lipoprotein- CTCTGACGAG[A/G]TCCCTTGCAA M A G I V related protein 1 (alpha-2- macroglobulin receptor) G303u23 WIAF-10045 X13916 11871 LRP1, low density lipoprotein- GTGCGCACCG[A/G]GAAAGCGGCC M A G E G related protein 1 (alpha-2- macroglobulin receptor) G3031u1 WIAF-14097 HT1128 611 PSMC3, proteasome (prosome, TGGGGATCCA[A/G]CCTCCAAAAG S A G Q Q macropain) 26S subunit, ATPase, 3 G3034u1 WIAF-12836 HT1182 137 TCF12, transcription factor 12 ATAAGGGAGC[G/A]TGAGGAGTCT M G A R H (HTF4, helix-loop-helix transcription factors 4) G3034u2 WIAF-12837 HT1182 421 TCF12, transcription factor 12 ATCTTCAATT[A/G]TGGGTTCCTT M A G M V (HTF4, helix-loop-helix transcription factors 4) G3038u1 WIAF-12864 HT1373 1700 NFKB1, nuclear factor of kappa AGAGAAGGCT[A/G]TGCAGCTTGC M A G M V light polypeptide gene enhancer in B-cells 1 (p105) G3038u2 WIAF-12881 HT1373 1936 NFKB1, nuclear factor of kappa TGTACCAGAC[G/A]CCCTTGCACT S G A T T light polypeptide gene enhancer in B-cells 1 (p105) G3038u3 WIAF-12882 HT1373 2641 NFKB1, nuclear factor of kappa AGCTGCAGCT[G/C]TATAAGTTAC S G C L L light polypeptide gene enhancer in B-cells 1 (p105) G3039u1 WIAF-13027 HT1375 3761 GLI3, GLI-Kruppel family member AACAGCCCCG[G/T]AAGTGGCACC M G T G V GLI3 (Greig cephalopolysyndactyly syndrome) G3039u2 WIAF-13028 HT1375 3963 GLI3, GLI-Kruppel family member CGCCAAATGA[G/T]TCAGCTGGCA M G T E D GLI3 (Greig cephalopolysyndactyly syndrome) G304u1 WIAF-12242 HT637 158 FABP3, fatty acid binding protein CTCACCCTAA[A/G]AACACACAGC M A G K R 3, muscle and heart (mammary- derived growth inhibitor) G3043u1 WIAF-12867 HT1486 842 IRF2, interferon regulatory GTGCCGAGGG[G/A]CGGCCACACT S G A G G factor 2 G3047u1 WIAF-12875 HT1518 1233 transcription factor 1, nucleolar TCCGTTTCCT[C/T]GAGAGCCTGC S C T L L G3047u2 WIAF-12876 HT1518 1746 transcription factor 1, nucleolar GGATTAAGAA[G/A]GCAGCCGAAG S G A K K G3047u3 WIAF-12877 HT1518 1829 transcription factor 1, nucleolar TCCAAGAAGA[T/C]GAAATTCCAG M T C M T G3048u1 WIAF-12884 HT1530 628 transcription factor USF AGTGGAGCGT[C/T]GCCGCCGAGA M C T R C G305u1 WIAF-10150 HT0034 777 prolyl 4-hydroxylase, beta CCCTTGTCAT[C/T]GAGTTCACCG S C T I I subunit/protein disulfide isomerase/thyroid hormone-binding protein, alt. transcript 1 G305u2 WIAF-10154 HT0034 186 prolyl 4-hydroxylase, beta TGGCGGCCCA[C/A]AAGTACCTGC M C A H Q subunit/protein disulfide isomerase/thyroid hormone-binding protein, alt. transcript 1 G305u3 WIAF-10155 HT0034 1428 prolyl 4-hydroxylase, beta GGACGGTCAT[T/C]GATTACAACG S T C I I subunit/protein disulfide isomerase/thyroid hormone-binding protein, alt. transcript 1 G3050u1 WIAF-12860 HT1558 2098 FSRG1: female sterile homeotic- AACATTGCAA[T/C]GGCATTTTGA S T C N N related gene 1 (mouse homolog) G3050u2 WIAF-12861 HT1558 2845 FSRG1: female sterile homeotic- TAGGCCCTTC[T/C]GGCTTTGGAC S T C S S related gene 1 (mouse homolog) G3050u3 WIAF-12862 HT1558 3409 FSRG1: female sterile homeotic- CCTCGTCGTC[G/A]TCTTCAGACA S G A S S related gene 1 (mouse homolog) G3050u4 WIAF-12874 HT1558 1699 FSRG1: female sterile homeotic- TCTCTTCTGT[G/C]TCACACACAG S G C V V related gene 1 (mouse homolog) G3050u5 WIAF-12878 HT1558 2093 FSRG1: female sterile homeotic- GTTAAAACAT[T/G]GCAATGGCAT M T G C G related gene 1 (mouse homolog) G3050u6 WIAF-12879 HT1558 2746 FSRG1: female sterile homeotic- CTGGGGCCGA[C/T]GAAGATGACA S C T D D related gene 1 (mouse homolog) G3051u1 WIAF-12866 HT1569 1423 MEF2B, MADS box transcription CTTGGCCGAC[G/A]GCTGGCCCCG S G A T T enhancer factor 2, polypeptide B (myocyte enhancer factor 2B) G3051u2 WIAF-13022 HT1569 661 MEF2B, MADS box transcription CAGAGTACAG[C/T]GAGCCCCACG S C T S S enhancer factor 2, polypeptide B (myocyte enhancer factor 2B) G3057a1 WIAF-12142 HT1669 5565 alpha-fetoprotein enhancer-binding AGACTGCTCT[T/C]GAGGCTCATA S T C L L protein G3057a2 WIAF-12143 HT1669 5634 alpha-fetoprotein enhancer-binding CTCTGTCTGC[G/A]ATGCTCTTAG S G A A A protein G3057a3 WIAF-12144 HT1669 5664 alpha-fetoprotein enhancer-binding GGGGACTCCA[G/T]ATGAAAGGAG M G T Q H protein G3057a4 WIAF-12145 HT1669 5703 alpha-fetoprotein enhancer-binding GCTTTTCCCA[C/T]CTACCCCCAA S C T H H protein G3057u5 WIAF-12885 HT1669 2227 alpha-fetoprotein enhancer-binding TCTGGAGATC[C/T]ATATGAGGTC M C T H Y protein G3057u6 WIAF-12892 HT1669 3720 alpha-fetoprotein enhancer-binding AGACCTTGCC[G/A]GCTCAGCTAC S G A P P protein G3057u7 WIAF-12893 HT1669 4137 alpha-fetoprotein enhancer-binding CAAGGTTTAC[G/A]GACTACCAGC S G A T T protein G3057u8 WIAF-12897 HT1669 4783 alpha-fetoprotein enhancer-binding GAAGACCAAC[A/C]CTCCCCAGCA M A C T P protein G3057u9 WIAF-12898 HT1669 5215 alpha-fetoprotein enhancer-binding TCCAACCTCC[A/C]CAATGAACAC M A C T P protein G3057u10 WIAF-12904 HT1669 7266 alpha-fetoprotein enhancer-binding CCCTGCAGGC[C/T]GCGTTGACTT S C T A A protein G3057u11 WIAF-12907 HT1669 8345 alpha-fetoprotein enhancer-binding CCAACAGACG[A/C]CTATTCGGAG M A C D A protein G3057u12 WIAF-12943 HT1669 4257 alpha-fetoprotein enhancer-binding TGGTGTGGTT[T/C]CAGAATGCCC S T C F F protein G3057u13 WIAF-12951 HT1669 7333 alpha-fetoprotein enhancer-binding ACCAGGCTTT[T/A]CTCCTTATTA M T A S T protein G3057u14 WIAF-13030 HT1669 303 alpha-fetoprotein enhancer-binding GCAGCCTGTC[G/A]GAGGACGAGT S G A S S protein G3057u15 WIAF-13031 HT1669 777 alpha-fetoprotein enhancer-binding GCCTTCCAGA[G/A]GAGGACGAGG S G A E E protein G306u1 WIAF-10118 HT0040 1618 CPT2, carnitine CTCTACTGCC[G/A]TCCACTTTGA M G A V I palmitoyltransferase II G307u1 WIAF-10076 HT0114 110 EDN2, endothelin 2 CGTTGCGCTA[G/A]CCCTGCTCGT M G A A T G3070u1 WIAF-12972 HT2085 625 pre-B-cell leukemia transcription AGAAATATGA[A/G]CAGGCATGTA S A G E E factor 3 G3070u2 WIAF-12973 HT2085 841 pre-B-cell leukemia transcription GTAACTTCAG[T/C]AAACAGGCCA S T C S S factor 3 G3071u1 WIAF-12886 HT2086 995 AGER, advanced glycosylation end CCTGCGAGGC[T/C]GTGATGATCC S T C A A product-specific receptor G3071u2 WIAF-12887 HT2086 1475 AGER, advanced glycosylation end GAGGCCAGAT[C/G]TACAGCCCAC M C G I M product-specific receptor G3071u3 WIAF-12935 HT2086 933 AGER, advanced glycosylation end ACGCATGGTG[A/G]GCATCATCCA M A G S G product-specific receptor G3071u4 WIAF-12936 HT2086 1052 AGER, advanced glycosylation end GTAACTTCAG[C/T]AAACAGGCCA S C T S S product-specific receptor G3071u5 WIAF-12937 HT2086 836 AGER, advanced glycosylation end AGAAGTATGA[G/A]CAGGCATGTA S G A E E product-specific receptor G308u1 WIAF-10094 HT0192 484 ANX4, annexin IV (placental ATGGACGGAG[C/G]CTTGAAGATG M C G S R anticoagulant protein II) G308u2 WIAF-10095 HT0192 333 ANX4, annexin IV (placental GGGATGATGA[C/T]GCCCACGGTG M C T T M anticoagulant protein II) G3081u1 WIAF-12997 HT2188 689 PSMC2, proteasome (prosome, GGCATTGAGC[C/T]TCCCAAGGGC M C T P L macropain) 26S subunit, ATPase, 2 G3083u1 WIAF-12976 HT2228 106 IGHMBP2, immunoglobulin mu TGCTGGAGCT[T/C]GAGAGAGACG S T C L L binding protein 2 G3083u2 WIAF-12985 HT2228 2260 IGHMBP2, immunoglobulin mu TGGAGTTCAT[G/C]GCCAGCAAGA M G C M I binding protein 2 G3083u3 WIAF-12986 HT2228 2060 IGHMBP2, immunoglobulin mu GGGACCTGCT[A/G]CGTCCACCAG M A G T A binding protein 2 G3083u4 WIAF-12987 HT2228 2365 IGHMBP2, immunoglobulin mu ACGACAGTTC[C/T]GGGGAAGGGA S C T S S binding protein 2 G3083u5 WIAF-13005 HT2228 411 IGHMBP2, immunoglobulin mu TTTGATGAGT[C/T]CCACGATTTC M C T S F binding protein 2 G3083u6 WIAF-13006 HT2228 272 IGHMBP2, immunoglobulin mu ATACGGGTCC[G/A]CGGCAGCTCT M G A A T binding protein 2 G3083u7 WIAF-13010 HT2228 2581 IGHMBP2, immunoglobulin mu TCAGGAGCGC[G/A]CAGGGGCAGC S G A A A binding protein 2 G3083u8 WIAF-13011 HT2228 2594 IGHMBP2, immunoglobulin mu GGGGCAGCCC[G/A]CCAGCAAGGA M G A A T binding protein 2 G3088u1 WIAF-12984 HT2318 884 HIVEP1, human immunodeficiency TGTGGCACTA[C/T]GTCCCCCTCC M C T T M virus type I enhancer-binding protein 1 G3088u2 WIAF-12988 HT2318 2469 HIVEP1, human immunodeficiency TCTTGTCACC[A/G]CGTCAACACC S A G P P virus type I enhancer-binding protein 1 G3088u3 WIAF-12989 HT2318 3066 HIVEP1, human immunodeficiency TTCTTGGTAC[T/C]GGACAGTCCC S T C T T virus type I enhancer-binding protein 1 G3088u4 WIAF-12991 HT2318 4008 HIVEP1, human immunodeficiency TTATCCGGCA[G/T]CACAACATCC M G T Q H virus type I enhancer-binding protein 1 G3088u5 WIAF-12992 HT2318 4880 HIVEP1, human immunodeficiency CAAATCCATG[C/G]ACCGCCTAGC M C G A G virus type I enhancer-binding protein 1 G3088u6 WIAF-12993 HT2318 5148 HIVEP1, human immunodeficiency TTGACAGCAT[G/A]TCTAATTCGC M G A M I virus type I enhancer-binding protein 1 G3088u7 WIAF-12999 HT2318 5834 HIVEP1, human immunodeficiency CCAGCTGATA[A/G]TTCATCAACA M A G N S virus type I enhancer-binding protein 1 G3088u8 WIAF-13000 HT2318 6065 HIVEP1, human immunodeficiency CAAAGTCAAC[G/A]GCCAGTCACT M G A R Q virus type I enhancer-binding protein 1 G3088u9 WIAF-13001 HT2318 7652 HIVEP1, human immunodeficiency CATAGGAATA[C/T]GGTCACAGAA M C T T M virus type I enhancer-binding protein 1 G3088u10 WIAF-13008 HT2318 741 HIVEP1, human immunodeficiency TTCTGCAGCA[A/G]CCATCTGAAC S A G Q Q virus type I enhancer-binding protein 1 G3088u11 WIAF-13009 HT2318 948 HIVEP1, human immunodeficiency CAGAACTGAG[C/T]ACCTTGTCAC S C T S S virus type I enhancer-binding protein 1 G3088u12 WIAF-13012 HT2318 1909 HIVEP1, human immunodeficiency TGAAACTTTA[C/T]TAAAATCAAG S C T L L virus type I enhancer-binding protein 1 G3088u13 WIAF-13013 HT2318 2803 HIVEP1, human immunodeficiency TCTTCTGTCT[G/A]TACCTTCACT M G A V I virus type I enhancer-binding protein 1 G3088u14 WIAF-13015 HT2318 3342 HIVEP1, human immunodeficiency GCGGTCTGCA[A/G]CCTCAGATTC S A G Q Q virus type I enhancer-binding protein 1 G3088u15 WIAF-13016 HT2318 3542 HIVEP1, human immunodeficiency CCTAAACATA[G/A]TGTTACCATA M G A S N virus type I enhancer-binding protein 1 G3088u16 WIAF-13017 HT2318 4972 HIVEP1, human immunodeficiency TGGGTCTTCT[A/G]AAAGTGAGGA M A G K E virus type I enhancer-binding protein 1 G3095u1 WIAF-12994 HT2435 701 TCF2, transcription factor 2, CCGCTCTGTA[C/T]ACCTGGTACG S C T Y Y hepatic; LF-B3; variant hepatic nuclear factor G3095u2 WIAF-13018 HT2435 362 TCF2, transcription factor 2, GGGCCGAGCC[C/T]GACACCAAGC S C T P P hepatic; LF-B3; variant hepatic nuclear factor G3095u3 WIAF-13020 HT2435 1620 TCF2, transcription factor 2, CCAGTTCTCC[C/T]AGCAGCTGCA N C T Q * hepatic; LF-B3; variant hepatic nuclear factor G3100a1 WIAF-12147 HT2483 526 ZNF141, zinc finger protein 141 GAATGAGTGT[A/G]AGTTGCAGAA M A G K E (clone pHZ-44) G3102u1 WIAF-12975 HT2508 259 NRF1, nuclear respiratory factor CGCCTTCTTC[G/T]CCCGAGGACA S G T S S 1 G3103u1 WIAF-13617 HT2511 1106 E2F2, E2F transcription factor 2 CCTTGGACCA[G/T]CTCATCCAGA M G T Q H G3103u2 WIAF-13659 HT2511 1154 E2F2, E2F transcription factor 2 CTGAGGACAA[G/A]GCCAACAAGA S G A K K G311u1 WIAF-10291 HT0402 1339 A2M, alpha-2-macroglobulin GTCCCTGTTA[C/T]GGCTACCAGT S C T Y Y G311u2 WIAF-10292 HT0402 1201 A2M, alpha-2-macroglobulin TCATATTCAT[C/T]AGAGGAAATG S C T I I G311u3 WIAF-10293 HT0402 3041 A2M, alpha-2-macroglobulin TACTCCAGAG[G/A]TCAAGTCCAA M G A V I G311u4 WIAF-10294 HT0402 3676 A2M, alpha-2-macroglobulin TGACATCCTA[T/C]GTGCTCCTCG S T C Y Y G311u5 WIAF-10296 HT0402 3364 A2M, alpha-2-macroglobulin ATATCACCAT[C/T]GCCCTTCTGG S C T I I G311u6 WIAF-10297 HT0402 3203 A2M, alpha-2-macroglobulin CCAAGCTCGA[G/T]CCTACATCTT M G T A S G311a7 WIAF-10494 HT0402 1122 A2M, alpha-2-macroglobulin TCACACTTTC[G/A]ACAGGGAATT M G A R Q G3119u1 WIAF-13947 HT2654 2876 GLI, glioma-associated oncogene TTTCTGGGGG[G/A]TTCCCAGGTT M G A G D homolog (zinc finger protein) G3119u2 WIAF-13959 HT2654 654 GLI, glioma-associated oncogene AGTGCCGGGA[G/A]GAACCCTTGG S G A E E homolog (zinc finger protein) G3119u3 WIAF-13965 HT2654 3376 GLI, glioma-associated oncogene TGGGGAAACA[G/C]AATTCCTCAA M G C E Q homolog (zinc finger protein) G312u1 WIAF-10006 HT0428 898 PLAU, plasminogen activator, CTCACCACAA[C/T]GACATTGCCT S C T N N urokinase G312u2 WIAF-10029 HT0428 498 PLAU, plasminogen activator, GGCCTAAAGC[C/T]GCTTGTCCAA M C T P L urokinase G312a3 WIAF-10521 HT0428 767 PLAU, plasminogen activator, TGATTACCCA[A/C]AGAAGGAGGA M A C K Q urokinase G3125u1 WIAF-13675 HT2674 740 GTF2F2, general transcription ACATCACAAA[A/G]CAACCTGTGG S A G K K factor IIF, polypeptide 2 (30 kD subunit) G313u1 WIAF-10129 HT0462 3086 platelet-derived growth factor, CATGCGTGTG[G/A]ACTCAGACAA M G A D N alpha polypeptide (GB:M21574) G313u2 WIAF-10130 HT0462 1078 platelet-derived growth factor, ATGAGAAAGG[T/G]TTCATTGAAA S T G G G alpha polypeptide (GB:M21574) G313u3 WIAF-10133 HT0462 1571 platelet-derived growth factor, GGAGATCCAC[T/C]CCCGAGACAG M T C S P alpha polypeptide (GB:M21574) G313u4 WIAF-10135 HT0462 2611 platelet-derived growth factor, CTCGCAACGT[C/T]CTCCTGGCAC S C T V V alpha polypeptide (GB:M21574) G314u1 WIAF-10069 HT0467 1890 ALOX15, arachidonate 15- TCAGGGAGGA[G/A]CTGGCTGCCC S G A E E lipoxygenase G3141u1 WIAF-13934 HT27498 878 NFATC3, nuclear factor of CCAGAGGATA[G/A]CTGGCTACTC M G A S N activated T-cells, cytoplasmic 3 G3141u2 WIAF-13936 HT27498 1189 NFATC3, nuclear factor of GCCTGCCTCA[T/C]GCAATGGGAA M T C C R activated T-cells, cytoplasmic 3 G3141u3 WIAF-13938 HT27498 2241 NFATC3, nuclear factor of CTCTGCGGGG[T/C]TTCCCTTCAG S T C G G activated T-cells, cytoplasmic 3 G3141u4 WIAF-13944 HT27498 702 NFATC3, nuclear factor of ATGCCTCTGA[C/T]GAGGCAGCCC S C T D D activated T-cells, cytoplasmic 3 G3159u1 WIAF-13891 HT2757 523 SP4, Sp4 transcription factor CTTCAAAAGA[G/A]AATAACGTTT S G A E E G3159u2 WIAF-13892 HT2757 1514 SP4, Sp4 transcription factor ACAGAATGTT[C/T]AACTTCAAGC N C T Q * G3159u3 WIAF-13893 HT2757 2236 SP4, Sp4 transcription factor TGTTTTGTGG[C/T]AAAAGATTCA S C T G G G3165u1 WIAF-13860 HT27636 437 transcription factor B-ATF AGCAGCTCAC[A/G]GAGGAACTGA S A G T T G3165u2 WIAF-13861 HT27636 512 transcription factor B-ATF CCAGCACGCC[C/G]TCGCCCCCCG S C G P P G3173u1 WIAF-13556 HT2772 1686 ZNF74, zinc finger protein 74 TGCACAGCGA[G/A]GGGAAGCCCT S G A E E (Cos52) G3175u1 WIAF-13948 HT2776 2037 transcriptional regulator, via TGTTCGGACC[A/G]GAAGCACCCA S A G P P glucocorticoid receptor G3182u1 WIAF-14036 HT2783 1614 MHC2TA, MHC class II ATCCTAGACG[C/G]CTTCGAGGAG M C G A G transactivator G3182u2 WIAF-14037 HT2783 2791 MHC2TA, MHC class II TGAGCGACAC[G/A]GTGGCGCTGT S G A T T transactivator G3182u3 WIAF-14059 HT2783 1657 MHC2TA, MHC class II TGCACAGCAC[G/A]TGCGGACCGG S G A T T transactivator G3182u4 WIAF-14060 HT2783 1606 MHC2TA, MHC class II TTCTGCTCAT[C/T]CTAGACGCCT S C T I I transactivator G3183u1 WIAF-13950 HT27861 392 zinc finger protein C2H2-150 TACTCTAGAG[G/A]AGCCTGTTGG M G A E K G3184u1 WIAF-13864 HT27862 271 zinc finger protein C2H2-171 GAAACTCCAG[T/G]TCAAAGACTT M T G F V G3184u2 WIAF-13865 HT27862 248 zinc finger protein C2H2-171 CTGCTTGAAT[T/C]CATGTATGAR M T C F S G320u1 WIAF-10136 HT0791 552 ANX7, annexin VII (synexin) CCAACTTCGA[T/C]GCTATAAGAG S T C D D G320u2 WIAF-10137 HT0791 1350 ANX7, annexin VII (synexin) TTGACCTTGT[A/G]CAAATAAAAC S A G V V G3208u1 WIAF-14186 HT27930 485 zinc finger protein ZNF37A GTCAGAAGTC[A/G]GCCCTAATTG S A G S S G3218u1 WIAF-13526 HT28104 187 zinc finger protein ZNF169, CCCGACAGCT[C/T]ATTAAGAAAG M C T H Y Krueppel-type G323u1 WIAF-10066 HT0915 1361 Homo sapiens inducible nitric ACTTCTGTGA[C/T]GTCCAGCGCT S C T D D oxide synthase (NOS) mRNA, complete cds. G325u1 WIAF-10106 HT0962 3817 FBN1, fibrillin 1 (Marfan TGTGAATGCC[C/T]GCCTGGCCAT M C T P L syndrome) G325u2 WIAF-10113 HT0962 722 FBN1, fibrillin 1 (Marfan AGATAGCTCC[T/G]TCCTGTGGCT S T G P P syndrome) G325u3 WIAF-10114 HT0962 2022 FBN1, fibrillin 1 (Marfan GATCTGCAAT[A/C]ATGGACGCTG M A C N H syndrome) G325u4 WIAF-10116 HT0962 3603 FBN1, fibrillin 1 (Marfan GAACTGCACA[G/C]ACATTGACGA M G C D H syndrome) G325u5 WIAF-10117 HT0962 2270 FBN1, fibrillin 1 (Marfan TCTGCATGAA[C/T]GGGCGTTGCG S C T N N syndrome) G326u1 WIAF-10036 HT1009 1854 KLKB1, kallikrein B plasma, GCAAACACAA[C/T]GGAATGTGGC S C T N N (Fletcher factor) 1 G327u1 WIAF-10052 HT1011 1599 HRG, histidine-rich glycoprotein AAGCCAGACA[A/T]TCAGCCCTTT M A T N I G327u2 WIAF-10054 HT1011 1083 HRG, histidine-rich glycoprotein CCACTATTGC[C/T]CATGTCCTGC M C T P L G327u3 WIAF-10055 HT1011 1140 HRG, histidine-rich glycoprotein GCCCAAAGAC[A/G]TTCTCATAAT M A G H R G328u1 WIAF-10145 HT1087 255 SAA1, serum amyloid A1 GTGCCTGGGC[T/C]GCAGAAGTGA S T C A A G328a2 WIAF-10511 HT1087 248 SAA1, serum amyloid A1 CCTGGGGGTG[C/T]CTGGGCTGCA M C T A V G328a3 WIAF-10512 HT1087 305 SAA1, serum amyloid A1 TTCTTTGGCC[A/G]TGGTGCGGAG M A G H R G328a4 WIAF-13126 HT1087 295 SAA1, serum amyloid A1 TATCCAGAGA[T/C]TCTTTGGCCA M T C F L G328a5 WIAF-13127 HT1087 82 SAA1, serum amyloid A1 CTTGGTCCTG[G/A]GTGTCAGCAG M G A G S G329u1 WIAF-10140 HT1141 2514 PLCG1, phospholipase C, gamma 1 CTGACCTTCA[T/C]CAAGAGCGCC M T C I T (formerly subtype 148) G329u2 WIAF-10162 HT1141 1036 PLCG1, phospholipase C, gamma 1 TATGCCCGGA[C/A]ACCATGAACA M C A D E (formerly subtype 148) G329u3 WIAF-10163 HT1141 911 PLCG1, phospholipase C, gamma 1 GTTCATGCTC[A/G]GCTTCCTCCG M A G S G (formerly subtype 148) G3295u1 WIAF-14017 HT3460 1229 FUBP, far upstream element CCATAAAAAG[C/T]ATAAGCCAGC S C T S S binding protein G3296u1 WIAF-14168 HT3466 6289 transcription factor TFIIIC, RNA CAGCCTGGAC[G/A]AGAGCCCCAT M G A E K polymerase III, alpha subunit G3296u2 WIAF-14179 HT3466 235 transcription factor TFIIIC, RNA GGGCATCAGC[T/A]TCTATGAGGA M T A F I polymerase III, alpha subunit G3298u1 WIAF-13523 HT3504 1803 DNA-binding protein HRFX2 ACTTTGCCAA[C/T]GTGCAGGAGC S C T N N G3298u2 WIAF-13524 HT3504 1743 DNA-binding protein HRFX2 GGGCGGTGCT[G/A]CAGAACACGT S G A L L G3298u3 WIAF-13528 HT3504 2002 DNA-binding protein HRFX2 GTTCTTGCTG[A/G]AATGGTCCTT M A G K E G33u1 WIAF-10254 X82540 1044 INHBC, inhibin, beta C AAGGCCAACA[C/T]AGCTGCAGGC M C T T I G33u2 WIAF-10255 X82540 1136 INHBC, inhibin, beta C CAGCAACATT[G/A]TCAAGACTGA M G A V I G33u3 WIAF-10256 X82540 1185 INHBC, inhibin, beta C GGGTGCAGTT[A/G]GTCTATGTGT N A G * W G33u4 WIAF-10259 X82540 892 INHBC, inhibin, beta C TTTTTGTGGA[C/T]TTCCGTGAGA S C T D D G3303u1 WIAF-13566 HT3523 981 POU6F1, POU domain, class 6, CAGGCCAGGA[G/A]ATCACTGAAA S G A E E transcription factor 1 G3304u1 WIAF-13932 HT3544 970 SP2, Sp2 transcription factor TCAACAACCT[C/T]GTGAACGCCA S C T L L G3304u2 WIAF-13935 HT3544 1891 SP2, Sp2 transcription factor AGAAGCACGT[T/G]TGCCACATCC S T G V V G3304u3 WIAF-13943 HT3544 920 SP2, Sp2 transcription factor TGTGGTGAAG[T/C]TGACAGGTGG S T C L L G3311u1 WIAF-13839 HT3585 757 GATA3, GATA-binding protein 3 CCCACTCCCG[T/C]GGCAGCATGA S T C R R G3311u2 WIAF-13840 HT3585 901 GATA3, GATA-binding protein 3 TCGGATGCAA[G/A]TCCAGGCCCA S G A K K G3316u1 WIAF-13818 HT3607 282 zinc finger protein HKE-T1, AAAGAGTTTC[A/G]GTCAGAGTTC M A G S G Kruppel-like G3319u1 WIAF-14214 HT3613 1086 SMARCA3, SWI/SNF related, matrix AAACTCTTAC[A/G]GCCATTGCAG S A G T T associated, actin dependent regulator of chromatin, subfamily a, member 3 G3319u2 WIAF-14221 HT3613 1261 SMARCA3, SWI/SNF related, matrix TAGATGTAGT[G/C]AACAACCCAG M G C E Q associated, actin dependent regulator of chromatin, subfamily a, member 3 G3320u1 WIAF-13692 HT3622 624 BCL6, B-cell CLL/lymphoma 6 (zinc ATTTGCGGGA[G/C]GGCAACATCA M G C E D finger protein 51) G3320u2 WIAF-13717 HT3622 1062 BCL6, B-cell CLL/lymphoma 6 (zinc ACAGCCGGCC[G/A]ACTTTGGAGG S G A P P finger protein 51) G3321u1 WIAF-13761 HT3641 235 STAT2, signal transducer and TCTTGGATCA[G/C]CTGAACTATG M G C Q H activator of transcription 2, 113 kD G3321u2 WIAF-13762 HT3641 774 STAT2, signal transducer and CAAAAAGCCT[G/C]CATCAGAGCT M G C C S activator of transcription 2, 113 kD G3328u1 WIAF-13543 HT3681 1550 transcription factor znf6 CCACAATGGT[A/G]TCAGAGGAGG S A G V V G3328u2 WIAF-13544 HT3681 1389 transcription factor znf6 AGAGGATTTA[G/C]AGGAAGATGA M G C E Q G3336u1 WIAF-13848 HT3732 216 XBP1, X-box binding protein 1 ACCTGAGCCC[C/T]GAGGAGAAGG S C T P P G334u1 WIAF-10008 HT1220 893 THBS1, thrombospondin 1 TACATTGGCC[A/C]CAAGACAAAG M A C H P G334u2 WIAF-10009 HT1220 2000 THBS1, thrombospondin 1 TCACAGCCCT[T/C]CGGCCAGGGT M T C F S G334u3 WIAF-10016 HT1220 1521 THBS1, thrombospondin 1 CCCAGATGAA[T/C]GGGAAACCCT S T C N N G334u4 WIAF-10017 HT1220 2210 THBS1, thrombospondin 1 GGCTGGCCCA[A/G]TGAGAACCTG M A G N S G334u5 WIAF-10018 HT1220 2979 THBS1, thrombospondin 1 GTGAGACCGA[T/C]TTCCGCCGAT S T C D D G334u6 WIAF-10033 HT1220 1136 THBS1, thrombospondin 1 TGTCACTGTC[A/G]GAACTCAGTT M A G Q R G334u7 WIAF-10034 HT1220 1859 THBS1, thrombospondin 1 AGTGGAAATG[G/A]CATCCAGTGC M G A G D G3343u1 WIAF-13545 HT3770 1104 ZNF76, zinc finger protein 76 GCAGTGCCCA[C/T]GGCGAGCTGG S C T H H (expressed in testis) G3343u2 WIAF-13561 HT3770 425 ZNF76, zinc finger protein 76 GAGCAGTATG[C/A]CAGCAAGGTT M C A A D (expressed in testis) G3343u3 WIAF-13562 HT3770 143 ZNF76, zinc finger protein 76 CACCAGGTGA[C/T]GGTACAGAAA M C T T M (expressed in testis) G3343u4 WIAF-13563 HT3770 646 ZNF76, zinc finger protein 76 GAAGAGCCAC[G/T]TTCGTACCCA M G T V F (expressed in testis) G3343u5 WIAF-13564 HT3770 611 ZNF76, zinc finger protein 76 AGCTGTGGAA[A/G]GGCCTTTGCC M A G K R (expressed in testis) G3344u1 WIAF-13664 HT3772 925 zinc finger protein MAZ AGCTGTCGCA[C/T]TCGCACGAGA S C T H H G3345u1 WIAF-13508 HT3823 315 TCF6L1, transcription factor 6- TTCGATTTTC[T/C]AAAGAACAAC S T C S S like 1 (mitochondrial transcription factor 1-like) G3345u2 WIAF-13509 HT3823 167 TCF6L1, transcription factor 6- GGCGTGCTGA[G/C]TGCCCTGGGA M G C S T like 1 (mitochondrial transcription factor 1-like) G3345u3 WIAF-13531 HT3823 625 TCF6L1, transcription factor 6- TTATAACGTT[T/G]ATGTAGCTGA M T G Y D like 1 (mitochondrial transcription factor 1-like) G3352u1 WIAF-13589 HT4005 1190 MITF, microphthalmia-associated CTCGGAACTG[G/A]GACTGAGGCC M G A G E transcription factor G3352u2 WIAF-13604 HT4005 1156 MITF, microphthalmia-associated TCTCACGGAT[G/A]GCACCATCAC M G A G S transcription factor G3353u1 WIAF-13937 HT4010 360 GTF2H3, general transcription ATCTAATGAC[C/A]AAAAGTGACA S C A T T factor IIH, polypeptide 3 (34 kD subunit) G3358u1 WIAF-13671 HT4187 398 ETV5, ets variant gene 5 (ets- GATGATGAAC[A/G]GTTTGTCCCA M A G Q R related molecule) G3358u2 WIAF-13672 HT4187 223 ETV5, ets variant gene 5 (ets- TCAGCAAGTC[C/T]CTTTTATGGT M C T P S related molecule) G3358u3 WIAF-13673 HT4187 1236 ETV5, ets variant gene 5 (ets- GACTGGAAGG[C/G]AAAGTCAAAC S C G G G related molecule) G3358u4 WIAF-13674 HT4187 1678 ETV5, ets variant gene 5 (ets- TTACCTCCTG[G/A]ACATGGACCG M G A D N related molecule) G3358u5 WIAF-13706 HT4187 414 ETV5, ets variant gene 5 (ets- TCCCAGATTT[T/C]CAGTCTGATA S T C F F related molecule) G3358u6 WIAF-13707 HT4187 1238 ETV5, ets variant gene 5 (ets- CTGGAAGGCA[A/G]AGTCAAACAG M A G K R related molecule) G336u1 WIAF-10152 HT1258 566 ACAT1, acetyl-Coenzyme A AGAGCATGTC[C/A]AATGTTCCAT S C A S S acetyltransferase 1 (acetoacetyl Coenzyme A thiolase) G3369u1 WIAF-14047 HT4302 614 zinc finger protein DB1 ATCTCAATCG[A/G]CACAAGCTCT S A G R R G337u1 WIAF-10268 HT1259 464 EDNRB, endothelin receptor type B AAAGGAGACA[G/T]GACGGCAGGA M G T R M G337u2 WIAF-10298 HT1259 1281 EDNRB, endothelin receptor type B TGAAGCTCAC[T/A]CTTTATAATC S T A T T G3373u1 WIAF-14203 HT4342 1253 MTF1, metal-regulatory CTCAACAGAC[A/G]GCTTCCTTGA S A G T T transcription factor 1 G3390u1 WIAF-14182 HT4483 680 ZNF133, zinc finger protein 133 AGAGCCAGAG[C/T]TCTACCTCGA M C T L F (clone pHZ-13) G3390u2 WIAF-14184 HT4483 1026 ZNF133, zinc finger protein 133 GCTCAGACAG[G/A]GAACCCTGAG M G A G E (clone pHZ-13) G3390u3 WIAF-14185 HT4483 1423 ZNF133, zinc finger protein 133 AAAAGCCTTA[T/C]GTGTGCCGGG S T C Y Y (clone pHZ-13) G3390u4 WIAF-14197 HT4483 811 ZNF133, zinc finger protein 133 CTGGGGATCC[A/G]GGCCCAGGGG S A G P P (clone pHZ-13) G3390u5 WIAF-14198 HT4483 1420 ZNF133, zinc finger protein 133 GGGAAAAGCC[T/G]TATGTGTGCC S T G P P (clone pHZ-13) G3390u6 WIAF-14199 HT4483 2143 ZNF133, zinc finger protein 133 CAGCTCTAAT[C/T]ACACACAAGC S C T I I (clone pHZ-13) G3391u1 WIAF-13631 HT4484 391 ZNF136, zinc finger protein 136 AGCATTGTAT[A/G]TGGAGAAGTC M A G Y C (clone pHZ-20) G3396u1 WIAF-13978 HT4491 1283 ZNF135, zinc finger protein 135 CACAGCTCCT[C/T]GCTCAGCCAG M C T S L (clone pHZ-17) G3396u2 WIAF-13979 HT4491 1296 ZNF135, zinc finger protein 135 TCAGCCAGCA[C/T]GAAAGGACGC S C T H H (clone pHZ-17) G3396u3 WIAF-13980 HT4491 1028 ZNF135, zinc finger protein 135 AGTCACAGCT[C/T]GTCCCTCACC M C T S L (clone pHZ-17) G3396u4 WIAF-13981 HT4491 1057 ZNF135, zinc finger protein 135 GCGAATCCAC[A/G]CTGGGGAGAA M A G T A (clone pHZ-17) G3396u5 WIAF-13982 HT4491 1152 ZNF135, zinc finger protein 135 CAGGAGAGAA[A/G]CCCTATGAAT S A G K K (clone pHZ-17) G3396u6 WIAF-13983 HT4491 1243 ZNF135, zinc finger protein 135 AAAGCCGTAT[G/C]GGTGCAATGA M G C G R (clone pHZ-17) G3396u7 WIAF-13984 HT4491 1045 2HF135, zinc finger protein 135 CACCAAACAT[C/T]AGCGAATCCA N C T Q * (clone pHZ-17) G340u1 WIAF-10139 HT1386 459 CYP27A1, cytochrome P450, CCTATGGGCC[G/A]TTCACCACGG S G A P P subfamily XXVIIA (steroid 27- hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1 G340u2 WIAF-10160 HT1386 801 CYP27A1, cytochrome P450, TCCCCAAGTG[G/A]ACTCGCCCCG N G A W * subfamily XXVIIA (steroid 27- hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1 G341u1 WIAF-10121 HT1388 912 MUT, methylmalonyl Coenzyme A GAGCTGGCCT[A/G]TACTTTAGCA M A G Y C mutase G341u2 WIAF-10128 HT1388 2087 MUT, methylmalonyl Coenzyme A TGCTGTGGGC[G/A]TAAGCACCCT M G A V I mutase G3410u1 WIAF-13749 HT4550 1720 zinc finger homeodomain protein TGAGTCCTCT[G/T]TTTCATCAGC M G T V F G3410u2 WIAF-13750 HT4550 2843 zinc finger homeodomain protein AAACATCATT[T/C]GATTGAACAC M T C L S G3410u3 WIAF-13751 HT4550 2745 zinc finger homeodomain protein AGATATTCCA[A/T]AAGAGTAGTT M A T Q H G3410u4 WIAF-13775 HT4550 236 zinc finoer homeodomain protein AGAGAAGGGA[A/C]TGCTAAGAAC M A C N T G3410u5 WIAF-13776 HT4550 195 zinc finger homeodomain protein TGCCAACAGA[C/T]CAGACAGTGT S C T D D G3410u6 WIAF-13777 HT4550 606 zinc finger homeodomain protein ATAACTTTAG[T/C]TGCTCCCTGT S T C S S G3410u7 WIAF-13793 HT4550 2073 zinc finger homeodomain protein CAGTTTTACC[A/G]GTGGGATCAA S A G P P G343u1 WIAF-10120 HT1552 561 HK1, hexokinase 1 CTTGCCAACA[A/G]TCCAAAATAG S A G Q Q G343u2 WIAF-10124 HT1552 159 HK1, hexokinase 1 ACAAGTATCT[G/C]TATGCCATGC S G C L L G348u1 WIAF-10269 HT1906 2212 PECAM1, platelet/endothelial cell TGACGATGTC[A/G]GAAACCATGC S A G G G adhesion molecule (CD31 antigen) G348u2 WIAF-10277 HT1906 1656 PECAM1, platelet/endothelial cell GCCATTCCCA[C/T]GCCAAAATGT S C T H H adhesion molecule (CD31 antigen) G348u3 WIAF-10283 HT1906 577 PECAM1, platelet/endothelial cell AGAGTACCAG[C/G]TGTTGGTGGA S C G V V adhesion molecule (CD31 antigen) G348a5 WIAF-13119 HT1906 ? PECAM1, platelet/endothelial cell ATTGTTCCC[C/G] ? C G adhesion molecule (CD31 antigen) G351u1 WIAF-10123 HT1990 1047 OSBP, oxysterol binding protein TGCTGGCAGA[G/A]TCAGATGAAT S G A E E G351u2 WIAF-10132 HT1990 1023 OSBP, oxysterol binding protein TGGCCAAGGC[C/A]AAAGCTGTGA S C A A A G355u1 WIAF-10146 HT2143 1670 THBS4, thrombospondin 4 AACTGCCTGA[G/A]TGTCTTAAAT M G A S N G355u2 WIAF-10165 HT2143 1186 THBS4, thrombospondin 4 TCGAAATGGA[G/C]CGTGCGTTCC M G C A P G355a3 WIAF-10510 HT2143 1962 THBS4, thrombospondin 4 ACTGCCCCAC[C/G]GTCATTAACA S C G T T G355a4 WIAF-13125 HT2143 1963 THBS4, thrombospondin 4 CTGCCCCACC[G/a]TCATTAACAG M G a V I G3552u1 WIAF-12701 HT28101 1006 CLCN2, chloride channel 2 AAGAGACTAT[T/C]ACAGCCCTCT S T C I I G3552u2 WIAF-12731 HT28101 1823 CLCN2, chloride channel 2 CCGCCACCAG[C/T]AGTACCGGGT N C T Q * G3552u3 WIAF-12736 HT28101 2254 CLCN2, chloride channel 2 GGAGCGCAGA[G/C]TCGGCAGGCA M G C E D G3565u1 WIAF-12744 HT2896 334 calcyclin GCCCTCAAGG[G/A]CTGAAAATAA M G A G D G357u1 WIAF-10267 HT2244 4300 C4B, complement component 4B ATGAGTACGA[T/C]GAGCTTCCAG S T C D D G357u2 WIAF-10280 HT2244 5095 C4B, complement component 4B TCATGGGTCT[G/A]GATGGGGCCA S G A L L G357u3 WIAF-10295 HT2244 2996 C4B, complement component 4B CTCAGATCCA[T/C]TGGACACTTT S T C L L G359u1 WIAF-10026 HT2411 936 PLAT, plasminogen activator, CGCAGGCTGA[A/G]GTGGGAGTAC M A G T M tissue G359a2 WIAF-10520 HT2411 1444 PLAT, plasminogen activator, AGGCCTTGTC[T/C]CCTTTCTATT S T C S S tissue G3592u1 WIAF-12759 HT4214 743 CLCN4, chloride channel 4 CTTCTAACGA[G/A]ACCACTTTTG S G A E E G3592u2 WIAF-12761 HT4214 835 CLCN4, chloride channel 4 GCTTACATTC[T/G]GAATTACTTA M T G L R G361u1 WIAF-10053 HT2479 857 cystathionine beta synthase, alt. TGGCTCACTA[C/T]GACACCACCG S C T Y Y transcript 1 G361u2 WIAF-10056 HT2479 1097 cystathionine beta synthase, alt. TCATCCCCAC[G/A]GTGCTGGACA S G A T T transcript 1 G362u1 WIAF-10058 HT2638 223 ADRB2, adrenergic, beta-2-, GGCACCCAAT[G/A]GAAGCCATGC M G A G R receptor, surface G362u2 WIAF-10059 HT2638 429 ADRB2, adrenergic, beta-2-, TCATGGGCCT[G/A]GCAGTGGTGC S G A L L receptor, surface G362u3 WIAF-10060 HT2638 256 ADRB2, adrenergic, beta-2-, CGTCACGCAG[G/C]AAAGGGACGA M G C E Q receptor, surface G362u4 WIAF-10093 HT2638 1230 ADRB2, adrenergic, beta-2-, AGGCCTATGG[G/C]AATGGCTACT S G C G G receptor, surface G3620u1 WIAF-12808 HT97200 458 ACATN, acetyl-Coenzyme A CACTCTCTGG[A/G]TATGAAGAGC M A G D G transporter G3627u1 WIAF-12820 HT97387 347 NAPG, N-ethylmaleimide-sensitive GCAGAAACTA[C/T]CAGAGGCCGT M C T P S factor attachment protein, gamma G366u1 WIAF-10046 HT2764 987 BDKRB2, bradykinin receptor B2 GCCTCCTTCA[T/C]GGCCTACAGC M T C M T G366a2 WIAF-10500 HT2764 820 BDKRB2, bradykinin receptor B2 AGATCCAGAC[G/A]GAGAGGAGGG S G A T T G366a3 WIAF-10501 HT2764 961 BDKRB2, bradykinin receptor B2 GCATCATCGA[T/C]GTAATCACAC S T C D D G367u1 WIAF-10156 HT27685 6965 ACACA, acetyl-Coenzyme A ATCATCCATA[T/C]GACGCAGCAC N T C * C carboxylase alpha G370u1 WIAF-10281 HT27888 3250 LEPR, leptin receptor AAAATTCTCC[G/A]TTGAAGGATT S G A P P G370u2 WIAF-10282 HT27888 3229 LEPR, leptin receptor TCACCAAGTG[C/T]TTCTCTAGCA S C T C C G370u3 WIAF-10284 HT27888 1005 LEPR, leptin receptor CAATATCAAG[T/C]GAAATATTCA M T C V A G370u4 WIAF-10285 HT27888 1894 LEPR, leptin receptor CAGAGAATAA[C/T]CTTCAATTCC S C T N N G370u5 WIAF-10299 HT27888 1222 LEPR, leptin receptor TTCTGACAAG[T/C]GTTGGGTCTA S T C S S G370u6 WIAF-10300 HT27888 2161 LEPR, leptin receptor CTATGAAAAA[G/C]GAGAAAATG M G C K N G371u1 WIAF-10107 HT27943 349 CRAT, carnitine acetyltransferase TCATCTACTC[G/C]AGCCCAGGCG S G C S S G371a2 WIAF-12093 HT27943 287 CRAT, carnitine acetyltransferase GGAGAACTGG[C/T]TGTCTGAGTG S C T L L G372a1 WIAF-10506 HT28247 1099 HADHA, hydroxyacyl-Coenzyme A TGGAGCTCCA[C/A]AGAAGGATGT M C A Q K dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit G374u1 WIAF-10103 HT28496 4435 FASN, fatty acid synthase CACCTCCCAC[G/A]TCCCGGAGGT M G A V I G374u2 WIAF-10104 HT28496 5996 FASN, fatty acid synthase CTGGACAGGG[T/C]GACCCGAGAG M T C V A G374u3 WIAF-10105 HT28496 5644 FASN, fatty acid synthase CAAGAGCTAC[A/G]TCATCGCTGG M A G I V G374u4 WIAF-10115 HT28496 6387 FASN, fatty acid synthase TGGCACACAT[C/T]CTGGGCATCC S C T I I G374u5 WIAF-10119 HT28496 567 FASN, fatty acid synthase GGGGCATCAA[C/T]GTCCTGCTGA S C T N N G374a6 WIAF-12094 HT28496 5520 FASN, fatty acid synthase ACATGGCCCA[A/G]GGGAAGCACA S A G Q Q G377u1 WIAF-10142 HT2996 929 PCCB, propionyl Coenzyme A GGACCCGGCT[T/C]CCGTCCGTGA M T C S P carboxylase, beta polypeptide G377u2 WIAF-10143 HT2996 1416 PCCB, propionyl Coenzyme A CACCTTTGTG[G/A]TGATACCAAC M G A G D carboxylase, beta polypeptide G380u1 WIAF-10122 HT3159 831 INSR, insulin receptor TCTACCTGGA[C/T]GGCAGGTGTG S C T D D G380u2 WIAF-10126 HT3159 1698 INSR, insulin receptor GGCAGGATGC[A/G]TGTGGTTCCA S A G A A G380u4 WIAF-11605 HT3159 2382 INSR, insulin receptor GCGTGCCCAC[G/A]AGTCCGGAGG S G A T T G383u1 WIAF-10125 HT33546 3633 phospholipase C, beta 3, alt. AGCAGCGGGC[G/A]AGGCTCCCCC M G A R Q transcript 2 G385u1 WIAF-10141 HT3383 1505 PRCP, prolylcarboxypeptidase ATGACAGTGC[A/G]GGAAAGCAGC S A G A A (angiotensinase C) G385u2 WIAF-10157 HT3383 1360 PRCP, prolylcarboxypeptidase ATCACAGACA[C/G]TCTGGTTGCA M C G T S (angiotensinase C) G387u1 WIAF-11729 HT3439 2697 SREBF2, sterol regulatory element CACTCTCCAG[G/C]AGCTCCGTGC M G C R S binding transcription factor 2 G387u2 WIAF-11770 HT3439 1901 SREBF2, sterol regulatory element GCTGCTGCCG[C/G]CAACCTACAA M C G A G binding transcription factor 2 G388u1 WIAF-10270 HT3440 245 SELPLG, selectin P ligand CTCCAGAAAT[G/A]CTGAGGAACA M G A M I G390u1 WIAF-10276 HT3568 2049 NOS3, nitric oxide synthase 3 TTGCTCGTGC[C/G]GTGGACACAC S C G A A (endothelial cell) G391u1 WIAF-10013 HT3630 6205 VWF, von Willebrand factor AGGACCTGGA[G/C]GTGATTCTCC M G C E D G391u2 WIAF-10265 HT3630 4554 VWF, von Willebrand factor GCCCCTGAGA[A/G]CAAGGCCTTC M A G N S G391u3 WIAF-10266 HT3630 7489 VWF, von Willebrand factor TGGCCTCAAC[C/T]GCCACCAATG S C T T T G391u4 WIAF-10272 HT3630 2470 VWF, von Willebrand factor ACTGTACCAT[G/A]AGTGGAGTCC M G A M I G391u5 WIAF-10273 HT3630 2615 VWF, von Willebrand factor GCTCGAGTGT[A/G]CGAAAACGTG M A G T A G391u6 WIAF-10274 HT3630 2635 VWF, von Willebrand factor GCCAGAACTA[T/C]GACCTGGAGT S T C Y Y G391u7 WIAF-10275 HT3630 4045 VWF, von Willebrand factor TCTCGGAACC[C/A]CCGTTGCACG S G A P P G391u8 WIAF-10278 HT3630 4446 VWF, von Willebrand factor AACTTTGTCC[G/A]CTACGTCCAG M G A R H G391u9 WIAF-10279 HT3630 5152 VWF, von Willebrand factor GCCCTAATGC[C/T]AACGTGCAGG S C T A A G391u10 WIAF-10286 HT3630 3448 VWF, von Willebrand factor TTACCAGTGA[C/T]GTCTTCCAGG S C T D D G391u11 WIAF-10287 HT3630 4891 VWF, von Willebrand factor ACATGGTGAC[C/T]GTGGAGTACC S C T T T G391u12 WIAF-10288 HT3630 4805 VWF, von Willebrand factor CAGGAGCAAG[G/A]AGTTCATGGA M G A E K G391u13 WIAF-10289 HT3630 4943 VWF, von Willebrand factor CCTGCAGCGG[G/T[TGCGAGAGAT M G T V L G391u14 WIAF-10290 HT3630 4915 VWF, von Willebrand factor TCAGCGAGGC[A/C]CAGTCCAAAG S A C A A G391a15 WIAF-10517 HT3630 6194 VWF, von Willebrand factor AAACAAGGAG[C/T]AGGACCGGGA N C T Q * G391a16 WIAF-13222 HT3630 6419 VWF, von Willebrand factor TCACCTTGGT[C/T]ACATCTTCAC M C T H Y G3941u1 WIAF-14123 HT3464 1265 mannosidase, alpha, lysosomal CAGGTGTGCA[A/G]CCAGCTGGAG M A G N S G3941u2 WIAF-14135 HT3464 965 mannosidase, alpha, lysosomal ACCAACCACA[C/T]TGTGATGACC M C T T I G395u1 WIAF-10271 HT4158 1627 ECE1, endothelin converting TCACTGCCGA[T/C]CAGCTCAGGA S T C D D enzyme 1 G395a2 WIAF-13110 HT4158 1493 ECE1, endothelin converting CATCTACAAC[A/T]TGATAGGATA M A T M L enzyme 1 G3959u1 WIAF-13634 HT4490 250 ADTB1, adaptin, beta 1 (beta TGAAGAAGCT[G/A]GTATACCTCT S G A L L prime) G3959u2 WIAF-13640 HT4490 2029 ADTB1, adaptin, beta 1 (beta TTCTTGGCGG[T/C]GGCCTTGACA S T C G G prime) G3959u3 WIAF-13641 HT4490 2395 ADTB1, adaptin, beta 1 (beta AGGTCCACGC[G/A]CCACTCAGCC S G A A A prime) G3967u1 WIAF-13997 HT2958 918 ACTC, actin, alpha, cardiac GAGGCACCAC[T/C]ATGTACCCTG S T C T T muscle G3968u1 WIAF-14159 HT1986 1747 ACTN3, actinin, alpha 3 CGAGGCTGAC[C/T]GAGAGCGAGG N C T R * G3968u2 WIAF-14164 HT1986 1900 ACTN3, actinin, alpha 3 GGTGCCCAGC[C/T]GTGACCAGAC M C T R C G3968u3 WIAF-14165 HT1986 2184 ACTN3, actinin, alpha 3 ACACCGTCTA[C/T]AGCATGGAGC S C T Y Y G3968u4 WIAF-14167 HT1986 2557 ACTN3, actinin, alpha 3 GATCTTGGCA[G/A]GAGACAAGAA M G A G R G3968u5 WIAF-14175 HT1986 1212 ACTN3, actinin, alpha 3 GGCTGCTCTC[G/A]GAGATCCGGC S G A S S G3979u1 WIAF-13884 HT0623 776 GPC1, glypican 1 TGCTGCTGCC[T/G]GATGACTACC S T G P P G3979u2 WIAF-13885 HT0623 680 GPC1, glypican 1 TGTACTACCG[C/T]GGTGCCAACC S C T R R G3979u3 WIAF-13886 HT0623 1361 GPC1, glypican 1 AGCTGGTCTC[T/C]GAAGCCAAGG S T C S S G3979u4 WIAF-13887 HT0623 1163 GPC1, glypican 1 AGAGTGTCAT[C/T]GGCAGCGTGC S C T I I G3979u5 WIAF-13888 HT0623 1670 GPC1, glypican 1 ACGCCAGTGA[C/T]GACGGCAGCG S C T D D G3979u6 WIAF-13905 HT0623 1069 GPC1, glypican 1 CTTGCCAACC[A/T]GGCCGACCTG M A T Q L G3979u7 WIAF-13906 HT0623 1514 GPC1, glypican 1 TCATGGGTGA[C/T]GGCCTGGCCA S C T D D G3979u8 WIAF-13907 HT0623 1720 GFC1, glypican 1 GACCTCTGCG[G/C]CCGGAAGGTC M G C G A G3979u9 WIAF-13908 HT0623 1676 GPC1, glypican 1 GTGACGACGG[C/T]AGCGGCTCGG S C T G G G3979u10 WIAF-13909 HT0623 1719 GPC1, glypican 1 TGACCTCTGC[G/A]GCCGGAAGGT M G A G S G399u1 WIAF-10102 HT48511 450 AQP3, aquaporin 3 TCTGGCACTT[T/C]GCCGACAACC S T C F F G399u2 WIAF-10111 HT48511 192 AQP3, aquaporin 3 GCTCCGTGGC[C/T]CAGGTTGTGC S C T A A G399u3 WIAF-10112 HT48511 165 AQP3, aquaporin 3 CCCTCATCCT[C/G]GTGATGTTTG S C G L L G3997u1 WIAF-13649 HT27682 473 MFAP2, microfibrillar-associated TGTGTGCCCA[C/T]GAGGAGCTCC S C T H H protein 2 G3997u2 WIAF-13650 HT27682 377 MFAP2, microfibrillar-associated CCATACACAG[G/T]CCTTGGAAAC M G T R S protein 2 G3997u3 WIAF-13876 HT27682 453 MFAP2, microfibrillar-associated GGAGATCTGT[G/T]TTCGTACAGT M G T V F protein 2 G4022u1 WIAF-14020 HT2426 240 TGM1, transglutaminase 1 (K TGGCTGCTGT[T/C]CATGCCGAAA M T C S P polypeptide epidermal type I, protein-glutamine-gamma- glutamyltransferase) G4022u2 WIAF-14021 HT2426 371 TGM1, transglutaminase 1 (K CCCGGGGCAG[C/T]GGTGTCAATG S C T S S polypeptide epidermal type I, protein-glutamine-gamma- glutamyltransferase) G4022u3 WIAF-14022 HT2426 506 TGM1, transglutaminase 1 (K ACGAGCTGAT[A/G]GTGCGCCGCG M A G I M polypeptide epidermal type I, protein-glutamine-gamma- glutamyltransferase) G4022u4 WIAF-14031 HT2426 2491 TGM1, transglutaminase 1 (K GCTGGAGGTG[A/T]CAGTCACTTA M A T D V polypeptide epidermal type I, protein-glutamine-gamma- glutamyltransferase) G4038u1 WIAF-13998 HT4211 411 LAMB3, laminin, beta 3 (nicein GGTGGCAGTC[C/A]CAGAATGATG S C A S S (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u2 WIAF-13999 HT4211 258 LAMB3, laminin, beta 3 (nicein CTTCATCTAC[C/T]TGTGGACTGA S C T T T (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u3 WIAF-14002 HT4211 1830 LAMB3, laminin, beta 3 (nicein GAGGCTACTG[C/T]AATCGCTACC S C T C C (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u4 WIAF-14003 HT4211 2668 LAMB3, laminin, beta 3 (nicein GACCAGGCAG[A/T]TGATTAGGGC M A T M L (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u5 WIAF-14018 HT4211 248 LAMB3, laminin, beta 3 (nicein TTTCTCCGAG[C/T]TTCATCTACC M C T A V (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u6 WIAF-14019 HT4211 887 LAMB3, laminin, beta 3 (nicein CACGGCCATG[C/T]TGATCGCTGC M C T A V (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u7 WIAF-14023 HT4211 1266 LAMB3, laminin, beta 3 (nicein AGTGTGATCC[G/A]GATGGGGCAG S G A P P (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u8 WIAF-14025 HT4211 1693 LAMB3, laminin, beta 3 (nicein CTATGGAGAC[G/A]TGGCCACAGG M G A V M (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u9 WIAF-14026 HT4211 1553 LAMB3, laminin, beta 3 (nicein GGCTGTGAAC[C/T]GTGTGCCTGC M C T P L (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u10 WIAF-14029 HT4211 3562 LAMB3, laminin, beta 3 (nicein CCTGACAGGA[C/T]TGGAGAAGCG S C T L L (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u11 WIAF-14030 HT4211 3546 LAMB3, laminin, beta 3 (nicein TGCTGCGCTC[A/G]GCGGACCTGA S A G S S (125 kD), kalinin (140 kD), BM600 (125 kD)) G4045u1 WIAF-13571 HT0652 1266 adducin, beta subunit TGGAGCAGGA[G/T]AAGCACCGGC M G T E D G4050u1 WIAF-14106 HT1466 1366 villin CGTTTGGCAG[G/A]GCAGCCAGGC M G A G S G4050u2 WIAF-14107 HT1466 1468 villin GGTCCCAATG[G/A]GCAAGGAGCC M G A G S G4050u3 WIAF-14108 HT1466 1932 villin CCACAGAGAT[C/T]CCTGACTTCA S C T I I G4050u4 WIAF-14110 HT1466 2438 villin TTTGGGATGA[C/T]TCCAGCTGCC M C T T I G4057u1 WIAF-13648 HT33633 371 CNN3, calponin 3, acidic TTCAGGCTTA[T/C]GGTATGAAGC S T C Y Y G4066u1 WIAF-13676 HT4301 654 troponin T, beta, skeletal AGATTGACAA[G/A]TTCGAGTTTG S G A K K G4066u2 WIAF-13677 HT4301 774 troponin T, beta, skeletal GCAAAGTCGG[C/T]GGGCGCTGGA S C T G G G4066u3 WIAF-13708 HT4301 625 troponin T, beta, skeletal GGAGCTCTGG[G/C]AGACCCTGCA M G C E Q G4080u1 WIAF-14142 HT1396 13130 HSPG2, heparan sulfate GATTCTCCTC[G/A]GGCATCACAG S G A S S proteoglycan 2 (perlecan) G4080u2 WIAF-14150 HT1396 10340 HSPG2, heparan sulfate TTGAGTTCCA[C/T]TGTGCTGTGC S C T H H proteoglycan 2 (perlecan) G4080u3 WIAF-14151 HT1396 12392 HSPG2, heparan sulfate AATGCTATGA[T/C]AGCTCCCCAT S T C D D proteoglycan 2 (perlecan) G4080u4 WIAF-14152 HT1396 3416 HSPG2, heparan sulfate TGGCTGTGCC[C/T]GAGGAAACCG S C T P P proteoglycan 2 (perlecan) G4080u5 WIAF-14154 HT1396 4588 HSPG2, heparan sulfate GTGCCGCTGG[T/C]GGCCAGCATC M T C V A proteoglycan 2 (perlecan) G4080u6 WIAF-14156 HT1396 9582 HSPG2, heparan sulfate GGACAGCCAC[G/A]CGGTGCTGCA M G A A T proteoglycan 2 (perlecan) G4096u1 WIAF-13890 HT4237 394 motor protein CAAAGAAATC[G/A]ATTCAGTCGG S G A S S G4096u2 WIAF-13910 HT4237 455 motor protein ATCTAAACAG[C/T]CTGCCTCACA M C T P S G4096u3 WIAF-13911 HT4237 1150 motor protein CTAAGGTTGT[A/G]TCTCAGTATC S A G V V G4109u1 WIAF-14034 HT28223 1238 phosphoglucomutase-related protein TACAGCGTGG[C/T]GAAGACGGAT M C T A V G4109u2 WIAF-14035 HT28223 1043 phosphoglucomutase-related protein ATTATTGCTG[C/A]CCGGAAGCAG M C A A D G4112u1 WIAF-13615 HT4401 374 KIF5A, kinesin family member 5A AGATGTCCTT[G/A]CTGGCTACAA M G A A T G4112u2 WIAF-13623 HT4401 2767 KIF5A, kinesin family member 5A AGAGAGTTAA[G/T]GCCCTGGAGG M G T K N G4114u1 WIAF-14113 HT4160 830 fibrinogen-like protein pT49 AACTTCACCA[G/A]AACATGGCAA M G A R K G4118u1 WIAF-14010 HT0841 564 MYL5, myosin, light polypeptide TCGATGTGGC[G/A]GGCAACCTGG S G A A A 5, regulatory G4118u2 WIAF-14011 HT0841 368 MYL5, myosin, light polypeptide TTCACCATGT[T/C]TCTGAACCTG M T C F S 5, regulatory G4118u3 WIAF-14012 HT0841 533 MYL5, myosin, light polypeptide GAGGTGGACC[A/G]GATGTTCCAG M A G Q R 5, regulatory G4122u1 WIAF-13955 HT97538 161 myosin-I TCGAGAACCT[A/G]CGGCGGCGAT S A G L L G4124u1 WIAF-13895 HT0925 1517 TGM3, transglutaminase 3 (E TCGCTGGCAT[G/A]CTGGCAGTAG M G A M I polypeptide, protein-glutamine- gamma-glutamyltransferase) G4124u2 WIAF-13896 HT0925 1433 TGM3, transglutaminase 3 (E AACCCAACAC[G/A]CCATTTGCCG S G A T T polypeptide, protein-glutamine- gamma-glutamyltransferase) G4126u1 WIAF-13830 HT2465 1039 myosin binding protein H ACTCGTACTC]C/G]TTCCGGGTCT S C G S S G4126u2 WIAF-13853 HT2465 369 myosin binding protein H AGAGAGGGAG[G/C]CTCGGACTGG M G C G A G4130u1 WIAF-13614 HT1657 198 CFL1, cofilin 1 (non-muscle) CTGTCGACGA[T/C]CCCTACGCCA S T C D D G4138u1 WIAF-13598 HT33664 601 MAGP2: Microfibril-associated GAAAGATGAG[C/T]TTTGCCGTCA M C T L F glycoprotein-2 G4138u2 WIAF-13599 HT33664 405 MAGP2: Microfibril-associated ATGACTTGGC[C/T]TCCCTCAGTG S C T A A glycoprotein-2 G4138u3 WIAF-13600 HT33664 327 MAGP2: Microfibril-associated AAGATCCTAA[T/C]CTGGTGAATG S T C N N glycoprotein-2 G4159u1 WIAF-14048 HT3443 1119 SNL, singed (Drosophila)-like GCTGCTACTT[T/C]GACATCGAGT S T C F F (sea urchin fascin homolog like) G4170u1 WIAF-13580 HT5069 1131 Golgi protein, peripheral, GAAATATACC[A/G]TAAGTATGGA M A G I V brefeldin A-sensitive G4170u2 WIAF-13581 HT5069 930 Golgi protein, peripheral, GTATAATAAA[C/T]TCCTGGAGTT M C T L F brefeldin A-sensitive G4170u3 WIAF-13582 HT5069 2312 Golgi protein, peripheral, AGCACCCTTA[A/G]GCATCTTGGA N A G * * brefeldin A-sensitive G4170u4 WIAF-13596 HT5069 359 Golgi protein, peripheral, TCAACCAGCT[T/G]TCTGTGCCTT S T G L L brefeldin A-sensitive G4170u5 WIAF-13597 HT5069 1007 Golgi protein, peripheral, AAAAAGGCAA[T/A]ACTGTTCCTG M T A N K brefeldin A-sensitive G4171u1 WIAF-13688 HT1587 667 KIF5B, kinesin family member 5B TTTTTAATTA[T/C]ATTTACTCCA S T C Y Y G4171u2 WIAF-13689 HT1587 1036 KIF5B, kinesin family member 5B TTAGTAAAAC[T/C]GGAGCTGAAG S T C T T G4176u1 WIAF-14204 HT33754 130 TNR, tenascin R (restrictin, GCTCATTGGC[G/A]TCAACCTGAT M G A V I janusin) G4176u2 WIAF-14205 HT33754 463 TNR, tenascin R (restrictin, CTGTCCATGT[G/T]CCAGTTCAGC M G T A S janusin) G4176u3 WIAF-14206 HT33754 249 TNR, tenascin R (restrictin, ACTACAACAC[G/A]TCCAGCAAAG S G A T T janusin) G4176u4 WIAF-14208 HT33754 2009 TNR, tenascin R (restrictin, CTGGTCCCCA[G/A]GGGCATTGGT M G A R K janusin) G4176u5 WIAF-14209 HT33754 2175 TNR, tenascin R (restrictin, CAGCCTCCTC[G/A]GAGACCTCCA S G A S S janusin) G4176u6 WIAF-14210 HT33754 3318 TNR, tenascin R (restrictin, AATCCACCGA[C/T]GGAAGCCGCA S C T D D janusin) G4176u7 WIAF-14211 HT33754 3221 TNR, tenascin R (restrictin, CCGGCAAACC[T/C]GACAGCCAGT M T C L P janusin) G4176u8 WIAF-14217 HT33754 1635 TNR, tenascin R (restrictin, TCTCGGACAC[C/T]GTGGCTTTTG S C T T T janusin) G4178u1 WIAF-14138 HT0224 2827 ACTN2, actinin, alpha 2 GCTGCGTTCT[C/T]TTCCGCACTC M C T S F G4178u2 WIAF-14139 HT0224 2818 ACTN2, actinin, alpha 2 CTGGATTACG[C/T]TGCGTTCTCT M C T A V G418u1 WIAF-11750 L07594 2370 TGFBR3, transforming growth GAGTGCACTT[C/T]CCTATCCCGC S C T F F factor, beta receptor III (betaglycan, 300 kD) G418u2 WIAF-11751 L07594 2586 TGFBR3, transforming growth AGAAGACGTT[C/T]ACCAAGCCCC S C T F F factor, beta receptor III (betaglycan, 300 kD) G418u3 WIAF-11752 L07594 2671 TGFBR3, transforming growth AATTTCTCCA[C/T]CAATTTTCCA M C T P S factor, beta receptor III (betaglycan, 300 kD) G418u4 WIAF-11771 L07594 438 TGFBR3, transforming growth TGTGTGAACT[G/T]TCACCTGTCA S G T L L factor, beta receptor III (betaglycan, 300 kD) G418u5 WIAF-11744 L07594 392 TGFBR3, transforming growth CTGATGAGCT[T/C]CTGTTTAGCC M T C F S factor, beta receptor III (betaglycan, 300 kD) G418u6 WIAF-11772 L07594 1470 TGFBR3, transforming growth AGCTACGGAT[C/T]CTGCTGGACC S C T I I factor, beta receptor III (betaglycan, 300 kD) G418u7 WIAF-11773 L07594 1170 TGFBR3, transforming growth TCTTGAAGTG[C/A]AAAAAGTCTG N C A C * factor, beta receptor III (betaglycan, 300 kD) G418u8 WIAF-11745 L07594 1463 TGFBR3, transforming growth CCTCCTGAGC[T/C]ACGGATCCTG M T C L P factor, beta receptor III (betaglycan, 300 kD) G418u9 WIAF-11746 L07594 2211 TGFBR3, transforming growth ATGTTGAGGT[A/G]TCTGTTACTA S A G V V factor, beta receptor III (betaglycan, 300 kD) G4181u1 WIAF-14207 HT2008 425 SPTBN1, spectrin, beta, non- CTCTGCGCGG[C/T]TTTTTGAGCG M C T L F erythrocytic 1 G4181u2 WIAF-14213 HT2008 3565 SPTBN1, spectrin, beta, non- AGACAGCGAT[C/T]GCCTCGGAGG S C T I I erythrocytic 1 G4181u3 WIAF-14218 HT2008 1258 SPTBN1, spectrin, beta, non- ACCTTCTGGA[A/G]TGGATTGAAC S A G E E erythrocytic 1 G4181u4 WIAF-14219 HT2008 1780 SPTBN1, spectrin, beta, non- AGCTCGAGGC[C/T]GAGAATTACC S C T A A erythrocytic 1 G4181u5 WIAF-14220 HT2008 3637 SPTBN1, spectrin, beta, non- ACATCAAGAA[T/C]GAGATCGACA S T C N N erythrocytic 1 64183u1 WIAF-13976 HT2640 404 TPM4, tropomyosin 4 CCAAGCACAT[T/C]GCGGAAGAGG S T C I I G4185u1 WIAF-13554 HT3451 257 MFAP1, microfibrillar-associated AAGGCCAGAC[T/G]ATGCCCCTAT M T G Y D protein 1 G4185u2 WIAF-13555 HT3451 1108 MFAP1, microfibrillar-associated CCAACAAAGC[T/G]GTTAAGGGCA S T G A A protein 1 G4185u3 WIAF-13570 HT3451 274 MFAP1, microfibrillar-associated CTATGGAGTC[C/T]TCAGATGAGG S C T S S protein 1 G4196u1 WIAF-13665 HT97558 941 NUP88, nucleoporin 88 kD GGGTCCATTG[C/A]CCATGCATCT M C A A D G4196u2 WIAF-13666 HT97558 1092 NUP88, nucleoporin 88 kD ATGACCACAC[G/A]TCAGAAAAGT S G A T T G4196u3 WIAF-13667 HT97558 1551 NUP88, nucleoporin 88 kD TCCATCCAGC[G/A]TCTCCTCCCC S G A A A G4196u4 WIAF-13668 HT97558 2220 NUP88, nucleoporin 88 kD AGGGTGAACA[T/C]ATAAGGGAAA S T C H H G4196u5 WIAF-13669 HT97558 2205 NUP88, nucleoporin 88 kD CCATCCTGAA[A/G]GAGGAGGGTG S A G K K G4208u1 WIAF-13921 HT1122 1329 VCL, vinculin TGATCCTAAA[G/C]AAAGAGATGA M G C E Q G4208u2 WIAF-13922 HT1122 2438 VCL, vinculin CCATCTCCCC[A/G]ATGGTGATGG S A G P P G4208u3 WIAF-13941 HT1122 818 VCL, vinculin GGGATGAAGA[T/C]GCCTGGGCCA S T C D D G4208u4 WIAF-13942 HT1122 1556 VCL, vinculin AAGCACAGCG[G/A]TGGATTGATA S G A R R G4213u1 WIAF-13605 HT2813 163 NUP153, nucleoporin 153 kD GCCAGGGTGG[T/C]TACAAAGATA S T C L L G4213u2 WIAF-13606 HT2813 742 NUP153, nucleoporin 153 kD GAATTCTTCA[A/G]TCCTTAAAAC M A G I V G4213u3 WIAF-13609 HT2813 1800 NUP153, nucleoporin 153 kD TTAGACCTGC[A/C]GAAATCCTGA S A C A A G4213u4 WIAF-13627 HT2813 1829 NUP153, nucleoporin 153 kD AGTGTTCTAG[A/C]TATTCTGAAA M A C D A G4213u5 WIAF-13632 HT2813 3258 NUP153, nucleoporin 153 kD CTTTTGGCAA[C/T]GTGGAGCCTG S C T N N G4213u6 WIAF-13635 HT2813 4162 NUP153, nucleoporin 153 kD CTCTGGAACA[A/G]CTCCTAATTC M A G T A G4218u1 WIAF-13854 HT1681 1122 phosphatidyl-inositol glycan, AACCTTATTA[T/C]TTTATGTGAG M T C I T class A G4223u1 WIAF-14160 HT1684 1434 CD36L2, CD36 antigen (collagen ATTAGATGAC[T/C]TTGTTGAAAC M T C F L type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) G4223u2 WIAF-14173 HT1684 696 CD36L2, CD36 antigen (collagen GTGGTCCCAG[G/A]TGCACTTCCT M G A V M type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) G4223u3 WIAF-14174 HT1684 986 CD36L2, CD36 antigen (collagen CAGACAAGTG[C/T]AATATGATTA S C T C C type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) G4223u4 WIAF-14176 HT1684 1437 CD36L2, CD36 antigen (collagen AGATGACTTT[G/A]TTGAAACGGG M G A V I type I receptor, thrombospondin receptor)-like 2 (lysosomal integral membrane protein II) G4227u1 WIAF-14056 HT1929 912 proteoglycan 2 ATGCCTCCAA[G/A]AAAGATGGGG S G A K K G4227u2 WIAF-14057 HT1929 1254 proteoglycan 2 GGAACTTTGC[G/A]TACTGGGCTG S G A A A G4227u3 WIAF-14058 HT1929 1321 proteoglycan 2 CCGAGGAGGC[T/C]ACTGGCGTCG M T C Y H G4229u1 WIAF-13961 HT1689 74 SDC4, syndecan 4 (amphiglycan, GCTGCTGCTG[T/C]TCTTCGTAGG M T C F L ryudocan) G4230u1 WIAF-13525 HT4995 602 TRAM protein CCATAACCTG[A/C]TGACATTTCA M A C M L G4243u1 WIAF-14169 HT2901 406 KRT17, keratin 17 AGCTGGAGGT[G/A]AAGATCCGTG S G A V V G4243u2 WIAF-14170 HT2901 478 KRT17, keratin 17 ACAGGACAAT[T/C]GAGGAGCTGC S T C I I G4243u3 WIAF-14171 HT2901 389 KRT17, keratin 17 GGAGGAGGCC[A/G]ACACTGAGCT M A G N D G4243u4 WIAF-14178 HT2901 564 KRT17, keratin 17 CTGGCTGCTG[A/C]TGACTTCCGC M A C D A G4244u1 WIAF-14086 HT1056 386 clathrin, light polypeptide a ATCGATTGCA[G/C]TCAGAGCCTG M G C Q H G4246u1 WIAF-14044 HT97492 259 SLN, sarcolipin GTCCTATCAG[T/C]ACTGAGAGGC M T C Y H G4246u2 WIAF-14045 HT97492 189 SLN, sarcolipin ACACCCGGGA[G/A]CTGTTTCTCA S G A E E G4254u1 WIAF-13546 HT3393 86 TNNI2, troponin I, skeletal, fast ACCTGAAGAG[C/T]GTGATGCTGC S C T S S G4254u2 WIAF-13553 HT3393 530 TNNI2, troponin I, skeletal, fast TCGAGGAGAA[G/C]TCTGGCATGG M G C K N G4255u1 WIAF-13644 HT2907 562 CRYAB, crystallin, alpha B AGTTCCACAG[G/A]AAATACCGGA S G A R R G4255u2 WIAF-13645 HT2907 367 CRYAB, crystallin, alpha B CCTCCTTCCT[G/A]CGGGCACCCA S G A L L G4255u3 WIAF-13872 HT2907 271 CRYAB, crystallin, alpha B CCAGCCGCCT[C/T]TTTGACCAGT S C T L L G4255u4 WIAF-13873 HT2907 580 CRYAB, crystallin, alpha B GGATCCCAGC[T/C]GATGTAGACC S T C A A G4257u1 WIAF-14052 HT1694 394 PIGF, phosphatidylinositol TAGAGTTGGC[A/G]TTGGAAACAT S A G A A glycan, class F G4257u2 WIAF-14053 HT1694 252 PIGF, phosphatidylinositol TATTTAGTAG[T/C]GAAACCAAAT M T C V A glycan, class F G4257u3 WIAF-14069 HT1694 291 PIGF, phosphatidylinositol TCATTATCAC[A/G]CAAGGTAACT M A G H R glycan, class F G4264u1 WIAF-13519 HT0968 1720 TJP1, tight junction protein 1 CGGTCAGTGG[C/T]TTCCAGCCAG M C T A V (zona occludens 1) G4264u2 WIAF-13520 HT0968 2272 TJP1, tight junction protein 1 CATGCTGATG[A/G]TCACACACCT M A G D G (zona occludens 1) G4264u3 WIAF-13529 HT0968 5408 TJP1, tight junction protein 1 AGCCTCCTGA[A/T]GCTGATGGTG M A T E D (zona occludens 1) G434u1 WIAF-11748 M21121 286 SCYA5, small inducible cytokine TACATCAACT[C/T]TTTGGAGATG M C T S F A5 (RANTES) G434u2 WIAF-11749 M21121 137 SCYA5, small inducible cytokine GCTTTGCCTA[C/T]ATTGCCCGCC S C T Y Y A5 (RANTES) G435u1 WIAF-11741 M31933 754 FCGR2B, Fc fragment of IgG, low GTCACTGGGA[T/C]TGCTGTAGCG M T C I T affinity IIb, receptor for (CD32) G435u2 WIAF-11743 M31933 395 FCGR2B, Fc fragment of IgG, low GGGAGTACAC[G/A]TGCCAGACTG S G A T T affinity IIb, receptor for (CD32) G435u3 WIAF-11742 M31933 673 FCGR2B, Fc fragment of IgG, low TACACGCTGT[T/A]CTCATCCAAG M T A F Y affinity IIb, receptor for (CD32) G4369u1 WIAF-13728 HT0900 1176 GBE1, glucan (1,4-alpha-), TTACGTCCAT[G/A]CTTTATCATC M G A M I branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) G4369u2 WIAF-13729 HT0900 1609 GBE1, glucan (1,4-alpha-), GAGTGTCCTG[A/G]CTCCTTTTAC M A G T A branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) G4373u1 WIAF-13559 HT0940 1117 HSD17B2, hydroxysteroid (17-beta) GCCAGCAAGG[A/T]CTTCTCTCCG M A T D V dehydrogenase 2 G4373u2 WIAF-13560 HT0940 1195 HSD17B2, hydroxysteroid (17-beta) CCAGGGAAAG[G/A]CGCTTACTTG M G A G D dehydrogenase 2 G438u1 WIAF-11830 M63121 583 TNFRSF1A, tumor necrosis factor ACCGTGTGTG[G/A]CTGCAGGAAG M G A G D receptor superfamily, member 1A G438u2 WIAF-11790 M63121 618 TNFRSF1A, tumor necrosis factor TTATTGGAGT[G/A]AAAACCTTTT M G A E K receptor superfamily, member 1A G440u1 WIAF-11806 M74447 261 TAP2, transporter 2, ABC (ATP TGCTAAAGCT[A/G]AGAGGGCTGC S A G L L binding cassette) G440u2 WIAF-11807 M74447 2089 TAP2, transporter 2, ABC (ATP CAGGCTGCAG[G/A]CAGTTCAGCG M G A A T binding cassette) G440u3 WIAF-11808 M74447 2155 TAP2, transporter 2, ABC (ATP TGCCCAGCTC[C/T]AGGAGGGACA N C T Q * binding cassette) G440u4 WIAF-11818 M74447 1789 TAP2, transporter 2, ABC (ATP GAACAACATT[G/A[CTTATGGGCT M G A A T binding cassette) G440u5 WIAF-11819 M74447 1565 TAP2, transporter 2, ABC (ATP AAGGGGCTGA[C/T]GTTTACCCTA M C T T M binding cassette) G440u6 WIAF-11820 M74447 1254 TAP2, transporter 2, ABC (ATP TGCACTTGGG[G/T]GTGCAGATGC S G T G G binding cassette) G440u7 WIAF-11788 M74447 1231 TAP2, transporter 2, ABC (ATP GTACCTGCTC[A/G]TAAGGAGGGT M A G I V binding cassette) G440u8 WIAF-11821 M74447 1404 TAP2, transporter 2, ABC (ATP TGCTCAGCAA[C/T]GTGGGAGCTG S C T N N binding cassette) G440u9 WIAF-11783 M74447 2187 TAP2, transporter 2, ABC (ATP CCCGCCTGGT[T/G]CAGCAGCGGC S T G V V binding cassette) G440u10 WIAF-11786 M74447 1825 TAP2, transporter 2, ABC (ATP TGATAAGGTG[A/G]TGGCGGCTGC M A G M V binding cassette) G4400u1 WIAF-14007 HT97396 839 A33 GCCAATCAAA[G/T]GAGGGCTCAC M G T K N G4404u1 WIAF-14013 HT1215 109 ACP2, acid phosphatase 2, CCGCCCACCC[G/A]GGCCCGGAGT M G A R Q lysosomal G4404u2 WIAF-14016 HT1215 1271 ACP2, acid phosphatase 2, ACCGCCACGT[C/T]GCAGATGGGG S C T V V lysosomal G4406u1 WIAF-13661 HT3564 872 ACPP, acid phosphatase, prostate ACAAAAAACT[T/C]ATCATGTATT S T C L L G4406u2 WIAF-13662 HT3564 839 ACPP, acid phosphatase, prostate ATCACATGAA[G/A]AGAGCAACTC S G A K K G4406u3 WIAF-13881 HT3564 741 ACPP, acid phosphatase, prostate AGAATTGTCA[G/T]AATTGTCCCT N G T E * G441u1 WIAF-10166 M77349 698 TGFBI, transforming growth GTGCCCGGCT[C/G]CTGAAAGCCG S C G L L factor, beta-induced, 68 kD G441u2 WIAF-10168 M77349 1028 TGFBI, transforming growth GGCTGTCTGT[A/G]GAGACCCTGG S A G V V factor, beta-induced, 68 kD G441u3 WIAF-10169 M77349 1667 TGFBI, transforming growth ACACAGTCTT[T/C]GCTCCCACAA S T C F F factor, beta-induced, 68 kD G441u4 WIAF-10171 M77349 1463 TGFBI, transforming growth GTAATAGCCT[C/T]TGCATTGAGA S C T L L factor, beta-induced, 68 kD G4411u1 WIAF-14005 HT97468 492 acyl-CoA GCTGACCAAT[A/G]AGGCCACCCT M A G K E G4411u2 WIAF-14008 HT97468 1076 acyl-CoA TGCCCGAGAC[C/T]GAGGACGAGA S C T T T G4412u1 WIAF-13576 HT1882 657 ACADS, acyl-Coenzyme A GCAAAACAAG[G/A]GCATCAGTGC M G A G S dehydrogenase, C-2 to C-3 short chain G4412u2 WIAF-13579 HT1882 1022 ACADS, acyl-Coenzyme A TGACCTGGCG[C/T]GCTGCCATGC S C T R R dehydrogenase, C-2 to C-3 short chain G4415u1 WIAF-14080 HT2503 2170 acyl-Coenzyme A:cholesterol TCATTATATT[C/T]GAGCAGATTC S C T F F acyltransferase G4415u2 WIAF-14081 HT2503 1993 acyl-Coenzyme A:cholesterol TTTCAGTTCC[C/T]TATTTTCTGT S C T P P acyltransferase G4415u3 WIAF-14098 HT2503 2006 acyl-Coenzyme A:cholesterol TTTTCTGTTT[C/G]AACATTGGCG M C G Q E acyltransferase G4415u4 WIAF-14101 HT2503 2365 acyl-Coenzyme A:cholesterol GGGGTTATGT[C/T]GCTATGAAGT S C T V V acyltransferase G4417u1 WIAF-13819 HT0542 356 AOAH, acyloxyacyl hydrolase TCCAGCCAAC[G/A]ATGACCAGTC M G A D N (neutrophil) G4417u2 WIAF-13820 HT0542 340 AOAH, acyloxyacyl hydrolase TTCAGTCCTC[G/A]GCCTCTCCAG S G A S S (neutrophil) G4417u3 WIAF-13824 HT0542 1595 AOAH, acyloxyacyl hydrolase GCTAAATAAA[G/A]ACATGACCTA M G A D N (neutrophil) G4417u4 WIAF-13841 HT0542 382 AOAH, acyloxyacyl hydrolase CCAGCCTCTC[G/A]AATGGGCACA S G A S S (neutrophil) G4417u5 WIAF-13842 HT0542 458 AOAH, acyloxyacyl hydrolase CAACTCGACG[G/A]TCCAGGCCTC M G A V I (neutrophil) G4417u6 WIAF-13843 HT0542 1201 AOAH, acyloxyacyl hydrolase GATTTCTGGA[C/T]TCCACTGTTG S C T D D (neutrophil) G4417u7 WIAF-13844 HT0542 1321 AOAH, acyloxyacyl hydrolase ACCTGAAGAA[A/G]TTTATAGAAA S A G K K (neutrophil) G4417u8 WIAF-13845 HT0542 1404 AOAH, acyloxyacyl hydrolase GATGTCTGCA[G/A]TGGGAAGAGT M G A S N (neutrophil) G4417u9 WIAF-13846 HT0542 1759 AOAH, acyloxyacyl hydrolase AATTTACAAA[C/T]TTCAATCTTT S C T N N (neutrophil) G4417u10 WIAF-13847 HT0542 1644 AOAH, acyloxyacyl hydrolase CTCCAGGTCA[G/A]CCCCTGCCAC M G A S N (neutrophil) G442u1 WIAF-11828 M94582 933 IL8RA, interleukin 8 receptor, CACATCGACC[G/A]GGCTCTGGAT M G A R Q alpha G442u2 WIAF-11829 M94582 721 IL8RA, interleukin 8 receptor, TCATCGTGCC[A/G]CTGCTGATCA S A G P P alpha G442u3 WIAF-11780 M94582 1027 IL8RA, interleukin 8 receptor, GCCATGGACT[C/T]CTCAAGATTC S C T L L alpha G442u4 WIAF-11792 M94582 78 IL8RA, interleukin 8 receptor, ATGGAGAGTG[A/G]CAGCTTTGAA M A G D G alpha G4423u1 WIAF-13752 HT2216 71 ADSL, adenylosuccinate lyase GCTATGCCAG[C/T]CCGGAGATGT S C T S S G4423u2 WIAF-13794 HT2216 126 ADSL, adenylosuccinate lyase ATGGCGGCAG[C/T]TGTGGCTGTG S C T L L G4423u3 WIAF-13795 HT2216 674 ADSL, adenylosuccinate lyase AGCTTGACAA[G/A]ATGGTGACAG S G A K K G4428u1 WIAF-13954 HT97524 57 ADFP, adipose differentiation- TGGTCAACCT[G/A]CCCTTGGTGA S G A L L related protein; adipophilin G4434u1 WIAF-13506 HT0863 551 ARF3, ADP-ribosylation factor 3 TCTGGAGACA[C/T]TACTTCCAGA S C T H H G444u1 WIAF-10172 U28694 398 CCR3, chemokine (C-C motif) CGAGATCTTT[T/G]TCATAATCCT M T G F V receptor 3 G444u2 WIAF-10181 U28694 214 CCR3, chemokine (C-C motif) TCCTCATAAA[A/G]TACAGGAGGC S A G K K receptor 3 G4440u1 WIAF-14054 HT1392 136 ADRBK1, adrenergic, beta, GCAAGAAGAT[A/C]CTGCTGCCCG S A C I I receptor kinase 1 G445u1 WIAF-10183 U40373 319 Human cell surface glycoprotein TAGAAGGGCA[C/T]GTGGTGATTC S C T H H CD44, mRNA, complete cds. G4456u1 WIAF-13629 HT0626 796 ALDOC, aldolase C, fructose- CCCTGCTCAA[G/A]CCCAACATGG S G A K K bisphosphate G446u1 WIAF-11832 U64198 754 IL12RB2, interleukin 12 receptor, TGAAGCCTTC[C/G]CATGTAATTT S C G S S beta 2 G446u2 WIAF-11795 U64198 2569 IL12RB2, interleukin 12 receptor, TTTTCTCAAC[G/A]CATTACTTCC S G A T T beta 2 G446u3 WIAF-11833 U64198 2500 IL12RB2, interleukin 12 receptor, TGCAAGGTAA[A/G]GCCAATTGGA S A G K K beta 2 G446u4 WIAF-11835 U64198 1918 IL12RB2, interleukin 12 receptor, CTCCTCGCCA[G/C]GTCTCTGCAA M G C Q H beta 2 G446u5 WIAF-11793 U64198 991 IL12RB2, interleukin 12 receptor, GTGGAGCAGA[G/A]ATCTTCGTTG S G A E E beta 2 G446u6 WIAF-11794 U64198 2469 IL12RB2, interleukin 12 receptor, AGTTCCCACG[G/C]AAATGAGAGG M G C G A beta 2 G446a7 WIAF-13128 U64198 1964 IL12RB2, interleukin 12 receptor, GGTGACTTGG[C/g]AGCCTCCCAG M C g Q E beta 2 G446a8 WIAF-13129 U64198 2060 IL12RB2, interleukin 12 receptor, TCTAAACTGG[C/G]TACGGAGTCG M C G L V beta 2 G447u1 WIAF-11796 X03663 384 CSF1R, colony stimulating factor CCAGTGTCCC[C/T]GAGCTGGTCG S C T P P 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog G447u2 WIAF-11836 X03663 1026 CSF1R, colony stimulating factor ACAACAACAC[T/C]AAGCTCGCAA S T C T T 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog G447u3 WIAF-11837 X03663 886 CSF1R, colony stimulating factor GCTGAAAGTG[C/A]AGAAAGTCAT M C A Q K 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog G447u4 WIAF-11797 X03663 2425 CSF1R, colony stimulating factor GAAGAAATAT[G/A]TCCGCAGGGA M G A V I 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog G4473u1 WIAF-13904 HT1352 860 FUCA1, fucosidase, alpha-L-1, TTCAAGCCAC[A/G]GAGCTTGCCA M A G Q R tissue G4473u2 WIAF-13916 HT1352 440 FUCA1, fucosidase, alpha-L-1, ACAAACTGGC[C/T]GAGTCCTGTG M C T P L tissue G4479u1 WIAF-13637 HT1995 2465 AMPD2, adenosine monophosphate GCCTCAATGA[G/T]CCTGGTCCAT — G T — — deaminase 2 (isoform L) G4479u2 WIAF-13866 HT1995 1258 AMPD2, adenosine monophosphate TGGATGTGCA[T/C]GCGGACAGGA S T C H H deaminase 2 (isoform L) G4479u3 WIAF-13867 HT1995 1280 AMPD2, adenosine monophosphate CACTTTCCAT[C/T]GCTTTGACAA M C T R C deaminase 2 (isoform L) G4479u4 WIAF-13868 HT1995 1201 AMPD2, adenosine monophosphate TGCGGGAGGT[C/T]TTTGAGAGCA S C T V V deaminase 2 (isoform L) G4479u5 WIAF-13869 HT1995 1579 AMPD2, adenosine monophosphate GTACCAAGGG[C/T]CAGCTGGCCA S C T G G deaminase 2 (isoform L) G4492u1 WIAF-14084 HT3390 866 ANX11, annexin XI (56 kD CCTGGGGAGT[C/T[GCTCCAACAA M C T R C autoantigen) G4492u2 WIAF-14085 HT3390 850 ANX11, annexin XI (56 kD AGGCCATCAT[T/C]GACTGCCTGG S T C I I autoantigen) G450u1 WIAF-10170 X85740 1196 CCR4, chemokine (C-C motif) TCCAAATTTA[C/T]TCTGCTGACA S C T Y Y receptor 4 G4502u1 WIAF-13510 HT4840 165 ASS, argininosuccinate synthetase AAGGCTATGA[C/T]GTCATTGCCT S C T D D G4502u2 WIAF-13511 HT4840 369 ASS, argininosuccinate synthetase GGCCCTGCAT[C/T]GCCCGCAAAC S C T I I G4502u3 WIAF-13512 HT4840 73 ASS, argininosuccinate synthetase AATCCCAGAC[G/A]CTATGTCCAG — G A — — G4502u4 WIAF-13513 HT4840 129 ASS, argininosuccinate synthetase TGGACACCTC[G/C]TGCATCCTCG S G C S S G4502u5 WIAF-13514 HT4840 285 ASS, argininosuccinate synthetase AGTTTGTGGA[G/A]GAGTTCATCT S G A E E G4502u6 WIAF-13515 HT4840 234 ASS, argininosuccinate synthetase AGGCACTGAA[G/A[CTTGGGGCCA S G A K K G4502u7 WIAF-13516 HT4840 316 ASS, argininosuccinate synthetase CCAGTCCAGC[G/A]CACTGTATGA M G A A T G4502u8 WIAF-13537 HT4840 426 ASS, argininosuccinate synthetase TGTCCCACGG[C/T]GCCACAGGAA S C T G G G4502u9 WIAF-13538 HT4840 530 ASS, argininosuccinate synthetase GAATTCTACA[A/G]CCGGTTCAAG M A G N S G4502u10 WIAF-13539 HT4840 750 ASS, argininosuccinate synthetase TTCTCGAGAT[C/T]GAGTTCAAAA S C T I I G4502u11 WIAF-13540 HT4840 960 ASS, argininosuccinate synthetase ATGCTCATTT[A/G]GACATCGAGG S A G L L G4508u1 WIAF-13663 HT28557 1767 ARSD, arylsulfatase D CAGTTTTCCA[T/C]GAGCAACATC M T C M T G4508u2 WIAF-13693 HT28557 433 ARSD, arylsulfatase D TTCAGTGGAA[C/T]GCAGGCTCAG S C T N N G4508u3 WIAF-13694 HT28557 747 ARSD, arylsulfatase D GGTTTCTTCT[C/G]TGTCTCCGCG M C G S C G4508u4 WIAF-13696 HT28557 1012 ARSD, arylsulfatase D CCACGAGTGC[A/G]TTCCTGGGGA S A G A A G4508u5 WIAF-13697 HT28557 1302 ARSD, arylsulfatase D CGAGTGATTG[G/A]AGAGCCCACG M G A G E G4508u6 WIAF-13698 HT28557 1285 ARSD, arylsulfatase D GGGTGCTCCC[G/A]GCCGGCCGAG S G A P P G4508u7 WIAF-13699 HT28557 1807 ARSD, arylsulfatase D AGCCGTGCTG[C/T]GGACATTTCC S C T C C G4508u8 WIAF-13718 HT28557 483 ARSD, arylsulfatase D GCAAGAATCT[T/C]GCAGCAGCAT M T C L S G4518u1 WIAF-13809 HT3430 515 ASPA, aspartoacylase ACAACACCAC[C/T]TCTAACATGG S C T T T (aminoacylase 2, Canavan disease) G4518u2 WIAF-13810 HT3430 851 ASPA, aspartoacylase AAGTTGATTA[C/T]CCCCGGGATG S C T Y Y (aminoacylase 2, Canavan disease) G4518u3 WIAF-13811 HT3430 787 ASPA, aspartoacylase CATCATTTCA[A/G]TGAAGGAAAA M A G N S (aminoacylase 2, Canavan disease) G4518u4 WIAF-13837 HT3430 618 ASPA, aspartoacylase ACCCTGCTAC[G/A]TTTATCTGAT M G A V I (aminoacylase 2, Canavan disease) G452a1 WIAF-10509 HT0695 553 APOA4, apolipoprotein A-IV ACCCAGGTCA[A/G]CACGCAGGCC M A G N S G452a2 WIAF-13124 HT0695 563 APOA4, apolipoprotein A-IV ACACGCAGGC[C/T]GAGCAGCTGC S C T A A G4524u1 WIAF-14120 HT1541 726 ATP5A1, ATP synthase, H+ CTCAATTGCT[A/G]TTGACACAAT M A G I V transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle G4524u2 WIAF-14131 HT1541 153 ATP5A1, ATP synthase, H+ ATCTTTCATT[G/T]CTGCAAGGAA M G T A S transporting, mitochondrial F1 complex, alpha subunit, isoform 1, cardiac muscle G4526u1 WIAF-14130 HT4994 400 ATPSD, ATP synthase, H+ TCCATCGCAG[T/C]GAACGCCGAC M T C V A transporting, mitochondrial F1 complex, delta subunit G453u1 WIAF-10138 HT0768 1747 PDGFRB, platelet-derived growth CTGCCGCCCA[C/T]GCTGCTGGGG M C T T M factor receptor, beta polypeptide G453u2 WIAF-10147 HT0768 2957 PDGFRB, platelet-derived growth TTTTGCCTTT[A/G]AAGTGGATGG S A G L L factor receptor, beta polypeptide G453u3 WIAF-10148 HT0768 3608 PDGFRB, platelet-derived growth AGCCGGAGCC[A/G]GAGCTGGAAC S A G P P factor receptor, beta polypeptide G453u4 WIAF-10149 HT0768 457 PDGFRB, platelet-derived growth CAGGGCCTGG[T/G]CGTCACACCC M T G V G factor receptor, beta polypeptide G453u5 WIAF-10151 HT0768 1505 PDGFRB, platelet-derived growth AGCTGACACT[G/C]GTTCGCGTGA S G C L L factor receptor, beta polypeptide G453u6 WIAF-10153 HT0768 3446 PDGFRB, platelet-derived growth ACCCCAAACC[C/T]GAGGTTGCTG S C T P P factor receptor, beta polypeptide G453u7 WIAF-10161 HT0768 2030 PDGFRB, platelet-derived growth TTTGGCAGAA[G/A]AAGCCACGTT S G A K K factor receptor, beta polypeptide G4533u1 WIAF-13616 HT1618 343 ATP synthase, H+ transporting, GTTACATGAT[C/T]GACAACGTGA S C T I I subunit D, vacuolar G4534u1 WIAF-13569 HT3556 654 ATP6E, ATPase, H+ transporting, TAAAGGTTTC[C/T]AACACCCTGG S C T S S lysosomal (vaculoar proton pump) 31 kD G4535u1 WIAF-13747 HT27972 357 APT50, ATP synthase, H+ TCACTACCAA[C/T]CTGATCAATT S C T N N transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein) G4535u2 WIAF-13748 HT27972 144 APT50, ATP synthase, H+ AGGTATACGG[T/C]ATTGAAGGTC S T C G G transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein) G4535u3 WIAF-13792 HT27972 329 APT50, ATP synthase, H+ ATCACAGCAA[A/G]AGAGAGGTTC M A G K R transporting, mitochondrial F1 complex, O subunit (oligomycin sensitivity conferring protein) G4539u1 WIAF-13711 HT48520 288 ATPase, 14 kDa subunit, vacuolar TGCCCTGGAC[G/A]CCCACCAGCA M G A A T G4548u1 WIAF-14127 HT1574 3138 ATPase, Ca2+ transporting, plasma CGCAATGTCT[T/C]TGACGGCATC M T C F S membrane, isoform 2 G4548u2 WIAF-14137 HT1574 2089 ATPase, Ca2+ transporting, plasma GCACTATCTG[C/T]GTGGCCTACC S C T C C membrane, isoform 2 G4548u3 WIAF-14140 HT1574 2924 ATPase, Ca2+ transporting, plasma CAGGACCATG[A/T]TGAAGAACAT M A T M L membrane, isoform 2 G4549u1 WIAF-14161 HT1346 524 ATP2B4, ATPase, Ca++ TGCACTGACC[C/T]AGATTAATGT N C T Q * transporting, plasma membrane 4 G4549u2 WIAF-14162 HT1346 715 ATP2B4, ATPase, Ca++ ATGTCACGCT[C/T]ATCATCCTGG S C T L L transporting, plasma membrane 4 G4549u3 WIAF-14163 HT1346 508 ATP2B4, ATPase, Ca++ AGCTGCGTTC[G/A]AGGGATGCAC S G A S S transporting, plasma membrane 4 G4549u4 WIAF-14166 HT1346 1084 ATP2B4, ATPase, Ca++ TGATCCAAGG[G/A]AATGATCTGA S G A G G transporting, plasma membrane 4 G4552u1 WIAF-13630 HT0867 710 ATP7A, ATPase, Cu++ transporting, TACTAGCACT[A/G]TTGAAGGAAA M A G I V alpha polypeptide (Menkes syndrome) G456u1 WIAF-10074 HT2834 408 EDN1, endothelin 1 CCTGGCGGCT[T/G]CGCCGGTCCA S T G L L G456u2 WIAF-10075 HT2834 585 EDN1, endothelin 1 CAGACCGTGA[A/G]AATAGATGCC S A G E E G456a3 WIAF-10507 HT2834 861 EDN1, endothelin 1 TGAAAGGCAA[T/G]CCCTCCAGAG M T G K N G4565u1 WIAF-14041 HT28561 320 ATP1G1, ATPase, Na+/K+ CGAGGCTGCT[G/A]TTACGGCTCA S G A L L transporting, gamma 1 polypeptide G4565u2 WIAF-14062 HT28561 216 ATP1G1, ATPase, Na+/K+ CAGTGACGGG[G/A]ACAAAGGTCT M G A D N transporting, gamma 1 polypeptide G4565u3 WIAF-14063 HT28561 315 ATP1G1, ATPase, Na+/K+ ACCGCCGAGG[C/A]TGCTGTTACG M C A L M transporting, gamma 1 polypeptide G4565u4 WIAF-14064 HT28561 531 ATP1G1, ATPase, Na+/K+ TTTCCCCAGG[T/C]GAATGGGCTG N T C * R transporting, gamma 1 polypeptide G4568u1 WIAF-14212 HT0082 717 AMFR, autocrine motility factor TGCCTCATGC[A/G]TACGTCCCAC M A G I V receptor G457a1 WIAF-10489 HT2903 321 SELL, selectin L (lymphocyte ACAAATCTCT[C/T]ACTGAAGAAG S C T L L adhesion molecule 1) G457a2 WIAF-10490 HT2903 577 SELL, selectin L (lymphocyte CCAGTGTCAG[T/C]TTGTGATTCA M T C F L adhesion molecule 1) G457a3 WIAF-10491 HT2903 601 SELL, selectin L (lymphocyte TGAGCCTTTG[G/C]AGGCCCCAGA M G C E Q adhesion molecule 1) G457a4 WIAF-10492 HT2903 637 SELL, selectin L (lymphocyte CTGTACTCAC[C/T]CTTTGGGAAA M C T P S adhesion molecule 1) G4573u1 WIAF-13568 HT28320 943 MGAT2, mannosyl (alpha-1,6-)- CGGACAACCT[G/T]ACGCTGCGGT S G T L L glycoprotein beta-1,2-N- acetylglucosaminyltransferase G4574u1 WIAF-13805 HT0198 163 beta-1,4 N- CGGCCTCCGG[C/G]TACCTCTTGC M C G L V acetylgalactosaminyltransferase G4574u2 WIAF-13806 HT0198 415 beta-1,4 N- TGCCACAAGA[G/A]AGCAGGAGTT M G A E K acetylgalactosaminyltransferase G4574u3 WIAF-13807 HT0198 726 beta-1,4 N- AACTACAACT[G/T]GTCACTTACA S G T L L acetylgalactosaminyltransferase G4574u4 WIAF-13836 HT0198 559 beta-1,4 N- AGGGCTGAGC[C/A]TTCAGGCAGC M C A L I acetylgalactosaminyltransferase G4575u1 WIAF-13626 HT0341 1251 GCNT1, glucosaminyl (N-acetyl) AGTATGATCT[A/G]TCTGACATGC S A G L L transferase 1, core 2 (beta-1,6-N- acetylglucosaminyltransferase) G4577u1 WIAF-13971 HT1495 1268 SIAT1, sialyltransferase 1 (beta- ATTTCTTTAA[C/T]AACTACAAGA S C T N N galactoside alpha-2,6- sialytransferase) G458u1 WIAF-10063 HT2968 1464 ALB, albumin GTGCAGAAGA[C/A]TATCTATCCG M C A D E G458u2 WIAF-10089 HT2968 1470 ALB, albumin AAGACTATCT[A/C]TCCGTGGTCC S A C L L G458u3 WIAF-10091 HT2968 1707 ALB, albumin TTGTTGAGCT[C/T]GTGAAACACA S C T L L G458a4 WIAF-10504 HT2968 889 ALB, albumin CAGGGCGGAC[C/T]TTGCCAAGTA M C T L F G458a5 WIAF-10508 HT2968 1475 ALB, albumin TATCTATCCG[T/A]GGTCCTGAAC M T A V E G458a6 WIAF-12091 HT2968 1330 ALB, albumin CCAGAATGCG[C/T]TATTAGTTCG S C T L L G458a7 WIAF-12092 HT2968 1408 ALB, albumin CCTAGGAAAA[G/a]TGGGCAGCAA M G a V M G4592u1 WIAF-14126 HT2128 985 branched-chain keto acid ACCAGCCCTT[T/C]CTCATCGAGG S T C F F dehydrogenase E1, alpha polypeptide G4593u1 WIAF-13574 HT97373 1743 BARD1, BRCA1 associated RING GCTAGCCACT[G/C]CTCAGTAATG M G C C S domain 1 G4593u2 WIAF-13592 HT97373 1167 BARD1, BRCA1 associated RING TGTTCTTCAC[C/T]ACCTTCATGC M C T P L domain 1 G4593u3 WIAF-13593 HT97373 1591 BARD1, BRCA1 associated RING AGAATGGGCA[C/T]GTGGATATAG S C T H H domain 1 G4593u4 WIAF-13594 HT97373 2030 BARD1, BRCA1 associated RING AAAGTATGAA[A/G]TTCCTGAAGG M A G I V domain 1 G4593u5 WIAF-13595 HT97373 2006 BARD1, BRCA1 associated RING AAGAAAAGTA[T/C]GTGAACAGGA M T C C R domain 1 G4599u1 WIAF-13920 HT4273 1803 CDH13, cadherin 13, H-cadherin TCGTACCCGA[C/T]GTCTCCTACG S C T D D (heart) G4614u1 WIAF-13733 HT4835 91 S100A3, S100 calcium-binding AGGATGGCCA[G/A]GCCTCTGGAG M G A R K protein A3 G4614u2 WIAF-13734 HT4835 203 S100A3, S100 calcium-binding TGCTGCAGAA[G/A]GAGCTGGCCA S G A K K protein A3 G4614u3 WIAF-13769 HT4835 344 S100A3, S100 calcium-binding TCTACTGCCA[C/T]GAGTACTTCA S C T H H protein A3 G462u1 WIAF-10134 HT4753 600 PDGFA, platelet-derived growth ACGGGGTCCA[C/T]GCCACTAAGC S C T H H factor alpha polypeptide G4627u1 WIAF-14042 HT0771 186 ANX6, annexin VI (p68) GGAGGCCATA[C/T]TGGACATAAT S C T L L G4627u2 WIAF-14043 HT0771 1664 ANX6, annexin VI (p68) CAGACACACC[T/C]AGTGGAGACA S T C P P G4627u3 WIAF-14067 HT0771 1498 ANX6, annexin VI (p68) AAGGAGGACT[A/G]TCACAAGTCC M A G Y C G4644u1 WIAF-13801 HT1736 1990 CPS1, carbamoyl-phosphate TGGTGGAGAA[G/A]TCAGTGACAG S G A K K synthetase 1, mitochondrial G4644u2 WIAF-13802 HT1736 1866 CPS1, carbamoyl-phosphate ATTGGCTACC[C/T]AGTGATGATC M C T P L synthetase 1, mitochondrial G4644u3 WIAF-13803 HT1736 1993 CPS1, carbamoyl-phosphate TGGAGAAGTC[A/C]GTGACAGGTT S A C S S synthetase 1, mitochondrial G4644u4 WIAF-13804 HT1736 1860 CPS1, carbamoyl-phosphate GACACCATTG[G/A]CTACCCAGTG M G A G D synthetase 1, mitochondrial G4644u5 WIAF-13831 HT1736 1087 CPS1, carbamoyl-phosphate AGCCTGTTTT[G/T]AATATCACAA M G T L F synthetase 1, mitochondrial G4644u6 WIAF-13835 HT1736 1958 CPS1, carbamoyl-phosphate CACAAAGGCC[T/C]TTGCTATGAC M T C F L synthetase 1, mitochondrial G4644u7 WIAF-13855 HT1736 1332 CPS1, carbamoyl-phosphate AAAGCTACCA[C/A]CATTACATCA M C A T N synthetase 1, mitochondrial G4659u1 WIAF-14143 HT1183 1830 catenin, alpha GTGCCAACGT[T/C]CCTCAACCGT S T C V V G466u1 WIAF-10164 U00968 2403 SREBF1, sterol regulatory element AGCAGTGCCC[G/A]CCAGGCCTGC M G A R H binding transcription factor 1 G4662u1 WIAF-13710 HT2142 2183 CTNNB1, catenin (cadherin- TTTTGTTCCG[A/C]ATGTCTGAGG S A C R R associated protein), beta 1 (88 kD) G467a1 WIAF-13304 X72861 827 ADRB3, adrenergic, beta-3-, GGCCATCGCC[T/C]GGACTCCGAG M T C W R receptor G467a2 WIAF-13305 X72861 832 ADRB3, adrenergic, beta-3-, TCGCCTGGAC[T/A]CCGAGACTCC S T A T T receptor G467a3 WIAF-13306 X72861 870 ADRB3, adrenergic, beta-3-, TTCGTGACTT[C/T]GCTGGCCGCA M C T S L receptor G467a4 WIAF-13307 X72861 1761 ADRB3, adrenergic, beta-3-, TGCGCCGCCG[C/T]CCGCCCGGCC M C T A V receptor G467a5 WIAF-13308 X72861 1899 ADRB3, adrenergic, beta-3-, TCTGTTGATC[A/C]GAACCTGTGG — A C — — receptor G4671u1 WIAF-13956 HT1925 161 NDUFB7, NADH dehydrogenase TGGTGGCCAC[A/G]CAGCAGGAGA S A G T T (ubiquinone) 1 beta subcomplex, 7 (18 kD, B18) G4673u1 WIAF-13889 HT0191 1349 CDC25A, cell division cycle 25A TCTGGGGCCA[G/C]CCCCAAAGAG M G C S T G4674u1 WIAF-13821 HT1393 261 CDC25B, cell division cycle 25B ACGACCTCGC[C/T]GGGCTCGGCA S C T A A G4674u2 WIAF-13822 HT1393 1297 CDC25B, cell division cycle 25B GATGGTGGCC[C/T]TATTGACGGG S C T L L G4674u3 WIAF-13823 HT1393 1083 CDC25B, cell division cycle 25B ATAAGCGGAG[G/A]CGGAGCGTGA S G A R R G4674u4 WIAF-13827 HT1393 1446 CDC25B, cell division cycle 25B AGAGCCCCAT[C/T]GCGCCCTGTA S C T I I G468a1 WIAF-13309 L37019 192 ASIP, agouti (mouse)-signaling AAATCCAAAC[C/A]GATCGGCAGA M C A P Q protein G4691u1 WIAF-13753 HT97602 179 CMKBR9, chemokine (C-C motif) TATAGCCTGA[T/A]TTTTGTGTTG M T A I N receptor 9 G4691u2 WIAF-13754 HT97602 134 CMKBR9, chemokine (C-C motif) AAGGATGCAG[T/C]GGTGTCCTTT M T C V A receptor 9 G4691u3 WIAF-13755 HT97602 193 CMKBR9, chemokine (C-C motif) TGTGTTGGGC[C/T]TCAGCGGGAA M C T L F receptor 9 G4691u4 WIAF-13756 HT97602 770 CMKBR9, chemokine (C-C motif) AAAATAGCTG[C/T]AGCCTTGGTG M C T A V receptor 9 G4691u5 WIAF-13759 HT97602 1130 CMKBR9, chemokine (C-C motif) TCTGAGAACT[A/C]CCCTAACAAG M A C Y S receptor 9 G4691u6 WIAF-13796 HT97602 482 CMKBR9, chemokine (C-C motif) AGGCTGAGGA[C/A]CCGGGCCAAG M C A T N receptor 9 G4691u7 WIAF-13797 HT97602 259 CMKBR9, chemokine (C-C motif) GATGGTTGAG[A/G]TCTATCTGCT M A G I V receptor 9 G4691u8 WIAF-13798 HT97602 434 CMKBR9, chemokine (C-C motif) ATGAGCCTGG[A/G]CAAGTACCTG M A G D G receptor 9 G4691u9 WIAF-13799 HT97602 755 CMKBR9, chemokine (C-C motif) CAGGGCCGGG[C/T]TTTAAAAATA M C T A V receptor 9 G4699u1 WIAF-14040 HT4277 1426 BAAT, bile acid Coenzyme A: amino TTCCAGATGT[G/T]ACCAGTCAAC S G T V V acid N-acyltransferase (glycine N- choloyltransferase) G4726u1 WIAF-14128 HT48614 1606 AOC3, amine oxidase, copper TCCACCCCAG[T/C]GGGGCCATAG S T C S S containing 3 (vascular adhesion protein 1) G4726u2 WIAF-14129 HT48614 2242 AOC3, amine oxidase, copper TTCCTAACAC[A/G]GTGACTGTGG S A G T T containing 3 (vascular adhesion protein 1) G4726u3 WIAF-14141 HT48614 659 AOC3, amine oxidase, copper CCTGCCCTAT[C/T]ACCGACGCCC M C T H Y containing 3 (vascular adhesion protein 1) G4744u1 WIAF-13683 HT2599 564 CTH, cystathionase (cystathionine ATATTGTCCA[T/C]AAGCATGGAG S T C H H gamma-lyase) G4748u1 WIAF-14144 HT1061 242 CYBA, cytochrome b-245, alpha GGGACAGAAG[C/T]ACATGACCGC M C T H Y polypeptide G4748u2 WIAF-14145 HT1061 265 CYBA, cytochrome b-245, alpha TGGTGAAGCT[G/C]TTCGGGCCCT S G C L L polypeptide G4750u1 WIAF-14116 HT48417 156 CYB5, cytochrome b-5 TGAAGTACTA[C/T]ACCCTAGAGG S C T Y Y G4751u1 WIAF-13770 HT1285 495 UQCRC2, ubiquinol-cytochrome c AGAATTTCGT[C/A]GTTGGGAAGT M C A R S reductase core protein II G4788u1 WIAF-13931 HT28249 1864 DSC3, desmocollin 3 CTGTTGATCC[T/C]GATGAACCTG S T C R P G4788u2 WIAF-13933 HT28249 2000 DSC3, desmocollin 3 TGGATTTCAA[G/T]AATATACCAT N G T E * G4788u3 WIAF-13945 HT28249 2524 DSC3, desmocollin 3 ACACTTACTC[G/A]GAGTGGCACA S G A S S G479u1 WIAF-12567 U36310 894 GPD2, glycerol-3-phosphate GGGAAAGTGC[A/G]TGTGAGCGGC M A G H R dehydrogenase 2 (mitochondrial) G479u2 WIAF-12574 U36310 1657 GPD2, glycerol-3-phosphate CTGGCAAAAG[G/T]TGGCCTATTG M G T R S dehydrogenase 2 (mitochondrial) G479u3 WIAF-12575 U36310 1131 GPD2, glycerol-3-phosphate GTTATTTTCT[T/C]CTTACCCTGG M T C F S dehydrogenase 2 (mitochondrial) G480u1 WIAF-12575 HT336 250 GRB2, growth factor receptor- AATGAAACCA[C/A]ATCCGTGGTT M C A H N bound protein 2 G4819u1 WIAF-13985 HT97576 1804 EYA1, eyes absent (Drosophila) CCCTGCACCA[T/C]GCCTTGGAAC S T C H H homolog 1 G482u1 WIAF-12181 J04501 1186 GYS1, glycogen synthase 1 CTGACGTCTT[T/C]CTGGAGGCAT S T C F F (muscle) G482u2 WIAF-12195 J04501 1406 GYS1, glycogen synthase 1 CCTTCCCGAC[A/G]TGAACAAGAT M A G M V (muscle) G4827u1 WIAF-14177 HT97477 68 elongation CGAGCTGGCC[A/G]TGATGGTGAT M A G H R G483a1 WIAF-12113 HT4341 1850 GSY2 TTACCAGCAT[G/T]CCAGACACCT M G T A S G483u2 WIAF-12148 HT4341 1130 GSY2 GTTTTTCATT[A/C]TGCCTGCCAA M A C M L G483u3 WIAF-12149 HT4341 880 GSY2 GCTTGAATGT[T/G]AAGAAATTTT S T G V V G483u4 WIAF-12150 HT4341 1115 GSY2 CATCACAGTG[G/A]TGGTGTTTTT M G A V M G483u5 WIAF-12156 HT4341 1230 GSY2 GAAAAGTTTG[G/A]AAAAAAACTC M G A G E G483u6 WIAF-12159 HT4341 2033 GSY2 TGAGAGATAC[G/A]ATGAGGAAGA M G A D N G483u7 WIAF-12160 HT4341 1836 GSY2 TACTTAGGCA[G/C]ATATTACCAG M G C R T G483u8 WIAF-12161 HT4341 1678 GSY2 CTTACGGTAT[T/C]TACATCGTTG S T C I I G483u9 WIAF-12177 HT4341 790 GSY2 GCGCTCACGT[G/C]TTCACCACGG S G C V V G483u10 WIAF-12188 HT4341 1728 GSY2 TGCAATCAGC[T/C]GACTAAGTTT M T C L P G484u1 WIAF-12151 HT5111 487 GSY3 CATCAAAGTG[A/G]TTGGCAATGG M A G I V G484u2 WIAF-12187 HT5111 1141 GSY3 AACCCGGGAA[C/T]AAATCCGAGA N C T Q * G489u1 WIAF-12152 HT2607 1181 IRS1, insulin receptor substrate AAGAAGTGGC[G/A]GCACAAGTCG M G A R Q 1 G489u2 WIAF-12184 HT2607 1031 IRS1, insulin receptor substrate ATGGCGAGCC[C/T]TCCGGAGAGC M C T P L 1 G492a1 WIAF-13345 L08603 307 MC4R, melanocortin 4 receptor AGAAACCATT[A/G]TCATCACCCT M A G I V G493u1 WIAF-12154 X67594 346 MC1R, melanocortin 1 receptor CGCGCTGGTG[G/T]TGGCCACCAT M G T V L (alpha melanocyte stimulating hormone receptor) G493u2 WIAF-12167 X67594 646 MC1R, melanocortin 1 receptor GACCCTGCCG[C/T]GGGCGCGGCA M C T R W (alpha melanocyte stimulating hormone receptor) G493u3 WIAF-12170 X67594 1110 MC1R, melanocortin 1 receptor AGGTGCTGAC[A/G]TGCTCCTGGT S A G T T (alpha melanocyte stimulating hormone receptor) G493u4 WIAF-12186 X67594 442 MC1R, melanocortin 1 receptor CGGGAGCAAC[G/T]TGCTGGAGAC M G T V L (alpha melanocyte stimulating hormone receptor) G498u1 WIAF-11809 J04127 1305 CYP19, cytochrome P450, subfamily CTTATAGGTA[C/T]TTTCAGCCAT S C T Y Y XIX (aromatization of androgens) G498u2 WIAF-11810 J04127 1377 CYP19, cytochrome P450, subfamily TGAAAGCCAT[C/T]CTCGTTACAC S C T I I XIX (aromatization of androgens) G498u3 WIAF-11811 J04127 1406 CYP19, cytochrome P450, subfamily CGATTCCACG[T/C]GAAGACATTG M T C V A XIX (aromatization of androgens) G498u4 WIAF-11838 J04127 1055 CYP19, cytochrome P450, subfamily ATTGGTGAGA[G/A]AGACATAAAG M G A R K XIX (aromatization of androgens) G498u5 WIAF-11800 J04127 1001 CYP19, cytochrome P450, subfamily ATTGCAAAGC[A/G]CCCTAATGTT M A G H R XIX (aromatization of androgens) G499u1 WIAF-11785 HT1439 2142 ESR1, estrogen receptor 1 TCCCTGCCAC[A/G]GTCTGAGAGC S A G T T G499u2 WIAF-11801 HT1439 443 ESR1, estrogen receptor 1 CCCCTGAACC[G/A]TCCGCAGCTC M G A R H G500u1 WIAF-11803 X99101 793 ESR1, estrogen receptor 1 CATGATCAGC[T/C]GGGCCAAGAA M T C W R G500u2 WIAF-11816 X99101 489 ESR1, estrogen receptor 1 GGAAGTGTTA[C/T]GAAGTGGGAA S C T Y Y G500u3 WIAF-11817 X99101 474 ESR1, estrogen receptor 1 AGGCCTGCCG[A/G]CTTCGGAAGT S A G R R G505u1 WIAF-11824 HT1113 1063 PRLR, prolactin receptor GCTTTGAAGG[G/A]CTATAGCATG M G A G D G505u2 WIAF-11827 HT1113 2083 PRLR, prolactin receptor GCAACATCAA[G/A]CAAGTGCAGG M G A S N G505u3 WIAF-11787 HT1113 582 PRLR, prolactin receptor GAGGACATAC[A/G]TCATGATGGT M A G I V G505u4 WIAF-11802 HT1113 792 PRLR, prolactin receptor CCTGTATGAA[A/C]TTCGATTAAA M A C I L G509u1 WIAF-11789 M32313 378 SRD5A1, steroid-5-alpha- CACTGTTGGC[A/G]TGTACAATGG S A G A A reductase, alpha polypeptide 1 (3- oxo-5 alpha-steroid delta 4- dehydrogenase alpha 1) G510a1 WIAF-13348 U17280 582 STAR, steroidogenic acute CCAATGTCAA[G/A]GAGATCAAGG S G A K K regulatory protein G52u1 WIAF-10224 HT0488 1139 inhibin, beta B CCAACATGAT[T/C]GTGGAGGAGT S T C I I G520u1 WIAF-13507 D31770 517 ACVR2, activin A receptor, type CTTATTTTCC[G/A]GAGATGGAAG S G A P P II G520u2 WIAF-13532 D31770 1177 ACVR2, activin A receptor, type CAGCTTGCAT[T/G]GCTGACTTTG M T G I M II G520u3 WIAF-13533 D31770 1189 ACVR2, activin A receptor, type CTGACTTTGG[G/C]TTGGCCTTAA S G C G G II G520u4 WIAF-13534 D31770 1024 ACVR2, activin A receptor, type TCTCTTGGAA[T/C]GAACTGTGTC S T C N N II G523u1 WIAF-12155 HT4996 538 OXTR, oxytocin receptor TGAGCGGGAA[C/T]GCGTGTGTGC S C T N N G523u2 WIAF-12180 HT4996 1057 OXTR, oxytocin receptor TCTGGCAGAA[C/T]TTGCGGCTCA S C T N N G524a1 WIAF-13349 L05144 190 PCK1, phosphoenolpyruvate TGGACAGCCT[G/A]CCCCAGGCAG S G A L L carboxykinase 1 (soluble) G528u1 WIAF-11831 V00572 988 PGK1, phosphoglycerate kinase 1 AAGCCACTGT[G/C]GCTTCTGGCA S G C V V G53u1 WIAF-10307 HT0508 723 DNA repair protein XRCC1 CCAGCGACCC[G/A]GCAGGACCTA S G A P P G53u2 WIAF-10308 HT0508 746 DNA repair protein XRCC1 TATGCAGCTG[C/T]TACCCTCCAG M C T A V G53u3 WIAF-10309 HT0508 1884 DNA repair protein XRCC1 GGGATCCCAG[C/T]TTTGAGGAGG S C T S S G53u4 WIAF-10362 HT0508 425 DNA repair protein XRCC1 AACCCCAACC[G/A]CGTTCGCATG M G A R H G534a1 WIAF-13310 U28281 1284 SCTR, secretin receptor GCTTCCTCAA[T/C]GGGGAGGTGC S T C N N G534a2 WIAF-13311 U28281 1404 SCTR, secretin receptor AGCAGAGCCA[G/A]GGCACCTGCA S G A Q Q G535u1 WIAF-12157 HT5001 1158 SHC1 ATGCTCTTCG[G/C]GTGCCTCCAC S G C R R G535u2 WIAF-12196 HT5001 774 SHC1 ATGAGGAGGA[G/A]GAAGAGCCAC S G A E E G536u1 WIAF-13923 M20747 535 SLC2A4, solute carrier family 2 GCCTGGCCAA[C/T]GCTGCTGCCT S C T N N (facilitated glucose transporter), member 4 G538u1 WIAF-11812 M55531 438 SLC2A5, solute carrier family 2 GCAGCAGAGT[C/T]GCCACATCAT S C T V V (facilitated glucose transporter), member 5 G538u2 WIAF-11813 M55531 124 SLC2A5, solute carrier family 2 GACGCTTGTG[C/T]TTGCCCTGGC M C T L F (facilitated glucose transporter), member 5 G538u3 WIAF-11791 M55531 816 SLC2A5, solute carrier family 2 ACAGGGAGGT[G/A]GCCGAGATCC S G A V V (faciliatated glucose transporter), member 5 G539u1 WIAF-12158 K03195 224 Human (HepG2) glucose transporter TCATGCTGGC[T/C]GTGGGAGGAG S T C A A gene mRNA, complete cds. G539u2 WIAF-12191 K03195 1244 Human (HepG2) glucose transporter CCATCGCGCT[A/G]GCACTGCTGG S A G L L gene mRNA, complete cds. G540a1 WIAF-12114 HT960 1100 SOS1 AGTGAAGATC[A/C]AGAAGACAAG M A C Q P G540u2 WIAF-12165 HT960 933 SOS1 ATGATCGTTT[C/T]CTTAGTCAGT S C T F F G540u3 WIAF-12178 HT960 399 SOS1 TAGTAGCAGT[C/T]TTAGAATACA S C T V V G540u4 WIAF-12193 HT960 195 SOS1 CTCAGCCCCG[A/C]AGTGCTTCAG S A C R R G540u5 WIAF-12197 HT960 1329 SOS1 GTTGTAATGA[A/G]TTTATAATGG S A G E E G540u6 WIAF-12198 HT960 1339 SOS1 ATTTATAATG[G/A]AAGGAACTCT M G A E K G543a1 WIAF-13312 J00306 1373 SST, somatostatin AAGCAGGAAC[T/C]GGCCAAGTAC M T C L P G543a2 WIAF-13313 J00306 1603 SST, somatostatin AGTATTGTCC[A/G]TATCAGACCT — A G — — G544u1 WIAF-12174 HT27489 982 SUR, sulfonylurea receptor CCATTGACAT[G/C]GCCACGGAAA M G C M I (hyperinsulinemia) G546u1 WIAF-13618 HT225 426 TKT, transketolase (Wernicke- GCTACATTGC[C/T]GAGCAGAACA S C T A A Korsakoff syndrome) G551u1 WIAF-11709 HT1118 257 TNFRSF1B, tumor necrosis factor GCTGCAGCAA[A/G]TGCTCGCCGG S A G K K receptor superfamily, member 1B G551u2 WIAF-11710 HT1118 449 TNFRSF1B, tumor necrosis factor TCTGCACCTG[C/T]AGGCCCGGCT S C T C C receptor superfamily, member 1B G551u3 WIAF-11719 HT1118 648 TNFRSF1B, tumor necrosis factor GATCTGTAAC[G/A]TGGTGGCCAT M G A V M receptor superfamily, member 1B G551u4 WIAF-11673 HT1118 676 TNFRSF1B, tumor necrosis factor AATGCAAGCA[T/G]GGATGCAGTC M T G M R receptor superfamily, member 1B G551u5 WIAF-11720 HT1118 808 TNFRSF1B, tumor necrosis factor CCAAGCACCT[C/T]CTTCCTGCTC M C T S F receptor superfamily, member 1B G552u1 WIAF-12229 HT5108 384 TRAP3 GCCGCTGCCC[G/A]CTCATGCTGA S G A P P G555u1 WIAF-12211 U94592 478 UCP2, uncoupling protein 2 CGCGCTACAG[T/C]CAGCGCCCAG M T C V A (mitochondrial, proton carrier) G556u1 WIAF-11804 AF001787 480 UCP2, uncoupling protein 2 TCGGCCTCTA[T/C]GACTCCGTCA S T C Y Y (mitochondrial, proton carrier) G556u2 WIAF-11805 AF001787 563 UCP2, uncoupling protein 2 TGCACCACAG[G/A]AGCCATGGCG M G A G E (mitochondrial, proton carrier) G556u3 WIAF-11823 AF001787 1113 UCP2, uncoupling protein 2 TACGGGAATC[A/G]CCGTTTTGAA S A G S S (mitochondrial, proton carrier) G556u4 WIAF-11782 AF001787 386 UCP2, uncoupling protein 2 ATCCTGACCA[T/C]GGTGCGGACT M T C M T (mitochondrial, proton carrier) G561a1 WIAF-12111 HT1176 2430 IDE, insulin-degrading enzyme ACTGTGGCAT[C/A]GAGATATACT S C A I I G561u2 WIAF-12222 HT1176 3099 IDE, insulin-degrading enzyme ATATTAACTT[C/G]ATGGCTGCAA M C G F L G562u1 WIAF-12223 HT27503 680 tumor necrosis factor receptor CCTGTAGTGA[A/C]TCGGCCGCTG M A C N T type 1 associated protein G562u2 WIAF-12224 HT27503 900 tumor necrosis factor receptor CGCTGCAGCG[C/A]CTGGTGGAGG S C A R R type 1 associated protein G573u1 WIAF-12199 HT28094 469 SSTR1, somatostatin receptor 1 GGACCGCTAC[G/C]TGGCCGTGGT M G C V L G573u2 WIAF-12208 HT28094 480 SSTR1, somatostatin receptor 1 TGGCCGTGGT[G/A]CATCCCATCA S G A V V G573u3 WIAF-12209 HT28094 879 SSTR1, somatostatin receptor 1 TGCAGCTGGT[T/C]AACGTGTTTG S T C V V G574u1 WIAF-11822 HT4058 1054 SSTR5, somatostatin receptor 5 GCCACGGAGC[C/T]GCGTCCAGAC M C T P L G575u1 WIAF-12200 HT28095 99 SSTR3, somatostatin receptor 3 ACGTGTCGGC[G/A]GGCCCAAGCC S G A A A G575u2 WIAF-12217 HT28095 453 SSTR3, somatostatin receptor 3 CCACCGCTC[G/A]GCCCGCTGGC S G A S S G585u1 WIAF-12204 HT1022 1133 PYGL, phosphorylase, glycogen; AGCTGAATGA[T/C]ACTCACCCTC S T C D D liver (Hers disease, glycogen storage disease type VI) G585u2 WIAF-12205 HT1022 1988 PYGL, phosphorylase, glycogen; AGCTGATCAC[T/C]TCAGTGGCAG S T C T T liver (Hers disease, glycogen storage disease type VI) G585u3 WIAF-12225 HT1022 1883 PYGL, phosphorylase, glycogen; TGTACAACCG[C/T]ATTAAGAAAG S C T R R liver (Hers disease, glycogen storage disease type VI) G585u4 WIAF-12226 HT1022 2037 PYGL, phosphorylase, glycogen; AAGCAAGTTG[A/G]AAGTCATCTT M A G K E liver (Hers disease, glycogen storage disease type VI) G585u5 WIAF-12231 HT1022 1387 PYGL, phosphorylase, glycogen; GATGTGGACC[C/G]TCTGAGAAGG M C G P R liver (Hers disease, glycogen storage disease type VI) G586a1 WIAF-12112 HT1878 2410 PFKM, phosphofructokinase, muscle CCGGGGAAGC[T/G]GCCGTCTAAA S T G A A G586u2 WIAF-12206 HT1878 375 PFKM, phosphofructokinase, muscle GGACGACTCC[G/A[AGCTGCCTAC M G A R Q G586u3 WIAF-12207 HT1878 322 PFKM, phosphofructokinase, muscle TGGGAGGCAC[G/A]GTGATTGGAA S G A T T G586u4 WIAF-12227 HT1878 334 PFKM, phosphofructokinase, muscle TGATTGGAAG[T/C]GCCCGGTGCA S T C S S G586u5 WIAF-12228 HT1878 408 PFKM, phosphofructokinase, muscle CGTGGGATCA[C/G]CAATCTCTGT M C G T S G586u6 WIAF-12235 HT1878 717 PFKM, phosphofructokinase, muscle CACGTGGAT[A/G]CCTGGCCCTT M A G Y C G587u1 WIAF-12615 HT3847 366 phosphofructokinase, liver ATGGCAGCCT[T/C]ACAGGTGCCA S T C L L G589u1 WIAF-12210 L39211 1327 CPT1A, carnitine CAGCGTTCTT[C/T]GTGACGTTAG S C T F F palmitoyltransferase I, liver G589u2 WIAF-12215 L39211 2080 CPT1A, carnitine AATATCTCGC[T/C]GTGGAGTCCC S T C A A palmitoyltransferase I, liver G589u3 WIAF-12216 L39211 679 CPT1A, carnitine ACTTCAAACG[G/T]ATGACAGCAC S G T R R palmitoyltransferase I, liver G589u4 WIAF-12218 L39211 1844 CPT1A, carnitine CCTCACATAC[G/C]AGGCCTCCAT M G C E Q palmitoyltransferase I, liver G592u1 WIAF-11814 X96586 1089 NSMAF, neutral sphingomyelinase TCCGGGATCT[C/T]AGTAAGCCAG S C T L L (N-SMase) activation asociated factor G592u2 WIAF-11815 X96586 2020 NSMAF, neutral sphingomyelinase AAGTATATCA[T/G]TTTCAAATAT M T G F V (N-SMase) activation asociated factor G592u3 WIAF-11834 X96586 1673 NSMAF, neutral sphingomyelinase GTAGCCATGC[T/C]TACGCAAATC M T C L P (N-SMase) activation asociated factor G592u4 WIAF-11784 X96586 1889 NSMAF, neutral sphingomyelinase CACGAGCACT[A/G]TAAAATCCAC M A G Y C (N-SMase) activation asociated factor G592u5 WIAF-11798 X96586 1677 NSMAF, neutral sphingomyelinase CCATGCTTAC[G/A]CAAATCTTGG S G A T T (N-SMase) activation associated factor G592u6 WIAF-11799 X96586 2429 NSMAF, neutral sphingomyelinase TGCCATTCAG[G/C]GATTGTATGT M G C G A (N-SMase) activation associated factor G592a7 WIAF-13156 X96586 2205 NSMAF, neutral sphingomyelinase ATTCTGCATC[G/A]TGGGACTCTA S G A S S (N-SMase) activation associated factor G594u1 WIAF-10065 HT3921 1153 annexin V, alt. transcript 2 TTGTGAAATC[T/A]ATTCGAAGTA S T A S S G594u2 WIAF-10098 HT3921 567 annexin V, alt. transcript 2 CGAAGTAATG[C/T]TCAGCGCCAG M C T A V G594u3 WIAF-10099 HT3921 774 annexin V, alt. transcript 2 ATTGCTTCAA[G/C]GACACCTGAA M G C R T G594a4 WIAF-10505 HT3921 424 annexin V, alt. transcript 2 GAGTAGTCGC[C/T]ATGGCACAGG — C T — — G594a5 WIAF-13123 HT3921 571 annexin V, alt. transcript 2 GTAATGCTCA[G/C]CGCCAGGAAA M G C Q H G595u1 WIAF-12203 HT27983 1008 NRIP1, nuclear receptor TGCAAGATTA[C/T]AGGCTGTTGC N C T Q * interacting protein 1 G595u2 WIAF-12220 HT27983 785 NRIP1, nuclear receptor CCCTCAGTCA[T/C]GATTCTTTAA S T C H H interacting protein 1 G595u3 WIAF-12232 HT27983 1231 NRIP1, nuclear receptor GTTGGCAGTT[A/T]CCAGCTCCCA M A T Y F interacting protein 1 G595u4 WIAF-12261 HT27983 2048 NRIP1, nuclear receptor GCAGTACTCA[G/A]TCTGAAAAGC S G A Q Q interacting protein 1 G595u5 WIAF-12274 HT27983 2376 NRIP1, nuclear receptor TCCTGAACCA[G/T]GGCTTTCTGG M G T G W interacting protein 1 G595u6 WIAF-12275 HT27983 3498 NRIP1, nuclear receptor ACTATATTAC[A/G]TGCTTCAAAA M A G M V interacting protein 1 G595u7 WIAF-12276 HT27983 3671 NRIP1, nuclear receptor ACAATAGCCA[T/C]ATGGGAAATA S T C H H interacting protein 1 G595u8 WIAF-12294 HT27983 2020 NRIP1, nuclear receptor ATCAAATGGA[A/G]TTCCCCACCA M A G N S interacting protein 1 G595u9 WIAF-12295 HT27983 3140 NRIP1, nuclear receptor ATTTGTCCCC[G/A]CACAGAAGTA S G A P P interacting protein 1 G596u1 WIAF-10144 HT3537 3299 PC, pyruvate carboxylase TGCGGTCCAT[C/T]TTGGTCAAGG S C T I I G596u2 WIAF-10158 HT3537 2662 PC, pyruvate carboxylase ACCAACCTGC[A/C]CTTCCAGGCC M A C H P G596u3 WIAF-10159 HT3537 2156 PC, pyruvate carboxylase CCATCTCATA[C/A]ACGGGCGACG N C A Y * G598a1 WIAF-12118 HT48666 5585 HERC1, hect (homologous to the E6 GGGACCTATG[C/T]TGATAAACTG M C T A V AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u2 WIAF-12236 HT48666 4456 HERC1, hect (homologous to the E6 CCTGTTAATA[T/C]TAGGAGTAAG S T C L L AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u3 WIAF-12237 HT48666 6356 HERC1, hect (homologous to the E6 GGTAATGAAG[G/T]CACGTGTGTT M G T G V AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u4 WIAF-12240 HT48666 12219 HERC1, hect (homologous to the E6 GTACCTTTGT[C/T]ATCCAGGCCA S C T V V AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u5 WIAF-12241 HT48666 12480 HERC1, hect (homologous to the E6 CCAGGCAGAT[C/G]GAGGCCTTAC M C G I M AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u6 WIAF-12244 HT48666 12975 HERC1, hect (homologous to the E6 GAGTAATCAT[T/A]GAAGATGTGG S T A I I AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u7 WIAF-12245 HT48666 1424 HERC1, hect (homologous to the E6 TCCAATAATC[A/T]GTCAACTTTA M A T Q L AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u8 WIAF-12250 HT48666 5854 HERC1, hect (homologous to the E6 TTCAAAGCA[A/T]TTCAATCAAA M A T I F AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u9 WIAF-12251 HT48666 6754 HERC1, hect (homologous to the E6 TATTCAGCTC[G/A]TCCGTATCCT M G A V I AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u10 WIAF-12252 HT48666 7635 HERC1, hect (homologous to the E6 ATCTTTACCT[C/T]GGTGCTATGA S C T L L AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u11 WIAF-12254 HT48666 9189 HERC1, hect (homologous to the E6 GTGGAAATCC[A/G]TACTACCTGT S A G P P AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u12 WIAF-12255 HT48666 10119 HERC1, hect (homologous to the E6 TTGTGGCATT[G/C]CTAGCAGACA M G C L F AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u13 WIAF-12257 HT48666 11109 HERC1, hect (homologous to the E6 ATCCATCTAT[T/C]GTAAATGGCA S T C I I AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u14 WIAF-12258 HT48666 13513 HERC1, hect (homologous to the E6 CTATGGACCT[C/T]AGATAACTGT N C T Q * AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u15 WIAF-12259 HT48666 13697 HERC1, hect (homologous to the E6 ACCATCACAG[A/G]GATGTGCCAG M A G E G AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u16 WIAF-12265 HT48666 1098 HERC1, hect (homologous to the E6 CCCTTTACGA[G/A]GCAGCATTAT S G A E E AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u17 WIAF-12272 HT48666 6079 HERC1, hect (homologous to the E6 TATGTGGGAG[A/G]CACCCATTGC M A G T A AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u18 WIAF-12273 HT48666 9551 HERC1, hect (homologous to the E6 AAGAGCTCCT[C/T]TGGGAGAATA M C T S F AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u19 WIAF-12277 HT48666 666 HERC1, hect (homologous to the E6 GTCTTTGCAA[C/T]GATGTCATTC S C T N N AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u20 WIAF-12278 HT48666 882 HERC1, hect (homologous to the E6 GCTCATTGCG[A/G]TATCTTCTTG S A G R R AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u21 WIAF-12279 HT48666 893 HERC1, hect (homologous to the E6 TATCTTCTTG[A/T]ATGGATAGAA M A T E V AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u22 WIAF-12280 HT48666 13276 HERC1, hect (homologous to the E6 AGAAGTCAGC[A/G]TTCACACGGT M A G I V AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u23 WIAF-12283 HT48666 6519 HERC1, hect (homologous to the E6 CCTGTGTGTT[A/T]GACATGGAAG M A T L F AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u24 WIAF-12284 HT48666 8386 HERC1, hect (homologous to the E6 GGGGTTCTCT[C/T]TTCGGCAGAT M C T L F AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u25 WIAF-12286 HT48666 10266 HERC1, hect (homologous to the E6 CAGCTCAGCA[A/T]CTCGTGCGCA M A T Q H AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u26 WIAF-12287 HT48666 10099 HERC1, hect (homologous to the E6 CTTTGTTGTA[A/G]CACAGGCCCT M A G T A AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u27 WIAF-12289 HT48666 11835 HERC1, hect (homologous to the E6 AGAACTGTCT[G/C]CCTGACCCTG S G C L L AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u28 WIAF-12290 HT48666 12689 HERC1, hect (homologous to the E6 TTAAACCACA[C/T]TTTGGCAGTG M C T T I AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u29 WIAF-12291 HT48666 14655 HERC1, hect (homologous to the E6 ACGTGGACAA[C/T]GCCGAGGGCT S C T N N AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u30 WIAF-12296 HT48666 393 HERC1, hect (homologous to the E6 ATTCCCCATT[T/C]GCCGGGGCAC S T C F F AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u31 WIAF-12297 HT48666 479 HERC1, hect (homologous to the E6 GGCAAGGTGA[A/G]GCAGCAGCAG M A G K R AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u32 WIAF-12298 HT48666 1197 HERC1, hect (homologous to the E6 ATGCTCCCAT[T/C]GTCTCCGAAA S T C I I AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u33 WIAF-12300 HT48666 3595 HERC1, hect (homologous to the E6 TCCAGAGGAA[C/T]AGGACACTGC N C T Q * AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G598u34 WIAF-12301 HT48666 3661 HERC1, hect (homologous to the E6 CACTCCTCAA[T/C]TGGATAAATG S T C L L AP (UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD) 1 G601u1 WIAF-12246 HT27734 106 PRKMK5, protein kinase, mitogen- TGGAGAACCA[G/A]GTGCTGGTAA S G A Q Q activated, kinase 5 (MAP kinase kinase 5) G601u2 WIAF-12247 HT27734 351 PRKMK5, protein kinase, mitogen- GTAAATGGAC[A/G]GTTAATAGAG M A G Q R activated, kinase 5 (MAP kinase kinase 5) G601u3 WIAF-12292 HT27734 617 PRKMK5, protein kinase, mitogen- AGCATATCAT[G/C]TCCCGAGTGG M G C V L activated, kinase 5 (MAP kinase kinase 5) G603u1 WIAF-12248 HT4291 1336 mitogen-activated protein (MAP) AGTCATCAGC[T/C]TTGTGCCACC M T C F L kinase p38 G603u2 WIAF-12281 HT4291 1230 mitogen-activated protein (MAP) CTCAGTACCA[C/T]GATCCTGATG S C T H H kinase p38 G610u1 WIAF-12249 HT48690 1012 protein kinase, mitogen-activated CCGAGCCATA[T/C]GATGAGAGCG S T C Y Y p38Beta (MAP kinase p38Beta) G610u2 WIAF-12263 HT48690 799 protein kinase, mitogen-activated AAATCTCCTC[G/A]GAACACGCCC S G A S S p38Beta (MAP kinase p38Beta) G610u3 WIAF-12264 HT48690 848 protein kinase, mitogen-activated GCCCCAGAAG[G/A]ACCTGAGCAG M G A D N p38Beta (MAP kinase p38Beta) G610u4 WIAF-12282 HT48690 439 protein kinase, mitogen-activated TCCTGGTTTA[C/T]CAGCTGCTGC S C T Y Y p38Beta (MAP kinase p38Beta) G612u1 WIAF-12344 HT1436 1513 RAF1, v-raf-1 murine leukemia TTTGCATGCA[A/G]AGAACATCAT M A G K E viral oncogene homolog 1 G614u1 WIAF-12267 HT321 603 BRAF, v-raf murine sarcoma viral GACAGTCTAA[A/G]GAAAGCACTG M A G K R oncogene homolog B1 G614u2 WIAF-12268 HT321 2282 BRAF, v-raf murine sarcoma viral CCAAACAGAG[G/A]ATTTTAGTCT M G A D N oncogene homolog B1 G614u3 WIAF-12299 HT321 973 BRAF, v-raf murine sarcoma viral AGGAAGAGGC[G/A]TCCTTAGCAG S G A A A oncogene homolog B1 G616u1 WIAF-12253 HT48746 498 TRAF-interacting protein (I-TRAF) AAGAAGACAA[G/T]AGGTTTCTTC N G T E * G616u2 WIAF-12269 HT48746 1338 TRAF-interacting protein (I-TRAF) GCATATACCT[C/G]GAGTATGTGA M C G R G G616u3 WIAF-12285 HT48746 377 TRAF-interacting protein (I-TRAF) ATAACAATTA[T/C]GGCTGTGTCC S T C Y Y G616u4 WIAF-12288 HT48746 1032 TRAF-interacting protein (I-TRAF) TGAAATTCAG[G/A]GAATTGACCC M G A G R G617u1 WIAF-12256 HT1614 52 PPP1CA, protein phosphatase 1, GAAGCTCAAC[C/T]TGGACTCGAT S C T L L catalytic subunit, alpha isoform G617u2 WIAF-12270 HT1614 792 PPP1CA, protein phosphatase 1, AAGACGGCTA[C/T]GAGTTCTTTG S C T Y Y catalytic subunit, alpha isoform G618u1 WIAF-12238 HT27508 1598 protein phosphatase, 2A B56-alpha CATTGAACCA[A/C]CACAGTTCAA M A C T P subunit G618u2 WIAF-12271 HT27508 1135 protein phosphatase, 2A B56-alpha ATCAGAAATT[C/T]GTACAACAGC S C T F F subunit G62u1 WIAF-10369 HT0855 214 ERCC6, excision repair cross- AGGAGTACCT[G/C]TCCTTTCGTT S G C L L complementing rodent repair deficiency, complementation group 6 G62u2 WIAF-10370 HT0855 926 ERCC6, excision repair cross- AAAACTGTCT[T/C]TTGAAAGGAA M T C F L complementing rodent repair deficiency, complementation group 6 G62u3 WIAF-10428 HT0855 2904 ERCC6, excision repair cross- AGCACGGACA[C/T]GCAGGCCCGG M C T T M complementing rodent repair deficiency, complementation group 6 G62u4 WIAF-10430 HT0855 3386 ERCC6, excision repair cross- TGACCCTCAC[A/G]TGAGTAGTAA M A G M V complementing rodent repair deficiency, complementation group 6 G62u5 WIAF-10451 HT0855 1376 ERCC6, excision repair cross- TTCTGGGGAA[G/A]AAGCTGAAGC M G A E K complementing rodent repair deficiency, complementation group 6 G62u6 WIAF-10452 HT0855 3716 ERCC6, excision repair cross- TAAGCATTGC[A/G]GAGACGCCAA M A G R G complementing rodent repair deficiency, complementation group 6 G62u7 WIAF-10453 HT0855 3967 ERCC6, excision repair cross- CCCTGAAAGC[A/C]CTGAGGCTCT S A C A A complementing rodent repair deficiency, complementation group 6 G62u8 WIAF-10454 HT0855 4016 ERCC6, excision repair cross- TGGTGTTCCC[A/G]CCTGGACTGG M A G T A complementing rodent repair deficiency, complementation group 6 G62u9 WIAF-10455 HT0855 3979 ERCC6, excision repair cross- TGAGGCTCTC[T/C]CGTCAGCGGT S T C S S complementing rodent repair deficiency, complementation group 6 G62u10 WIAF-10456 HT0855 3729 ERCC6, excision repair cross- GACGCCAAGT[T/G]TGAAGGAACT M T G F C complementing rodent repair deficiency, complementation group 6 G62u11 WIAF-10476 HT0855 1275 ERCC6, excision repair cross- TCTGGAGATG[G/A]TACTGACTAT M G A G D complementing rodent repair deficiency, complementation group 6 G62u12 WIAF-10477 HT0855 2017 ERCC6, excision repair cross- TGATCTTGGA[C/T]GAAGGACACA S C T D D complementing rodent repair deficiency, complementation group 6 G62u13 WIAF-10479 HT0855 3265 ERCC6, excision repair cross- CTAACATATC[T/C]GTAAATGATG S T C S S complementing rodent repair deficiency, complementation group 6 G62u14 WIAF-10481 HT0855 4317 ERCC6, excision repair cross- GGGCACCTGC[A/G]GGAAGCTTCT M A G Q R complementing rodent repair deficiency, complementation group 6 G620a1 WIAF-12116 HT1943 1256 PPP2CB, protein phosphatase 2 TATCATGGAA[T/A]TAGATGACAC M T A L I (formerly 2A), catalytic subunit, beta isoform G620a2 WIAF-12117 HT1943 1326 PPP2CB, protein phosphatase 2 CCTCATGTTA[C/G]ACGGCGCACC M C G T R (formerly 2A), catalytic subunit, beta isoform G620u3 WIAF-12239 HT1943 819 PPP2CB, protein phosphatase 2 TTTTATGATG[A/G]ATGTCTGCGA M A G E G (formerly 2A), catalytic subunit, beta isoform G623u1 WIAF-12260 HT3979 459 PPP1CB, protein phosphatase 1, TTCATGGACA[A/G]TATACAGATT S A G Q Q catalytic subunit, beta isoform G625u1 WIAF-12266 HT1961 227 PPP2R2A, protein phosphatase 2 CATTCTGGAG[A/G]ATTACTAGCA M A G E G (formerly 2A), regulatory subunit B (PR 52), alpha isoform G628a1 WIAF-12104 HT2780 1104 PPP1CC, protein phosphatase 1, AGGGGTATGA[T/A]CACAAAGCAA M T A I N catalytic subunit, gamma isoform G628a2 WIAF-12105 HT2780 973 PPP1CC, protein phosphatase 1, CCAATTATTG[C/T]GGAGAGTTTG S C T C C catalytic subunit, gamma isoform G628u3 WIAF-12311 HT2780 888 PPP1CC, protein phosphatase 1, GATCTTATAT[G/T]TAGAGCCCAT M G T C F catalytic subunit, gamma isoform G630a1 WIAF-12103 HT5086 704 protein phosphatase 2A, 130 kDa AAAGATGCAG[A/G]TCTGAACTCT M A G D G regulatory subunit G630a2 WIAF-12106 HT5086 1015 protein phosphatase 2A, 130 kDa CGATGGGAAC[G/T]CCCCATCCTT M G T A S regulatory subunit G630a3 WIAF-12107 HT5086 1024 protein phosphatase 2A, 130 kDa CGCCCCATCC[T/c]TTGGTTTACT M T c F L regulatory subunit G630a4 WIAF-12108 HT5086 837 protein phosphatase 2A, 130 kDa ACTTAAAGGA[T/C]ATTGCAGGAG S T C D D regulatory subunit G630u5 WIAF-12325 HT5086 1200 protein phosphatase 2A, 130 kDa TAAAGATGTG[C/T]TTGGACATCT S C T C C regulatory subunit G630u6 WIAF-12326 HT5086 2810 protein phosphatase 2A, 130 kDa ATGTTCAGGG[C/T]TGCAGGGGGA M C T A V regulatory subunit G630u7 WIAF-12351 HT5086 512 protein phosphatase 2A, 130 kAa ATTATGGCAG[C/T]AACTTACAGA M C T A V regulatory subunit G630u8 WIAF-12352 HT5086 703 protein phosphatase 2A, 130 kDa CAAAGATGCA[G/A]ATCTGAACTC M G A D N regulatory subunit G630u9 WIAF-12353 HT5086 1069 protein phosphatase 2A, 130 kDa ACCTTTGTCT[C/T]ATAGAAACTC M C T H Y regulatory subunit G634u1 WIAF-11825 X04434 2283 IGF1R, insulin-like growth factor TGCAAGTGGC[C/T]AACACCACCA S C T A A 1 receptor G634u2 WIAF-11826 X04434 2279 IGF1R, insulin-like growth factor GTCATGCAAG[T/C]GGCCAACACC M T C V A 1 receptor G634u3 WIAF-11781 X04434 1731 IGF1R, insulin-like growth factor ACAAGGACGT[G/A]GAGCCCGGCA S G A V V 1 receptor G634a4 WIAF-13106 X04434 948 IGF1R, insulin-like growth factor TCCACGACGG[C/A]GAGTGCATGC S C A G G 1 receptor G634a5 WIAF-13107 X04434 1089 IGF1R, insulin-like growth factor CTTCTGCTCA[G/C]ATGCTCCAAG M G C Q H 1 receptor G634a6 WIAF-13108 X04434 2539 IGF1R, insulin-like growth factor AGAAGGAGCA[G/A]ATGACATTCC M G A D N 1 receptor G634a7 WIAF-13109 X04434 2606 IGF1R, insulin-like growth factor AAGTGGCCGG[A/C]ACCTGAGAAT M A C E A 1 receptor G634a8 WIAF-13113 X04434 1543 IGF1R, insulin-like growth factor CTCCACCACC[A/T]CGTCGAAGAA M A T T S 1 receptor G634a9 WIAF-13112 X04434 1549 IGF1R, iusulin-like growth factor CACCACGTCG[A/G]AGAATCGCAT M A G K E 1 receptor G634a10 WIAF-13113 X04434 1596 IGF1R, insulin-like growth factor CCCCTGACTA[C/T]AGGGATCTCA S C T Y Y 1 receptor G645u1 WIAF-12332 HT5191 1127 retinoic acid-binding protein II TCTGCAGACT[C/T]TTCAGGAGAG M C T L F G645u2 WIAF-12333 HT5191 1048 retinoic acid-binding protein II AAGCATTAGA[G/A]GCCTTACAGA S G A R E G646u1 WIAF-12303 X81479 1204 EMR1, egf-like module containing, CAAATATCCA[T/C]GTGGACTAAA M T C M T mucin-like, hormone receptor-like sequence 1 G646u2 WIAF-12304 X81479 1919 EMR1, egf-like module containing, TTCTGCTGTG[T/G]CGCTCCATCC M T G C W mucin-like, hormone receptor-like sequence 1 G646u3 WIAF-12316 X81479 590 EMR1, egf-like module containing, CTTGCCCAGA[G/T]CATGCAACTT M G T E D mucin-like, hormone receptor-like sequence 1 G646u4 WIAF-12317 X81479 799 EMR1, egf-like module containing, GCACCAAGCA[G/A]TGGACAGTTG M G A S N mucin-like, hormone receptor-like sequence 1 G646u5 WIAF-12318 X81479 558 EMR1, egf-like module containing, TGAAGACGTG[A/G]ATGAATGTGC M A G N D mucin-like, hormone receptor-like sequence 1 G646u6 WIAF-12334 X81479 207 EMR1, egf-like module containing, TTACTATTGC[A/G]CTTGCAAACA M A G T A mucin-like, hormone receptor-like sequence 1 G646u7 WIAF-12335 X81479 458 EMR1, egf-like module containing, TCACCAGCAG[G/C]GTCTGCCCTG M G C R S mucin-like, hormone receptor-like sequence 1 G646u8 WIAF-12336 X81479 1308 EMR1, egf-like module containing, CTCAGCAAAT[G/A]TCACTCCGGC M G A V I mucin-like, hormone receptor-like sequence 1 G646u9 WIAF-12337 X81479 1285 EMR1, egf-like module containing, ACACTGGCAT[C/T]TTTTTGGAAA M C T S F mucin-like, hormone receptor-like sequence 1 G646u10 WIAF-12338 X81479 2026 EMR1, egf-like module containing, GACAACAAGA[C/T]GGGCTGCGCC M C T T M mucin-like, hormone receptor-like sequence 1 G647u1 WIAF-12339 HTS190 174 RARA, retinoic acid receptor, TGCCTCCCTA[C/T]GCCTTCTTCT S C T Y Y alpha G648a1 WIAF-13332 HT0070 469 retinoic acid receptor, beta AACGTGAGCC[A/G]GGAGCAGCGT — A G — — G648a2 WIAF-13333 HT0070 532 retinoic acid receptor, beta ATTGTTTTTA[A/G]GGTGAGAAAT — A G — — G650u1 WIAF-12323 X52773 862 RXRA, retinoid X receptor, alpha CTCGCCGAAC[G/A]ACCCTGTCAC M G A D N G650u2 WIAF-12341 X52773 102 RXRA, retinoid X receptor, alpha TCCTGCCGCT[C/T]GATTTCTCCA S C T L L G650u3 WIAF-12348 X52773 673 RXRA, retinoid X receptor, alpha GGCCATGGGC[A/G]TGAAGCGGGA M A G M V G650u4 WIAF-12349 X52773 902 RXRA, retinoid X receptor, alpha GAGAAACAGC[T/C]TTTCACCCTG N T C L P G653a1 WIAF-13326 HT1458 439 RARB, retinoic acid receptor, AGGAGAAAGC[T/C]CTGAAAGCAT S T C A A beta G655a1 WIAF-13327 J0S252 1158 PCSK2, proprotain convertase CCTTCAGCAA[C/T]GGGAGGAAAA S C T N N subtilisin/kexin type 2 G655a2 WIAF-13334 J05252 678 PCSK2, proprotein convertase CCTATCCTTA[C/A]CCTCGGTACA N C A Y * subtilisin/kexin type 2 G655a3 WIAF-13335 J05252 744 PCSK2, proprotein convertase TTTCTGCTGC[C/T]GCCAACAACA S C T A A subtilisin/kexin type 2 G658u1 WIAF-11856 J02943 971 CBG, corticosteroid binding TCTATGACCT[T/C]GGAGATGTGC S T C L L globulin G658u2 WIAF-13407 J02943 771 CRG, corticosteroid binding CCTTCATGAC[T/G]CAGAGCTCCC M T G S A globulin G658u3 WIAF-13408 J02943 773 CBG, corticosteroid binding TTCATGACTC[A/G]GAGCTCCCCT S A G S S globulin G658u4 WIAF-13409 J02943 1046 CSG, corticosteroid binding TCACCCAGGA[C/T]GCCCAGCTGA S C T D D globulin G663u1 WIAF-13400 WT3157 1202 TPO, thyroid peroxidase CGCCACGCGC[G/A]CCTGCGGCCT S G A A A G663u2 WIAF-13401 HT3157 1282 TPO, thyroid peroxidase GGCCGCGCCA[G/C]CGAGGTCCCC M G C S T G668a1 WIAF-13350 U53506 350 D102, deiodinase, iodothyronine, TCGATGCCTA[C/A]AAACAGGTGA N C A Y * type II G668a2 WIAF-13351 U53506 354 D102, deiodinase, iodothyronine, TGCCTACAAA[C/A]AGGTGAAATT M C A Q K type II G668a3 WIAF-13352 U53506 408 D102, deiodinase, iodothyronine, TGTCTCCAGT[A/G]CAGAAGGAGG M A G T A type II G673a1 WIAF-13328 M57464 1723 Human ret proto-oncogene mRNA for CGAGCCTGGG[G/A]AGCCCCGGGG M G A E K tyrosine kinase. G673a2 WIAF-13336 M57464 1186 Human ret proto-oncogene mRNA for GGCTCGCCGA[T/A]TTGCCCAGAT M T A F I tyrosine kinase. G673a3 WIAF-13337 MS7464 3227 Human ret proto-oncogene rnRNA for ACTGCCAGGC[G/A]TTCAGTGGCA S G A A A tyrosine kinase. G673a4 WIAF-13338 M57464 2118 Human ret proto-oncogene mRNA for TTGGAAAAAC[T/A]CTAGGAGAAG S T A T T tyrosine kinase. G673a5 WIAF-13339 M57464 2238 Human ret proto-oncogene mRNA for CGAGTGAGCT[T/G]CGAGACCTGC S T G L L tyrosine kinase. G678u1 WIAF-13353 D49492 1439 GDF10, growth differentiation TCGGCTGGAA[T/A]GAATGGATAA M T A N K factor 10 G68u1 WIAF-10434 HT1115 1214 ERCC3, excision repair cross- CTGTGGAGCA[G/A]TGGAAAGCCC S G A Q Q complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) G68u2 WIAF-10435 HT1115 1155 ERCC3, excision repair cross- TGTGACTGCT[G/C]CATGCACTGT M G C A P complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) G68u3 WIAF-10436 HT1115 1327 ERCC3, excision repair cross- AGCACCTACT[C/T]CATGCTGGGC M C T S F complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) G68u4 WIAF-10461 HT1115 926 ERCC3, excision repair cross- AGGAAATGAT[T/C]GAGGAACTCC S T C I I complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) G68u5 WIAF-10464 HT1115 1430 ERCC3, excision repair cross- AAGTGCACAC[C/T]ATACCAGCCA S C T T T complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) G684a1 WIAF-13359 X51801 712 BMP7, bone morphogenetic protein GTTTATCAGG[T/G]GCTCCAGGAG M T G V G 7 (osteogenic protein 1) G684a2 WIAF-13360 X51801 719 BMP7, bone morphogenetic protein AGGTGCTCCA[G/A]GAGCACTTGG S G A Q Q 7 (osteogenic protein 1) G68a3 WIAF-13361 X51801 796 BMP7, bone morphogenetic protein GGCTGGCTGG[T/G]GTTTGACATC M T G V G 7 (osteogenic protein 1) G684a4 WIAF-13362 X51801 862 BMP7, bone morphogenetic protein GGCCTGCAGC[T/G]CTCGGTGGAG M T G L R 7 (osteogenic protein 1) G684a5 WIAF-13363 X51801 658 BMP7, bone morphogenetic protein ATCTACAAGG[A/G]CTACATCCGG M A G D G 7 (osteogenic protein 1) G684u6 WIAF-13834 X51801 1421 BMP7, bone morphogenetic protein GCCACTAGCT[C/T]CTCCGAGAAT — C T — — 7 (osteogenic protein 1) G685a1 WIAF-13329 DB9675 862 BMPR1B, bone morphogenetic GTTCCCTTTA[T/G]GATTATCTGA N T G Y * protein receptor, type IB G685a2 WIAF-13330 D89675 920 BMPR1B, bone morphogenetic GCTAAATCAA[T/C]GCTGAAGTTA M T C M T protein receptor, type IB G6B5a3 WIAF-13331 D89675 770 BMPR1B, bone morphogenetic TATCAGACAG[T/G]GTTGATGAGG M T G V G protein receptor, type IB G685a4 WIAF-13340 D89675 1303 BMPR1B, bone morphogenetic TCCTTATCAT[G/A]ACCTAGTGCC M G A D N protein receptor, type IB G685a5 WIAF-13341 D89675 1372 BMPR1B, bone morphogenetic GTTACGCCCC[T/G]CATTCCCAAA M T G S A protein receptor, type IB G665a6 WIAF-13342 D89675 1173 BMPR1B, bone morphogenetic TGTTGGACGA[G/A]AGCTTGAACA S G A E E protein receptor, type IB G6B6u1 WIAF-13816 Z48923 2705 BMPR2, bone morphogenetic protein AAATTTGGCA[G/A]CAAGCACAAA N G A S N receptor, type II (serine/threonine kinase) G686u2 WIAF-13817 Z48923 2749 BMPR2, bone morphogenetic protein TGGAGTTGCC[A/T]AGATGAATAC N A T K * receptor, type II (serine/threonine kinase) G687a1 WIAF-13343 MT1455 626 CALB1, calbindin 1, (28 kD) ATGATCAGGA[C/T]GGCAATGGAT S C T D D G696u1 WIAF-11839 HT27700 1075 calcium-sensing receptor GGGCACAATT[G/C]CAGCTGATGA M G C A P G696u2 WIAF-11840 HT27700 1551 calcium-sensing receptor TACCTGTGGA[C/T]ACCTTTCTGA S C T D D G696u3 WIAF-11841 HT27700 1688 calcium-sensing receptor TTACGGATAT[C/T]CTACAATGTG M C T S F G696u4 WIAF-11842 HT27700 1698 calcium-sensing receptor CCTACAATGT[G/T]TACTTAGCAG S G T V V G696u5 WIAF-11858 MT27700 1767 calcium-sensing receptor GGAGAGGGCT[C/T]TTCACCAATG S C T L L G696u6 WIAF-11859 HT27700 1689 calcium-sensing receptor TACGGATATC[C/T]TACAATGTGT S C T G S G696u7 WIAF-11860 MT27700 2541 calciun-sensing receptor TCGTGCTCTG[C/T]ATCTCATGCA S T T C C G696u8 WIAF-11861 HT27700 2581 calcium-sensing receptor TGTCCTCCTG[G/A]TGTTTGAGGC M G A V M G696u9 WIAF-11863 HT27700 3159 calcium-sensing receptor TCTCCCGCAA[G/C]CGGTCCAGCA M G C K N G696u10 WIAF-11872 HT27700 562 calcium-sensing receptor TCCTATTCAT[T/A]TTGGAGTAGC M T A F I G696u11 WIAF-11878 HT27700 2941 calcium-sensing receptor CATTCCAGCC[T/G]ATGCCAGCAC M T G Y D G696u12 WIAF-13396 HT27700 1145 calcium-sensing receptor AGGGATATCT[G/A]CATCGACTTC M G A C Y G696u13 WIAF-13395 HT27700 670 calcium-sensing receptor GATATTTGCC[A/G]TAGAGGAGAT M A G I V G696u14 WIAF-13396 HT27700 2243 calcium-sensing receptor TTCTGGTCCA[A/G]TGAGAACCAC M A G H S G696u15 WIAF-13397 HT27700 2742 calcium-sensing receptor AGCTGGAGGA[T/C]GAGATCATCT S T C D D G698u1 WIAF-13547 X61598 393 CBP1, collagen-binding protein 1 TCAGCAACTC[G/C]ACGGCGCGCA S G C S S G698u2 WIAF-13549 X61598 628 CBP1, collagen-binding protein 1 CGGCGCCCTG[C/T]TAGTCAACGC S C T L L G698u3 WIAF-13550 X61598 1230 CBP1, collagen-binding protein 1 GCGGCTCCCT [G/A]CTATTCATTG S G A L L G701u1 WIAF-12382 HT27657 706 CGRP tyos I receptor AACGATGTTG[C/A]AGCAGGAACT M C A A E G701u2 WIAF-12391 HT27657 841 CGRP type I receptor TGGACAAATT[A/T]TACCCAGTGT M A T Y F G704u1 WIAF-14046 X60382 1396 COL10A1, collagen, type X, alpha AGGCATTCCA[G/A]GATTCCCTGG M G A G R 1 (Schmid metaphyseal chondrodysplasia) G704u2 WIAF-14070 X60382 1648 COL10A1, collagen, type X, alpha TGCCAACCAG[G/C]GGGTAACAGG M G C G R 1 (Schmid metaphyseal chondrodysplasia) G704u2 WIAF-14070 X60382 1648 COL10A1, collagen, type X, alpha CATACCACGT[G/C]CATGTGAAAG S G C V V 1 (Schmid metaphyseal chondrodysplasia) G704u3 WIAF-14071 X60382 1824 COL10A1, collagen, type X, alpha CATACCACGT[G/C]CATGTGAAAG S G C V V 1 (Schmid metaphyseal chondrodysplasia) G704u4 WIAF-14072 X60382 1582 COL10A1, collagen, type X, alpha AGTCATGCCT[G/C]AGGGTTTTAT M G C E Q 1 (Schmid metaphyseal chondrodysplasia) G705a1 WIAF-13228 J04177 686 COL11A1, collagen, type XI, alpha AGAAGAAAAC[T/A]GTGACAATGA S T A T T 1 G705e2 WIAF-13229 J04177 698 COL11A1, collagen, type XI, alpha TGACAATGAT[T/A]GTTGATTGTA S T A I I 1 G705a3 WIAF-13230 J04177 888 COL11A1, collagen, type XI, alpha TAGTCCAGAC[T/A]GTGACTCTTC M T A C S 1 G705a4 WIAF-13231 J04177 894 COL11A1, collagen, type XI, alpha AGACTGTGAC[T/A]CTTCAGCACC H T A S T 1 G705a5 WIAF-13232 J04177 651 COL11A1, collagen, type XI, alpha TGACCGGAAG[T/A]GGCATCGGGT M T A W R 1 G705a6 WIAF-13233 J04177 661 COL11A1, collagen, type XI, alpha TGGCATCGGG[T/A]AGCAATCAGC M T A V E 1 G705a7 WIAF-13234 J04177 1597 COL11A1, collagen, type XI, alpha CGTCCTGGCT[T/C]ACCAGGGGCT M T C L S 1 G705a8 WIAF-13235 J04177 2745 COL11A1, collagen, type XI, alpha TGGGTTTCCA[G/A]GTGCCAATGG M G A G S 1 G705a9 WIAF-13236 J04177 4385 COL11A1, collagen, type XI, alpha GTCCAGAAGG[T/A]CTTCGGGGCA S T A G G 1 G705a10 WIAF-13237 J04177 4576 COL11A1, collagen, type XI, alpha GAAAAAGGTG[A/T]CCGAGGGCTC M A T D V 1 G705a11 WIAF-13238 J04177 4306 COL11A1, collagen, type XI, alpha GCTAAGGGGG[A/C]AGGAGGTGCA M A C E A 1 G705a12 WIAF-13239 J04177 4837 COL11A1, collagen, type XI, alpha AGACATACTG[A/G]AGGCATGCAA M A G E G 1 G705a13 WIAF-13240 J04177 4931 COL11A1, collagen, type XI, alpha AACAAGACAT[C/T]GAGCATATGA S C T I I 1 G705e14 WIAF-13346 J04177 299 COL11A1, collagen, type XI, alpha AAGCACTAGA[T/G]TTTCACAATT M T G D E 1 G705a15 WIAF-13347 J04177 2225 COL11A1, collagen, type XI, alpha GGGAGCCTGG[G/C]CCTCCAGGTC S G C G G 1 G705u16 WIAF-13679 J04177 5493 COL11A1, collagen, type XI, alpha AATTGATCAA[G/A]TACCTATTGT M G A V I 1 G705u17 WIAF-13700 J04177 3484 COL11A1, collagen, type XI, alpha GGAGTTCAAG[G/A]TCCTGTTGGT M G A G D 1 G705u18 WIAF-13709 J04177 5392 COL11A1, collagen, type XI, alpha GAGATGTCCT[A/T]TGACAATAAT M A T Y F 1 G707u1 WIAF-12363 U32169 4996 COL11A2, collagen, type XI, alpha TCCCCTGAGA[C/T]TCCGTGGGGC M C T L F 2 G707u2 WIAF-12374 U32169 3580 COL11A2, collagen, type XI, alpha CAATGGCGCT[G/A]ATGGCCCACA M G A D N 2 G707u3 WIAF-12385 U32169 2059 COL11A2, collagen, type XI, alpha GCCTGGCTCA[G/A]ACGGACCCCC M G A D N 2 G708a1 WIAF-13354 U73778 1885 COL12A1, collagen, type XII, GCCTCTCCTC[C/T]TGCAGAGACC M C T P L alpha 1 G708a2 WIAF-13355 U73778 3630 COL12A1, collagen, type XII, TGTTGGACAA[G/A]AAATGACAAC M G A E K alpha 1 G708a3 WIAF-13356 U73778 3905 COL12A1, collagen, type XII, GCTTGTTGCA[A/T]GCTGTGGCAA M A T Q H alpha 1 G708a4 WIAF-13357 U73778 7051 COL12A1, collagen, type XII, ATTCCACCAG[C/A]CCGGGATGTA M C A A D alpha 1 G708a5 WIAF-13358 U73778 8036 COL12A1, collagen, type XII, IAAGAAGTAAA[G/A]ACATTATTTT S G A K K alpha 1 G708a6 WIAF-13364 U73778 1461 COL12A1, collagen, type XII, TGGCTCCTAT[A/T]GCATTGGGAT M A T S C alpha 1 G708a7 WIAF-13365 U73778 2344 COL12A1, collagen, type XII, ATTACTTGGA[C/T]TCAAGCTCCA M C T T I alpha 1 G708a8 WIAF-13366 U73778 5207 COL12A1, collagen, type XII, CAGATAAGAT[G/A]GAGACCATCT M G A M I alpha 1 G708a9 WIAF-13367 U73778 6592 COL12A1, collagen, type XII, GAGCCCATGG[A/T]AGCCTTTGTT M A T E V alpha 1 G708a10 WIAF-13368 U73778 7434 COL12A1, collagen, type XII, CCAGGATGAG[G/A]TCAAGAAGGC M G A V I alpha 1 G708a11 WIAF-13369 U73778 9108 COL12A1, collagen, type XII, ACCTCGGGGG[C/G]TGCCTGGGCC M C G L V alpha 1 G708a12 WIAF-13370 U73778 9111 COL12A1, collagen, type XII, TCGGGGGCTG[C/T]CTGGGCCCCC M C T P S G708a13 WIAF-13371 U73778 9196 COL12A1, collagen, type XII, CCCCCTGGCC[G/A]TCCTGAAAC M G A I H alpha 1 G708u14 WIAF-13972 U73778 3044 COL12A1, collagen, type XII, CAGTATTTGC[C/A]ACTTACAGCA S C A A A alpha 1 G708U15 WIAF-13977 U73778 5853 COL12A1, collagen, type XII, TGTGACTGTA[G/C]TTCCCGTTTA M G C V L alpha 1 G710u1 WIAF-12371 D38163 3082 COL19A1, collagen, type XIX, AGGAAACAAG[G/T]GCTCCATGGG M G T G C alpha 1 G710u2 WIAF-12388 D38163 2889 COL19A1, collagen, type XIX, TCCAGGGACT[C/T]CAGGGAATGA M C T P S alpha 1 G711u1 WIAF-12360 L25286 1449 COL15A1, collagen, type XV, alpha TGTGGGTCCA[A/G]GCAGTGAAGA M A G S G 1 G711u2 WIAF-12372 L25286 4001 COL15A1, collagen, type XV, alpha ATATTCCAAT[A/G]TACTCCTTTG M A G I M 1 G711u3 WIAF-12373 L25286 3867 COL15A1, collagen, type XV, alpha CCATTTGCAA[G/T]ATCTGTCCAC M G T D Y 1 G711a4 WIAF-13372 L25286 395 COL15A1, collagen, type XV, alpha CCAGCAGCAC[C/T]CGTGGTGGCG S C T T T 1 G711a5 WIAF-13373 L25286 3101 COL15A1, collagen, type XV, alpha AAGGCGACCA[G/A]GGAGCCCAGG S G A Q Q 1 G712u1 WIAF-13619 M92642 3608 COL16A1, collagon, type XVI, GGCGACCAGG[G/A]ATTTCGGC M G A G B alpha 1 G712u2 WIAF-13620 M92642 4944 COL16A1, collagon, type XVI, CCATGAAAAC[C/T]ATGAAGGGGC S C T T T alpha 1 G712u3 WIAF-13621 M92642 4707 COL16A1, collagon, type XVI, CCAAAGGTGA[A/C]AAAGGGGACA M A C E D alpha 1 G712u4 WIAF-13654 M92642 421 COL16A1, collagon, type XVI, GCCCACGCGA[C/A]GAGTATTCCC S C A R R alpha 1 G712u5 WIAF-13655 M92642 444 COL16A1, collagon, type XVI, GGGGTCTCCC[G/A]GAGGAGTTTG S G A P P alpha 1 G712u6 WIAF-13656 N92642 338 COL16A1, collagon, type XVI, CTCATGAAGA[A/C]GTCTGCCATC M A C K T alpha 1 G712u7 WIAF-13862 N92542 3227 COL16A1, collagon, type XVI, CCTGGTCCTC[C/T]GGGATTGCCA M C T P L alpha 1 G712u8 WIAF-13863 M92642 3199 COL16A1, collagon, type XVI, TCCTGGCTGT[G/T]TTTGGAGCCC N G T V F alpha 1 G712u9 WIAF-13678 N92642 318 COL16A1, collagon, type XVI, ACCTCATCCA[C/T]CGACTCAGCC S C T H H alpha 1 G712u10 WIAF-13882 M92642 1346 COL16A1, collagon, type XVI, ACAGGCGAGA[A/G]GGGCCAGAAA N A G K R alpha 1 G712u11 WIAF-13883 N92642 1309 COL16A1, collagon, type XVI, GTCAGGAGCT[C/T]GGGGACCCTC S C T L L alpha 1 G715a1 WIAF-13344 Z74615 3504 COL1A1, collagen, type I, alpha 1 TCCTGGTGAA[C/G]AAGGTCCCTC M C G Q E G717u1 WIAF-12639 Z74616 3988 COL1A2, collagen, type I, alpha 2 ATGAGGAGAC[T/C]GGCAACCTGA S T C T T G720u1 WIAF-12367 X14420 3494 COL3A1, collagen, type III, alpha GGTGCAATCG[G/A]CAGTCCAGGA M G A G D 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) G720u2 WIAF-12383 X14420 3035 COL3A1, collagen, type III, alpha GGTGTCAAGG[G/A]TGAAAGTGGG N G A G D 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) G720a3 WIAF-13374 X14420 214 COL3A1, collagen, type III, alpha TCTTGGTCAG[T/C]CCTATGCGGA M T C S P 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) G720a4 WIAF-13376 X14420 1953 COL3A1, collagen, type III, alpha CTGGACCTCA[A/G]GGACCCCCAG S A G Q Q 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) G720a5 WIAF-13376 X14420 2194 COL3A1, collagen, type III, alpha TAGAGGTGGA[G/A]CTGGTCCCCC M G A A T 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) G720a6 WIAF-13377 X14420 3731 COL3A1, collagen, type III, alpha GGGATTGGAG[G/A]TGAAAAAGCT M G A G D 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) G722u1 WIAF-14132 HT3162 140 COL4A2, collagen, type IV, alpha GAGATTGGCG[C/T]GACTGGTGAT M C T A V 2 G724a1 WIAF-12120 X81053 3892 COL4A4, collagen, type IV, alpha CTCGTGGAAA[G/A]AAAGGTCCCC S G A K K 4 G724a2 WIAF-12121 X81053 4187 COL4A4, collagen, type IV, alpha GAAAGGACCA[A/G]TGGGATTCCC M A G M V 4 G724a3 WIAF-12122 X81053 3802 COL4A4, collagen, type IV, alpha ATGATGTGGG[G/A]CCACCTGGTC S G A G G 4 G724a4 WIAF-12123 X81053 1838 COL4A4, collagen, type IV, alpha ACCAGGAAAG[C/A]ATGGTGCCTC M C A H N 4 G724u5 WIAF-12364 X81053 376 COL4A4, collagen, type IV, alpha CTGTTTGCCA[C/T]TGTGTTCCTG S C T H H 4 G724u6 WIAF-12365 X81053 2018 COL4A4, collagen, type IV, alpha TCCAGGGGAT[C/G]ATGAAGATGC M C G H D 4 G724u7 WIAF-12366 X81053 4756 COL4A4, collagen, type IV, alpha GCCTTCCCGT[A/G]TTTAGCACGC S A G V V 4 G724u8 WIAF-12377 X81053 3595 COL4A4, collagen, type IV, alpha CTGGACCACC[A/G]GGGTGCCCAG S A G P P 4 G724u9 WIAF-12378 X81053 3516 COL4A4, collagen, type IV, alpha GGAGCATCCG[G/C]AGAGCAGGGC M G C G A 4 G724u10 WIAF-12379 X81053 4288 COL4A4, collagen, type IV, alpha CTGGTCTTCC[A/G]GGTCCCAGAG S A G P P 4 G724u11 WIAF-12380 X81053 5140 COL4A4, collagen, type IV, alpha GCCACTTTTT[C/A]GCAAATAAGT M C A F L 4 G724u12 WIAF-12387 X81053 207 COL4A4, collagen, type IV, alpha GACTTGCCTG[C/T]GATGTGGTCT — C T — — 4 G727u1 WIAF-12362 D90279 5135 COL5A1, collagen, type V, alpha 1 TTCAAGGTTT[A/T]CTGCAACTTC M A T Y F G727u2 WIAF-12369 D90279 4686 COL5A1, collagen, type V, alpha 1 AACAGGGTAT[C/T]ACTGGTCCTT S C T I I G727u3 WIAF-12370 D90279 4608 COL5A1, collagen, type V, alpha 1 TCGGTCCTCC[G/C]GGTGAACAGG S G C P P G727a4 WIAF-13300 D90279 2034 COL5A1, collagen, type V, alpha 1 ACGGCCTGGC[T/A]GGGTTGCCAG S T A A A G727a5 WIAF-13301 D90279 2073 COL5A1, collagen, type V, alpha 1 GTGACCCTGG[T/C]CCTTCCGGCC S T C G G G727a6 WIAF-13302 D98279 3763 COL5A1, collagen, type V, alpha 1 CGGGCAGAAA[G/A]GTGATGAAGG M G A G S G729u1 WIAF-11844 L02870 2345 COL7A1, collagen, type VII, alpha ATGGACTGGA[G/A]CCAGATACTG S G A E E 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u2 WIAF-11845 L02870 3083 COL7A1, collagen, type VII, alpha TATCCTGGCG[G/A]CCACTCAGAG S G A R R 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u3 WIAF-11846 L02870 3031 COL7A1, collagen, type VII, alpha GACTCGGTGA[C/T]TTTGGCCTGG N C T T I 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u4 WIAF-11851 L02870 1289 COL7A1, collagen, type VII, alpha CGGACTATGA[G/T]GTGACCGTGA W G T E D 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u5 WIAF-11852 L02870 1032 COL7A1, collagen, type VII, alpha CCAAGTGACT[G/T]TGATTGCCCT N G T V L 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u6 WIAF-11853 L02570 1897 COL7A1, collagen, type VII, alpha CGCCGGGAGC[C/T]GGAAACTCCA M C T P L 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u7 WIAF-11854 L02870 1827 COL7A1, collagen, type VII, alpha GCTTAGCTAC[A/T]CTGTGCGGGT M A T T G 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u8 WIAF-11855 L02870 1893 COL7A1, collagen, type VII, alpha TGTCCGCCGG[G/A]AGCCGGAAAC M G A E K 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u9 WIAF-11864 L02870 2142 COL7A1, collagen, type VII, alpha GGGCCCTGCT[G/A]CAGTCATCGT M G A A T 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u10 WIAF-11865 L02870 2353 COL7A1, collagen, type VII, alpha GAGCCAGATA[C/T]TGAGTATACG M C T T I 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u11 WIAF-11866 L02870 2221 COL7A1, collagen, type VII, alpha TCATCTGTCA[C/T]CATTACCTGG M C T T I 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u12 WIAF-11869 L02870 6585 COL7A1, collagen, type VII, alpha ACCAGGAGAG[C/T]GTGGTATGGC M C T R C 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u13 WIAF-11870 L02870 8169 COL7A1, collagen, type VII, alpha GGGTGACCGA[G/T]GCTTTGACGG M G T G C 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u14 WIAF-11877 L02870 438 COL7A1, collagen, type VII, alpha CGCCATCCGT[G/A]AGCTTAGCTA M G A E K 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u15 WIAF-11882 L02870 3481 COL7A1, collagen, type VII, alpha AGGATCCGTG[A/T]CATGCCCTAC M A T D V 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u16 WIAF-11883 L02870 5654 COL7A1, collagen, type VII, alpha ACGGAGAACC[T/C]CGGGACCCTG S T C P P 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u17 WIAF-12884 L02670 7124 COL7A1, collagen, type VII, alpha TGCCAGGGCC[G/C]CGAGGCGAGA S G C P P 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u18 WIAF-11885 L02870 7757 COL7A1, collagen, type VII, alpha GCTTGGATGG[T/C]GACAAAGGAC S T C G G 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u19 WIAF-13389 L02870 1615 COL7A1, collagen, type VII, alpha ACCGTGGTTC[C/T]CACTGTACCA M C T P L 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u20 WIAF-13390 L02870 2930 COL7A1, collagen, type VII, alpha TCCTAGGGCC[G/A]GCTGGAGAAG S G A P P 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u21 WIAF-13399 L02870 5145 COL7A1, collagen, type VII, alpha CCACGGAGAT[C/T]CTGGAGAGGA M C T P S 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G729u22 WIAF-13411 L02870 3472 COL7A1, collagen, type VII, alpha ATCTTGCAAA[G/A]GATCCGTGAC M G A R K 1 (epidermolysis bullosa, dystrophic, dominant and recessive) G730a1 WIAF-13303 X57527 305 COL8A1, collagen, type VIII, ATGGGCAAGG[A/G]AGCCGTTCCC M A G E G alpha 1 G732u1 WIAF-12616 M95610 936 COL9A2, collagen, type IX, alpha CAGGCGGGAC[A/G]GCCCGGAAGT S A G T T 2 G732u2 WIAF-12617 M95610 696 COL9A2, collagen, type IX, alpha AAGGGAGAGA[C/T]GGGCCCTCAT S C T D D 2 G732u3 WIAF-12619 M95610 1288 COL9A2, collagen, type IX, alpha AAGTGGGTGA[C/T]CCAGGGGTGG M C T P S 2 G732u4 WIAF-12620 M95610 962 COL9A2, collagen, type IX, alpha CCACCAGGGC[C/G]TAGCGGGTGT M C G P R 2 G737u1 WIAF-13394 M13436 ? INHBA, inhibin, beta A (activin TGCTCCCTG[G/T] ? G T A, activin AB alpha polypeptide) G738a1 WIAF-13383 M58549 183 MGP, matrix Gla protein ATGGAGAGCT[A/G]AAGTCCAAGA M A G K E G738a2 WIAF-13384 M58549 330 MGP, matrix Gla protein GCGCCGAGGG[A/G]CCAAATGAGA M A G T A G739u1 WIAF-11867 U94332 862 TNFRSF11B, tumor necrosis factor TGCTGAAGTT[A/G]TGGAAACATC S A G L L receptor superfamily, member 11b (osteoprotagerin) G739u2 WIAF-11874 U94332 1244 TNFRSF11B, tumor necrosis factor GTATCAGAAG[T/C]TATTTTTAGA S T C L L receptor superfamily, member 11b (osteoprotagerin) G743u1 WIAF-13402 HT847 1669 PTHR1, parathyroid hormone CCCTGGAGAC[C/A]CTCGAGACCA S C A T T receptor 1 G747u1 WIAF-12414 J03040 123 SPARC, secreted protein, acidic, CTCAGCAAGA[A/G]GCCCTGCCTG S A G E E cysteine-rich (osteonectin) G748u1 WIAF-12628 HT0157 117 VDR, vitamin D (1,25- CCTTCAGGGA[T/C]GGAGGCAATG M T C M T dihydroxyvitamin D3) receptor G748u2 WIAF-12629 HT0157 1171 VDR, vitamin D (1,25- CCGCGCGGAT[T/C]GAGGCCATCC S T C I I dihydroxyvitamin D3) receptor G748u3 WIAF-12640 HT0157 172 VDR, vitamin D (1,25- TTGACCGGAA[C/T]GTGCCCCGGA S C T W N dihydroxyvitamin D3) receptor G749u1 WIAF-11862 HT3734 679 osteopontin, alt. transcript 1 ATCACCTCAC[A/T]CATGGAAAGC M A T H L G749u2 WIAF-11875 HT3734 386 osteopontin, alt. transcript 1 AAGATGATGA[A/G]GACCATGTGG S A G D D G749u3 WIAF-11876 HT3734 419 osteopontin, alt. transcript 1 CCATTGACTC[G/A]AACGACTCTG S G A S S G749a4 WIAF-12084 HT3734 1711 osteopontin, alt. tranecript 1 TAAACAGGCT[G/A]ATTCTGGAAG M G A D N G749u5 WIAF-13387 HT3734 738 osteopontin, alt. transcript 1 CCAGGACCTG[A/C]ACGCGCCTTC M A C N H G749u6 WIAF-13388 HT3734 716 osteopontin, alt. transcript 1 CATACAAGGC[C/A]ATCCCCGTTG S C A A A G751u1 WIAF-12631 HT5036 410 ADM, adrenomedullin GACAGCAGTC[C/G]GGATGCCGCC M C G P R G752u1 WIAF-11843 HT1782 1405 CHGA, chromogranin A (parathyroid CGGCCATTGA[A/G]CGAGAGCTGG S A G E E secretory protein 1) G752u2 WIAF-11873 HT1782 1187 CHGA, chromogranin A (parathyroid GGACAACCGG[G/A]ACAGTTCCAT M G A D N secretory protein 1) G754u1 WIAF-13382 K02043 663 NPPA, natriuretic peptide GTACAATGCC[G/A]TGTCCAACGC M G A V M precursor A G756u1 WIAF-12395 HT3508 2086 SCNN1A, sodium channel, CAGTTCCTCC[A/G]CCTGTCCTCT M A G T A nonvoltage-gated 1 alpha G757u1 WIAF-12420 HT28563 797 SCNN1B, sodium channel, CCTGCAGGCC[A/C]CCAACATCTT M A C T P nonvoltage-gated 1, beta (Liddle syndrome) G757u2 WIAF-12421 HT28563 1006 SCNN1B, sodium channel, GAACTGAATT[C/T]GGCCTGAAGT S C T F F nonvoltage-gated 1, beta (Liddle syndrome) G757u3 WIAF-12430 HT28563 1768 SCNN1B, sodium channel, TCATCGACTT[T/C]GTGTGGATCA S T C F F nonvoltage-gated 1, beta (Liddle syndrome) G757u4 WIAF-12494 HT28563 662 SCNN1B, sodium channel, AAGCAGCTCA[G/C]CATCAGAAAA M G C A P nonvoltage-gated 1, beta (Liddle syndrome) G757u5 WIAF-12506 HT28563 1091 SCNN1B, sodium channel, GATGCTTCAC[G/C]AGCAGAGGTC M G C E Q nonvoltage-gated 1, beta (Liddle syndrome) G757u6 WIAF-12507 HT28563 1452 SCNN1B, sodium channel, ACCTGCATTG[G/T]CATGTGCAAG M G T G V nonvoltage-gated 1, beta (Liddle syndrome) G758u1 WIAF-12621 HT27856 415 SCNN1D, sodium channel, CGGGAACCCA[C/T]GTCGGCCGAG M C T R C nonvoltage-gated 1, delta G758u2 WIAF-12632 HT27856 325 SCNN1D, sodium channel, CCTCTTTGAG[C/T]GTCACTGGCA M C T R C nonvoltage-gated 1, delta G758u3 WIAF-12634 HT27856 879 SCNN1D, sodium channel, ATGGCGTCTG[G/A]ACAGCTCAGC N G A W * nonvoltage-gated 1, delta G758u4 WIAF-12635 HT27856 1138 SCNN1D, sodium channel, CGTGGAGGTG[G/C]AGCTGCTACA M G C E Q nonvoltage-gated 1, delta G762u1 WIAF-12622 HT27531 1850 NPR3, natriuretic peptide TAGGAGCTGG[C/T]TTGCTAATGG S C T G G receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) G762u2 WIAF-12623 HT27531 1926 NPR3, natriuretic peptide AGAAGAAAGT[A/G]ACCTTGGAAA M A G N D receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) G762u3 WIAF-12624 HT27531 1791 NPR3, natriuretic peptide CAAATCATCA[G/T]GTGGCCTAGA M G T G C receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) G762u4 WIAF-12636 HT27531 1963 NPR3, natriuretic peptide GAAGATTCCA[T/C]CAGATCCCAT M T C I T receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) G763u1 WIAF-12659 HT3183 1633 NPR2, natriuretic peptide CTGGGCCCTT[C/T]CCTGATGAAC M C T S F receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) G763u2 WIAF-12678 HT3183 668 NPR2, natriuretic peptide TGCCATCACT[T/C]CTGCTGTTGG S T C L L receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) G763u3 WIAF-12684 HT3183 2354 NPR2, natriuretic peptide TGTTTGAACT[C/T]AAACATATGA S C T L L receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) G764u1 WIAF-12698 HT1221 3021 NPR1, natriuretic peptide CCCCGTTACT[G/T]TCTCTTTGGG M G T C F receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) G764u2 WIAF-12708 HT1221 588 NPR1, natriuretic peptide GAGCGCCAAG[C/T]GCTCATGCTC M C T A V receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) G764u3 WIAF-12709 HT1221 1897 NPR1, natriuretic peptide GTCCCCGTGG[G/A]AGCCTGCAGG S G A G G receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) G765u1 WIAF-10012 HT2456 604 DCP1, dipeptidyl carboxypeptidase GCTGGCACAA[A/G]GCTGCGGGCA S A G N N 1 (angiotensin I converting enzyme) G765u2 WIAF-10014 HT2456 2350 DCP1, dipeptidyl carboxypeptidase TGATGGCCAC[A/G]TCCCGGAAAT S A G T T 1 (angiotensin I converting enzyme) G765u3 WIAF-10025 HT2456 1668 DCP1, dipeptidyl carboxypeptidase CCCACTGCAC[C/A]AGTGTGACAT M C A Q K 1 (angiotensin I converting enzyme) G765u4 WIAF-10027 HT2456 3220 DCP1, dipeptidyl carboxypeptidase TCCCCTTCAG[C/T]TACCTCGTCG S C T S S 1 (angiotensin I converting enzyme) G765u5 WIAF-10028 HT2456 3409 DCP1, dipeptidyl carboxypeptidase TCAGGTACTT[T/C]GTCAGCTTCA S T C F F 1 (angiotensin I converting enzyme) G765u6 WIAF-10040 HT2456 775 DCP1, dipeptidyl carboxypeptidase AGCCCCTCTA[C/T]CTGAACCTCC S C T Y Y 1 (angiotensin I converting enzyme) G772u1 WIAF-12626 HT2121 1064 AVPR2, arginine vasopressin TCAGCAGCAG[C/T]GTGTCCTCAG S C T S S receptor 2 (nephrogenic diabetes insipidus) G772u2 WIAF-12627 HT2121 998 AVPR2, arginine vasopressin CCTTTGTGCT[A/G]CTCATGTTGC S A G L L receptor 2 (nephrogenic diabetes insipidus) G773u1 WIAF-12644 HT2141 163 SLC6A6, solute carrier family 6 CTAGCAAGAT[C/T]GACTTTGTGC S C T X T (neurotransmitter transporter, taurine), member 6 G773u2 WIAF-12645 HT2141 445 SLC6A6, solute carrier family 6 TCGTCATCCT[G/C]GCCTGGGCCA S G C L L (neurotransmitter transporter, taurine), member 6 G773u3 WIAF-12665 HT2141 289 SLC6A6, solute carrier family 6 TGTTTGGGAG[C/T]GGCCTGCCTG S C T S G (neurotransmitter transporter, taurine), member 6 G773u4 WIAF-12666 HT2141 382 SLC6A6, solute carrier family 6 CCTTGTTCTC[T/C]GGTATCGGCT S T C S S (neurotransmitter transporter, taurine), member 6 G776u1 WIAF-11857 U66088 1457 SLC5A5, solute carrier family 5 TAGAAGACCT[C/T]ATCAAACCTC S C T L L (sodium iodide symporter), member 5 G776u2 WIAF-11871 U66088 2039 SLC5A5, solute carrier family 5 GATTGTTGTG[G/C]TGGGACCTCG M G C W C (sodium iodide symporter), member 5 G776u3 WIAF-13398 U66088 1379 SLC5A5, solute carrier family 5 GGCTTTTCCT[G/A]GCCTGTGCTT S G A L L (sodium iodide symporter), member 5 G777u1 WIAF-12646 HT27843 4348 SMRT ATACAATATC[A/G]GCCAGCCTGG M A G S G G777u2 WIAF-12664 HT27843 2031 SMRT CTGAGCTGGG[T/C]AAGCCGCGGC S T C G G G777u3 WIAF-12655 HT27843 2052 SMRT AGAGCCCCCT[G/A]ACCTATGAGG S G A L L G777u4 WIAF-12675 HT27843 2205 SMRT CTCGTGAGAT[C/T]GCCAAGTCCC S C T I I G778u1 WIAF-14093 HT1449 8212 TG, thyroglobulin ATCTCGTCTC[T/C]GAAGACATCT M T C L P G778u2 WIAF-14111 HT1449 6033 TG, thyroglobulin ATGTGAACGA[C/T]GGTGCGATGC M C T R W G778u3 WIAF-14112 HT1449 6894 TG, thyroglobulin GTATCTCAAT[G/T]TGTTCATCCC M G T V L G778u4 WIAF-14125 HT1449 2375 TG, thyroglobulin ATGGGCCTCC[T/C]GAGCAGGTCT S T C P P G778u5 WIAF-14136 HT1449 1931 TG, thyroglobulin AGGATGTCGA[A/G]TGCTTTTCCG S A G Q Q G783u1 WIAF-12649 X97674 4008 H. sapiens mRNA for transcriptional CTAGTGGTAT[G/C]CCAGCAACTA M G C M I intermediary factor 2. G783u2 WIAF-12658 X97674 2566 H. sapiens mRNA for transcriptional GCCTGGCAGT[G/A]AGCTGGACAA M G A E K intermediary factor 2. G783u3 WIAF-12671 X97674 3828 H. sapiens mRNA for transcriptional CTCTGAGGCC[T/C]GGAGTACCAA S T C P P intermediary factor 2. G785u1 WIAF-13385 HT1291 386 TTR, transthyretin (prealbumin, CCAACGACTC[C/T]GGCCCCCGCC S C T S S amyloidosis type I) G787u1 WIAF-12652 HT27477 468 TRIP15: thyroid receptor GAAAATTATA[T/C]TTAGAACGAG S T C Y Y interacting protein 15 G792u1 WIAF-12661 HT27476 265 thyroid receptor interactor 14 CAGCTGGAAC[G/A]TGAAGAGGGC M G A V M G793u1 WIAF-12643 HT5152 458 thyroid receptor interactor 8 GGAAGCTTTT[C/G]AAAGAATGTT M C G S * G794u1 WIAF-12664 HT5136 1110 PSMC5, proteasome (prosome, GCGTGTGCAC[G/A]GAAGCTGGCA S G A T T macropain) 26S subunit, ATPase, 5 G797u1 WIAF-11847 HT3919 140 glutamate receptor 3, flip isoform CTCACGGAGG[A/G]TTCCCCAACA S A G G G G797u2 WIAF-11848 HT3919 759 glutamate receptor 3, flip isoform GGTTGTGATC[C/T]TAGGGAAACA S C T L L G797u3 WIAF-11849 HT3919 1253 glutamate receptor 3. flip isoform GCTACTGGAA[C/T]GAGTATGAAA S C T N N G797u4 WIAF-11850 MT3919 1770 glutamate receptor 3, flip isoform TCTTTTCCTA[G/A]TCAGCAGGTT M G A V I G797u5 WIAF-13404 HT3919 2711 glutamate receptor 3, flip isoform GCTAGAACGT[G/A]TATGGAACAG S G A V V G797u6 WIAF-13405 HT3919 2376 glutamate receptor 3, flip isoform CTCAGCATTA[G/A]GAACGCCTGT M G A G R G798u1 WIAF-11868 X77748 2655 GRM3, glutamate receptor, TGCAGACGAC[A/G]ACCATGTGCA S A G T T metabotropic 3 G798u2 WIAF-11879 X77748 2771 GRM3, glutamate receptor, CACAGACTGC[A/G]CCTCAACAGG M A G H R metabotropic 3 G798a3 WIAF-12085 X77748 2699 GRM3, glutamate receptor, GTGGTCTTGG[G/C]CTGTTTGTTT M G C G A metabotropic 3 G798a4 WIAF-12086 X77748 2738 GRM3, glutamate receptor, ATCCTGTTTC[A/G]ACCCCAGAAG M A G Q R metabotropic 3 G798a5 WIAF-12087 X77748 2072 GRM3, glutamate receptor, ACACCCTTGG[T/C]CAAAGCATCG M T C V A metabotropic 3 G798a6 WIAF-12088 X77748 2235 GRM3, glutamate receptor, CCCTGCTGAC[C/T]AAGACAAACT S C T T T metabotropic 3 G798u7 WIAF-13391 X77748 1131 GRM3, glutamate receptor, GCGCCAATGC[C/T]TCCTTCACCT S C T A A metabotropic 3 G799u1 WIAF-11880 M81883 2000 GAD1, glutamate decarboxylase 1 CAACAAATGC[C/T]TGGAACTGGC S C T L L (brain, 67 kD) G799u2 WIAF-11881 M81883 1822 GAD1, glutamate decarboxylase 1 AGGGTATACT[C/T]CAAGGATGCA S C T L L (brain, 67 kD) G799u3 WIAF-13392 MB1883 661 GAD1, glutamate decarboxylase 1 GCGTGGCCCA[T/C]GGATGCACCA S T C H H (brain, 67 kD) G799u4 WIAF-13393 MB1883 556 GAD1, glutamate decarboxylase 1 AGCTGATGGC[G/A]TCTTCGACCC S G A A A (brain, 67 kD) G799u5 WIAF-13410 MB1883 1229 GAD1, glutamate decarboxylase 1 CCTCATGGAA[C/T]AAATAACACT N C T Q * G801u1 WIAF-23403 D49394 1596 HTR3, 5-hydroxytryptamine TTTACCTGCT[A/G]GCGGTGCTGG S A G L L (serotonin) receptor 3 G803a1 WIAF-13118 U66406 1446 EFNB3, ephrin-B3 CTGGGCCTGG[G/A]GGGTGGAGGT M G A G E G804u1 WIAF-11887 Z26653 7237 LAMA2, laminin, alpha 2 (merosin, TCACTGATGG[G/T]CACATAAAAG S G T G G congenital muscular dystrophy) G804u2 WIAF-21901 Z26653 9351 LAMA2, laminin, alpha 2 (merosin, GCAAGCCACT[G/C]GAGGTTAATT M G C W S congenital muscular dystrophy) G804u3 WIAF-11924 Z26653 8740 LAMA2, laminin, alpha 2 (merosin, ACACTACCCG[A/G]AGAATTGGTC S A G R R congenital muscular dystrophy) G804u4 WIAF-11943 Z26653 8577 LAMA2, laminin, alpha 2 (merosin, ACCAAAATCA[A/G]TGATGGCCAG M A G N S congenital muscular dystrophy) G804a5 WIAF-12089 Z26653 3372 LAMA2, laminin, alpha 2 (merosin, CTCTGTGACT[G/A]CTTCCTCCCT M G A C Y congenital muscular dystrophy) G804a6 WIAF-13227 Z26653 7047 LAMA2, laminin, alpha 2 (merosin, GTCAGTCCTC[A/g]GGTGGAAGAT M A g Q R congenital muscular dystrophy) G804u7 WIAF-13437 Z26653 6791 LAMA2, laminin, alpha 2 (merosin, TGTGAGAGCC[C/T]TGGATGGACC S C T L L congenital muscular dystrophy) G805u1 WIAF-13416 U14755 799 LHX1, LIM homeobox protein 1 AAGTAACAGC[A/G]GTGTTGCCAA M A G S G G805u2 WIAF-13417 U14755 743 LHX1, LIM homeobox protein 1 GGCGAGGAAC[T/C]CTACATCATC M T C L P G805u3 WIAF-13428 U14755 639 LHX1, LIM honeobox protein 1 GCCGTCAGGG[C/A]ATCTCCCCTA S C A G G G806u1 WIAF-11866 AF026547 2656 CSPG3, chondroitin sulfate TTGGAGTTCC[A/G]GCCATGTCTA S A G P P proteoglycan 3 (neurocan) G806u2 WIAF-11895 AF026547 529 CSPG3, chondroitin sulfate TGACCTTCGC[T/C]GAGGCCCAGG S T C A A proteoglycan 3 (neurocan) G806u3 WIAF-11896 AF026S47 477 CSPG3, chondroitin sulfate GAGGTGACAG[G/A]TGTTGTGTTC M G A G D proteoglycan 3 (neurocan) G806u4 WIAF-11917 AF026547 89 CSPG3, chondroitin sulfate ACAGGATATC[A/G]CCGATGCCAG M A G T A proteoglycan 3 (neurocan) G806u5 WIAF-11918 AF026547 213 CSPG3, chondroitin sulfate AGCGCAGCCC[G/C]AGATGCCCCT M G C R P proteoglycan 3 (neurocan) G806u6 WIAF-11929 AF026547 769 CSPG3, chondroitin sulfate GCTTTGCCCG[G/A]GAGCTGGGGG S G A R R proteoglycan 3 (neurocan) G806u7 WIAF-11931 AF026547 3148 CSPG3, chondroitin sulfate ACATTGATGA[C/T]TGCCTCTGCA S C T D D proteoglycan 3 (neurocan) G806u8 WIAF-11949 AF026547 209 CSPG3, chondroitin sulfate GCCAAGCGCA[G/A]CCCGAGATGC M G A A T proteoglycan 3 (neurocan) G806a9 WIAF-13114 AF026547 3430 CSPG3, chondroitin sulfate ATGAAAACAC[G/A]TGGATCGGCC S G A T T proteoglycan 3 (neurocan) G806u10 WIAF-13420 AF026547 2113 CSPG3, chondroitin sulfate CCAGGGCAGA[C/G]TTCAGAGAAA M C G D E proteoglycan 3 (neurocan) G806u11 WIAF-13431 AF026547 94 CSPG3, chondroitin sulfate ATATCACCGA[T/G]GCCAGCGAAA M T G D E proteoglycan 3 (neurocan) G806u12 WIAF-13432 AF026547 275 CSPG3, chondroitin sulfate ACAGGACTTG[C/T]CCATCCTGGT M C T P S proteoglycan 3 (neurocan) G808a1 WIAF-13117 Y13276 177 TLX, tailless homolog GCATGAGCAA[G/a]CCAGCCGGAT S G a K K (Drosophila) G810u1 WIAF-11890 X98248 990 SORT1, sortilin 1 ATAAGGATAC[C/A]ACAAGAAGGA S C A T T G810u2 WIAF-11891 X98248 1093 SORT1, sortilin 1 GGCAGCAAAT[G/T]ATGACATGGT M G T D Y G810u3 WIAF-11907 X98248 1683 SORT1, sortilin 1 CAGACGAAGG[T/G]CAATGCTGGC S T G G G G810u4 WIAF-11908 X98248 1433 SORT1, sortilin 1 ATCTCCCAGA[A/C]ACTGAATGTT M A C K T G810u5 WIAF-13909 X95248 1354 SORT1, sortilin 1 GAAGCCTCAA[A/G]ACAGTGAATG M A G N D G810u6 WIAF-11910 X98248 2180 SORT1, sortilin 1 TACCGGAAAA[T/A]TCCAGGGGAC M T A I N G810u7 WIAF-11911 X98248 2264 SORT1, sortilin 1 AACTTTTTGA[G/A]TCCGGAAAAA M G A S N G810u8 WIAF-11925 X98248 1993 SORT1, sortilin 1 TCGAGACTAT[G/A]TTGTGACCAA H G A V I G810u9 WIAF-11939 X98248 1351 SORT1, sortilin 1 GAGGAAGCCT[G/C]AAAACAGTGA M G C E Q G810u10 WIAF-11940 X98248 2232 SORT1, sortilin 1 AAGTAAAAGA[C/T]TTGAAAAAGA S C T D D G810a11 WIAF-13115 X98248 1769 SORT1, sortilin 1 TCCATGAATA[T/A]CAGCATTTPG W T A I N G810a12 WIAF-13116 X98248 1757 SORT1, sortilin 1 CCTGGAGCTA[G/A]GTCCATGAAT M G A R K GB11u1 WIAF-11893 HT3676 900 synapain I, alt. transcript 1 TGACCAAGAC[G/A]ATGCCACTG S G A T T G811u2 WIAF-11894 HT3676 758 synapain I, alt. transcript 1 ACCTTCTACC[C/T]CAATCACAAA M C T P L GB11u3 WIAF-11927 HT3676 996 synapain I, alt. transcript 1 CGTCAGTGTC[A/T]GGGAACTGGA S A T S S G811u4 WIAF-11928 HT3676 1054 synapain I, alt. transcript 1 CATGTCTGAc[A/G]CATACAAGCT H A G R G G811u5 WIAF-13418 HT3676 249 synapain I, alt. transcript 1 TGTCCAACGC[G/A]GTCAAGCAGA S G A A A G811u6 WIAF-13419 HT3676 432 synapain I, alt. transcript 1 TTAAAGTAGA[G/A]CAGGCCGAAT S G A E E G812u1 WIAF-11898 HT4564 163 STX1A, syntaxin 1A (brain) CCAACCCCGA[T/C]GAGAAGACGA S T C D D G812u2 WIAF-11942 HT4564 604 STX1A, syntaxin 1A (brain) TACACGACAT[G/T]TTCATGGACA M G T H I G813u1 WIAF-11934 U72508 939 Human B7 mRNA, complete cds. TATGACAGAG[G/A]ACAGAGGATG N G A G E GB13u2 WIAF-11948 U72508 619 Human B7 mRNA, complete cds. GCATCCACAT[G/C]GTGACAGGTC M G C M I G816u1 WIAF-11897 HT4230 151 HTR2B, 5-hydroxytryptamine CTAACTGGTC[T/G]GGATTACAGA S T G S S (serotonin) receptor 2B G816u2 WIAF-11930 HT4230 189 HTR2B, 5-hydroxytryptamine GAAATGAAAC[A/G]GATTGTTGGG M A G Q R (serotonin) receptor 2B G818u1 WIAF-11902 HT2694 753 TPH, tryptophan hydroxylase CTAACTGGTC[C/T]TGCACTCAAT S C T H H (tryptophan 5-monooxygenase) G818u2 WIAF-11903 HT2694 775 TPH, tryptophan hydroxylase TGTGAGACAC[A/G]GTTCAGATCC M A G S G (tryptophan 5-monooxygenase) G818u3 WIAF-11904 HT2694 1211 TPH, tryptophan hydroxylase TATAATCCAT[A/C]TACACGGAGT M A C Y S (tryptophan 5-monooxygenase) G818u4 WIAF-11905 HT2694 1081 TPH, tryptophan hydroxylase GATTACCTGC[A/C]AACAGGAATG M A C K Q (tryptophan 5-monooxygenase) G818u5 WIAF-11933 HT2694 795 TPH, tryptophan hydroxylase CCTTCTATAC[C/T]CCAGAGCCAG S C T T T (tryptophan 5-monooxygenase) G818u6 WIAF-11935 HT2694 1239 TPH, tryptophan hydroxylase TCCTGAAAGA[C/T]ACCAAGAGCA S C T D D (tryptophan 5-monooxygenase) G822u1 WIAF-11906 HT0207 936 ASMT, acetylserotonin N- CAGACGGAAA[G/T]TGCTCACACC M G T K N methyltransferase G822u2 WIAF-11919 HT0207 637 ASMT, acetylserotonin N- TGGTGGGACA[C/T]GGATAAAGCT M C T R W methyltransferase G822u3 WIAF-11936 HT0207 318 ASMT, acetylserotonin N- GAAAAGCTTT[C/T]TATCGAAACA S C T F F methyltransferase G822u4 WIAF-11937 HT0207 116 ASMT, acetylserotonin N- AATGACTACG[C/T]CAACGGCTTC W C T A V methyltransferase G822u5 WIAF-11938 HT0207 930 ASMT, acetylserotonin N- ACTGGGCAGA[C/T]GGAAAGTGCT S C T D D methyltransferase G822u6 WIAF-13427 HT0207 120 ASMT, acetylserotonin N- ACTACGCCAA[C/A]GGCTTCATGG M C A N K methyltransferase G825u1 WIAF-11888 HT4974 236 ADAR, adenosine deaminase, RNA- GCTCAGATAC[C/T]AGGAGCCTGG N C T Q * specific G825u2 WIAF-11900 HT4974 3076 ADAR, adenosine deaminase, RNA- TCTTTGACAA[A/G]TCCTGCAGCG S A G K K specific G825u3 WIAF-11912 HT4974 2537 ADAR, adenosine deaminase, RNA- CTTGATTGGG[G/C]AGAACGAGAA M G C E Q specific G825u4 WIAF-11941 HT4974 3558 ADAR, adenosine deaminase, RNA- GATGGCTATG[A/G]CCTGGAGATC M A G D G specific G825a5 WIAF-12090 HT4974 1305 ADAR, adenosine deaminase, RNA- CCTGAGACCA[A/G]AAGAAACGCA M A G K R specific G825u6 WIAF-13426 HT4974 3683 ADAR, adenosine deaminase, RNA- CCGCAGGGAT[C/T]TACTGAGACT S C T L L specific G826u1 WIAF-12554 X99383 2109 ADARB1, adenosine deaminase, RNA- AGATTACCAA[A/G]CCCAACGTGT S A G K K specific, B1 (homolog of rat RED1) G826u2 WIAF-12566 X99383 1698 ADARB1, adenosine deaminase, RNA- TGTCCTGCAG[T/G]GACAAGATTG M T G S R specific, B1 (homolog of rat RED1) G829u1 WIAF-13735 U49262 1404 DVL3, dishevelled 3 (homologous GGGTTGGAGG[T/C]CCGTGACTGC W T C V A to Drosophila dsh) G83u1 WIAF-10449 HT1576 133 DNMT1, DNA (cytosine-5-) ATGATGACCC[G/A]TCTCTTGAAG S G A P P methyltransferase 1 G83u2 WIAF-10450 HT1576 1871 DNMT1, DNA (cytosine-5-) AAGCTGGTCT[A/G]CCAGATCTTC M A G Y C methyltransferase 1 G83u3 WIAF-10468 HT1576 928 DNMT1, DNA (cytosine-5-) AAATCCACAG[A/G]TTTCTGATGA M A G I V methyltransferase 1 G83u4 WIAF-10469 HT1576 1562 DNMT1, DNA (cytosine-5-) AATTCCGACT[C/T]GACCTATGAG M C T S L methyltransferase 1 G83u5 WIAF-10471 HT1576 2424 DNMT1, DNA (cytosine-5-) GGGCCACGTC]G/A]GACCCTCTGG S G A S S methyltransferase 1 G83u6 WIAF-10473 HT1576 3790 DNMT1, DNA (cytosine-5-) GTTCTTCCTC[C/T]TGGAGAATGT S C T L L methyltransferase 1 G83u7 WIAF-10486 HT1576 1581 DNMT1, DNA (cytosine-5-) AGGACCTGAT[C/A]AACAAGATCG S C A I I methyltransferase 1 G832u1 WIAF-12577 L13387 1129 PAFAH1B1, platelet-activating AGACATTCAC[A/T]GGACACAGAG S A T T T factor acetylhydrolase, isoform 1b, alpha subunit (45 kD) G835u1 WIAF-12555 U38276 1311 SEMA3F, sema domain, CCTCTGGCTC[C/A]GTGTTCCGAG S C A S S immunoglobulin domain (Ig), short basic domain, secreted, 3F G835u2 WIAF-12556 U38276 1229 SEMA3F, sema domain, ACTCACTTTG[A/T]TGAGCTCCAG M A T D V immunoglobulin domain (Ig), short basic domain, secreted, 3F G835u3 WIAF-12557 U38276 1473 SEMA3F, sema domain, GAACCTTCAC[G/A]CCATCTATGA S G A T T immunoglobulin domain (Ig), short basic domain, secreted, 3F G835a4 WIAF-13138 U3B276 1726 SEMA3F, sema domain, TGACCAGGAG[A/T]TGGAGGAGCT M A T M L immunoglobulin domain (Ig), short basic domain, secreted, 3F G836u1 WIAF-12592 U28369 1056 SEMA3B, sema domain, AACGACGTGG[G/A]CGGCCAGCGC M G A G D immunoglobulin domain (Ig), short basic domain, secreted, 3B G836u2 WIAF-12609 U28369 1479 SEMA3B, sema domain, GTCCTGCCCA[C/T]TGGGGGGCGC M C T T I immunoglobulin domain (Ig), short basic domain, secreted, 3B G838u1 WIAF-12590 U72671 1107 ICAMS, intercellular adhesion CGCAGCTGGG[A/G]CCCAAGCTCT M A G T A molecule 5, telencephalin G838u2 WIAF-12591 U72671 966 ICAMS, intercellular adhesion CAGGCAGCTG[A/G]TCTGCAACGT M A G I V molecule 5, telencephalin G840a1 WIAF-12109 HT961 2232 SOS1, son of sevenless CTCAGGCAAA[T/C]GGAGTAAGCC S T C N N (Drosophila) homolog 1 G840a2 WIAF-12110 HT961 2404 SOS1, son of sevenless ACCGTCTAAA[C/G]TTGTAGGGAG M C G L V (Drosophila) homolog 1 G840u3 WIAF-12213 HT961 3813 SOS1, son of sevenless CAAGGGTACC[G/A]CGTCGATGCT S G A P P (Drosophila) homolog 1 G841u1 WIAF-12153 HT97420 1372 SMOH, smoothened (Drosophila) TTTTGGCTTC[C/G]TGGCCTTTGG M C G L V homolog G841u2 WIAF-12179 HT97420 858 SMOH, smoothened (Drosophila) CCCAGTTCAT[G/T]GATGGTGGCC M G T M I homolog G841u3 WIAF-12185 HT97420 1164 SMOH, smoothened (Drosophila) CTGTGAGTGG[C/G]ATTTGTTTTG S C G G G homolog G847u1 WIAF-12588 L41939 2019 RPHB2, EphB2 GGTCTGCAGT[G/T]GCCACCTGAA M G T G C G847u2 WIAF-12596 L41939 1806 EPHB2, EphB2 GTGTAACAGA[A/C]GACGGGGGTT S A C R R G847u3 WIAF-12613 L41939 2885 EPHB2, EphB2 AGGCCATCAA[G/C]ATGGGGCAGT M G C X H G848u1 WIAF-12685 L40636 2484 EPHB1, EphB1 GTCAACAGTA[A/G]CCTGGTGTGC M A G N S G848u2 WIAF-12690 L40636 2020 EPHB1, EphB1 CCTTCACTTA[T/C]GAGGATCCCA S T C Y Y G849u1 WIAF-11920 D83492 1544 EPHB6, EphB6 ACCTGTGTGG[C/T]TCATGCAGAG M C T A V G849u2 WIAF-11921 D83492 3301 EPHB6. EphB6 CTTTGGGATA]C/T]TCATGTGGGA M C T L F G849u3 WIAF-13412 D83492 1139 EPHB6, EphB6 GAGACCTTCA[C/T]CCTTTACTAC M C T T I G849u4 WIAF-13413 D83492 1895 EPHB6, EphB6 TTTGAGGTGC[A/C]AGGCTCAGCA M A C Q P G849u5 WIAF-13414 D83492 2338 EPHB6, EphB6 CTATGACCAG[G/A]CAGAAGACGA M G A A T G849u6 WiAF-13415 D83492 2567 EPHB6, EphB6 GGGGCTTTGG[C/G]CTTCCTCCTG M C G A G G849u7 WIAF-13422 D83492 2860 EPHB6, EphB6 GGCCATCCAG[G/A]CCCTGTGGGC M G A A T G849u8 WIAF-13423 D83492 2782 EPHB6, EphB6 GGAGGTCATT[G/C]GGACAGGCTC M G C G R G849u9 WIAF-13424 D83492 3038 EPHB6, EphB6 TTCCTCAGGC[A/G]GCGGGAGGGC M A G Q R G849u10 WIAF-13425 D83492 3637 EPHB6, EphB6 AGCCATTGGA[C/T]TGGAGTGCTA S C T L L G856u1 WIAF-12625 D45906 1323 LIMK2, LIM domain kinase 2 AGCTGAACCT[G/C]CTGACAGAGT S G C L L G858u1 WIAF-12630 U65019 864 MADH2, MAD (mothers against TTTGGTGTTC[G/A]ATAGCATATT S G A S S decapentaplegic, Drosophila) homolog 2 G86u1 WIAF-10437 HT1701 263 RAD51, RAD51 (S. cerevisiae) TGAAGCAAAT[G/C]CAGATACTTC M G C A P homolog (E coli RecA homolog) G86u2 WIAF-10465 HT1701 861 RAD51, RAD51 (S. cerevisiae) GCATCAGCCA[T/C]GATGGTAGAA M T C M T homolog (E coli RecA homolog) G86u3 WIAF-10466 HT1701 924 RAD51, RAD51 (S. cerevisiae) TACAGAACAG[A/G]CTACTCGGGT M A G D G homolog (E coli RecA homolog) G864a1 WIAF-13139 X82324 183 POU3F4, POU domain, class 3, CAGCAATGGG[C/]ATCCCCTCGG M C t H Y transcription factor 4 G866u1 WIAF-12637 HT0101 2576 glutamate receptor (GB:M64752) AAATCCCGTA[G/A]TGAATCCAAG M G A S N G866u2 WIAF-12638 HT0301 1131 glutamate receptor (GB:M64752) TAACAGGAAA[C/T]GTGCAGTTTA S C T N N G869u1 WIAF-13406 HT33620 3627 GRIN2C, glutamate receptor, AGATCAGCAG[G/T]GTAGCCCGTG M G T R S ionotropic, N-methyl D-aspartate 2C G870u1 WIAF-11889 HT4468 714 SLC1A1, solute carrier family 1 CAGAAGAGTC[C/G]TTCACAGCTG S C G S S (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 G870u2 WIAF-11913 HT4468 314 SLC1A1, solute carrier family 1 CTAGAGAAAT[T/A]CTACTTTGCT M T A F Y (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 G870u3 WIAF-11914 HT4468 579 SLC1A1, solute carrier family 1 AAGTCAGTAC[G/A]GTGGATGCCA S G A T T (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 G870u4 WIAF-11922 HT4468 706 SLC1A1, solute carrier family 1 GAACATGACA[G/A]AAGAGTCCTT M G A E K (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 G870u5 WIAF-11923 HT4468 978 SLC1A1, solute carrier family 1 GGGAGATCAT[A/G]GAAGTTGAAG M A G I M (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 G871u1 WIAF-11892 HT3187 1004 SLC1A3, solute carrier family 1 TTCTCTTAAC[G/C]AAGCCATCAT M G C E Q (glial high affinity glutamate transporter), member 3 G871u2 WIAF-11915 HT3187 1154 SLC1A3, solute carrier family 1 TGTTGGCTTA[C/T]TCATTCACGC M C T L F (glial high affinity glutamate transporter), member 3 G871u3 WIAF-11926 HT3187 1412 SLC1A3, solute carrier family 1 GGCTGCCATT[T/G]TCATTGCTCA M T G F V (glial high affinity glutamate transporter), member 3 G871u4 WIAF-11944 HT3187 1217 SLC1A3, solute carrier family 1 AAACCCTTGG[G/A]TTTTTATTGG M G A V I (glial high affinity glutamate transporter), member 3 G872u1 WIAF-13433 HT4077 1271 SLC1A2, solute carrier family 1 CTGTTGGAGC[A/C]ACCATTAACA S A C A A (glial high affinity glutamate transporter), member 2 G879u1 WIAF-11899 HT28317 1273 GRM2, glutamate receptor, GACTTTGTGC[T/C]CAACGTCAAG M T C L P metabotropic 2 G879u2 WIAF-11932 HT28317 2349 GRM2, glutamate receptor, CTTCTATGTC[A/G]CCTCCAGTGA M A G T A metabotropic 2 G879u3 WIAF-13421 HT28317 2186 GRM2, glutamate receptor, ATGCAAGTAT[G/T]TTGGGCTCGC M G T M I metabotropic 2 G879u4 WIAF-13429 HT28317 2567 GRM2, glutamate receptor, CCCAGTTTGT[C/T]CCCACTGTTT S C T V V metabotropic 2 G879u5 WIAF-13436 HT28317 2046 GRM2, glutamate receptor, ACAGGTGGCC[A/G]TCTGCCTGGC M A G I V metabotropic 2 G879u6 WIAF-13438 HT28317 2425 GRM2, glutamate receptor, GTGCTTGGCT[G/T]CCTCTTTGCG M G T C F metabotropic 2 G879u7 WIAF-13439 HT28317 2463 GRM2, glutamate receptor, CCTGTTCCAG[C/T]CGCAGAAGAA M C T P S metabotropic 2 G880u1 WIAF-12164 HT33719 2117 GRM4, glutamate receptor, AGCCCGACCT[T/G]GGCACCTGCT S T G L L metabotropic 4 G880u2 WIAF-12176 HT33719 2427 GRM4, glutamate receptor, GGACCTGTCG[C/T]TCATCTGCCT M C T L F metabotropic 4 G880u3 WIAF-12192 HT33719 2372 GRM4, glutamate receptor, ACCAGCGGAC[A/G]CTCGACCCCC S A G T T metabotropic 4 G883a1 WIAF-13140 HT48863 1408 GRM7, glutamate receptor, ATCGCAAATG[C/a]ACAGGACAGG M C a C * metabotropic 7 G883a2 WIAF-13141 HT48863 2027 GRM7, glutamate receptor, TCCTGTCTTC[C/t]TGGCAATGTT S C t L L metabotropic 7 G883a3 WIAF-13147 HT48863 1813 GRM7, glutamate receptor, TGTGCACACT[A/g]CCATGTAAGC S A g L L metabotropic 7 G883a4 WIAF-13148 HT48863 1536 GRM7, glutamate receptor, TGTGCGGACT[A/t]CCGGGGTGTC M A t Y F metabotropic 7 G883a5 WIAF-13149 HT48863 2473 GRM7, glutamate receptor, AAGCCAGAGG[G/a]GTTCTCAAGT S G s G G metabotropic 7 G883a6 WIAF-13150 HT48863 2434 GRM7, glutamate receptor, TCATAGACTA[C/t]GATGAACACA S C t Y Y metabotropic 7 G884u1 WIAF-11916 U95025 1052 GRM8, glutamate receptor, CGAACTCTTG[C/A]CAATAATCGA M C A A D metabotropic 8 G884u2 WIAF-11945 U95025 2016 GRM8, glutamate receptor, AAACAAACCG[T/C]ATCCACCGAA S T C R R metabotropic 8 G884u3 WIAF-11946 U95025 1852 GRM8, glutamate receptor, GAGGGCTTCA[G/A]GACGCGAACT M G A G R metabotropic 8 G884u4 WIAF-11947 U95025 2078 GRM8, glutamate receptor, ATTAGTCCAG[C/G]ATCTCAGCTG M C G A G metabotropic 8 G884u5 WIAF-13430 U95025 1897 GRM8, glutamate receptor, TTTTCTCTGT[T/G]ATTCAATCAC M T G Y D metabotropic 8 G884u6 WIAF-13435 U95025 2364 GRM8, glutamate receptor, TTACCATGTA[T/C]ACCACCTGCA S T C Y Y metabotropic 8 G885u1 WIAF-13434 AF002700 1363 GFRA2, GDNF family receptor alpha AACTCAGGCC[C/A]CAGCAGAGCC M C A P H 2 G886a1 WIAF-13142 U95847 497 GFRA1, GDNF family receptor alpha GAAGTCGCTC[T/a]ACAACTGCCG M T a Y N 1 G886a2 WIAF-13143 U95847 1385 GFRA1, GDNF family receptor alpha GTCTGAGAAT[G/a]AAATTCCCAC M G a E K 1 G886a3 WIAF-13151 U95847 781 GFRA1, GDNF family receptor alpha GCGTGTCCAA[T/c]GATGTCTGCA G T c N N 1 G892u1 WIAF-11956 U12140 798 NTRK2, neurotrophic tyrosine TGGGCAATCC[A/G]TTTACATGCT S A G P P kinase, receptor, type 2 G892u2 WIAF-11957 U12140 834 NTRK2, neurotrophic tyrosine GGATCAAGAC[T/A]CTCCAAGAGG S T A T T kinase, receptor, type 2 G892u3 WIAF-11958 U12140 956 NTRK2, neurotrophic tyrosine GCAAATCTGG[C/T]CGCACCTAAC M C T A V kinase, receptor, type 2 G892u4 WIAF-11960 U12140 1738 NTRK2, neurotrophic tyrosine CTCCAAGTTT[G/A]GCATGAAAGG M G A G S kinase, receptor, type 2 G892u5 WIAF-11962 U12140 2486 NTRK2, neurotrophic tyrosine GTCGGTGGCC[A/G]CACAATGCTG M A G H R kinase, receptor, type 2 G892u6 WIAF-11965 U12140 1106 NTRK2, neurotrophic tyrosine TCCTTAAGGA[T/C]AACTAACATT M T C X T kinase, receptor, type 2 G892u7 WIAF-11966 U12140 2085 NTRK2, neurotrophic tyrosine AGGATGCCAG[T/C]GACAATGCAC S T C S S kinase, receptor, type 2 G892u8 WIAF-11967 U12140 2230 NTRK2, neurotrophic tyrosine GGACCTCAAC[A/C]AGTTCCTCAG M A C K Q kinase, receptor, type 2 G892u9 WIAF-11968 U12140 2223 NTRK2, neurotrophic tyrosine AGCATGGGGA[C/T]CTCAACAAGT S C T D D kinase, receptor, type 2 G892u10 WIAF-11992 U12140 1602 NTRK2, neurotrophic tyrosine GTAATGAAAT[c/T]CCTTCCACAG S C T I I kinase, receptor, type 2 G892u11 WIAF-11998 U12140 1354 NTRK2, neurotrophic tyrosine TACTAAAATA[C/T]ATGTTACCAA M C T H Y kinase, receptor, type 2 G892u12 WIAF-11999 U12140 1944 NTRK2, neurotrophic tyrosine CATTTGTTCA]G/C]CACATCAAGC M G C Q H kinase, receptor, type 2 G892u13 WIAF-12000 U12140 2103 NTRK2, neurotrophic tyrosine CACGCAAGGA[C/T]TTCCACCGTG S C T D D kinase, receptor, type 2 G892u14 WIAF-12001 U12140 1860 NTRK2, neurotrophic tyrosine CTGTCATTAT[T/C]GGAATGACCA S T C I I kinase, receptor, type 2 G892a15 WIAF-13144 U12140 1868 NTRK2, neurotrophic tyrosine ATTGGAATGA[C/G]CAAGATCCCT M C G T S kinase, receptor, type 2 G892a16 WIAF-13145 U12140 1903 NTRK2, neurotrophic tyrosine CCAGTACTTT[G/T]GCATCACCAA M G T G C kinase, receptor, type 2 G892a17 WIAF-13140 U12140 1965 NTRK2, neurotrophic tyrosine CACATAACAT[T/G]GTTCTGAAAA M T G I M kinase, receptor, type 2 G892u18 WIAF-13442 U12140 958 NTRK2, neurotrophic tyrosine AAATCTGGCC[G/T]CACCTAACCT M G T A S kinase, receptor, type 2 G892u19 WIAF-13446 U12140 2502 NTRK2, neurotrophic tyrosine TGCTGCCCAT[T/C]CGCTGGATGC S T C I I kinase, receptor, type 2 G892u20 WIAF-13447 U12140 2317 NTRK2, neurotrophic tyrosine GATGCTGCAT[A/T]TAGCCCAGCA M A T I L kinase, receptor, type 2 G892u21 WIAF-13448 U12140 2364 NTRK2, neurotrophic tyrosine CGTCCCAGCA[C/A]TTCGTGCACC M C A H Q kinase, receptor, type 2 G892u22 WIAF-13449 Ul2140 2507 NTRK2, neurotrophic tyrosine CCCATTCGCT[G/A]GATGCCTCCA N G A W * kinase, receptor, type 2 G892u23 WIAF-13471 U12140 2389 NTRK2, neurotrophic tyrosine TTTGGCCACC[A/C]GGAACTGCCT S A C R R kinase, receptor, type 2 G892u24 WIAF-13472 U12140 2416 NTRK2, neurotrophic tyrosine GGAGAACTTG[C/T]TGGTGAAAAT S C T L L kinase, receptor, type 2 G892u25 WIAF-13474 U12140 359 NTRK2, neurotrophic tyrosine GGGATGTCGT[C/T]CTGGATAAGG M C T S F kinase, receptor, type 2 G892u26 WIAF-13479 U12140 1044 NTRK2, neurotrophic tyrosine TGTATTGGGA[T/C]GTTGGTAACC S T C D D kinase, receptor, type 2 G9u1 WIAF-10222 J03826 1130 FDXR, ferredoxin reductase GGTATAAGAG[C/T]CGCCGTGTCG S C T S S G9u2 WIAF-10258 J03826 388 FDKR, ferredoxin reductase CCGGAGCTGC[A/G]GGAGGCCTAC M A G Q R G900u1 WIAF-11970 HT3470 497 STK4A, syntaxin 4A (placental) TGCAATTCAA[T/C]GCAGTCCGAA M T C M T G901u1 WIAF-11969 HT27792 758 STX3A, syntaxin 3A TGCACACAGT[G/A]GACCACGTGG S G A V V G901u2 WIAF-11971 HT27792 317 STX3A, syntaxin 3A ACGTCCGGAA[C/A]AAACTGAAGA M C A N X 0901u3 WIAF-12002 HT27792 611 STX3A, syntaxin 3A AGCAAGCCCT[C/T]AGTGAGATTG S C T L L G901u4 WIAF-12003 HT27792 909 STX3A, syntaxin 3A GCTGAATTAA[G/A]AGTGGCCTAA — G A — — G901u5 WIAF-12004 HT27792 163 STX3A, syntaxin 3A ATTGAGGAAA[C/T]TCGGCTTAAC M C T T I G901a6 WIAF-13152 HT27792 62 STX3A, syntaxin 3A CAGCTGACAC[A/G]GGATGATGAT M A G Q R G901u7 WIAF-13453 HT27792 828 STX3A, syntaxin 3A CCGGAAGAAA[T/C]TGATAATTAT S T C L L G901u8 WIAF-13455 HT27792 226 STX3A, syntaxin 3A TACAGTATCA[T/C]TCTGTCTGCA M T C I T G902u1 WIAF-13454 HT27744 848 STX5A, syntaxin 5A ACTTCCAGTC[T/A]GTCACCTCCA S T A S S G902u2 WIAF-13456 HT27744 338 STX5A, ayntaxin 5A ATTTCGTGAG]A/G]GCCAAGGGCA S A G R R G905u1 WIAF-12202 HT27789 487 CREBL1, cAMP responsive element TCCAGATCAA[C/T]GTTATCCCCA S C T N N binding protein-like 1 G905u2 WIAF-12219 HT27789 151 CREBL1, cAMP responsive element ATTCTGGCCT[A/T]GATGAAGTGG S A T L L binding protein-like 1 G905u3 WIAF-12230 HT27789 649 CREBL1, cAMP responsive element AGTCCCTGTC[C/G]CCTTCAGGAT S C G S S binding protein-like 1 G906u1 WIAF-12214 HT4372 2127 N-ethylmaleimide-sensitive factor AAGGGAAGAA[G/A]GTCTGGATAG S G A K K G906u2 WIAF-12221 HT4372 514 N-ethylmaleimide-sensitive factor GGGAGAGCCT[G/A]CGACAGGGAA M G A A T G908u1 WIAF-12201 HT3665 98 RAB5A, RAB5A, member RAS GCCCAAATAC[T/G]GGAAATAAAA S T G T T oncogene family G91u1 WIAF-10438 HT1848 496 ERCC1, excision repair cross- TCGTGCGCAA[C/T]GTGCCCTGGG S C T H H complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) G91u2 WIAF-10439 HT1848 367 ERCC1, excision repair cross- CTGGGGCCAC[G/A]TGCCCCACAG S G A T T complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) G914a1 WIAF-13210 HT3672 252 synaptobrevin 1 GCAGTGCTGC[C/A]AAGCTAAAGA S C A A A G915a1 WIAF-12115 D63506 1390 Homo sapiens mRNA for unc- TTACCTTGGT[G/A]TTCCCATTGT M G A V I 18homologue, complete cds. G915u2 WIAF-12293 D63506 685 Homo sapiens mRNA for unc- ACAGCTTGTT[G/A]AAAAAAAGCT M G A E K 18homologue, complete cds. G916a1 WIAF-13209 HT28523 308 Huntingtin associated protein 1- GAGCAGTTTT[C/T]GGAGGCCAGC M C T S L like protein G916a2 WIAF-13211 HT28523 762 Huntingtin associated protein 1- CGGAGGAGTT[G/C]GTGCCCCAGG M G C L F like protein G916a3 WIAF-13212 HT28523 560 Huntingtin associated protein 1- GAGCTCAGAA[C/T]GTCTCTAAGG M C T T M like protein G917u1 WIAF-11972 U79734 1075 HIP1, huntingtin interacting AGAGCCAGCG[G/A]GTTGTGCTGC S G A R R protein 1 G917u2 WIAF-11973 U79734 1005 HIP1, huntingtin interacting GACCACTTAA[T/C]TGAGCGACTA M T C I T protein 1 G917u3 WIAF-11977 U79734 1539 HIP1, huntingtin interacting CTGCAAGGCA[G/A]CCTGGAAACT M G A S N protein 1 G917u4 WIAF-12005 U79734 817 HIP1, huntingtin interacting TGGTGGTGAT[C/T]CCTGCAGAGG S C T I I protein 1 G917u5 WIAF-12006 U79734 1906 HIP1, huntingtin interacting GCTGGAGCCA[G/C]TATCTGGCCT M G C Q H protein 1 G917u6 WIAF-13157 U79734 993 HIP1, huntingtin interacting AAGGATGAGA[A/G]GGACCACTTA M A G K R protein 1 G919u1 WIAF-11974 D30742 707 CAMK4, calcium/calmodulin- ACTGCGCACC[T/C]GAAATTCTTA S T C P P dependent protein kinase IV G919u2 WIAF-11991 D30742 1139 CAMK4, calcium/calmodulin- AGAGCCACAA[G/A]GCTAGCCGAG S G A K K dependent protein kinase IV G919u3 WIAF-12007 D30742 834 CAMK4, calcium/calmodulin- CATGTTCAGG[A/T]GAATTCTGAA N A T R * dependent protein kinase IV G919u4 WIAF-13443 D30742 1088 CAMK4, calcium/calmodulin- TGGCCTCTTC[C/G]CGCCTGGGAA S C G S S dependent protein kinase IV G920u1 WIAF-11979 X78520 1952 CLCN3, chloride channel 3 ATGACATTCC[T/C]GATCGTCCAG S T C P P G920u2 WIAF-11980 X78520 1819 CLCN3, chloride channel 3 ATAGCCTTCC[C/T]TAATCCATAC M C T P L G920u3 WIAF-11981 X78520 2094 CLCN3, chloride channel 3 CATTGGAGCG[A/G]TCGCAGGAAG M A G I V G920u4 WIAF-11983 X78520 2822 CLCN3, chloride channel 3 ATATTTTCCG[A/G]AAGCTGGGAC S A G R R G920u5 WIAF-11984 X78520 2745 CLCN3, chloride channel 3 GCCATTGAAG[C/T]TTCGAAGCAT M C T L F G920u6 WIAF-11987 X78520 2499 CLCN3, chloride channel 3 TCCCTTAGCT[G/T]TCCTGACACA M G T V F G920u7 WIAF-12008 X78520 1251 CLCN3, chloride channel 3 CATCATCAGA[G/A]GTTACTTGGG M G A G S G920u8 WIAF-12011 X78520 888 CLCN3, chloride channel 3 AGTAGTAACA[C/T]TAACAGGATT S C T L L G920u9 WIAF-13459 X78520 2804 CLCN3, chloride channel 3 CAATGGAGAT[T/C]GTGGTGGATA S T C I I G921u1 WIAF-11954 J02908 931 CLU, clusterin (complement lysis GAGAGGTTGA[C/T]CAGGAAATAC M C T T I inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone- repressed prostate message 2, apolipoprotein J) G921u2 WIAF-11955 J02908 880 CLU, clusterin (complement lysis CCCTCCCAGG[C/T]TAAGCTGCGG M C T A V inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone- repressed prostate message 2, apolipoprotein J) G921u3 WIAF-11990 J02908 1051 CLU, clusterin (complement lysis CTCACGCAAG[G/C]CGAAGACCAG M G C G A inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone- repressed prostate message 2, apolipoprotein J) G921u4 WIAF-13469 J02908 986 CLU, clusterin (complement lysis TCAACACCTC[C/T]TCCTTGCTGG S C T S S inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone- repressed prostate message 2, apolipoprotein J) G923u1 WIAF-11993 M19650 1059 Human 2′,3′-cyclic nucleotide 3′- GAGCTAAGCC[G/A]GGGCAAGCTC M G A R Q phosphodiesterase mRNA, complete cs. G923u2 WIAF-11994 M19650 1062 Human 2′,3′-cyclic nucleotide 3′- CTAAGCCGGG[G/T]CAAGCTCTAT M G T G V phosphodiesterase mRNA, complete cs. G923u3 WIAF-13445 M19650 1141 Human 2′,3′-cyclic nucleotide 3′- TCTTCACGGG[G/A]TACTACGGGA S G A G G phosphodiesterase mRNA, complete cs. G925u1 WIAF-11953 L11315 666 CAK, cell adhesion kinase GGGTCATGAG]T/C]GTCTGTCTGC S T C S S G925u2 WIAF-11959 L11315 2562 CAK, cell adhesion kinase TGCTGCCCAT[C/T]CGCTGGATGG S C T T I G925u3 WIAF-11996 L11315 2049 CAK, cell adhesion kinase AAGATCTGGT[T/C]AGTCTTGATT S T C V V G925u4 WIAF-13440 L11315 1601 CAK. cell adhesion kinase TACCAGGAGC[C/T]CCGGCCTCGT M C T P L G925u5 WIAF-13441 L11315 1629 CAK, cell adhesion kinase CGCCCCACTC[C/T]GCTCCCTGTG S C T S S G925u6 WIAF-13451 L11315 2262 CAK, cell adhesion kinase TGGAGAACGG[C/T]GACCTCAACC S C T G G G926u1 WIAF-11961 AF018956 577 NRP1, neuropilin 1 TGAAAGCTTT[G/T]ACCTGGAGCC M G T D Y G926u2 WIAF-11963 AF018956 1683 NRP1, neuropilin 1 CCACGCGATT[C/G]ATCAGGATCT M C G F L G926u3 WIAF-11975 AF018956 2176 NRP1, neuropilin 1 GACCTTCTGG]T/C]ATCACATGTC M T C Y H G926u4 WIAF-11976 AF018956 2092 NRP1, neuropilin 1 TTCCCAAGCT[G/T]ACGAAAATCA M G T D Y G926a5 WIAF-13158 AF018956 747 NRP1, neuropilin 1 TTTTTTACAC[C/T]GACAGCGCGA S C T T T G926a6 WIAF-13159 AF018956 996 NRP1, neuropilin 1 ACTTGGGCCT[T/C]CTGCGCTTTG S T C L L G926u7 WIAF-13444 AF018956 644 NRP1, neuropilin 1 GAAATCTGGG[A/C]TGGATTCCCT M A C D A G926u8 WIAF-13450 AF018956 1738 NRP1, neuropilin 1 CAGAATGGAG[C/G]TGCTGGGCTG M C G L V G926u9 WIAF-13452 AF018956 537 NRP1, neuropilin 1 TTGTCTTTGC[G/A]CCAAAGATGT S G A A A G926u10 WIAF-13457 AF018956 2197 NRP1, neuropilin 1 TGGGTCCCAC[G/A]TCGGCACACT M G A V I G927u1 WIAF-11978 AF022860 870 NRP2, neuropilin 2 GGATTGCTAA[T/C]GAACAGATCA S T C N N G927u2 WIAF-11982 AF022860 1674 NRP2, neuropilin 2 ATGACACCCC[T/G]GACATCCGAA S T G P P G927u3 WIAF-11985 AF022860 1250 NRP2, neuropilin 2 TGGCACTCAG[G/A]TATCGCCCTC M G A G D G927u4 WIAF-11986 AF022860 1071 NRP2, neuropilin 2 ATGGCTACTA[C/T]GTCAAATCCT S C T Y Y G927u5 WIAF-12009 AF022860 726 NRP2, neuropilin 2 GTTCATCGAC]G/A]GGGATCCTCT S G A T T G927u6 WIAF-12010 AF022860 2522 NRP2, neuropilin 2 GCAACCTCAG[G/T]GTCTGGCGCC M G T G V G927u7 WIAF-12012 AF022860 123 NRP2, neuropilin 2 GCTATATCAC[C/T]TCTCCCGGTT S C T T T G927a8 WIAF-13160 AF022860 2427 NRP2, neuropilin 2 CTTTTGGAGT[G/T]GACATCCCAG S G T V V G927a9 WIAF-13161 AF022860 2430 NRP2, neuropilin 2 TTGCAGTGGA[C/G]ATCCCAGAAA M C G D E G927a10 WIAF-13162 AF022860 2463 NRP2, neuropilin 2 AAGGATATGA[A/G]GATGAAATTG S A G E E G927a11 WIAF-13163 AF022860 2473 NRP2, neuropilin 2 AGATGAAATT[G/T]ATGATGAATA M G T D Y G927u12 WIAF-13480 AF022860 724 NRP2, neuropilin 2 TCGTTCATCG[A/T]CGGGGATCCT M A T T S G927u13 WIAF-13481 AF022860 767 NRP2, neuropilin 2 ATGGCGGTGG[C/T]CAAGGATGGC M C T A V G930a1 WIAF-13164 HT2608 609 GABRA2, gamma-aminobutyric acid ACAATGGGAA[G/a]AAATCAGTAG S G a K K (GABA) A receptor, alpha 2 G931a1 WIAF-13153 HT2609 1111 GABRA3, gamma-aminobutyric acid ACTGGTTCAT[A/g]GCCGTCTGTT M A g I M (GABA) A receptor, alpha 3 G931a2 WIAF-13165 HT2609 1448 GABRA3, gamma-aminobutyric acid TGTCAGCAAG[G/A]TTGACAAAAT M G A V I (GABA) A receptor, alpha 3 G932a1 WIAF-13154 HT27773 1077 GABRA4, gamma-aminobutyric acid CAAAAGAAAG[A/G]CATCAAAGCC M A G T A (GABA) A receptor, alpha 4 G932a2 WIAF-13155 HT27773 1189 GABRA4, gamma-aminobutyric acid AGAACAAATG[C/A]TTTGGTTCAC M C A A D (GABA) A receptor, alpha 4 G936u1 WIAF-12308 HT3432 1027 GABRB2, gamma-aminobutyric acid AATTACGATG[C/T]TTCAGCTGCA M C T A V (GABA) A receptor, beta 2 G936u2 WIAF-12327 HT3432 362 GABRB2, gamma-aminobutyric acid AAGGCTATGA[C/T]ATTCGTCTGA S C T D D (GABA) A receptor, beta 2 G936u3 WIAF-12328 HT3432 571 GABRB2, gamma-aminobutyric acid CTCTGGGTGC[C/T]TGATACCTAT M C T P L (GABA) A receptor, beta 2 G939u1 WIAF-12330 HT2236 1219 GABRB2, gamma-aminobutyric acid CTGGATGGAA[G/C]CTACAGTGAG M G C S T (GABA) receptor, rho 2 G939u2 WIAF-12355 HT2236 1003 GABRB2, gamma-aminobutyric acid ACCACCATCA[T/C]CACGGGCGTG M T C I T (GABA) receptor, rho 2 G939u3 WIAF-12356 HT2236 1041 GABRB2, gamma-aminobutyric acid CGTCTCCTAC]G/A]TCAAGGCCGT M G A V I (GABA) receptor, rho 2 G950u1 WIAF-13622 U64871 785 Human putative G protein-coupled GTCCTGCTCC[A/C]GTTCACCACT M A C Q P receptor (GBR19) gene, complete cds. G950u2 WIAF-13624 U64871 443 Human putative G protein-coupled GATAACAGCA[A/C]GCCACATTTG M A C K T receptor (GBR19) gene, complete cds. G950u3 WIAF-13625 U64871 818 Human putative G protein-coupled CTGGGTAGTG[C/T]AACGTGCAAG M C T A V receptor (GBR19) gene, complete cds. G955a1 WIAF-13166 HT3860 5110 calcium channel, voltage-gated, CTGGCCTCTT[T/c]ACCGTGGAGA S T c F F alpha 1 subunit, L type, alt. transcript 1 G955a2 WIAF-33167 HT3860 3842 calcium channel, voltage-gated, CTACCCCAAC[C/a]CAGAAACTAC M C a P T alpha 1 subunit, L type, alt. transcript 1 G955a3 WIAF-13168 HT3860 5624 calcium channel, voltage-gated, GTGTGCCCCA[G/a]AGTCCGAGCC M G a E K alpha 1 subunit, L type, alt. transcript 1 G955a4 WIAF-13169 HT3860 5703 calcium channel, voltage-gated, ATCAGCTTCT[A/g]CATGCTCTGT M A g Y C alpha 1 subunit, L type, alt. transcript 1 G955a5 WIAF-13170 HT3860 5889 calcium channel, voltage-gated, ACCACCTGGA[T/c]GAGTTTAAAA S T c D D alpha 1 subunit, L type, alt. transcript 1 G955a6 WIAF-13171 HT3860 6616 calcium channel, voltage-gated, CCGGCTCCAA[C/t]GCCAACATCA S C t N N alpha 1 subunit, L type, alt. transcript 1 G956u1 WIAF-14187 HT2199 1334 calcium channel, voltage-gated, CTTCACATAG[C/T]CCTTTTGGTA M C T A V alpha 1D subunit, DHP-sensitive G956u2 WIAF-14188 HT2199 1452 calcium channel, voltage-gated, AAGAGGACCC[A/T]GCTCCATGTG S A T P P alpha 1D subunit, DHP-sensitive G956u3 WIAF-14189 HT2199 1614 calcium channel, voltage-gated, GCTGGACAGA[C/T]GTGCTCTACT S C T D D alpha 1D subunit, DHP-sensitive G956u4 WIAF-14190 HT2199 2540 calcium channel, voltage-gated, GGCAAGTTTA[A/T]TTTTGATGAA M A T N I alpha 1D subunit, DHP-sensitive G956u5 WIAF-14191 HT2199 3210 calcium channel, voltage-gated, TGCTGAGCAG[T/C]GCTGCCCTGG S T C S S alpha 1D subunit, DHP-sensitive G956u6 WIAF-14192 HT2199 3326 calcium channel, voltage-gated, TTGAAGATGA[C/T]AACTTTTGGA M C T T I alpha 1D subunit, DHP-sensitive G956u7 WIAF-14193 HT2199 3274 calcium channel, voltage-gated, ACTGGGTTAC[T/C]TTGACTATGC M T C F L alpha 1D subunit, DHP-sensitive G956u8 WIAF-14194 HT2199 5127 calcium channel, voltage-gated, TGCCTGTCAA[C/T]AGTGACGGGA S C T N N alpha 1D subunit, DHP-sensitive G956u9 WIAF-14195 HT2199 5173 calcium channel, voltage-gated, TGCTTTGGTT[C/T]GAACGGCTCT N C T R * alpha 1D subunit, DHP-sensitive G956u10 WIAF-14200 HT2199 1437 calcium channel, voltage-gated, CAGATATCGT[A/G]GCTGAAGAGG S A G V V alpha 1D subunit, DHP-sensitive G956u11 WIAF-14201 HT2199 2567 calcium channel, voltage-gated, ACCAAGCGGA[G/T]CACCTTTGAC M G T S I alpha 1D subunit, DHP-sensitive G956u12 WIAF-14202 HT2199 4464 calcium channel, voltage-gated, TCACCTTTTT[C/T]CGTCTTTTCC S C T F F alpha 1D subunit, DHP-sensitive G956u13 WIAF-14215 HT2199 6927 calcium channel, voltage-gated, GCTACAGCGA[C/T]CAAGAGCCAG S C T D D alpha 1D subunit, DHP-sensitive G956u14 WIAF-14216 HT2199 6858 calcium channel, voltage-gated, CCCGAGCCAA[C/T]GGCGATGTGG S C T N N alpha 1D subunit, DHP-sensitive G957u1 WIAF-12306 HT4229 915 calcium channel, voltage-gated, TACATCGAGC[G/A]TGCTTCATGA M G A ? R alpha 1E subunit, alt. transcript 2 G9S7u2 WIAF-12309 HT4229 3555 calcium channel, voltage-gated, GCCACTACAT[C/T]GTGAACCTGC S C T I I alpha 1E subunit, alt. transcript 2 G957u3 WIAF-12310 HT4229 4116 calcium channel, voltage-gated, ATGTAGATCA[C/T]GAGAAAAACA S C T M H alpha 1E subunit, alt. transcript 2 G957u4 WIAF-12313 HT4229 5181 calcium channel, voltage-gated, AGAACGAGAA[T/C]GAACGCTGCG S T C N N alpha 1E subunit, alt. transcript 2 G957u5 WIAF-12314 HT4229 5971 calcium channel, voltage-gated, TATGGACCCC[G/A]CCGATGACGG S G A T T alpha 1E subunit, alt. transcript 2 G957u6 WIAF-12315 HT4229 5985 calcium channel, voltage-gated, ATGACGGACA[G/T]TTCCAAGAAC M G T Q M alpha 1E subunit, alt. transcript 2 G957u7 WIAF-12329 HT4229 3100 calcium channel, voltage-gated, GCTGGCAGGA[G/A]GCCTTGATGA M G A G S alpha 1E subunit, alt. transcript 2 G957u8 WIAF-12331 HT4229 6492 calcium channel, voltage-gated, CCCTCCTTTC[C/T]TACAGCTCCC M C T ? R alpha 1E subunit, alt. transcript 2 G957u9 WIAF-12354 HT4229 3839 calcium channel, voltage-gated, AACGCTTTGG[G/C]AACCAACAAA M G C G A alpha 1E subunit, alt. transcript 2 G957u10 WIAF-12357 HT4229 4753 calcium channel, voltage-gated, TGACTTCATC[A/G]CCGTGATTGG M A G T A alpha 1E subunit, alt. transcript 2 G960u1 WIAF-12305 HT3336 1246 CACNB3, calcium channel, voltage- TTGATGCCCT[C/T]TGATGAGGCC M C T S F dependent, beta 3 subunit G960u2 WIAF-12340 HT3336 1288 CACNB3, calcium channel, voltage- TGGACAGGAT[C/T]TTCACAGCGT M C T S F dependent, beta 3 subunit G960u3 WIAF-12345 HT3336 641 CACNB3, calcium channel, voltage- AGGCTCTCTT[C/T]GACTTCCTCA S C T F F dependent, beta 3 subunit C960u4 WIAF-12346 HT3336 576 CACNB3, calcium channel, voltage- CATGCGGCCT[G/A]GCGTGCTGGT W G A V M dependent, beta 3 subunit G961u1 WIAF-12322 U95019 2037 CACNB2, calcium channel, voltage- ACTCTGCCTA[C/T]GTAGAGCGAA S C T Y Y dependent, beta 2 subunit G961u2 WIAF-12347 U95019 2007 CACNB2, calcium channel, voltage- CATTTGACTC[G/A]GAAACCCAGG S G A S S dependent, beta 2 subunit G962u1 WIAF-12324 U95020 1423 CACNB4, calcium channel, voltage- CCAATTGAAA[G/A]ACGAAGTCTA M G A R K G962u2 WIAF-12342 U95020 167 CACNB4, calcium channel, voltage- GGAGCAGGTT[G/T]AAAAGATCCG M G T L F G962u3 WIAF-12350 U95020 1571 CACNB4, calcium channel, voltage- ACACTTACAA[A/G]CCCCATAGGA S A G K K G965u1 WIAF-12312 U40583 1276 CHRNA7, cholinergic receptor, TCCTGCACGG[T/C]GGGCAACCCC S T C G G nicotinic, alpha polypeptide 7 G968a1 WIAF-12119 HT27592 1008 CHRNA1, cholinergic receptor, ACACACACCA[C/T]CGCTCACCCA S C T H M nicotinic, alpha polypepide 1 (muscle) G968u2 WIAF-12368 HT27592 1136 CHRNA1, cholinergic receptor, AAGATTTTTA[C/T]AGAAGACATT M C T T I nicotinic, alpha polypepide 1 (muscle) G973a1 WIAF-13172 HT48774 800 CHRNA2, cholinergic receptor, ACACTTCAGA[C/t]GTGGTGATTG S C t D D nicotinic, alpha polypeptide 2 (neuronal) G973a2 WIAF-13173 HT48774 927 CHRNA2, cholinergic receptor, CTGGAACCCC[G/a]CTGATTTTGG M G a A T nicotinic, alpha polypeptide 2 (neuronal) G977u1 WIAF-13949 Y08419 366 CHRNA5, cholinergic receptor, AAGTTATACG[T/C]GTTCCTTCAG S T C R R nicotinic, alpha polypeptide 5 G978a1 WIAF-13179 Y08417 1331 CHRNB3, cholinergic receptor, CCATTAGATA[C/a]ATTTCGAGAC N C a Y * nicotinic, beta polypeptide 3 G983a1 WIAF-13214 HT0374 236 NPY, neuropeptide Y GATACTACTC[G/A]GCGCTGCGAC S G A S S G983a2 WIAF-13215 HT0374 290 NPY, neuropeptide Y GAAAACGATC[C/T]AGCCCAGAGA S C T S S G983a3 WIAF-13216 HT0374 111 NPY, neuropeptide Y GCGACTGGGG[C/T]TGTCCGGACT S C T L L G987a1 WIAF-13174 HT27830 159 PPYR1, pancreatic polypeptide TGGTCTTCAT[C/T]GTCACTTCCT S C T I I receptor 1 G987a2 WIAF-13175 HT27830 222 PPYR1, pancreatic polypeptide TGATGTGTGT[G/A]ACTGTGAGGC S G A V V receptor 1 G987a3 WIAF-13176 HT27830 322 PPYR1, pancreatic polypeptide GCCGCTGACC[G/T]CCGTCTACAC M G T A S receptor 1 G987a4 WIAF-13177 HT27830 1074 PPYR1, pancreatic polypeptide TGGAGGAGTC[G/A]GAGCATCTGC S G A S S receptor 1 G987a5 WIAF-13178 HT27830 975 PPYR1, pancreatic polypeptide CCTCCACCTG[C/T]GTCAACCCAT S C T C C receptor 1 G987a6 WIAF-13180 HT27830 615 PPYR1, pancreatic polypeptide AGTTCCTGGC[A/g]GATAAGGTGG S A g A A receptor 1 G987a7 WIAF-13181 HT27830 718 PPYR1, pancreatic polypeptide GGGCTTCATC[C/T]TGGTCTGTTA S C T L L receptor 1 G987a8 WIAF-13182 HT27830 745 PPYR1, pancreatic polypeptide CATCTACCGG[C/t]GCCTCCAGAG M C t P C receptor 1 G987e9 WIAF-13183 HT27830 842 PPYR1, pancreatic polypeptide GTGATGGTGG[T/A]GGCCTTTGCC M T A V E receptor 1 G987a10 WIAF-13184 HT27830 852 PPYR1, pancreatic polypeptide TGGCCTTTGC[c/T]GTGCTCTGGC S C T A A receptor 1 G987a11 WIAF-13185 HT27830 889 PPYR1, pancreatic polypeptide CAACAGCCTG[G/a]AAGACTGGCA H G a E K receptor 1 G987a12 WIAF-13186 HT27830 924 PPYR1, pancreatic polypeptide CCATCTGCCA[C/T]GGGAACCTCA S C T H H receptor 1 G989u1 WIAF-13573 D86519 891 NPY6R, neuropeptide Y receptor Y6 TGACTCATGC[C/T]TACTGGGGCA S C T A A G989u2 WIAF-13588 D86519 465 NPY6R, neuropeptide Y receptor Y6 ACCACCCAGC]A/G]TCTAATACAA S A G A A G989u3 WIAF-13591 D86519 980 NPY6R, neuropeptide Y receptor Y6 GAGCCCTTCC[G/A]CAACCTCTCT M G A R N G991u1 WIAF-12390 HT97376 336 Notch2 AAGGTACTTG[C/T]GTTCAGAAAA S C T C C G993u1 WIAF-12359 U95299 1343 NOTCH4, Notch (Drosophila) TCCACACTCT[G/T]CCTGTGTCAG M G T C F homolog 4 G993u2 WIAF-12361 U95299 2020 NOTCH4, Notch (Drosophila) TAAGGACCAG[A/G]AAGACAAGGC H A G K E homolog 4 G993u3 WIAF-12384 U95299 5775 NOTCH4, Notch (Drosophila) GGGCCTATTC[G/T]CATTGCCGGA S G T S S homolog 4 G996a1 WIAF-13213 HT3329 356 OPRM1, opioid receptor, mu 1 CTTAGATGGC[A/G]ACCTGTCCGA M A G N D LPLa4 WIAF-13314 HT1320 443 LPL, lipoprotein lipase ATGTATGAGA[G/T]TTGGGTGCCA M G T S I LPLa5 WIAF-13315 HT1320 579 LPL, lipoprotein lipase GACAGGATGT[G/A]GCCCGGTTTA S G A V V LPLa6 WIAF-13316 HT1320 609 LPL, lipoprotein lipase TGGAGGAGGA[G/A]TTTAACTACC S G A E E LPLa7 WIAF-13317 HT1320 1338 LPL, lipoprotein lipase CAAATAAGAC[C/A]TACTCCTTCC S C A T T LPLa8 WIAF-13318 HTl32C 1117 LPL, lipoprotein lipase CAATCTGGGC[T/G]ATGAGATCAA M T G Y D LPLa9 WIAF-13319 HT1320 715 LPL, lipoprotein lipase CAGAATTACT[G/A]GCCTCGATCC M G A G S LPLa10 WIAF-13320 HT1320 834 LPL. lipoprotein lipase CTGGTCGAAG[C/A]ATTGGAATCC M C A S R LPLa11 WIAF-13321 HT1320 951 LPL, lipoprotein lipase GACGTGGAGA[T/A]GTG&ACCAGC M T A D R LPLa12 WIAF-13322 HT1320 1595 LPL, lipoprotein lipase AATAAGAAGT[C/G]AGGCTGAAAC N C G S * LPLa13 WIAF-13323 HT1320 1597 LPL, lipoprotein lipase TAAGAAGTCA[G/A]GCTGAAACTG M G A G S LPLa14 WIAF-13324 HT1320 1606 LPL, lipoprotein lipase AGGCTGAAAC[T/C]GGGCGAATCT — T C — — LPLa15 WIAF-13325 HT1320 1611 LPL, lipoprotein lipase GAAACTGGGC[G/A]AATCTACAGA — G A — —

While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.

2551 1 5722 DNA Homo sapiens 1 ggacgcacag gcattccccg cgcccctcca gccctcgccg ccctcgccac cgctcccggc 60 cgccgcgctc cggtacacac aggatccctg ctgggcacca acagctccac catggggctg 120 gcctggggac taggcgtcct gttcctgatg catgtgtgtg gcaccaaccg cattccagag 180 tctggcggag acaacagcgt gtttgacatc tttgaactca ccggggccgc ccgcaagggg 240 tctgggcgcc gactggtgaa gggccccgac ccttccagcc cagctttccg catcgaggat 300 gccaacctga tcccccctgt gcctgatgac aagttccaag acctggtgga tgctgtgcgg 360 gcagaaaagg gtttcctcct tctggcatcc ctgaggcaga tgaagaagac ccggggcacg 420 ctgctggccc tggagcggaa agaccactct ggccaggtct tcagcgtggt gtccaatggc 480 aaggcgggca ccctggacct cagcctgacc gtccaaggaa agcagcacgt ggtgtctgtg 540 gaagaagctc tcctggcaac cggccagtgg aagagcatca ccctgtttgt gcaggaagac 600 agggcccagc tgtacatcga ctgtgaaaag atggagaatg ctgagttgga cgtccccatc 660 caaagcgtct tcaccagaga cctggccagc atcgccagac tccgcatcgc aaaggggggc 720 gtcaatgaca atttccaggg ggtgctgcag aatgtgaggt ttgtctttgg aaccacacca 780 gaagacatcc tcaggaacaa aggctgctcc agctctacca gtgtcctcct cacccttgac 840 aacaacgtgg tgaatggttc cagccctgcc atccgcacta actacattgg ccacaagaca 900 aaggacttgc aagccatctg cggcatctcc tgtgatgagc tgtccagcat ggtcctggaa 960 ctcaggggcc tgcgcaccat tgtgaccacg ctgcaggaca gcatccgcaa agtgactgaa 1020 gagaacaaag agttggccaa tgagctgagg cggcctcccc tatgctatca caacggagtt 1080 cagtacagaa ataacgagga atggactgtt gatagctgca ctgagtgtca ctgtcagaac 1140 tcagttacca tctgcaaaaa ggtgtcctgc cccatcatgc cctgctccaa tgccacagtt 1200 cctgatggag aatgctgtcc tcgctgttgg cccagcgact ctgcggacga tggctggtct 1260 ccatggtccg agtggacctc ctgttctacg agctgtggca atggaattca gcagcgcggc 1320 cgctcctgcg atagcctcaa caaccgatgt gagggctcct cggtccagac acggacctgc 1380 cacattcagg agtgtgacaa aagatttaaa caggatggtg gctggagcca ctggtccccg 1440 tggtcatctt gttctgtgac atgtggtgat ggtgtgatca caaggatccg gctctgcaac 1500 tctcccagcc cccagatgaa tgggaaaccc tgtgaaggcg aagcgcggga gaccaaagcc 1560 tgcaagaaag acgcctgccc catcaatgga ggctggggtc cttggtcacc atgggacatc 1620 tgttctgtca cctgtggagg aggggtacag aaacgtagtc gtctctgcaa caaccccgca 1680 ccccagtttg gaggcaagga ctgcgttggt gatgtaacag aaaaccagat ctgcaacaag 1740 caggactgtc caattgatgg atgcctgtcc aatccctgct ttgccggcgt gaagtgtact 1800 agctaccctg atggcagctg gaaatgtggt gcttgtcccc ctggttacag tggaaatggc 1860 atccagtgca cagatgttga tgagtgcaaa gaagtgcctg atgcctgctt caaccacaat 1920 ggagagcacc ggtgtgagaa cacggacccc ggctacaact gcctgccctg ccccccacgc 1980 ttcaccggct cacagccctt cggccagggt gtcgaacatg ccacggccaa caaacaggtg 2040 tgcaagcccc gtaacccctg cacggatggg acccacgact gcaacaagaa cgccaagtgc 2100 aactacctgg gccactatag cgaccccatg taccgctgcg agtgcaagcc tggctacgct 2160 ggcaatggca tcatctgcgg ggaggacaca gacctggatg gctggcccaa tgagaacctg 2220 gtgtgcgtgg ccaatgcgac ttaccactgc aaaaaggata attgccccaa ccttcccaac 2280 tcagggcagg aagactatga caaggatgga attggtgatg cctgtgatga tgacgatgac 2340 aatgataaaa ttccagatga cagggacaac tgtccattcc attacaaccc agctcagtat 2400 gactatgaca gagatgatgt gggagaccgc tgtgacaact gtccctacaa ccacaaccca 2460 gatcaggcag acacagacaa caatggggaa ggagacgcct gtgctgcaga cattgatgga 2520 gacggtatcc tcaatgaacg ggacaactgc cagtacgtct acaatgtgga ccagagagac 2580 actgatatgg atggggttgg agatcagtgt gacaattgcc ccttggaaca caatccggat 2640 cagctggact ctgactcaga ccgcattgga gatacctgtg acaacaatca ggatattgat 2700 gaagatggcc accagaacaa tctggacaac tgtccctatg tgcccaatgc caaccaggct 2760 gaccatgaca aagatggcaa gggagatgcc tgtgaccacg atgatgacaa cgatggcatt 2820 cctgatgaca aggacaactg cagactcgtg cccaatcccg accagaagga ctctgacggc 2880 gatggtcgag gtgatgcctg caaagatgat tttgaccatg acagtgtgcc agacatcgat 2940 gacatctgtc ctgagaatgt tgacatcagt gagaccgatt tccgccgatt ccagatgatt 3000 cctctggacc ccaaagggac atcccaaaat gaccctaact gggttgtacg ccatcagggt 3060 aaagaactcg tccagactgt caactgtgat cctggactcg ctgtaggtta tgatgagttt 3120 aatgctgtgg acttcagtgg caccttcttc atcaacaccg aaagggacga tgactatgct 3180 ggatttgtct ttggctacca gtccagcagc cgcttttatg ttgtgatgtg gaagcaagtc 3240 acccagtcct actgggacac caaccccacg agggctcagg gatactcggg cctttctgtg 3300 aaagttgtaa actccaccac agggcctggc gagcacctgc ggaacgccct gtggcacaca 3360 ggaaacaccc ctggccaggt gcgcaccctg tggcatgacc ctcgtcacat aggctggaaa 3420 gatttcaccg cctacagatg gcgtctcagc cacaggccaa agacgggttt cattagagtg 3480 gtgatgtatg aagggaagaa aatcatggct gactcaggac ccatctatga taaaacctat 3540 gctggtggta gactagggtt gtttgtcttc tctcaagaaa tggtgttctt ctctgacctg 3600 aaatacgaat gtagagatcc ctaatcatca aattgttgat tgaaagactg atcataaacc 3660 aatgctggta ttgcaccttc tggaactatg ggcttgagaa aacccccagg atcacttctc 3720 cttggcttcc ttcttttctg tgcttgcatc agtgtggact cctagaacgt gcgacctgcc 3780 tcaagaaaat gcagttttca aaaacagact catcagcatt cagcctccaa tgaataagac 3840 atcttccaag catataaaca attgctttgg tttccttttg aaaaagcatc tacttgcttc 3900 agttgggaag gtgcccattc cactctgcct ttgtcacaga gcagggtgct attgtgaggc 3960 catctctgag cagtggactc aaaagcattt tcaggcatgt cagagaaggg aggactcact 4020 agaattagca aacaaaacca ccctgacatc ctccttcagg aacacgggga gcagaggcca 4080 aagcactaag gggagggcgc atacccgaga cgattgtatg aagaaaatat ggaggaactg 4140 ttacatgttc ggtactaagt cattttcagg ggattgaaag actattgctg gatttcatga 4200 tgctgactgg cgttagctga ttaacccatg taaataggca cttaaataga agcaggaaag 4260 ggagacaaag actggcttct ggacttcctc cctgatcccc acccttactc atcaccttgc 4320 agtggccaga attagggaat cagaatcaaa ccagtgtaag gcagtgctgg ctgccattgc 4380 ctggtcacat tgaaattggt ggcttcattc tagatgtagc ttgtgcagat gtagcaggaa 4440 aataggaaaa cctaccatct cagtgagcac cagctgcctc ccaaaggagg ggcagccgtg 4500 cttatatttt tatggttaca atggcacaaa attattatca acctaactaa aacattcctt 4560 ttctcttttt tccgtaatta ctaggtagtt ttctaattct ctcttttgga agtatgattt 4620 ttttaaagtc tttacgatgt aaaatattta ttttttactt attctggaag atctggctga 4680 aggattattc atggaacagg aagaagcgta aagactatcc atgtcatctt tgttgagagt 4740 cttcgtgact gtaagattgt aaatacagat tatttattaa ctctgttctg cctggaaatt 4800 taggcttcat acggaaagtg tttgagagca agtagttgac atttatcagc aaatctcttg 4860 caagaacagc acaaggaaaa tcagtctaat aagctgctct gccccttgtg ctcagagtgg 4920 atgttatggg attccttttt tctctgtttt atcttttcaa gtggaattag ttggttatcc 4980 atttgcaaat gttttaaatt gcaaagaaag ccatgaggtc ttcaatactg ttttacccca 5040 tcccttgtgc atatttccag ggagaaggaa agcatataca cttttttctt tcatttttcc 5100 aaaagagaaa aaaatgacaa aaggtgaaac ttacatacaa atattacctc atttgttgtg 5160 tgactgagta aagaattttt ggatcaagcg gaaagagttt aagtgtctaa caaacttaaa 5220 gctactgtag tacctaaaaa gtcagtgttg tacatagcat aaaaactctg cagagaagta 5280 ttcccaataa ggaaatagca ttgaaatgtt aaatacaatt tctgaaagtt atgttttttt 5340 tctatcatct ggtataccat tgctttattt ttataaatta ttttctcatt gccattggaa 5400 tagaatattc agattgtgta gatatgctat ttaaataatt tatcaggaaa tactgcctgt 5460 agagttagta tttctatttt tatataatgt ttgcacactg aattgaagaa ttgttggttt 5520 tttctttttt ttgttttttt tttttttttt tttttttttg cttttgacct cccattttta 5580 ctatttgcca ataccttttt ctaggaatgt gctttttttt gtacacattt ttatccattt 5640 tacattctaa agcagtgtaa gttgtatatt actgtttctt atgtacaagg aacaacaata 5700 aatcatatgg aaatttatat tt 5722 2 1170 PRT Homo sapiens 2 Met Gly Leu Ala Trp Gly Leu Gly Val Leu Phe Leu Met His Val Cys 1 5 10 15 Gly Thr Asn Arg Ile Pro Glu Ser Gly Gly Asp Asn Ser Val Phe Asp 20 25 30 Ile Phe Glu Leu Thr Gly Ala Ala Arg Lys Gly Ser Gly Arg Arg Leu 35 40 45 Val Lys Gly Pro Asp Pro Ser Ser Pro Ala Phe Arg Ile Glu Asp Ala 50 55 60 Asn Leu Ile Pro Pro Val Pro Asp Asp Lys Phe Gln Asp Leu Val Asp 65 70 75 80 Ala Val Arg Ala Glu Lys Gly Phe Leu Leu Leu Ala Ser Leu Arg Gln 85 90 95 Met Lys Lys Thr Arg Gly Thr Leu Leu Ala Leu Glu Arg Lys Asp His 100 105 110 Ser Gly Gln Val Phe Ser Val Val Ser Asn Gly Lys Ala Gly Thr Leu 115 120 125 Asp Leu Ser Leu Thr Val Gln Gly Lys Gln His Val Val Ser Val Glu 130 135 140 Glu Ala Leu Leu Ala Thr Gly Gln Trp Lys Ser Ile Thr Leu Phe Val 145 150 155 160 Gln Glu Asp Arg Ala Gln Leu Tyr Ile Asp Cys Glu Lys Met Glu Asn 165 170 175 Ala Glu Leu Asp Val Pro Ile Gln Ser Val Phe Thr Arg Asp Leu Ala 180 185 190 Ser Ile Ala Arg Leu Arg Ile Ala Lys Gly Gly Val Asn Asp Asn Phe 195 200 205 Gln Gly Val Leu Gln Asn Val Arg Phe Val Phe Gly Thr Thr Pro Glu 210 215 220 Asp Ile Leu Arg Asn Lys Gly Cys Ser Ser Ser Thr Ser Val Leu Leu 225 230 235 240 Thr Leu Asp Asn Asn Val Val Asn Gly Ser Ser Pro Ala Ile Arg Thr 245 250 255 Asn Tyr Ile Gly His Lys Thr Lys Asp Leu Gln Ala Ile Cys Gly Ile 260 265 270 Ser Cys Asp Glu Leu Ser Ser Met Val Leu Glu Leu Arg Gly Leu Arg 275 280 285 Thr Ile Val Thr Thr Leu Gln Asp Ser Ile Arg Lys Val Thr Glu Glu 290 295 300 Asn Lys Glu Leu Ala Asn Glu Leu Arg Arg Pro Pro Leu Cys Tyr His 305 310 315 320 Asn Gly Val Gln Tyr Arg Asn Asn Glu Glu Trp Thr Val Asp Ser Cys 325 330 335 Thr Glu Cys His Cys Gln Asn Ser Val Thr Ile Cys Lys Lys Val Ser 340 345 350 Cys Pro Ile Met Pro Cys Ser Asn Ala Thr Val Pro Asp Gly Glu Cys 355 360 365 Cys Pro Arg Cys Trp Pro Ser Asp Ser Ala Asp Asp Gly Trp Ser Pro 370 375 380 Trp Ser Glu Trp Thr Ser Cys Ser Thr Ser Cys Gly Asn Gly Ile Gln 385 390 395 400 Gln Arg Gly Arg Ser Cys Asp Ser Leu Asn Asn Arg Cys Glu Gly Ser 405 410 415 Ser Val Gln Thr Arg Thr Cys His Ile Gln Glu Cys Asp Lys Arg Phe 420 425 430 Lys Gln Asp Gly Gly Trp Ser His Trp Ser Pro Trp Ser Ser Cys Ser 435 440 445 Val Thr Cys Gly Asp Gly Val Ile Thr Arg Ile Arg Leu Cys Asn Ser 450 455 460 Pro Ser Pro Gln Met Asn Gly Lys Pro Cys Glu Gly Glu Ala Arg Glu 465 470 475 480 Thr Lys Ala Cys Lys Lys Asp Ala Cys Pro Ile Asn Gly Gly Trp Gly 485 490 495 Pro Trp Ser Pro Trp Asp Ile Cys Ser Val Thr Cys Gly Gly Gly Val 500 505 510 Gln Lys Arg Ser Arg Leu Cys Asn Asn Pro Ala Pro Gln Phe Gly Gly 515 520 525 Lys Asp Cys Val Gly Asp Val Thr Glu Asn Gln Ile Cys Asn Lys Gln 530 535 540 Asp Cys Pro Ile Asp Gly Cys Leu Ser Asn Pro Cys Phe Ala Gly Val 545 550 555 560 Lys Cys Thr Ser Tyr Pro Asp Gly Ser Trp Lys Cys Gly Ala Cys Pro 565 570 575 Pro Gly Tyr Ser Gly Asn Gly Ile Gln Cys Thr Asp Val Asp Glu Cys 580 585 590 Lys Glu Val Pro Asp Ala Cys Phe Asn His Asn Gly Glu His Arg Cys 595 600 605 Glu Asn Thr Asp Pro Gly Tyr Asn Cys Leu Pro Cys Pro Pro Arg Phe 610 615 620 Thr Gly Ser Gln Pro Phe Gly Gln Gly Val Glu His Ala Thr Ala Asn 625 630 635 640 Lys Gln Val Cys Lys Pro Arg Asn Pro Cys Thr Asp Gly Thr His Asp 645 650 655 Cys Asn Lys Asn Ala Lys Cys Asn Tyr Leu Gly His Tyr Ser Asp Pro 660 665 670 Met Tyr Arg Cys Glu Cys Lys Pro Gly Tyr Ala Gly Asn Gly Ile Ile 675 680 685 Cys Gly Glu Asp Thr Asp Leu Asp Gly Trp Pro Asn Glu Asn Leu Val 690 695 700 Cys Val Ala Asn Ala Thr Tyr His Cys Lys Lys Asp Asn Cys Pro Asn 705 710 715 720 Leu Pro Asn Ser Gly Gln Glu Asp Tyr Asp Lys Asp Gly Ile Gly Asp 725 730 735 Ala Cys Asp Asp Asp Asp Asp Asn Asp Lys Ile Pro Asp Asp Arg Asp 740 745 750 Asn Cys Pro Phe His Tyr Asn Pro Ala Gln Tyr Asp Tyr Asp Arg Asp 755 760 765 Asp Val Gly Asp Arg Cys Asp Asn Cys Pro Tyr Asn His Asn Pro Asp 770 775 780 Gln Ala Asp Thr Asp Asn Asn Gly Glu Gly Asp Ala Cys Ala Ala Asp 785 790 795 800 Ile Asp Gly Asp Gly Ile Leu Asn Glu Arg Asp Asn Cys Gln Tyr Val 805 810 815 Tyr Asn Val Asp Gln Arg Asp Thr Asp Met Asp Gly Val Gly Asp Gln 820 825 830 Cys Asp Asn Cys Pro Leu Glu His Asn Pro Asp Gln Leu Asp Ser Asp 835 840 845 Ser Asp Arg Ile Gly Asp Thr Cys Asp Asn Asn Gln Asp Ile Asp Glu 850 855 860 Asp Gly His Gln Asn Asn Leu Asp Asn Cys Pro Tyr Val Pro Asn Ala 865 870 875 880 Asn Gln Ala Asp His Asp Lys Asp Gly Lys Gly Asp Ala Cys Asp His 885 890 895 Asp Asp Asp Asn Asp Gly Ile Pro Asp Asp Lys Asp Asn Cys Arg Leu 900 905 910 Val Pro Asn Pro Asp Gln Lys Asp Ser Asp Gly Asp Gly Arg Gly Asp 915 920 925 Ala Cys Lys Asp Asp Phe Asp His Asp Ser Val Pro Asp Ile Asp Asp 930 935 940 Ile Cys Pro Glu Asn Val Asp Ile Ser Glu Thr Asp Phe Arg Arg Phe 945 950 955 960 Gln Met Ile Pro Leu Asp Pro Lys Gly Thr Ser Gln Asn Asp Pro Asn 965 970 975 Trp Val Val Arg His Gln Gly Lys Glu Leu Val Gln Thr Val Asn Cys 980 985 990 Asp Pro Gly Leu Ala Val Gly Tyr Asp Glu Phe Asn Ala Val Asp Phe 995 1000 1005 Ser Gly Thr Phe Phe Ile Asn Thr Glu Arg Asp Asp Asp Tyr Ala Gly 1010 1015 1020 Phe Val Phe Gly Tyr Gln Ser Ser Ser Arg Phe Tyr Val Val Met Trp 1025 1030 1035 1040 Lys Gln Val Thr Gln Ser Tyr Trp Asp Thr Asn Pro Thr Arg Ala Gln 1045 1050 1055 Gly Tyr Ser Gly Leu Ser Val Lys Val Val Asn Ser Thr Thr Gly Pro 1060 1065 1070 Gly Glu His Leu Arg Asn Ala Leu Trp His Thr Gly Asn Thr Pro Gly 1075 1080 1085 Gln Val Arg Thr Leu Trp His Asp Pro Arg His Ile Gly Trp Lys Asp 1090 1095 1100 Phe Thr Ala Tyr Arg Trp Arg Leu Ser His Arg Pro Lys Thr Gly Phe 1105 1110 1115 1120 Ile Arg Val Val Met Tyr Glu Gly Lys Lys Ile Met Ala Asp Ser Gly 1125 1130 1135 Pro Ile Tyr Asp Lys Thr Tyr Ala Gly Gly Arg Leu Gly Leu Phe Val 1140 1145 1150 Phe Ser Gln Glu Met Val Phe Phe Ser Asp Leu Lys Tyr Glu Cys Arg 1155 1160 1165 Asp Pro 1170 3 3074 DNA Homo sapiens 3 gaattccggg gagcaggaag agccaacatg ctggccccgc gcggagccgc cgtcctcctg 60 ctgcacctgg tcctgcagcg gtggctagcg gcaggcgccc aggccacccc ccaggtcttt 120 gaccttctcc catcttccag tcagaggcta aacccaggcg ctctgctgcc agtcctgaca 180 gaccccgccc tgaatgatct ctatgtgatt tccaccttca agctgcagac taaaagttca 240 gccaccatct tcggtcttta ctcttcaact gacaacagta aatattttga atttactgtg 300 atgggacgct taagcaaagc catcctccgt tacctgaaga acgatgggaa ggtgcatttg 360 gtggttttca acaacctgca gctggcagac ggaaggcggc acaggatcct cctgaggctg 420 agcaatttgc agcgaggggc cggctcccta gagctctacc tggactgcat ccaggtggat 480 tccgttcaca atctccccag ggcctttgct ggcccctccc agaaacctga gaccattgaa 540 ttgaggactt tccagaggaa gccacaggac ttcttggaag agctgaagct ggtggtgaga 600 ggctcactgt tccaggtggc cagcctgcaa gactgcttcc tgcagcagag tgagccactg 660 gctgccacag gcacagggga ctttaaccgg cagttcttgg gtcaaatgac acaattaaac 720 caactcctgg gagaggtgaa ggaccttctg agacagcagg ttaaggaaac atcatttttg 780 cgaaacacca tagctgaatg ccaggcttgc ggtcctctca agtttcagtc tccgacccca 840 agcacggtgg tcgccccggc tccccctgca ccgccaacac gcccacctcg tcggtgtgac 900 tccaacccat gtttccgagg tgtccaatgt accgacagta gagatggctt ccagtgtggg 960 ccctgccccg agggctacac aggaaacggg atcacctgta ttgatgttga tgagtgcaaa 1020 taccatccct gctacccggg cgtgcactgc ataaatttgt ctcctggctt cagatgtgac 1080 gcctgcccag tgggcttcac agggcccatg gtgcagggtg ttgggatcag ttttgccaag 1140 tcaaacaagc aggtctgcac tgacattgat gagtgtcgaa atggagcgtg cgttcccaac 1200 tcgatctgcg ttaatacttt gggatcttac cgctgtgggc cttgtaagcc ggggtatact 1260 ggtgatcaga taaggggatg caaagtggaa agaaactgca gaaacccaga gctgaaccct 1320 tgcagtgtga atgcccagtg cattgaagag aggcaggggg atgtgacatg tgtgtgtgga 1380 gtcggttggg ctggagatgg ctatatctgt ggaaaggatg tggacatcga cagttacccc 1440 gacgaagaac tgccatgctc tgccaggaac tgtaaaaagg acaactgcaa atatgtgcca 1500 aattctggcc aagaagatgc agacagagat ggcattggcg acgcttgtga cgaggatgct 1560 gacggagatg ggatcctgaa tgagcaggat aactgtgtcc tgattcataa tgtggaccaa 1620 aggaacagcg ataaagatat ctttggggat gcctgtgata actgcctgag tgtcttaaat 1680 aacgaccaga aagacaccga tggggatgga agaggagatg cctgtgatga tgacatggat 1740 ggagatggaa taaaaaacat tctggacaac tgcccaaaat ttcccaatcg tgaccaacgg 1800 gacaaggatg gtgatggtgt gggggatgcc tgtgacagtt gtcctgatgt cagcaaccct 1860 aaccagtctg atgtggataa tgatctggtt ggggactcct gtgacaccaa tcaggacagt 1920 gatggagatg ggcaccagga cagcacagac aactgcccca ccgtcattaa cagtgcccag 1980 ctggacaccg ataaggatgg aattggtgac gagtgtgatg atgatgatga caatgatggt 2040 atcccagacc tggtgccccc tggaccagac aactgccggc tggtccccaa cccagcccag 2100 gaggatagca acagcgacgg agtgggagac atctgtgagt ctgactttga ccaggaccag 2160 gtcatcgatc ggatcgacgt ctgcccagag aacgcagagg tcaccctgac cgacttcagg 2220 gcttaccaga ccgtgggcct ggatcctgaa ggggatgccc agatcgatcc caactgggtg 2280 gtcctgaacc agggcatgga gattgtacag accatgaaca gtgatcctgg cctggcagtg 2340 gggtacacag cttttaatgg agttgacttc gaagggacct tccatgtgaa tacccagaca 2400 gatgatgact atgcaggctt tatctttggc taccaagata gctccagctt ctacgtggtc 2460 atgtggaagc agacggagca gacatattgg caagccaccc cattccgagc agttgcagaa 2520 cctggcattc agctcaaggc tgtgaagtct aagacaggtc caggggagca tctccggaac 2580 tccctgtggc acacggggga caccagtgac caggtcaggc tgctgtggaa ggactccagg 2640 aatgtgggct ggaaggacaa ggtgtcctac cgctggttcc tacagcacag gccccaggtg 2700 ggctacatca gggtacgatt ttatgaaggc tctgagttgg tggctgactc tggcgtcacc 2760 atagacacca caatgcgtgg aggccgactt ggcgttttct gcttctctca agaaaacatc 2820 atctggtcca acctcaagta tcgctgcaat gacaccatcc ctgaggactt ccaagagttt 2880 caaacccaga atttcgaccg cttcgataat taaaccaagg aagcaatctg taactgcttt 2940 tcggaacact aaaaccatat atattttaac ttcaattttc tttagctttt accaacccaa 3000 atatatcaaa acgttttatg tgaatgtggc aataaaggag aagagatcat ttttaaaaaa 3060 aaaaaaaaaa aaaa 3074 4 961 PRT Homo sapiens 4 Met Leu Ala Pro Arg Gly Ala Ala Val Leu Leu Leu His Leu Val Leu 1 5 10 15 Gln Arg Trp Leu Ala Ala Gly Ala Gln Ala Thr Pro Gln Val Phe Asp 20 25 30 Leu Leu Pro Ser Ser Ser Gln Arg Leu Asn Pro Gly Ala Leu Leu Pro 35 40 45 Val Leu Thr Asp Pro Ala Leu Asn Asp Leu Tyr Val Ile Ser Thr Phe 50 55 60 Lys Leu Gln Thr Lys Ser Ser Ala Thr Ile Phe Gly Leu Tyr Ser Ser 65 70 75 80 Thr Asp Asn Ser Lys Tyr Phe Glu Phe Thr Val Met Gly Arg Leu Ser 85 90 95 Lys Ala Ile Leu Arg Tyr Leu Lys Asn Asp Gly Lys Val His Leu Val 100 105 110 Val Phe Asn Asn Leu Gln Leu Ala Asp Gly Arg Arg His Arg Ile Leu 115 120 125 Leu Arg Leu Ser Asn Leu Gln Arg Gly Ala Gly Ser Leu Glu Leu Tyr 130 135 140 Leu Asp Cys Ile Gln Val Asp Ser Val His Asn Leu Pro Arg Ala Phe 145 150 155 160 Ala Gly Pro Ser Gln Lys Pro Glu Thr Ile Glu Leu Arg Thr Phe Gln 165 170 175 Arg Lys Pro Gln Asp Phe Leu Glu Glu Leu Lys Leu Val Val Arg Gly 180 185 190 Ser Leu Phe Gln Val Ala Ser Leu Gln Asp Cys Phe Leu Gln Gln Ser 195 200 205 Glu Pro Leu Ala Ala Thr Gly Thr Gly Asp Phe Asn Arg Gln Phe Leu 210 215 220 Gly Gln Met Thr Gln Leu Asn Gln Leu Leu Gly Glu Val Lys Asp Leu 225 230 235 240 Leu Arg Gln Gln Val Lys Glu Thr Ser Phe Leu Arg Asn Thr Ile Ala 245 250 255 Glu Cys Gln Ala Cys Gly Pro Leu Lys Phe Gln Ser Pro Thr Pro Ser 260 265 270 Thr Val Val Ala Pro Ala Pro Pro Ala Pro Pro Thr Arg Pro Pro Arg 275 280 285 Arg Cys Asp Ser Asn Pro Cys Phe Arg Gly Val Gln Cys Thr Asp Ser 290 295 300 Arg Asp Gly Phe Gln Cys Gly Pro Cys Pro Glu Gly Tyr Thr Gly Asn 305 310 315 320 Gly Ile Thr Cys Ile Asp Val Asp Glu Cys Lys Tyr His Pro Cys Tyr 325 330 335 Pro Gly Val His Cys Ile Asn Leu Ser Pro Gly Phe Arg Cys Asp Ala 340 345 350 Cys Pro Val Gly Phe Thr Gly Pro Met Val Gln Gly Val Gly Ile Ser 355 360 365 Phe Ala Lys Ser Asn Lys Gln Val Cys Thr Asp Ile Asp Glu Cys Arg 370 375 380 Asn Gly Ala Cys Val Pro Asn Ser Ile Cys Val Asn Thr Leu Gly Ser 385 390 395 400 Tyr Arg Cys Gly Pro Cys Lys Pro Gly Tyr Thr Gly Asp Gln Ile Arg 405 410 415 Gly Cys Lys Val Glu Arg Asn Cys Arg Asn Pro Glu Leu Asn Pro Cys 420 425 430 Ser Val Asn Ala Gln Cys Ile Glu Glu Arg Gln Gly Asp Val Thr Cys 435 440 445 Val Cys Gly Val Gly Trp Ala Gly Asp Gly Tyr Ile Cys Gly Lys Asp 450 455 460 Val Asp Ile Asp Ser Tyr Pro Asp Glu Glu Leu Pro Cys Ser Ala Arg 465 470 475 480 Asn Cys Lys Lys Asp Asn Cys Lys Tyr Val Pro Asn Ser Gly Gln Glu 485 490 495 Asp Ala Asp Arg Asp Gly Ile Gly Asp Ala Cys Asp Glu Asp Ala Asp 500 505 510 Gly Asp Gly Ile Leu Asn Glu Gln Asp Asn Cys Val Leu Ile His Asn 515 520 525 Val Asp Gln Arg Asn Ser Asp Lys Asp Ile Phe Gly Asp Ala Cys Asp 530 535 540 Asn Cys Leu Ser Val Leu Asn Asn Asp Gln Lys Asp Thr Asp Gly Asp 545 550 555 560 Gly Arg Gly Asp Ala Cys Asp Asp Asp Met Asp Gly Asp Gly Ile Lys 565 570 575 Asn Ile Leu Asp Asn Cys Pro Lys Phe Pro Asn Arg Asp Gln Arg Asp 580 585 590 Lys Asp Gly Asp Gly Val Gly Asp Ala Cys Asp Ser Cys Pro Asp Val 595 600 605 Ser Asn Pro Asn Gln Ser Asp Val Asp Asn Asp Leu Val Gly Asp Ser 610 615 620 Cys Asp Thr Asn Gln Asp Ser Asp Gly Asp Gly His Gln Asp Ser Thr 625 630 635 640 Asp Asn Cys Pro Thr Val Ile Asn Ser Ala Gln Leu Asp Thr Asp Lys 645 650 655 Asp Gly Ile Gly Asp Glu Cys Asp Asp Asp Asp Asp Asn Asp Gly Ile 660 665 670 Pro Asp Leu Val Pro Pro Gly Pro Asp Asn Cys Arg Leu Val Pro Asn 675 680 685 Pro Ala Gln Glu Asp Ser Asn Ser Asp Gly Val Gly Asp Ile Cys Glu 690 695 700 Ser Asp Phe Asp Gln Asp Gln Val Ile Asp Arg Ile Asp Val Cys Pro 705 710 715 720 Glu Asn Ala Glu Val Thr Leu Thr Asp Phe Arg Ala Tyr Gln Thr Val 725 730 735 Gly Leu Asp Pro Glu Gly Asp Ala Gln Ile Asp Pro Asn Trp Val Val 740 745 750 Leu Asn Gln Gly Met Glu Ile Val Gln Thr Met Asn Ser Asp Pro Gly 755 760 765 Leu Ala Val Gly Tyr Thr Ala Phe Asn Gly Val Asp Phe Glu Gly Thr 770 775 780 Phe His Val Asn Thr Gln Thr Asp Asp Asp Tyr Ala Gly Phe Ile Phe 785 790 795 800 Gly Tyr Gln Asp Ser Ser Ser Phe Tyr Val Val Met Trp Lys Gln Thr 805 810 815 Glu Gln Thr Tyr Trp Gln Ala Thr Pro Phe Arg Ala Val Ala Glu Pro 820 825 830 Gly Ile Gln Leu Lys Ala Val Lys Ser Lys Thr Gly Pro Gly Glu His 835 840 845 Leu Arg Asn Ser Leu Trp His Thr Gly Asp Thr Ser Asp Gln Val Arg 850 855 860 Leu Leu Trp Lys Asp Ser Arg Asn Val Gly Trp Lys Asp Lys Val Ser 865 870 875 880 Tyr Arg Trp Phe Leu Gln His Arg Pro Gln Val Gly Tyr Ile Arg Val 885 890 895 Arg Phe Tyr Glu Gly Ser Glu Leu Val Ala Asp Ser Gly Val Thr Ile 900 905 910 Asp Thr Thr Met Arg Gly Gly Arg Leu Gly Val Phe Cys Phe Ser Gln 915 920 925 Glu Asn Ile Ile Trp Ser Asn Leu Lys Tyr Arg Cys Asn Asp Thr Ile 930 935 940 Pro Glu Asp Phe Gln Glu Phe Gln Thr Gln Asn Phe Asp Arg Phe Asp 945 950 955 960 Asn 5 31 DNA Homo sapiens 5 tggatggctg gcccartgag aacctggtgt g 31 6 31 DNA Homo sapiens 6 gagtgtcgaa atggascgtg cgttcccaac t 31 7 21 DNA Homo sapiens 7 ctgcaggagt rgctggatga a 21 8 21 DNA Homo sapiens 8 catctggacc ytgctgggca a 21 9 21 DNA Homo sapiens 9 gtgctggtgt scgcagccat c 21 10 21 DNA Homo sapiens 10 tgcgcgccaa satgaccaac g 21 11 21 DNA Homo sapiens 11 tgtgctccac ygcctccatc c 21 12 21 DNA Homo sapiens 12 gcagagcacg ygcagagctg c 21 13 21 DNA Homo sapiens 13 atggtcggcc yggcatggac c 21 14 21 DNA Homo sapiens 14 gcaagatgac ycagcgcatg g 21 15 21 DNA Homo sapiens 15 tcgctcatca rcttctacat c 21 16 21 DNA Homo sapiens 16 ggggcgggct kgacctgcca a 21 17 21 DNA Homo sapiens 17 agaccctgtc rgtgatcatg g 21 18 21 DNA Homo sapiens 18 ggaggaggac ktttgggagc c 21 19 21 DNA Homo sapiens 19 tttgggagcc ygacgtgaat g 21 20 21 DNA Homo sapiens 20 ccgacgtgaa kgcagagaac t 21 21 21 DNA Homo sapiens 21 acctacacgc rcatctaccg c 21 22 21 DNA Homo sapiens 22 gtgcagccac ktctgctccc g 21 23 21 DNA Homo sapiens 23 gaaatcgcag ytgcctacat c 21 24 21 DNA Homo sapiens 24 accctgttgc wgagtctgtc t 21 25 21 DNA Homo sapiens 25 tctcctacaa ycaagacatc g 21 26 21 DNA Homo sapiens 26 cactcaaccc mgtcatctat g 21 27 21 DNA Homo sapiens 27 acgccgactt ycagaaggtg t 21 28 21 DNA Homo sapiens 28 cgaggaggag rgtcctttcg a 21 29 21 DNA Homo sapiens 29 gatcgcatgt yccagatcta t 21 30 21 DNA Homo sapiens 30 tgtctctggc ygtgtctgac c 21 31 21 DNA Homo sapiens 31 tgccgccagg sagcaacggc a 21 32 21 DNA Homo sapiens 32 ggcagttcgc kctataccag c 21 33 21 DNA Homo sapiens 33 tggggccctc rcaggtggtc a 21 34 21 DNA Homo sapiens 34 tggccggtta ytggcccttt g 21 35 21 DNA Homo sapiens 35 cttcgacatc wtgtgctcca c 21 36 21 DNA Homo sapiens 36 atcagcgtgg rccgctactg g 21 37 21 DNA Homo sapiens 37 tggccctttg ragcgttctg c 21 38 21 DNA Homo sapiens 38 agcctgcgcg yttccatcaa g 21 39 21 DNA Homo sapiens 39 ggttctcaag mccctgtcgg t 21 40 21 DNA Homo sapiens 40 ctacatcccc rttgccatca t 21 41 21 DNA Homo sapiens 41 gatttcctcc ytggagaggg c 21 42 21 DNA Homo sapiens 42 ccctcaacgc ytcgttcctc c 21 43 21 DNA Homo sapiens 43 gctgctcaag ytggcgtcgc c 21 44 21 DNA Homo sapiens 44 tggagtccca rgagcggatc a 21 45 21 DNA Homo sapiens 45 ccccagtggt rtacctgaag g 21 46 21 DNA Homo sapiens 46 atgtgatgag wgagaaacat c 21 47 21 DNA Homo sapiens 47 ccccaagatc mggacaagcc t 21 48 21 DNA Homo sapiens 48 ccaactcagc yttcctgcat a 21 49 21 DNA Homo sapiens 49 gccgctcaga ytccgaggat g 21 50 21 DNA Homo sapiens 50 ggtacaagtt rcttaaccaa g 21 51 21 DNA Homo sapiens 51 ctggcctgcc rtgtccggga g 21 52 21 DNA Homo sapiens 52 agtgcaggga ygaaggcctc a 21 53 21 DNA Homo sapiens 53 gctgccacgg yctcgtcccg c 21 54 21 DNA Homo sapiens 54 agaagaatga ycaaatttac g 21 55 21 DNA Homo sapiens 55 ggattttctg wcatcaagtc c 21 56 21 DNA Homo sapiens 56 caagtgggtg racagcgaag g 21 57 21 DNA Homo sapiens 57 tcccaagagc ytccagtaga c 21 58 21 DNA Homo sapiens 58 tcatcaacaa ratgaaactg g 21 59 21 DNA Homo sapiens 59 tcccatgtca mccggatgac c 21 60 21 DNA Homo sapiens 60 gactatggga ycaaatttgc c 21 61 21 DNA Homo sapiens 61 tgcacacatg maaggccccc a 21 62 21 DNA Homo sapiens 62 cctgatgaat yttcacaaca a 21 63 21 DNA Homo sapiens 63 gacatgctgg ytggccatgg c 21 64 21 DNA Homo sapiens 64 actatgggat yaaatttgcc c 21 65 21 DNA Homo sapiens 65 tgcaaaggaa rggaaaggaa a 21 66 21 DNA Homo sapiens 66 atacttgcaa rgcccccaag a 21 67 21 DNA Homo sapiens 67 ggcaagggga raatgttgcc g 21 68 21 DNA Homo sapiens 68 ctggccaagc ygtggagtgc t 21 69 21 DNA Homo sapiens 69 caaattgcga ktgggtatta a 21 70 21 DNA Homo sapiens 70 gggacctaac yggcgtgcag a 21 71 21 DNA Homo sapiens 71 gccctcatca rtgcagatga g 21 72 21 DNA Homo sapiens 72 ctgaaggtct yatggcagag g 21 73 21 DNA Homo sapiens 73 tccgtgaagc raatgaacta c 21 74 21 DNA Homo sapiens 74 tgagacagac wtcaccgtcc a 21 75 21 DNA Homo sapiens 75 catgaatgtt rcctgtgctg g 21 76 21 DNA Homo sapiens 76 gccgccctgg rcgctattac g 21 77 21 DNA Homo sapiens 77 aacattaaga sgtgccacca a 21 78 21 DNA Homo sapiens 78 ctcatagatg yaaaaactgg a 21 79 21 DNA Homo sapiens 79 gatagatttt yagaagttaa a 21 80 21 DNA Homo sapiens 80 tcgagatgga rcagcggctg g 21 81 21 DNA Homo sapiens 81 gggagcgccg mgccatcgag a 21 82 21 DNA Homo sapiens 82 gggatcgcca ygggaactca a 21 83 21 DNA Homo sapiens 83 ccctccttct ycaagaactt t 21 84 21 DNA Homo sapiens 84 tctccaactt stacaaattc t 21 85 21 DNA Homo sapiens 85 actgaatctg maggccagga t 21 86 21 DNA Homo sapiens 86 aatttgagct wcttgataag g 21 87 21 DNA Homo sapiens 87 tcagaatcat ytgatggatc t 21 88 21 DNA Homo sapiens 88 ttcaagtgaa satgctgaaa g 21 89 21 DNA Homo sapiens 89 ctcttgacga kgacgaagat g 21 90 21 DNA Homo sapiens 90 ccggactctt ycagccatta a 21 91 21 DNA Homo sapiens 91 ctgagaaaga ygcggaagat t 21 92 21 DNA Homo sapiens 92 tggaacagaa ygaagacaga t 21 93 21 DNA Homo sapiens 93 gtttcctgta ytaaagcaac t 21 94 21 DNA Homo sapiens 94 agaacagctg ygaaagagcc a 21 95 21 DNA Homo sapiens 95 gatgtgcaga ygggagggcc a 21 96 21 DNA Homo sapiens 96 aagaatttga kctacttgat a 21 97 21 DNA Homo sapiens 97 acacttctga ytgcactccc g 21 98 21 DNA Homo sapiens 98 gccaccccat kaacctggag g 21 99 21 DNA Homo sapiens 99 gagtcaccac yttcacctta t 21 100 21 DNA Homo sapiens 100 acgtacatca mtgcctcgac g 21 101 21 DNA Homo sapiens 101 tctgtaccca yactcttgta c 21 102 21 DNA Homo sapiens 102 aggcaacatg sgtgactgga g 21 103 21 DNA Homo sapiens 103 tatgtgatgc raaaggaaga g 21 104 21 DNA Homo sapiens 104 ttcattttcc raatcctgct g 21 105 21 DNA Homo sapiens 105 caagcctact yaactgctgg a 21 106 21 DNA Homo sapiens 106 agaaagagga rgaactcaag g 21 107 21 DNA Homo sapiens 107 gcacttgaag magattgaga t 21 108 21 DNA Homo sapiens 108 atgcacttga rgcagattga g 21 109 21 DNA Homo sapiens 109 cgctgagccc ygccaaagac t 21 110 21 DNA Homo sapiens 110 cctcaccaac ygctcccctc t 21 111 21 DNA Homo sapiens 111 aagctggtta mtggcgacag a 21 112 21 DNA Homo sapiens 112 ctaactccca ygcacagcct t 21 113 21 DNA Homo sapiens 113 tggacatgaa ytacagccac t 21 114 21 DNA Homo sapiens 114 ccgcaattac racaagcaag c 21 115 21 DNA Homo sapiens 115 gtggaccagc raccttcaag c 21 116 21 DNA Homo sapiens 116 tatttgtgtc ygtacccaca c 21 117 21 DNA Homo sapiens 117 cgttaaggat ygggttaagg g 21 118 21 DNA Homo sapiens 118 aactcttcta ygttttcttc a 21 119 21 DNA Homo sapiens 119 agttcaagta yggtattgaa g 21 120 21 DNA Homo sapiens 120 ccagcgacct kcaagcagag c 21 121 21 DNA Homo sapiens 121 caacaagcaa rcaagtgagc a 21 122 21 DNA Homo sapiens 122 caaaactggg staattacag t 21 123 21 DNA Homo sapiens 123 agacctgtgc rtacaccaac c 21 124 21 DNA Homo sapiens 124 gacaccccag ygcccggcta c 21 125 21 DNA Homo sapiens 125 tccactcgga satcgtgaaa c 21 126 21 DNA Homo sapiens 126 ggggctggcc rataccatcg t 21 127 21 DNA Homo sapiens 127 ccatgttcga ygtgcatgtg a 21 128 21 DNA Homo sapiens 128 aggtggacca rctgtaccgg a 21 129 21 DNA Homo sapiens 129 cccccgacgg ygtgaagtgg c 21 130 21 DNA Homo sapiens 130 gcagaggagc rgcagaggat c 21 131 21 DNA Homo sapiens 131 atgacggacc ygtgtgtgaa g 21 132 21 DNA Homo sapiens 132 ccatcaccat ygccaaccag a 21 133 21 DNA Homo sapiens 133 acgtggggtc yctgttgctc a 21 134 21 DNA Homo sapiens 134 tagaagaaag rtattgcatc g 21 135 21 DNA Homo sapiens 135 atccaagagt ygcatgtcag c 21 136 21 DNA Homo sapiens 136 cacagaagag wcgtggcccg g 21 137 21 DNA Homo sapiens 137 caagtggctg sccctggaga g 21 138 21 DNA Homo sapiens 138 ttggcgggaa ycgcctgaaa c 21 139 21 DNA Homo sapiens 139 agagcctggc ygacaacctg t 21 140 21 DNA Homo sapiens 140 ctctgagtga rgatgacttt g 21 141 21 DNA Homo sapiens 141 ttgagacctt yggcaacagc a 21 142 21 DNA Homo sapiens 142 catgatctgc ytgttccaaa t 21 143 21 DNA Homo sapiens 143 aggtttggga raagtttgat c 21 144 21 DNA Homo sapiens 144 gcaacagcat satctgcctg t 21 145 21 DNA Homo sapiens 145 gctcagttaa rggagactgt g 21 146 21 DNA Homo sapiens 146 tgtacatcgc sgtcatcctg g 21 147 21 DNA Homo sapiens 147 atcaccctgg magctcagtt a 21 148 21 DNA Homo sapiens 148 atggctacac ragctttgac a 21 149 21 DNA Homo sapiens 149 tctgtgtgaa kgctggtaga a 21 150 21 DNA Homo sapiens 150 tcccagctgt raccctctgt a 21 151 21 DNA Homo sapiens 151 tctgtaacct saatggcttc c 21 152 21 DNA Homo sapiens 152 tcaccaccaa ygacctgtac c 21 153 21 DNA Homo sapiens 153 ccccatctgg mtgacccctc c 21 154 21 DNA Homo sapiens 154 ccctgcggca raaggccaac t 21 155 21 DNA Homo sapiens 155 cagtcaaagc rgctaaggga g 21 156 21 DNA Homo sapiens 156 caaaggaagc sttggcagtc a 21 157 21 DNA Homo sapiens 157 ctcccatgga kactgctcag a 21 158 21 DNA Homo sapiens 158 ggaacctgtt magatagagc t 21 159 21 DNA Homo sapiens 159 atgacacctc ygactgtgcc a 21 160 21 DNA Homo sapiens 160 aagccaagga rtggtgggcc t 21 161 21 DNA Homo sapiens 161 agtccctgta yggctttcca g 21 162 21 DNA Homo sapiens 162 agtcattttg yacataaacg a 21 163 21 DNA Homo sapiens 163 gaggaataca rcccattcct c 21 164 21 DNA Homo sapiens 164 ctgcctactc rctccagatc t 21 165 21 DNA Homo sapiens 165 cgtcctctga ragctctgtc a 21 166 21 DNA Homo sapiens 166 actttgccga ygccctgtct g 21 167 21 DNA Homo sapiens 167 gagcccatca ycaccacact c 21 168 21 DNA Homo sapiens 168 gcgttcactt wccttcggga c 21 169 21 DNA Homo sapiens 169 ccacagtgaa katctcgccg a 21 170 21 DNA Homo sapiens 170 ggcctggctg kccaggacac a 21 171 21 DNA Homo sapiens 171 aatgggcctc rgccccgcgg a 21 172 21 DNA Homo sapiens 172 ttggcaagag ytacaaggag t 21 173 21 DNA Homo sapiens 173 tggtcatgtt yatctactcc a 21 174 21 DNA Homo sapiens 174 tcaacatgta satcgccatc a 21 175 21 DNA Homo sapiens 175 gtcaagggtg rctgcggcaa c 21 176 21 DNA Homo sapiens 176 gtacatcgcc rtcatcctgg a 21 177 21 DNA Homo sapiens 177 gttcatctac kccatcttcg g 21 178 21 DNA Homo sapiens 178 tggtgaagat kactttgaga t 21 179 21 DNA Homo sapiens 179 ttctggctga ycttcagcat c 21 180 21 DNA Homo sapiens 180 ggagacagac raccagagcc a 21 181 21 DNA Homo sapiens 181 tctgcttctt mtgcagctat a 21 182 21 DNA Homo sapiens 182 cagggcagac kgtgcgccca g 21 183 21 DNA Homo sapiens 183 caggggacgc yggacccact a 21 184 21 DNA Homo sapiens 184 cgctgctgct rccactattg c 21 185 21 DNA Homo sapiens 185 tctgcgcgcg yagcccgcca t 21 186 21 DNA Homo sapiens 186 cagcatgtgg ycgccgtgga t 21 187 21 DNA Homo sapiens 187 atgagcgaaa rgtgaatgcg t 21 188 21 DNA Homo sapiens 188 ggttcctgag rgccaagatg g 21 189 21 DNA Homo sapiens 189 gtgaggctgt rtcgggtctg c 21 190 21 DNA Homo sapiens 190 ccaagaaatt saagaggaaa t 21 191 21 DNA Homo sapiens 191 atcagcctgg kgatgctgag g 21 192 21 DNA Homo sapiens 192 gccacgggat ygtggaggtt g 21 193 21 DNA Homo sapiens 193 ctttggcacc rtcatctgca a 21 194 21 DNA Homo sapiens 194 gggtgtctgt ragtgtgtcc a 21 195 21 DNA Homo sapiens 195 ctgctgcttc wgctcttgtt c 21 196 21 DNA Homo sapiens 196 aaacgctgtg yatcatctgg t 21 197 21 DNA Homo sapiens 197 gtgcgcttct ycgcctgccc c 21 198 21 DNA Homo sapiens 198 atttcatcac sctgggcacc g 21 199 21 DNA Homo sapiens 199 tgtgcatcat ytggttctcc t 21 200 21 DNA Homo sapiens 200 tgaacatcat wgacattgtg g 21 201 21 DNA Homo sapiens 201 cacagtgacc yggctctttt t 21 202 21 DNA Homo sapiens 202 ccctggagga ygggttctac g 21 203 21 DNA Homo sapiens 203 ataaatgccc rgagggaatt a 21 204 21 DNA Homo sapiens 204 ttccgggcaa ytcagaagaa a 21 205 21 DNA Homo sapiens 205 cactgtgcca ygtgccttta t 21 206 21 DNA Homo sapiens 206 acctcttcga yacagcagaa g 21 207 21 DNA Homo sapiens 207 acctggccga wgagatcctg t 21 208 21 DNA Homo sapiens 208 cgttactctg kggactactc c 21 209 21 DNA Homo sapiens 209 gcttggctgc rtcttcatga a 21 210 21 DNA Homo sapiens 210 cggtgatcgc yctgcgccac g 21 211 21 DNA Homo sapiens 211 ggaccctgcc ragcccaggt a 21 212 21 DNA Homo sapiens 212 gtggctcatc rccttcgccc a 21 213 21 DNA Homo sapiens 213 tggactactc rcgttttcac a 21 214 21 DNA Homo sapiens 214 ggccaccgct wtgagcctgt g 21 215 21 DNA Homo sapiens 215 ggccaccgct wtgagcctgt g 21 216 21 DNA Homo sapiens 216 cgcgggtcac ygaggagggc g 21 217 21 DNA Homo sapiens 217 ctggtgtcgc ycatcaccat c 21 218 21 DNA Homo sapiens 218 tctccatcga sacgcagacc a 21 219 21 DNA Homo sapiens 219 cactccccag maagactggg g 21 220 21 DNA Homo sapiens 220 cccagcaaga stgggggcag c 21 221 21 DNA Homo sapiens 221 gagtgtgcca mgcttttgga c 21 222 21 DNA Homo sapiens 222 acaaccccca rctggcccac g 21 223 21 DNA Homo sapiens 223 tcctgggcaa raccttgcag g 21 224 21 DNA Homo sapiens 224 cgagctgctc rtgcgcttct t 21 225 21 DNA Homo sapiens 225 ctctgggtcc rcgcgggcca t 21 226 21 DNA Homo sapiens 226 gttatcctca yctccatcat c 21 227 21 DNA Homo sapiens 227 caaccagcca rtggaggagg c 21 228 21 DNA Homo sapiens 228 catcatctgg ytctccttcg a 21 229 21 DNA Homo sapiens 229 gtgtattctg wggattactc c 21 230 21 DNA Homo sapiens 230 ttctctactt yggcttgcgg t 21 231 21 DNA Homo sapiens 231 gtggtctgca yctttggcga c 21 232 21 DNA Homo sapiens 232 gatgatactt sgctgcagga c 21 233 21 DNA Homo sapiens 233 tcgtggtctg yatctttggc g 21 234 21 DNA Homo sapiens 234 cactcatgag ygcgacgtac t 21 235 21 DNA Homo sapiens 235 ggatgtttca ytggtgtgca c 21 236 21 DNA Homo sapiens 236 catcctgact ygaagtgaag c 21 237 21 DNA Homo sapiens 237 ctggcaatga ycagattgac a 21 238 21 DNA Homo sapiens 238 agtttttgga ycaagacgat g 21 239 21 DNA Homo sapiens 239 tgcacgggat rttacgtcaa c 21 240 21 DNA Homo sapiens 240 tgctggtaat wgatgcatct a 21 241 21 DNA Homo sapiens 241 tctacctgca yacagtcatt c 21 242 21 DNA Homo sapiens 242 caaaggtata yagatgacaa c 21 243 21 DNA Homo sapiens 243 cctgaaaatg ragccacctt c 21 244 21 DNA Homo sapiens 244 tgaacatcag rtggagctac t 21 245 21 DNA Homo sapiens 245 actatgagaa ratagagaga a 21 246 21 DNA Homo sapiens 246 ctgaagaggg ygggtactca t 21 247 21 DNA Homo sapiens 247 agacaagcca rtaaaaacag a 21 248 21 DNA Homo sapiens 248 caccacagca rctgtcatgg c 21 249 21 DNA Homo sapiens 249 gcccaatgag rttaaagtct c 21 250 21 DNA Homo sapiens 250 gattttcacc ratcaagaga t 21 251 21 DNA Homo sapiens 251 atcaagagat yggggagtta c 21 252 21 DNA Homo sapiens 252 tacttccaca yactgttacg a 21 253 21 DNA Homo sapiens 253 tcactctcca stacctaaac a 21 254 21 DNA Homo sapiens 254 aggtaatggt raaaaaagac a 21 255 21 DNA Homo sapiens 255 gtcctgccga ktcccctgat g 21 256 21 DNA Homo sapiens 256 cccctgatga rggaatcact a 21 257 21 DNA Homo sapiens 257 agatgccact ratggcaagg a 21 258 21 DNA Homo sapiens 258 caccgctcaa yggattttct g 21 259 21 DNA Homo sapiens 259 ttccagagcc wacaacagat g 21 260 21 DNA Homo sapiens 260 gcggcctcgt sctcaccagc a 21 261 21 DNA Homo sapiens 261 tgtgggcgcc ktggtcgcct t 21 262 21 DNA Homo sapiens 262 gccgtgtcac ycgaggatga t 21 263 21 DNA Homo sapiens 263 aattccgatc kgatcctcag g 21 264 21 DNA Homo sapiens 264 caagcttatc ragaccctct c 21 265 21 DNA Homo sapiens 265 gcagatcact sttggcctcg t 21 266 21 DNA Homo sapiens 266 tcttggcctc rtcttcctct g 21 267 21 DNA Homo sapiens 267 tagagatagc ygcttacaga a 21 268 21 DNA Homo sapiens 268 cagctgcaac yctaactatt c 21 269 21 DNA Homo sapiens 269 gagcgaagca ygtgatcatg c 21 270 21 DNA Homo sapiens 270 atggagagaa yactgcccag t 21 271 21 DNA Homo sapiens 271 taatgtcggc ygagagcccc a 21 272 21 DNA Homo sapiens 272 gaccctgacc rctatgtctg t 21 273 21 DNA Homo sapiens 273 acttctcacc rggagatttg g 21 274 21 DNA Homo sapiens 274 aacgtgcaga ygaagcctta a 21 275 21 DNA Homo sapiens 275 cccacgttag yggaggtggt g 21 276 21 DNA Homo sapiens 276 cattgttcga ratttaggac t 21 277 21 DNA Homo sapiens 277 gacagcaggg ytataatgta t 21 278 21 DNA Homo sapiens 278 aagagtcaga wccacccaga c 21 279 21 DNA Homo sapiens 279 cagtaatttt yctcatcttg t 21 280 21 DNA Homo sapiens 280 taatgaatga mattgcagat a 21 281 21 DNA Homo sapiens 281 caatggaaga kgttcttgaa c 21 282 21 DNA Homo sapiens 282 cacttatacc ycttgtgtat g 21 283 21 DNA Homo sapiens 283 attcttggat ycagctattt g 21 284 21 DNA Homo sapiens 284 gactttggca stgaccacca g 21 285 21 DNA Homo sapiens 285 actactgctc rgaccaatac t 21 286 21 DNA Homo sapiens 286 ttgaaggtgt yttcagaaga t 21 287 21 DNA Homo sapiens 287 ccaaacacct ygtagaactc t 21 288 21 DNA Homo sapiens 288 ttcaggagcc yatcatggct c 21 289 21 DNA Homo sapiens 289 tatatattaa ktggcagaaa c 21 290 21 DNA Homo sapiens 290 cattcagatt scaaacaagg a 21 291 21 DNA Homo sapiens 291 ttccacatct rgtgattaga a 21 292 21 DNA Homo sapiens 292 gagaaatatg magtcttcat g 21 293 21 DNA Homo sapiens 293 aggagaaaag ytttaaaaaa t 21 294 21 DNA Homo sapiens 294 ttcaaaatga rtggttacat a 21 295 21 DNA Homo sapiens 295 cctgtgcact ycggtggtca c 21 296 21 DNA Homo sapiens 296 ttgccaagaa rtccaagaac c 21 297 21 DNA Homo sapiens 297 atgatccatg sgtagaacat g 21 298 21 DNA Homo sapiens 298 ccaccagacc wgacgagggg c 21 299 21 DNA Homo sapiens 299 tttgcaattc sttcaaggga g 21 300 21 DNA Homo sapiens 300 ggcaggagtg yggagagcct g 21 301 21 DNA Homo sapiens 301 tgcagcccac rgcagagaat g 21 302 21 DNA Homo sapiens 302 ggtgtcaact sttagccacg c 21 303 21 DNA Homo sapiens 303 acgcagatgc ygattgcttt g 21 304 21 DNA Homo sapiens 304 actttattaa yggttcttac t 21 305 21 DNA Homo sapiens 305 ttgcgtatgc ygataatagc c 21 306 21 DNA Homo sapiens 306 attctgatga yggctgttta a 21 307 21 DNA Homo sapiens 307 atttatgtgg watgctctca c 21 308 21 DNA Homo sapiens 308 tcattcatta ycatggtgta g 21 309 21 DNA Homo sapiens 309 cagcttttta ygactcactg a 21 310 21 DNA Homo sapiens 310 atcctgttat ygagatgtta g 21 311 21 DNA Homo sapiens 311 atttaatgga rgatccagac a 21 312 21 DNA Homo sapiens 312 aaaatataac rgaatgcagg a 21 313 21 DNA Homo sapiens 313 gaaataaagc mcaaactgta c 21 314 21 DNA Homo sapiens 314 tatgtattac ygaaaaagcc t 21 315 21 DNA Homo sapiens 315 ggatgaggat rtgaagctga t 21 316 21 DNA Homo sapiens 316 atgaggagga ygagcagctg a 21 317 21 DNA Homo sapiens 317 cactgagaat rgcaccagtc t 21 318 21 DNA Homo sapiens 318 tggagatgag raaatgggtc c 21 319 21 DNA Homo sapiens 319 tgaccatcaa yaaggaagat g 21 320 21 DNA Homo sapiens 320 ataacaagga ygtgtcggtg a 21 321 21 DNA Homo sapiens 321 cagatcaaga rtgacatcca g 21 322 21 DNA Homo sapiens 322 atccctgccc yggacagcaa g 21 323 21 DNA Homo sapiens 323 attgataatg raagctggcc a 21 324 21 DNA Homo sapiens 324 agtttagaaa rccaagctac a 21 325 21 DNA Homo sapiens 325 aaatgtagca matcagaagc c 21 326 21 DNA Homo sapiens 326 cttataatca rctggcttca a 21 327 21 DNA Homo sapiens 327 accatggttt yatatggaga c 21 328 21 DNA Homo sapiens 328 gaaaaaaata wtgattacat g 21 329 21 DNA Homo sapiens 329 agcatgtgag mccattgaga t 21 330 21 DNA Homo sapiens 330 atgattctgt ygtttcaatg t 21 331 21 DNA Homo sapiens 331 agtcagtgtg sagcatttga a 21 332 21 DNA Homo sapiens 332 catctcaaga sgagctcatt a 21 333 21 DNA Homo sapiens 333 tctcctgaac rtctaaaaga t 21 334 21 DNA Homo sapiens 334 agcgtccaga raggagagct t 21 335 21 DNA Homo sapiens 335 tatgggaagt rgtcatgcat c 21 336 21 DNA Homo sapiens 336 atctgcccag rgtccagctg c 21 337 21 DNA Homo sapiens 337 agtacaacca ratgccagtc a 21 338 21 DNA Homo sapiens 338 tctccacaaa rtgtgaccac a 21 339 21 DNA Homo sapiens 339 tccaggtccg yggcctggag a 21 340 21 DNA Homo sapiens 340 tacaacacca rtaacggggc t 21 341 21 DNA Homo sapiens 341 gcaatttgga yatctccaac a 21 342 21 DNA Homo sapiens 342 tgaaatttct yagtgagaac a 21 343 21 DNA Homo sapiens 343 ttcaccacac ytaaggagaa c 21 344 21 DNA Homo sapiens 344 tttcttccct satcctgatc t 21 345 21 DNA Homo sapiens 345 cagcaatgac mttcccatcg c 21 346 21 DNA Homo sapiens 346 cagctgagaa ygctgccaag g 21 347 21 DNA Homo sapiens 347 tgtccctagc ygaactcagg a 21 348 21 DNA Homo sapiens 348 agcgaacgac rcttcgctat g 21 349 21 DNA Homo sapiens 349 aaagcaatgc ygagaggatg a 21 350 21 DNA Homo sapiens 350 ttcgtgaatg rtctaaagcg g 21 351 21 DNA Homo sapiens 351 agtgtgaccc rgactgcctc c 21 352 21 DNA Homo sapiens 352 catgccaatt rcatcgttca c 21 353 21 DNA Homo sapiens 353 ctgaagccga ycagttgggc a 21 354 21 DNA Homo sapiens 354 tatgcaacac ytgtggacat g 21 355 21 DNA Homo sapiens 355 ttctggtgac ragtggtgga a 21 356 21 DNA Homo sapiens 356 tgattgggct rcctccagag g 21 357 21 DNA Homo sapiens 357 ctcttatcta yataaggatg a 21 358 21 DNA Homo sapiens 358 cagacctcag ygcctctctg g 21 359 21 DNA Homo sapiens 359 gtgagtgatg maggtttgaa g 21 360 21 DNA Homo sapiens 360 aaggtttgaa rggcaagatt a 21 361 21 DNA Homo sapiens 361 gtcacagcca yggacaagag c 21 362 21 DNA Homo sapiens 362 tgacgtttga yattgatgcc a 21 363 21 DNA Homo sapiens 363 tgaccgtgga ygagggtgtc c 21 364 21 DNA Homo sapiens 364 cccactgccg mttctatgag g 21 365 21 DNA Homo sapiens 365 tcatctcccg mtttgagggc t 21 366 21 DNA Homo sapiens 366 acctgtgttc wcaaagatgg c 21 367 21 DNA Homo sapiens 367 actcaagcta ygaggaaaag a 21 368 21 DNA Homo sapiens 368 ggggtactgg racatccgcg g 21 369 21 DNA Homo sapiens 369 gattgatggg rctcacaaga t 21 370 21 DNA Homo sapiens 370 cccagagcaa ygccatcctg c 21 371 21 DNA Homo sapiens 371 gtatatttga scccaagtgc c 21 372 21 DNA Homo sapiens 372 caacaagcct rtatgctgag c 21 373 21 DNA Homo sapiens 373 ggctttcatg kgccgttttg a 21 374 21 DNA Homo sapiens 374 cagagcaatg mcatcttgcg c 21 375 21 DNA Homo sapiens 375 tggacgcctt yccaaatctg a 21 376 21 DNA Homo sapiens 376 tggggctgga racggccgga g 21 377 21 DNA Homo sapiens 377 ggccggggac rcccacctgg g 21 378 21 DNA Homo sapiens 378 tcagcgaggc sgacaagaag a 21 379 21 DNA Homo sapiens 379 acaaggggga saccaaggca t 21 380 21 DNA Homo sapiens 380 agctgctgca rgacttcttc a 21 381 21 DNA Homo sapiens 381 attcctccga rgtcttttgt t 21 382 21 DNA Homo sapiens 382 gacgccttcc yaaacttgaa g 21 383 21 DNA Homo sapiens 383 ttggaaagtc rgctacatgg a 21 384 21 DNA Homo sapiens 384 ctctcggcta ygaactgttt g 21 385 21 DNA Homo sapiens 385 ggactgccat rgaccaggcc c 21 386 21 DNA Homo sapiens 386 caggtgttgg rgccactcat t 21 387 21 DNA Homo sapiens 387 tgttggggcc mctcattggg g 21 388 21 DNA Homo sapiens 388 ccaggtgccc raggagaagg t 21 389 21 DNA Homo sapiens 389 ccgcgttgac yctctggaga c 21 390 21 DNA Homo sapiens 390 tggaccacta yaagaagggg a 21 391 21 DNA Homo sapiens 391 tcatcgtggt ygccctgtat g 21 392 21 DNA Homo sapiens 392 ccattcacca ygaagacctc a 21 393 21 DNA Homo sapiens 393 ccctggccac scggaaggag g 21 394 21 DNA Homo sapiens 394 ccagcgccag yccacactgt c 21 395 21 DNA Homo sapiens 395 ccacgaagac ytcagcttcc a 21 396 21 DNA Homo sapiens 396 gtgaattaag rgaaataatg a 21 397 21 DNA Homo sapiens 397 gactgtgtga wttccctgat a 21 398 21 DNA Homo sapiens 398 agatatggat yaggtggaaa a 21 399 21 DNA Homo sapiens 399 gacagtttga wctgactact t 21 400 21 DNA Homo sapiens 400 tcagctagat rctgttgtca g 21 401 21 DNA Homo sapiens 401 gagtttctgg kctgagctca a 21 402 21 DNA Homo sapiens 402 gcacgcgcac rcccgcaggg t 21 403 21 DNA Homo sapiens 403 catcccgaat ycaggcatca c 21 404 21 DNA Homo sapiens 404 gcgtggtccg yttcgccatg c 21 405 21 DNA Homo sapiens 405 attttgccat kgttctgctc a 21 406 21 DNA Homo sapiens 406 ctgccatggg yagctccgtg c 21 407 21 DNA Homo sapiens 407 ccctcgaacc ygagacagca g 21 408 21 DNA Homo sapiens 408 ctgctggttg yactgtcagt g 21 409 21 DNA Homo sapiens 409 caccgttcac sttgctttgg c 21 410 21 DNA Homo sapiens 410 tctactgaag rgcattctgg c 21 411 21 DNA Homo sapiens 411 ccatcagcaa ygtcacagcc t 21 412 21 DNA Homo sapiens 412 aaatactttt ytttctacaa c 21 413 21 DNA Homo sapiens 413 ggacactctc rtcttttgct g 21 414 21 DNA Homo sapiens 414 aagcactatg ytcctttcct c 21 415 21 DNA Homo sapiens 415 tcttcatggc ygcgttaatc c 21 416 21 DNA Homo sapiens 416 ggacatggaa raagacatct t 21 417 21 DNA Homo sapiens 417 tgacattggc ratgcagctg a 21 418 21 DNA Homo sapiens 418 cggaaaatga rtgccaggca g 21 419 21 DNA Homo sapiens 419 tcataatgca ytaaaaacct c 21 420 21 DNA Homo sapiens 420 ccactgtgac wttggcaatg c 21 421 21 DNA Homo sapiens 421 gtcgctgact yggagagctc a 21 422 21 DNA Homo sapiens 422 gaagtgtata rgaatcccaa t 21 423 21 DNA Homo sapiens 423 ttctggctga mcctgtggag a 21 424 21 DNA Homo sapiens 424 atctttacct saagatgaaa c 21 425 21 DNA Homo sapiens 425 ctctgccgta rttttgcccc t 21 426 21 DNA Homo sapiens 426 atcctgggct ycattgggtc t 21 427 21 DNA Homo sapiens 427 ctgccgtagt yttgcccctg g 21 428 21 DNA Homo sapiens 428 agctggatgt rcctgtggta a 21 429 21 DNA Homo sapiens 429 cggcttcggc ytctccaact a 21 430 21 DNA Homo sapiens 430 gccggggcca ygtgagattc c 21 431 21 DNA Homo sapiens 431 tgtacggctt yggcctctcc a 21 432 21 DNA Homo sapiens 432 tgatgggcaa rcagctggag a 21 433 21 DNA Homo sapiens 433 gcaaagtccc ktttaacaaa a 21 434 21 DNA Homo sapiens 434 tggcatacat ygagcggaag a 21 435 21 DNA Homo sapiens 435 aaaggcttgg ygctgggcag t 21 436 21 DNA Homo sapiens 436 agccacagaa rccatgggat a 21 437 21 DNA Homo sapiens 437 cctgctattt waaagacttc t 21 438 21 DNA Homo sapiens 438 acaaagttga yttagaagag a 21 439 21 DNA Homo sapiens 439 tcatgagctt yggtatcctt a 21 440 21 DNA Homo sapiens 440 tcatgtaaca raaaatcaaa t 21 441 21 DNA Homo sapiens 441 aaaaaatcaa rtgtaataga t 21 442 21 DNA Homo sapiens 442 ttaccatgta ragtaagtaa t 21 443 21 DNA Homo sapiens 443 gaacgataca rtagtcaaat g 21 444 21 DNA Homo sapiens 444 tttagaggat kcaacactac a 21 445 21 DNA Homo sapiens 445 tttagacgtt wtatataaaa t 21 446 21 DNA Homo sapiens 446 agacgtttta yataaaatga c 21 447 21 DNA Homo sapiens 447 ataccaggag yttcaattac t 21 448 21 DNA Homo sapiens 448 ttttctttct kaaaatcgat g 21 449 21 DNA Homo sapiens 449 ctcagaaatc ytgatgacgt c 21 450 21 DNA Homo sapiens 450 ctgccaggct rcaagggcca a 21 451 21 DNA Homo sapiens 451 cacatgccag ygccaatccc c 21 452 21 DNA Homo sapiens 452 ggggctcagc ygacggccct c 21 453 21 DNA Homo sapiens 453 gacccctcag ycgtgcctgt g 21 454 21 DNA Homo sapiens 454 ccggagccca rggactgcgt c 21 455 21 DNA Homo sapiens 455 acggatgcac wgggccaggt c 21 456 21 DNA Homo sapiens 456 gcgccgctgc stggccgccc g 21 457 21 DNA Homo sapiens 457 ttggaattcc rggtcatgcc t 21 458 21 DNA Homo sapiens 458 aatcaactac ycaggaaaaa c 21 459 21 DNA Homo sapiens 459 cctgaggttg yggaaaagga a 21 460 21 DNA Homo sapiens 460 agaagatgag wttatgcctg a 21 461 21 DNA Homo sapiens 461 gagaggccgc racccaacac c 21 462 21 DNA Homo sapiens 462 tgttccagga rtccagtatc t 21 463 21 DNA Homo sapiens 463 agcttcagat ytgcccggcg a 21 464 21 DNA Homo sapiens 464 gcagtggtcc rgcggccact c 21 465 21 DNA Homo sapiens 465 tcatggacaa sgtggtgcgg t 21 466 21 DNA Homo sapiens 466 ttgtgtcaga wcccaaagct g 21 467 21 DNA Homo sapiens 467 aatattcagt yccaggcgcc a 21 468 21 DNA Homo sapiens 468 ctaaagaata rcccacctta t 21 469 21 DNA Homo sapiens 469 aactcatcct rgctacatgg c 21 470 21 DNA Homo sapiens 470 tcgagaacct yatgagtcag g 21 471 21 DNA Homo sapiens 471 tctttccaag yggactcttt c 21 472 21 DNA Homo sapiens 472 ctctggatgg ygatcctaca a 21 473 21 DNA Homo sapiens 473 ccggcactca yttccatttt c 21 474 21 DNA Homo sapiens 474 agcggcccag yttcagcacc a 21 475 21 DNA Homo sapiens 475 cccagcgggt yaagagtgac a 21 476 21 DNA Homo sapiens 476 gaagcccctg yatgagcagc t 21 477 21 DNA Homo sapiens 477 gagaggaagc ygatggggtc t 21 478 21 DNA Homo sapiens 478 ctgctggcat kgagtacctg g 21 479 21 DNA Homo sapiens 479 gatggtctgc yccggcactt c 21 480 21 DNA Homo sapiens 480 gtgacaaggc yaaggacaag t 21 481 21 DNA Homo sapiens 481 tgggcaccgg ytgcttcggg g 21 482 21 DNA Homo sapiens 482 cagaagctac rgggcagcag a 21 483 21 DNA Homo sapiens 483 tggatcaaca raatcccgat g 21 484 21 DNA Homo sapiens 484 actacaacgt ygatagaacc a 21 485 21 DNA Homo sapiens 485 ggccaatcca rtttgtggta c 21 486 21 DNA Homo sapiens 486 gtccaggctt ytaatgtaga t 21 487 21 DNA Homo sapiens 487 gcatcacaat ytgcagaaat c 21 488 21 DNA Homo sapiens 488 aaattctcag sagctattat c 21 489 21 DNA Homo sapiens 489 aaccaatgca kcgacacctt t 21 490 21 DNA Homo sapiens 490 gacactgaag ragctgtcag t 21 491 21 DNA Homo sapiens 491 ttctcttcag yagaatgatg a 21 492 21 DNA Homo sapiens 492 actgtgaagg wtctgctctg t 21 493 21 DNA Homo sapiens 493 aaaatcagag yaacttaaaa a 21 494 21 DNA Homo sapiens 494 agtactgggg ytcctcagtc t 21 495 21 DNA Homo sapiens 495 gccagtctct stgcctcaat a 21 496 21 DNA Homo sapiens 496 attctgggac kcccaaagac c 21 497 21 DNA Homo sapiens 497 ggagtgaccc rgtggagcaa g 21 498 21 DNA Homo sapiens 498 tccagaacca ytttgtggac g 21 499 21 DNA Homo sapiens 499 gcatacctca stggctacta a 21 500 21 DNA Homo sapiens 500 ccatcttggt ygtgaagatc c 21 501 21 DNA Homo sapiens 501 agagccaggt rtcggagcag c 21 502 21 DNA Homo sapiens 502 gtcgccgggg mccagcaaat a 21 503 21 DNA Homo sapiens 503 cctcccaaag ygctgggatt a 21 504 21 DNA Homo sapiens 504 gacgcagggt ytcccatgac c 21 505 21 DNA Homo sapiens 505 tatgatccat yttaactgag g 21 506 21 DNA Homo sapiens 506 tgcaactcct rctattaaga c 21 507 21 DNA Homo sapiens 507 taccgtgtaa ygtgaaccag c 21 508 21 DNA Homo sapiens 508 ttctgctgct ratggagcga g 21 509 21 DNA Homo sapiens 509 tgattcatga stgtcctcat c 21 510 21 DNA Homo sapiens 510 tagaggacat raacgagttc a 21 511 21 DNA Homo sapiens 511 gaattcagga ygttgtaccg t 21 512 21 DNA Homo sapiens 512 actcatgaag yagcttaatg c 21 513 21 DNA Homo sapiens 513 tttatgacat saagcggggc t 21 514 21 DNA Homo sapiens 514 tggaagactt ygagacgatt g 21 515 21 DNA Homo sapiens 515 aagacgcagt ytatcatgat g 21 516 21 DNA Homo sapiens 516 ttcaggcaaa ygagatcatg t 21 517 21 DNA Homo sapiens 517 tatgttgtat ytcgagagta a 21 518 21 DNA Homo sapiens 518 tctcgacccc ygtggtgctc t 21 519 21 DNA Homo sapiens 519 ggctgtgggg rctacgcaag a 21 520 21 DNA Homo sapiens 520 aggcccaggc rgtttggcac g 21 521 21 DNA Homo sapiens 521 gctgggacct sttccacaaa t 21 522 21 DNA Homo sapiens 522 tacatcccca rtcgtggccc t 21 523 21 DNA Homo sapiens 523 aaaacctcaa rgttataaag g 21 524 21 DNA Homo sapiens 524 tgcattccag rgacacgtgg c 21 525 21 DNA Homo sapiens 525 gggagccatc rtaaggaccc a 21 526 21 DNA Homo sapiens 526 agcttgccag yggcatcctc a 21 527 21 DNA Homo sapiens 527 cccatttgag magctgtgag c 21 528 21 DNA Homo sapiens 528 atgacctcag rgactttcca a 21 529 21 DNA Homo sapiens 529 gggacgcgaa stgcgcagcc a 21 530 21 DNA Homo sapiens 530 aagcggtcta ytccagggat t 21 531 21 DNA Homo sapiens 531 cctattgatc rgaagtcagt c 21 532 21 DNA Homo sapiens 532 gagtggatct yattgaagtt t 21 533 21 DNA Homo sapiens 533 tgccccctag ygactccgtg t 21 534 21 DNA Homo sapiens 534 gaaagcgcct raaactgacg a 21 535 21 DNA Homo sapiens 535 actcggggca yggcagcact t 21 536 21 DNA Homo sapiens 536 tcgcaggaac rtgtggactc t 21 537 21 DNA Homo sapiens 537 cgtcctgaga yctcagaaag a 21 538 21 DNA Homo sapiens 538 ggactgctct yaacacaagc g 21 539 21 DNA Homo sapiens 539 tgagctgttc sgatgctctg c 21 540 21 DNA Homo sapiens 540 catcccagac rcgggcagtc a 21 541 21 DNA Homo sapiens 541 ccttcggacc ycaggacgtc g 21 542 21 DNA Homo sapiens 542 actagtaaaa rctggacctt c 21 543 21 DNA Homo sapiens 543 atatttgcga yaagtaggat a 21 544 21 DNA Homo sapiens 544 cacacaaggt sgtgttatat t 21 545 21 DNA Homo sapiens 545 ttgaacacct ycctcgccgt g 21 546 21 DNA Homo sapiens 546 tttgtggcac yagcttggag c 21 547 21 DNA Homo sapiens 547 ttctatgaca yctaccatgc t 21 548 21 DNA Homo sapiens 548 agaaagcaac ycaaagtggg a 21 549 21 DNA Homo sapiens 549 tctgcaacga rcgcttcact c 21 550 21 DNA Homo sapiens 550 agacacggga stgcatctac t 21 551 21 DNA Homo sapiens 551 cctcacggat yacctcaagg g 21 552 21 DNA Homo sapiens 552 ggctcctgag rtgctcgagg g 21 553 21 DNA Homo sapiens 553 tgctgaagag ygacctcaca g 21 554 21 DNA Homo sapiens 554 ccagagacag ygcgacccgg a 21 555 21 DNA Homo sapiens 555 acctggccat ygtccacgcc a 21 556 21 DNA Homo sapiens 556 agtgcttgac wgacatttac c 21 557 21 DNA Homo sapiens 557 catgctggtc rtcctcatct t 21 558 21 DNA Homo sapiens 558 acatccacgc mgctcgaggg a 21 559 21 DNA Homo sapiens 559 ggtgctagtc ygcgccatca a 21 560 21 DNA Homo sapiens 560 cacctacctg stctggacct g 21 561 21 DNA Homo sapiens 561 cggtacacag ygacaattga g 21 562 21 DNA Homo sapiens 562 gagcacgggt ycctgtttga t 21 563 21 DNA Homo sapiens 563 cagagttatg wggcactgcg g 21 564 21 DNA Homo sapiens 564 tatattggga sattgctcga a 21 565 21 DNA Homo sapiens 565 gagatgtgtc yctccaaaga c 21 566 21 DNA Homo sapiens 566 agctgtactt ycaacagtta t 21 567 21 DNA Homo sapiens 567 ggggaaacca rtgaaaagcg t 21 568 21 DNA Homo sapiens 568 tcacctgctg ytataacttc a 21 569 21 DNA Homo sapiens 569 tgaaagaagt rgcaacgctg t 21 570 21 DNA Homo sapiens 570 gcatctctgc ygaagccaag g 21 571 21 DNA Homo sapiens 571 tgaccagcct ycgccgctcg g 21 572 21 DNA Homo sapiens 572 cagagtgcaa rcgcagccac a 21 573 21 DNA Homo sapiens 573 ataacaaccc yatctggtca g 21 574 21 DNA Homo sapiens 574 tgaagctctt ytttggtggc c 21 575 21 DNA Homo sapiens 575 cggcgggagg yactgaggag g 21 576 21 DNA Homo sapiens 576 gcagctcttc rccaatgggg a 21 577 21 DNA Homo sapiens 577 tcactgtcca rgtgcccagc a 21 578 21 DNA Homo sapiens 578 gactggccag mccagcctca g 21 579 21 DNA Homo sapiens 579 ggcttctgca kacagtcaag c 21 580 21 DNA Homo sapiens 580 ttttacaaat ragcagagaa t 21 581 21 DNA Homo sapiens 581 gctgtgtttc sggatgcaag c 21 582 21 DNA Homo sapiens 582 cagtaacatg ygcatctact g 21 583 21 DNA Homo sapiens 583 agcgccaggc mccgagcagt g 21 584 21 DNA Homo sapiens 584 ggtggctggc rtcctggttc t 21 585 21 DNA Homo sapiens 585 tgaagccgga rgacagtggc a 21 586 21 DNA Homo sapiens 586 ctgcatgatc ktcgggagcc c 21 587 21 DNA Homo sapiens 587 tctgggattc ygcaaaaggg a 21 588 21 DNA Homo sapiens 588 gagtggccat scacctgtgc t 21 589 21 DNA Homo sapiens 589 ttgtagcccc rtcacccttg g 21 590 21 DNA Homo sapiens 590 ctgtgtgtga ygtgcatggg a 21 591 21 DNA Homo sapiens 591 ggtggtaacc rtcgggctag a 21 592 21 DNA Homo sapiens 592 ctgatgggat sctatggaac c 21 593 21 DNA Homo sapiens 593 atgatgccat ygatgccctc g 21 594 21 DNA Homo sapiens 594 ctgtctctgg ytggccaaag g 21 595 21 DNA Homo sapiens 595 agaaagggat macctgccgc a 21 596 21 DNA Homo sapiens 596 agaggccgca ygtcggatct c 21 597 21 DNA Homo sapiens 597 ccgtttgcct rcctcgtcca g 21 598 21 DNA Homo sapiens 598 gtttgactgt rgaccagctg c 21 599 21 DNA Homo sapiens 599 gtgtctgaga ractccggac c 21 600 21 DNA Homo sapiens 600 gggactaaga sctgggaaga a 21 601 21 DNA Homo sapiens 601 tctccgatga yacactcttt c 21 602 21 DNA Homo sapiens 602 gctgctctcc yggagatggc a 21 603 21 DNA Homo sapiens 603 gtggccttct ycaccaatgg g 21 604 21 DNA Homo sapiens 604 acagccctcc rtgtgctacc t 21 605 21 DNA Homo sapiens 605 tgcctggaac yttggctggg c 21 606 21 DNA Homo sapiens 606 agattcactc rggctctgtc a 21 607 21 DNA Homo sapiens 607 ccattgctgc yttcttgccg g 21 608 21 DNA Homo sapiens 608 tggccaataa matcttggcc a 21 609 21 DNA Homo sapiens 609 atgacggaca ratttgccca g 21 610 21 DNA Homo sapiens 610 agcagcttcg katggcaatg a 21 611 21 DNA Homo sapiens 611 tcacgagggc rgagcaggtg g 21 612 21 DNA Homo sapiens 612 ggcgcagcat ycggcttttc a 21 613 21 DNA Homo sapiens 613 gcccctcacc rtatcagcct t 21 614 21 DNA Homo sapiens 614 tcagggcgct ytgtgacaga g 21 615 21 DNA Homo sapiens 615 caaggtggca ycattagtct t 21 616 21 DNA Homo sapiens 616 tttcgaagtt ycttaccaac c 21 617 21 DNA Homo sapiens 617 ctccagcatg sgaagtcggt g 21 618 21 DNA Homo sapiens 618 acagtgcaac rgctgatgct g 21 619 21 DNA Homo sapiens 619 gtctgagaga ytccggaccc t 21 620 21 DNA Homo sapiens 620 ggagggccct ytggagcgcc c 21 621 21 DNA Homo sapiens 621 tggttgtcgg ktgctgcaga c 21 622 21 DNA Homo sapiens 622 agctgctgac rcggccacac a 21 623 21 DNA Homo sapiens 623 tagtgagcca rcaccacatc t 21 624 21 DNA Homo sapiens 624 catcgatggg rctgataggt t 21 625 21 DNA Homo sapiens 625 tgagtgggat sgtggaaggg a 21 626 21 DNA Homo sapiens 626 gtggaaggga racacacttg g 21 627 21 DNA Homo sapiens 627 gaggggaaga raatgaggtg t 21 628 21 DNA Homo sapiens 628 aagaaatata yacttgagtg g 21 629 21 DNA Homo sapiens 629 tgatcgctat stagcaaccc t 21 630 21 DNA Homo sapiens 630 tcttaaaatt sacatggacc a 21 631 21 DNA Homo sapiens 631 cactgggagt ygccatatct g 21 632 21 DNA Homo sapiens 632 agattatgag yctccatttg g 21 633 21 DNA Homo sapiens 633 tgggaactgc ragatacatg g 21 634 21 DNA Homo sapiens 634 tactccagtt sctgacggct g 21 635 21 DNA Homo sapiens 635 tcgtgaagaa ygacctaacc t 21 636 21 DNA Homo sapiens 636 tgtcatcatc mtcttctact g 21 637 21 DNA Homo sapiens 637 cctccacagt ratcacactc c 21 638 21 DNA Homo sapiens 638 cctgtctgac ratcctggac t 21 639 21 DNA Homo sapiens 639 gaagccacag racttgcact t 21 640 21 DNA Homo sapiens 640 agataaataa yggcggctgt t 21 641 21 DNA Homo sapiens 641 gggtggatgt yttcacccaa c 21 642 21 DNA Homo sapiens 642 ctgagacgta yggaccccag t 21 643 21 DNA Homo sapiens 643 tggttatggg mcaaatggat g 21 644 21 DNA Homo sapiens 644 tctgggttat saaaactgaa a 21 645 21 DNA Homo sapiens 645 gcctttcact yacaccaggc a 21 646 21 DNA Homo sapiens 646 gcaaggtgcc rggaaacttc a 21 647 21 DNA Homo sapiens 647 agaggagtgc rtctccctca c 21 648 21 DNA Homo sapiens 648 caggtatctt rgaagttttg c 21 649 21 DNA Homo sapiens 649 tagaagccat ygtcagcagt g 21 650 21 DNA Homo sapiens 650 acatgggagg ycctgaaact c 21 651 21 DNA Homo sapiens 651 tactatattg ratttcggta c 21 652 21 DNA Homo sapiens 652 agaagacgct rtccattttc a 21 653 21 DNA Homo sapiens 653 atcgtggaga rcggcggggc a 21 654 21 DNA Homo sapiens 654 gggcctcacg ytctttgcag t 21 655 21 DNA Homo sapiens 655 tgaaaatggc yttggaggca g 21 656 21 DNA Homo sapiens 656 aggagacgac yttctacacg c 21 657 21 DNA Homo sapiens 657 ggtgtgcctg rcatgggcct g 21 658 21 DNA Homo sapiens 658 catgttgcca ragccaacgt c 21 659 21 DNA Homo sapiens 659 ctatgtctgc sgagtcagca t 21 660 21 DNA Homo sapiens 660 agggcacggg ytccgaggcg t 21 661 21 DNA Homo sapiens 661 cctcactgcc kccagccctc t 21 662 21 DNA Homo sapiens 662 acagccaaga mctgggaact c 21 663 21 DNA Homo sapiens 663 acctgcacct kcgctgcagc g 21 664 21 DNA Homo sapiens 664 cctggctcta ytctcctgga c 21 665 21 DNA Homo sapiens 665 tcctgaatcc ytggattact g 21 666 21 DNA Homo sapiens 666 gccactgaag racaggcaaa t 21 667 21 DNA Homo sapiens 667 cgctgaagac rccccacggg g 21 668 21 DNA Homo sapiens 668 agagctgccc ragaagctcc c 21 669 21 DNA Homo sapiens 669 tccgagaggc racaaggttt g 21 670 21 DNA Homo sapiens 670 ccagtgtgga mgaactaaag g 21 671 21 DNA Homo sapiens 671 tcttcagggg rcccaatggt g 21 672 21 DNA Homo sapiens 672 gttccttttg matttctccc g 21 673 21 DNA Homo sapiens 673 ccagggcctg ygggtagagt c 21 674 21 DNA Homo sapiens 674 tcaagaacca yacagagatc g 21 675 21 DNA Homo sapiens 675 tgcaattcaa rgatggtaca g 21 676 21 DNA Homo sapiens 676 cggcgcagac racactggtg g 21 677 21 DNA Homo sapiens 677 atgggcacaa ygtgtgggcc c 21 678 21 DNA Homo sapiens 678 gcatctttgg ygatgaggat g 21 679 21 DNA Homo sapiens 679 gctcgctgct yatcgtgcag a 21 680 21 DNA Homo sapiens 680 agcctgagtg yttcggaccc g 21 681 21 DNA Homo sapiens 681 accacaaggc rtccatggtg c 21 682 21 DNA Homo sapiens 682 cagacgcccc rgctgtggtc a 21 683 21 DNA Homo sapiens 683 tccaaagaag raggaagctg g 21 684 21 DNA Homo sapiens 684 acatcccagc rcgccgaaac c 21 685 21 DNA Homo sapiens 685 tgaagatcgc rcagggtgtc t 21 686 21 DNA Homo sapiens 686 cccctacagg yatgtggtgg t 21 687 21 DNA Homo sapiens 687 tgaacatgat yctcccggac t 21 688 21 DNA Homo sapiens 688 gcaggccatc ycggaggcag g 21 689 21 DNA Homo sapiens 689 ggcctgcctg yggctgacct g 21 690 21 DNA Homo sapiens 690 gcagctgcct yaatgactgc c 21 691 21 DNA Homo sapiens 691 gttcgaatgt kagaacctct a 21 692 21 DNA Homo sapiens 692 tgaccagttt yccgcacatg g 21 693 21 DNA Homo sapiens 693 ctgacatcta ygtgctaggc t 21 694 21 DNA Homo sapiens 694 tgcgggcacg scagatgcac c 21 695 21 DNA Homo sapiens 695 tgctggcaat ygctgtggac c 21 696 21 DNA Homo sapiens 696 tggcaattgc kgtggaccgc t 21 697 21 DNA Homo sapiens 697 cctagatctc rggagttaat g 21 698 21 DNA Homo sapiens 698 tctcctctgt ycccataggt t 21 699 21 DNA Homo sapiens 699 ttgatgtgga yggcaaccga a 21 700 21 DNA Homo sapiens 700 atcaccatgg yctgcggctc c 21 701 21 DNA Homo sapiens 701 tggacgaggt mcagaccgga g 21 702 21 DNA Homo sapiens 702 attatgatgg rcctctgatg a 21 703 21 DNA Homo sapiens 703 tgttctcgaa rgaatgccaa g 21 704 21 DNA Homo sapiens 704 gcctaaacct stgtgaaccc a 21 705 21 DNA Homo sapiens 705 taccaggaaa yctgtggagg a 21 706 21 DNA Homo sapiens 706 tggccaggta yggtgtgaag c 21 707 21 DNA Homo sapiens 707 tgaggtggca ytggcgtatg c 21 708 21 DNA Homo sapiens 708 tgagtgaaaa yggagcattc c 21 709 21 DNA Homo sapiens 709 ctctggtccc rtatctggta g 21 710 21 DNA Homo sapiens 710 caggccccta yggcgccaac a 21 711 21 DNA Homo sapiens 711 gacaaggact kgaatatttt c 21 712 21 DNA Homo sapiens 712 aagagcatga yaaggcctgc g 21 713 21 DNA Homo sapiens 713 cagtgacccg kcctctgtct c 21 714 21 DNA Homo sapiens 714 ttgatttgga yaattctggt t 21 715 21 DNA Homo sapiens 715 atgtgtgact yttatcagag a 21 716 21 DNA Homo sapiens 716 caccacaaca ygcagacctt c 21 717 21 DNA Homo sapiens 717 gtgctccggc rcgcctggac t 21 718 21 DNA Homo sapiens 718 tgtgctccgg ygcgcctgga c 21 719 21 DNA Homo sapiens 719 gcaaagctcc rccacaacat g 21 720 21 DNA Homo sapiens 720 agttatcatc rtccaagttt a 21 721 21 DNA Homo sapiens 721 gctggccttc rcgaccacac t 21 722 21 DNA Homo sapiens 722 ctgctgccca ygggtcacac c 21 723 21 DNA Homo sapiens 723 gctccaggcg ktgcttgttc c 21 724 21 DNA Homo sapiens 724 cagaggtttg ytgggactcc c 21 725 21 DNA Homo sapiens 725 ggatctggag ygagtggagt g 21 726 21 DNA Homo sapiens 726 cgatgggacc rggacaggcc g 21 727 21 DNA Homo sapiens 727 gggacaggcc rtggaagtgg a 21 728 21 DNA Homo sapiens 728 ccagaacctg sagtgcttct t 21 729 21 DNA Homo sapiens 729 ccccacagcc mgagggcctc c 21 730 21 DNA Homo sapiens 730 gccgtggaga mggtgaacat c 21 731 21 DNA Homo sapiens 731 ctgctgaacc kcctggcaga c 21 732 21 DNA Homo sapiens 732 tatggcccaa sagcaggtgc g 21 733 21 DNA Homo sapiens 733 gcccgggaag ycttccgcct g 21 734 21 DNA Homo sapiens 734 accctaccac yggggaggtc a 21 735 21 DNA Homo sapiens 735 gggaggtcat ygggcacgtg g 21 736 21 DNA Homo sapiens 736 cggggtatgg yccaacagca g 21 737 21 DNA Homo sapiens 737 cgcccagcac rtggatgttg a 21 738 21 DNA Homo sapiens 738 ccctcatcaa sgaggcaggc t 21 739 21 DNA Homo sapiens 739 tgccacagac rattttgcgg a 21 740 21 DNA Homo sapiens 740 accagcctga rgtgtctcag g 21 741 21 DNA Homo sapiens 741 cagaccatgg ygtgtgacat c 21 742 21 DNA Homo sapiens 742 tatattggca ygggctatta t 21 743 21 DNA Homo sapiens 743 gtgccacaga sgattttgcg g 21 744 21 DNA Homo sapiens 744 ctgcatgcca yttcaagcaa a 21 745 21 DNA Homo sapiens 745 ggaaatttct ygttgatccc c 21 746 21 DNA Homo sapiens 746 cattgtggct rctcagtgaa g 21 747 21 DNA Homo sapiens 747 aaactgaaca rttcgtctga a 21 748 21 DNA Homo sapiens 748 gacaggtcta yctagacggg g 21 749 21 DNA Homo sapiens 749 ggtgggaatc wgtcgccctg g 21 750 21 DNA Homo sapiens 750 ttagtcctct stccctaagt t 21 751 21 DNA Homo sapiens 751 tggtgtatgt stctgactcc g 21 752 21 DNA Homo sapiens 752 tgcctagtgg ycattggcag a 21 753 21 DNA Homo sapiens 753 acctcacttc rtggtggtcc a 21 754 21 DNA Homo sapiens 754 ttgctggtac wcttctatcc a 21 755 21 DNA Homo sapiens 755 ttacccacga satgaggcag g 21 756 21 DNA Homo sapiens 756 cccccagtcc scggtgatgc a 21 757 21 DNA Homo sapiens 757 ggcaagaaga rcttcgagac t 21 758 21 DNA Homo sapiens 758 tacgataaga wgcaaacgtg g 21 759 21 DNA Homo sapiens 759 ccactcaaac ytttcaacaa a 21 760 21 DNA Homo sapiens 760 tggcgggcaa ygtgctggtg t 21 761 21 DNA Homo sapiens 761 gcagcctgcc rgagatcgac a 21 762 21 DNA Homo sapiens 762 tcctggctgc rgtcaccacc a 21 763 21 DNA Homo sapiens 763 aaggagcctg ycggggagaa c 21 764 21 DNA Homo sapiens 764 agaccaaggc yggccgcatc a 21 765 21 DNA Homo sapiens 765 gccgccgctc rgatgaggac t 21 766 21 DNA Homo sapiens 766 actatggact yacagcagcc g 21 767 21 DNA Homo sapiens 767 ataaaaagag ygaatagcac c 21 768 21 DNA Homo sapiens 768 atagccagtg sagtgctgga g 21 769 21 DNA Homo sapiens 769 accctaccgc yttcgttgtc a 21 770 21 DNA Homo sapiens 770 cctgccggga sttgccttgt t 21 771 21 DNA Homo sapiens 771 tggtggtcct stcctctctt g 21 772 21 DNA Homo sapiens 772 tagtatttca kgtatgctgc t 21 773 21 DNA Homo sapiens 773 agagtcccag rcccggccgg g 21 774 21 DNA Homo sapiens 774 aacatcatgt ytcgggtaac a 21 775 21 DNA Homo sapiens 775 ggtcaccctg rtcaccctgc c 21 776 21 DNA Homo sapiens 776 ccaaaccgcc yagatgtctt a 21 777 21 DNA Homo sapiens 777 cttgcggtga ragcgaattc c 21 778 21 DNA Homo sapiens 778 tgcttaagga rcattccata c 21 779 21 DNA Homo sapiens 779 agccaaatat sagcgatggc t 21 780 21 DNA Homo sapiens 780 ctgaagttta raatgggtat c 21 781 21 DNA Homo sapiens 781 tttaagaaaa rtggattgat t 21 782 21 DNA Homo sapiens 782 tctgcgctgt wcctcaggtg t 21 783 21 DNA Homo sapiens 783 cccgcaggga rttgcgtggt g 21 784 21 DNA Homo sapiens 784 aaggagatcc rctacccacc c 21 785 21 DNA Homo sapiens 785 tgccgggcgc rcctctcgct g 21 786 21 DNA Homo sapiens 786 gtgccgccga rgaaaaagtg c 21 787 21 DNA Homo sapiens 787 gttatcttgc wgagatctct g 21 788 21 DNA Homo sapiens 788 tgcaaaatat ycaggagacc g 21 789 21 DNA Homo sapiens 789 tggagttgat ytttcagtgc t 21 790 21 DNA Homo sapiens 790 tctactggct stctaactaa t 21 791 21 DNA Homo sapiens 791 ttgtcaaggc wgaatattac t 21 792 21 DNA Homo sapiens 792 ggtcccgatg yacaccttgc a 21 793 21 DNA Homo sapiens 793 aagaagtaat kgcaccgtct c 21 794 21 DNA Homo sapiens 794 tcgctgtcat rttcctggct a 21 795 21 DNA Homo sapiens 795 ggcatctaca rctgcattca t 21 796 21 DNA Homo sapiens 796 ctatgtattc yagggacaac a 21 797 21 DNA Homo sapiens 797 ggacattgac racatggcgg g 21 798 21 DNA Homo sapiens 798 aggtgtccaa rctggagtgg c 21 799 21 DNA Homo sapiens 799 ggtcacccgc raggtgaccg t 21 800 21 DNA Homo sapiens 800 gaccagccca wgttgttggg c 21 801 21 DNA Homo sapiens 801 ttggcatggt kgtaatccat a 21 802 21 DNA Homo sapiens 802 aaatggtata waattcaaaa t 21 803 21 DNA Homo sapiens 803 ttatctacca stgcttctca a 21 804 21 DNA Homo sapiens 804 attgatcaaa rccaatcttt g 21 805 21 DNA Homo sapiens 805 atttaaggac ragaccagca g 21 806 21 DNA Homo sapiens 806 caagtcaaca ytggatattg t 21 807 21 DNA Homo sapiens 807 tgcatgtgat yaagcgagat g 21 808 21 DNA Homo sapiens 808 caacacagct mgatatgtgg a 21 809 21 DNA Homo sapiens 809 gaagattgca magtatggta t 21 810 21 DNA Homo sapiens 810 gagtatgaaa satgacagca t 21 811 21 DNA Homo sapiens 811 tcagcactgg saatccctga a 21 812 21 DNA Homo sapiens 812 tcgctgcgcc kccactatgc t 21 813 21 DNA Homo sapiens 813 ttgacctctc saaggacatt c 21 814 21 DNA Homo sapiens 814 ccttgatggc rtatatttca g 21 815 21 DNA Homo sapiens 815 ctgtagaccg yggcttcttc a 21 816 21 DNA Homo sapiens 816 tcagaactag ygagacgggc a 21 817 21 DNA Homo sapiens 817 ggggtgatca raagaaagct c 21 818 21 DNA Homo sapiens 818 caattgtggc yattgcatca t 21 819 21 DNA Homo sapiens 819 tggtggacaa ygagctgcct g 21 820 21 DNA Homo sapiens 820 tgaatcttag ygtgacaact c 21 821 21 DNA Homo sapiens 821 ctgaatacaa yaacttcaag t 21 822 21 DNA Homo sapiens 822 agctgcgcta yggcgaagac g 21 823 21 DNA Homo sapiens 823 tgggccagtc ygctcgagat g 21 824 21 DNA Homo sapiens 824 tgcctgactt ygatgtggcc c 21 825 21 DNA Homo sapiens 825 cccagagcac rgtggtggca g 21 826 21 DNA Homo sapiens 826 ctgtgtcttc stgatctgca g 21 827 21 DNA Homo sapiens 827 tggataagac ycgagctttg a 21 828 21 DNA Homo sapiens 828 gatgctatta rgaaagccca c 21 829 21 DNA Homo sapiens 829 cccagatata ytacaactca a 21 830 21 DNA Homo sapiens 830 aactatctat raaaagccaa a 21 831 21 DNA Homo sapiens 831 aactattggg waatgtgttc a 21 832 21 DNA Homo sapiens 832 aatctgttca rtacagggat t 21 833 21 DNA Homo sapiens 833 ctgtcagatt rtagcaatga a 21 834 21 DNA Homo sapiens 834 tatagagata yacggaattc c 21 835 21 DNA Homo sapiens 835 ttgaagggcc raggagatct g 21 836 21 DNA Homo sapiens 836 gggccaagga ratctgttga a 21 837 21 DNA Homo sapiens 837 acatttttga ycctgagcaa a 21 838 21 DNA Homo sapiens 838 aagttgcctt ytgatccaga t 21 839 21 DNA Homo sapiens 839 aattaaaaag watgatcatt g 21 840 21 DNA Homo sapiens 840 aggtctttgg yaataaactc t 21 841 21 DNA Homo sapiens 841 ttcatatcaa ratcatcagt g 21 842 21 DNA Homo sapiens 842 tgaatgtttg yagcctggat a 21 843 21 DNA Homo sapiens 843 ctcatcacca rtgacaatac t 21 844 21 DNA Homo sapiens 844 ttgatgacat ytttaaaata g 21 845 21 DNA Homo sapiens 845 tagaaatggc rgacacagtc c 21 846 21 DNA Homo sapiens 846 tgacatcttt waaatagcgg t 21 847 21 DNA Homo sapiens 847 tctgtcatct yggctcatca c 21 848 21 DNA Homo sapiens 848 gagggctgcc yggaacgtct c 21 849 21 DNA Homo sapiens 849 atgggagcca ygtggactac a 21 850 21 DNA Homo sapiens 850 ggcttgaata ytgcctcaag g 21 851 21 DNA Homo sapiens 851 tcagtgcgga yaactataca c 21 852 21 DNA Homo sapiens 852 catgccttct yccaccttcg g 21 853 21 DNA Homo sapiens 853 agtggctatc rggagtttgt a 21 854 21 DNA Homo sapiens 854 tgttataatg sacaagccat a 21 855 21 DNA Homo sapiens 855 cctgagtgtc rtctatcggg a 21 856 21 DNA Homo sapiens 856 ttttaatgca ygatgtagct t 21 857 21 DNA Homo sapiens 857 tcctcgtggg yctcagcggg g 21 858 21 DNA Homo sapiens 858 agtcaagcat yctgggcctg c 21 859 21 DNA Homo sapiens 859 gcctccgtgt stcccaccga g 21 860 21 DNA Homo sapiens 860 acgatcgccc kgccagagat a 21 861 21 DNA Homo sapiens 861 aggaggtggc ragaggcgtg c 21 862 21 DNA Homo sapiens 862 cattgccatt rttctgaggt t 21 863 21 DNA Homo sapiens 863 ccagtgcaag mttcttcttc a 21 864 21 DNA Homo sapiens 864 ctactaataa wgacgatgat a 21 865 21 DNA Homo sapiens 865 ttccccagat rgctggctgg g 21 866 21 DNA Homo sapiens 866 atacagacta yttcttcccc a 21 867 21 DNA Homo sapiens 867 tcagagggtc rtcacacaca a 21 868 21 DNA Homo sapiens 868 ggaagcccca mcaaattcca g 21 869 21 DNA Homo sapiens 869 ctggagacaa ragcccacag a 21 870 21 DNA Homo sapiens 870 cctcttgatg rtctttgtgg c 21 871 21 DNA Homo sapiens 871 atcatggtgc ytggctgcca g 21 872 21 DNA Homo sapiens 872 aaagtccaat scagccagtg g 21 873 21 DNA Homo sapiens 873 acgatgaccc rccagagatc c 21 874 21 DNA Homo sapiens 874 aaatgaccca ygggaagaca a 21 875 21 DNA Homo sapiens 875 agccccagct matatgcaca g 21 876 21 DNA Homo sapiens 876 ctggtagtag sccctcagtg c 21 877 21 DNA Homo sapiens 877 cctgccagtg ycctcaccgg t 21 878 21 DNA Homo sapiens 878 tgatgctgag yttgaaactg g 21 879 21 DNA Homo sapiens 879 cacgtgattg rcaagttcct a 21 880 21 DNA Homo sapiens 880 cttcgagccc rcgtgattga c 21 881 21 DNA Homo sapiens 881 gctggcgggc raatacgcag a 21 882 21 DNA Homo sapiens 882 actgatgtcc rtcctttgta t 21 883 21 DNA Homo sapiens 883 ccttactgaa rgtttctagt t 21 884 21 DNA Homo sapiens 884 ctgttctccc raaaccagac t 21 885 21 DNA Homo sapiens 885 ccagaagaca rtgaaagtca c 21 886 21 DNA Homo sapiens 886 ttaagaacat rgcttcccat c 21 887 21 DNA Homo sapiens 887 tacattctaa rcattggagc a 21 888 21 DNA Homo sapiens 888 gtttgcacac rgaacaccta t 21 889 21 DNA Homo sapiens 889 accctccaat yattgctcga t 21 890 21 DNA Homo sapiens 890 gagaattatc rcttccatgc a 21 891 21 DNA Homo sapiens 891 tgacagtaca rgaatttgct c 21 892 21 DNA Homo sapiens 892 tttttcacca kctttgatga g 21 893 21 DNA Homo sapiens 893 accacaattc yagaaaatga c 21 894 21 DNA Homo sapiens 894 tgcaagtgga yttccagaag a 21 895 21 DNA Homo sapiens 895 cagagaatat mcaacgcttt c 21 896 21 DNA Homo sapiens 896 gagaatatac macgctttct c 21 897 21 DNA Homo sapiens 897 cgcctttctt matcatccag a 21 898 21 DNA Homo sapiens 898 tcggcatgtt ygcgtcggcc t 21 899 21 DNA Homo sapiens 899 gcctggccga yctggccgtg g 21 900 21 DNA Homo sapiens 900 tctctccgcc rgtcccgacg c 21 901 21 DNA Homo sapiens 901 agactctgca rcagcccgcg c 21 902 21 DNA Homo sapiens 902 ccttgaatag mtgctgtaat c 21 903 21 DNA Homo sapiens 903 tgtaatccct rgatatacat g 21 904 21 DNA Homo sapiens 904 aatatcctgt rgaaaaacta a 21 905 21 DNA Homo sapiens 905 ttgtggaagc rgatacccca g 21 906 21 DNA Homo sapiens 906 ctcttccaga yatttgttat c 21 907 21 DNA Homo sapiens 907 ctctgaagac wtggagatac t 21 908 21 DNA Homo sapiens 908 ctcatacgca rcctcaatgt c 21 909 21 DNA Homo sapiens 909 agcgactgca wcttcctccc g 21 910 21 DNA Homo sapiens 910 agtgcaacat maattagcag a 21 911 21 DNA Homo sapiens 911 aaggacttat ytggagacaa a 21 912 21 DNA Homo sapiens 912 tgaggggtct rgagggaaac t 21 913 21 DNA Homo sapiens 913 ggttctctgg mccctgcatt c 21 914 21 DNA Homo sapiens 914 aaaggagcga wcccacaatg t 21 915 21 DNA Homo sapiens 915 cgcactggct rgcctgcatc t 21 916 21 DNA Homo sapiens 916 acttcacctt yagcagcctc a 21 917 21 DNA Homo sapiens 917 ccggccgcat ygccgtccac t 21 918 21 DNA Homo sapiens 918 ccctcatgta ygctagcatc t 21 919 21 DNA Homo sapiens 919 ccctgctctg rtcaccaccc g 21 920 21 DNA Homo sapiens 920 accagcttac rcacaccgag g 21 921 21 DNA Homo sapiens 921 gtggagagac yctgcatagc t 21 922 21 DNA Homo sapiens 922 gagccatctt mcagcctgtt t 21 923 21 DNA Homo sapiens 923 tattccatat rttaaagaaa g 21 924 21 DNA Homo sapiens 924 cagaagaaac yagtacgtgt a 21 925 21 DNA Homo sapiens 925 tgggaacgtt kcaatgaatt a 21 926 21 DNA Homo sapiens 926 acatggcttc rgacatcctg c 21 927 21 DNA Homo sapiens 927 gcacaagagg mggcttccgg a 21 928 21 DNA Homo sapiens 928 atgacatgga ygaggaggac t 21 929 21 DNA Homo sapiens 929 agttttccgg ragtccctac a 21 930 21 DNA Homo sapiens 930 gctcccccta ytattatagc g 21 931 21 DNA Homo sapiens 931 gtcctgcccc mctcatcagc a 21 932 21 DNA Homo sapiens 932 tggcctctcc rgcagagtca g 21 933 21 DNA Homo sapiens 933 catagagggt yccaggtccc c 21 934 21 DNA Homo sapiens 934 ccggacagga rgtgcattcc c 21 935 21 DNA Homo sapiens 935 atgcagccat ygaactgcct a 21 936 21 DNA Homo sapiens 936 aactctttca ytgttgtttc a 21 937 21 DNA Homo sapiens 937 ccatggtgcc rgtggcaggc c 21 938 21 DNA Homo sapiens 938 actctgaagt rattcgttat g 21 939 21 DNA Homo sapiens 939 gttccaatgc rcatctgggc g 21 940 21 DNA Homo sapiens 940 acttgctctg raaatgaatt c 21 941 21 DNA Homo sapiens 941 actccttatg scatcactgt t 21 942 21 DNA Homo sapiens 942 ttgcttggaa racaatggtg g 21 943 21 DNA Homo sapiens 943 tacacaaaat rtcataattc a 21 944 21 DNA Homo sapiens 944 catctttgaa saccagttat a 21 945 21 DNA Homo sapiens 945 tcatggccac rgacccccag t 21 946 21 DNA Homo sapiens 946 agtggctggc rgtgggcatg g 21 947 21 DNA Homo sapiens 947 ccatggcaga rttgaatgcc a 21 948 21 DNA Homo sapiens 948 atcgccaaga rattgaatac g 21 949 21 DNA Homo sapiens 949 gccacacaga yggagccagc t 21 950 21 DNA Homo sapiens 950 ccgcctgcta ygccctggcc a 21 951 21 DNA Homo sapiens 951 acaaatacat ygtgacaggc t 21 952 21 DNA Homo sapiens 952 cggacagcgt ygccctgagg a 21 953 21 DNA Homo sapiens 953 ctgagttgtg wcatctccag a 21 954 21 DNA Homo sapiens 954 tgtcaccctc sgaaagcctc c 21 955 21 DNA Homo sapiens 955 tggacaacac rgtgcgctcc t 21 956 21 DNA Homo sapiens 956 acctggcctc rcccacgccc c 21 957 21 DNA Homo sapiens 957 ggcttcgcca rcgccaacct g 21 958 21 DNA Homo sapiens 958 cagcgccaac ytgcagggca g 21 959 21 DNA Homo sapiens 959 gccgtggata ycggcgtccc t 21 960 21 DNA Homo sapiens 960 agtggtttta ygaatatggg a 21 961 21 DNA Homo sapiens 961 gagagaagcc stacgaatgt g 21 962 21 DNA Homo sapiens 962 agccagcagt ygcagctggt t 21 963 21 DNA Homo sapiens 963 gaggcagcgg ycccgggcct g 21 964 21 DNA Homo sapiens 964 taaaagagag rgcggattcc c 21 965 21 DNA Homo sapiens 965 cccttcgacc mgtcgggttt g 21 966 21 DNA Homo sapiens 966 cactgcttac rttgccatga t 21 967 21 DNA Homo sapiens 967 ctctaaaaga sagggcggat t 21 968 21 DNA Homo sapiens 968 tgtggagact ygcagacatc g 21 969 21 DNA Homo sapiens 969 tggtgccact kggacccgaa t 21 970 21 DNA Homo sapiens 970 aaaagactca rtacttggcc t 21 971 21 DNA Homo sapiens 971 gtgccttcaa rgaaccttcc a 21 972 21 DNA Homo sapiens 972 gctgcagcaa rcaatatgac a 21 973 21 DNA Homo sapiens 973 ggccaaactc rgcgcccacc a 21 974 21 DNA Homo sapiens 974 agtcgcacga yaaactgcgg c 21 975 21 DNA Homo sapiens 975 acttcgaacc ygagaggcct t 21 976 21 DNA Homo sapiens 976 caggttctct rctcgcagta g 21 977 21 DNA Homo sapiens 977 tgactccttc kagcaccctt t 21 978 21 DNA Homo sapiens 978 ttatgcgaat rctttatttt c 21 979 21 DNA Homo sapiens 979 gggactcgga yttggcggcc g 21 980 21 DNA Homo sapiens 980 agaccctgga rctggagaag g 21 981 21 DNA Homo sapiens 981 tcagactcag rgaaaactgc g 21 982 21 DNA Homo sapiens 982 ggcgtgaaca rtcctcgagc a 21 983 21 DNA Homo sapiens 983 atggagctgg rgcccgacaa c 21 984 21 DNA Homo sapiens 984 gcgagctctg ygaccagtgc t 21 985 21 DNA Homo sapiens 985 gcctgccccg yattgaggca g 21 986 21 DNA Homo sapiens 986 ctggatcgca rgcaacatct a 21 987 21 DNA Homo sapiens 987 aaggcaccaa ygtgtgcgcg g 21 988 21 DNA Homo sapiens 988 ggctgaagga ygacggccgg a 21 989 21 DNA Homo sapiens 989 actgcatgga yggctcagat g 21 990 21 DNA Homo sapiens 990 acccgacctg yggccccagt g 21 991 21 DNA Homo sapiens 991 ccctgcgctg yaacatgttc g 21 992 21 DNA Homo sapiens 992 gaccagtatg rgaagccggg t 21 993 21 DNA Homo sapiens 993 agaagcgcat yctttggatt g 21 994 21 DNA Homo sapiens 994 ttggccgtgt sgagggcatt g 21 995 21 DNA Homo sapiens 995 ctgtcggcat ygacttccac g 21 996 21 DNA Homo sapiens 996 acgcctcaga ygagatgaac t 21 997 21 DNA Homo sapiens 997 acggcagcga ygaggaggcc t 21 998 21 DNA Homo sapiens 998 acgtctttga rgattacatc t 21 999 21 DNA Homo sapiens 999 acggatctga ygaggcccct g 21 1000 21 DNA Homo sapiens 1000 gccgccttgt ytactgggca g 21 1001 21 DNA Homo sapiens 1001 gatgcctatc kggactatat t 21 1002 21 DNA Homo sapiens 1002 caccagctac ytcattggcc g 21 1003 21 DNA Homo sapiens 1003 gatggctcca rgaggatcac c 21 1004 21 DNA Homo sapiens 1004 ctctgacgag rtcccttgca a 21 1005 21 DNA Homo sapiens 1005 gtgcgcaccg rgaaagcggc c 21 1006 21 DNA Homo sapiens 1006 tggggatcca rcctccaaaa g 21 1007 21 DNA Homo sapiens 1007 ataagggagc rtgaggagtc t 21 1008 21 DNA Homo sapiens 1008 atcttcaatt rtgggttcct t 21 1009 21 DNA Homo sapiens 1009 agagaaggct rtgcagcttg c 21 1010 21 DNA Homo sapiens 1010 tgtaccagac rcccttgcac t 21 1011 21 DNA Homo sapiens 1011 agctgcagct stataagtta c 21 1012 21 DNA Homo sapiens 1012 aacagccccg kaagtggcac c 21 1013 21 DNA Homo sapiens 1013 cgccaaatga ktcagctggc a 21 1014 21 DNA Homo sapiens 1014 ctcaccctaa raacacacag c 21 1015 21 DNA Homo sapiens 1015 gtgccgaggg rcggccacac t 21 1016 21 DNA Homo sapiens 1016 tccgtttcct ygagagcctg c 21 1017 21 DNA Homo sapiens 1017 ggattaagaa rgcagccgaa g 21 1018 21 DNA Homo sapiens 1018 tccaagaaga ygaaattcca g 21 1019 21 DNA Homo sapiens 1019 agtggagcgt ygccgccgag a 21 1020 21 DNA Homo sapiens 1020 cccttgtcat ygagttcacc g 21 1021 21 DNA Homo sapiens 1021 tggcggccca maagtacctg c 21 1022 21 DNA Homo sapiens 1022 ggacggtcat ygattacaac g 21 1023 21 DNA Homo sapiens 1023 aacattgcaa yggcattttg a 21 1024 21 DNA Homo sapiens 1024 taggcccttc yggctttgga c 21 1025 21 DNA Homo sapiens 1025 cctcgtcgtc rtcttcagac a 21 1026 21 DNA Homo sapiens 1026 tctcttctgt stcacacaca g 21 1027 21 DNA Homo sapiens 1027 gttaaaacat kgcaatggca t 21 1028 21 DNA Homo sapiens 1028 ctggggccga ygaagatgac a 21 1029 21 DNA Homo sapiens 1029 cttggccgac rgctggcccc g 21 1030 21 DNA Homo sapiens 1030 cagagtacag ygagccccac g 21 1031 21 DNA Homo sapiens 1031 agactgctct ygaggctcat a 21 1032 21 DNA Homo sapiens 1032 ctctgtctgc ratgctctta g 21 1033 21 DNA Homo sapiens 1033 ggggactcca katgaaagga g 21 1034 21 DNA Homo sapiens 1034 gcttttccca yctaccccca a 21 1035 21 DNA Homo sapiens 1035 tctggagatc yatatgaggt c 21 1036 21 DNA Homo sapiens 1036 agaccttgcc rgctcagcta c 21 1037 21 DNA Homo sapiens 1037 caaggtttac rgactaccag c 21 1038 21 DNA Homo sapiens 1038 gaagaccaac mctccccagc a 21 1039 21 DNA Homo sapiens 1039 tccaacctcc mcaatgaaca c 21 1040 21 DNA Homo sapiens 1040 ccctgcaggc ygcgttgact t 21 1041 21 DNA Homo sapiens 1041 ccaacagacg mctattcgga g 21 1042 21 DNA Homo sapiens 1042 tggtgtggtt ycagaatgcc c 21 1043 21 DNA Homo sapiens 1043 accaggcttt wctccttatt a 21 1044 21 DNA Homo sapiens 1044 gcagcctgtc rgaggacgag t 21 1045 21 DNA Homo sapiens 1045 gccttccaga rgaggacgag g 21 1046 21 DNA Homo sapiens 1046 ctctactgcc rtccactttg a 21 1047 21 DNA Homo sapiens 1047 cgttgcgcta rccctgctcg t 21 1048 21 DNA Homo sapiens 1048 agaaatatga rcaggcatgt a 21 1049 21 DNA Homo sapiens 1049 gtaacttcag yaaacaggcc a 21 1050 21 DNA Homo sapiens 1050 cctgcgaggc ygtgatgatc c 21 1051 21 DNA Homo sapiens 1051 gaggccagat stacagccca c 21 1052 21 DNA Homo sapiens 1052 acgcatggtg rgcatcatcc a 21 1053 21 DNA Homo sapiens 1053 gtaacttcag yaaacaggcc a 21 1054 21 DNA Homo sapiens 1054 agaagtatga rcaggcatgt a 21 1055 21 DNA Homo sapiens 1055 atggacggag scttgaagat g 21 1056 21 DNA Homo sapiens 1056 gggatgatga ygcccacggt g 21 1057 21 DNA Homo sapiens 1057 ggcattgagc ytcccaaggg c 21 1058 21 DNA Homo sapiens 1058 tgctggagct ygagagagac g 21 1059 21 DNA Homo sapiens 1059 tggagttcat sgccagcaag a 21 1060 21 DNA Homo sapiens 1060 gggacctgct rcgtccacca g 21 1061 21 DNA Homo sapiens 1061 acgacagttc yggggaaggg a 21 1062 21 DNA Homo sapiens 1062 tttgatgagt yccacgattt c 21 1063 21 DNA Homo sapiens 1063 atacgggtcc rcggcagctc t 21 1064 21 DNA Homo sapiens 1064 tcaggagcgc rcaggggcag c 21 1065 21 DNA Homo sapiens 1065 ggggcagccc rccagcaagg a 21 1066 21 DNA Homo sapiens 1066 tgtggcacta ygtccccctc c 21 1067 21 DNA Homo sapiens 1067 tcttgtcacc rcgtcaacac c 21 1068 21 DNA Homo sapiens 1068 ttcttggtac yggacagtcc c 21 1069 21 DNA Homo sapiens 1069 ttatccggca kcacaacatc c 21 1070 21 DNA Homo sapiens 1070 caaatccatg saccgcctag c 21 1071 21 DNA Homo sapiens 1071 ttgacagcat rtctaattcg c 21 1072 21 DNA Homo sapiens 1072 ccagctgata rttcatcaac a 21 1073 21 DNA Homo sapiens 1073 caaagtcaac rgccagtcac t 21 1074 21 DNA Homo sapiens 1074 cataggaata yggtcacaga a 21 1075 21 DNA Homo sapiens 1075 ttctgcagca rccatctgaa c 21 1076 21 DNA Homo sapiens 1076 cagaactgag yaccttgtca c 21 1077 21 DNA Homo sapiens 1077 tgaaacttta ytaaaatcaa g 21 1078 21 DNA Homo sapiens 1078 tcttctgtct rtaccttcac t 21 1079 21 DNA Homo sapiens 1079 gcggtctgca rcctcagatt c 21 1080 21 DNA Homo sapiens 1080 cctaaacata rtgttaccat a 21 1081 21 DNA Homo sapiens 1081 tgggtcttct raaagtgagg a 21 1082 21 DNA Homo sapiens 1082 ccgctctgta yacctggtac g 21 1083 21 DNA Homo sapiens 1083 gggccgagcc ygacaccaag c 21 1084 21 DNA Homo sapiens 1084 ccagttctcc yagcagctgc a 21 1085 21 DNA Homo sapiens 1085 gaatgagtgt ragttgcaga a 21 1086 21 DNA Homo sapiens 1086 cgccttcttc kcccgaggac a 21 1087 21 DNA Homo sapiens 1087 ccttggacca kctcatccag a 21 1088 21 DNA Homo sapiens 1088 ctgaggacaa rgccaacaag a 21 1089 21 DNA Homo sapiens 1089 gtccctgtta yggctaccag t 21 1090 21 DNA Homo sapiens 1090 tcatattcat yagaggaaat g 21 1091 21 DNA Homo sapiens 1091 tactccagag rtcaagtcca a 21 1092 21 DNA Homo sapiens 1092 tgacatccta ygtgctcctc g 21 1093 21 DNA Homo sapiens 1093 atatcaccat ygcccttctg g 21 1094 21 DNA Homo sapiens 1094 ccaagctcga kcctacatct t 21 1095 21 DNA Homo sapiens 1095 tcacactttc racagggaat t 21 1096 21 DNA Homo sapiens 1096 tttctggggg rttcccaggt t 21 1097 21 DNA Homo sapiens 1097 agtgccggga rgaacccttg g 21 1098 21 DNA Homo sapiens 1098 tggggaaaca saattcctca a 21 1099 21 DNA Homo sapiens 1099 ctcaccacaa ygacattgcc t 21 1100 21 DNA Homo sapiens 1100 ggcctaaagc ygcttgtcca a 21 1101 21 DNA Homo sapiens 1101 tgattaccca magaaggagg a 21 1102 21 DNA Homo sapiens 1102 acatcacaaa rcaacctgtg g 21 1103 21 DNA Homo sapiens 1103 catgcgtgtg ractcagaca a 21 1104 21 DNA Homo sapiens 1104 atgagaaagg kttcattgaa a 21 1105 21 DNA Homo sapiens 1105 ggagatccac ycccgagaca g 21 1106 21 DNA Homo sapiens 1106 ctcgcaacgt yctcctggca c 21 1107 21 DNA Homo sapiens 1107 tcagggagga rctggctgcc c 21 1108 21 DNA Homo sapiens 1108 ccagaggata rctggctact c 21 1109 21 DNA Homo sapiens 1109 gcctgcctca ygcaatggga a 21 1110 21 DNA Homo sapiens 1110 ctctgcgggg yttcccttca g 21 1111 21 DNA Homo sapiens 1111 atgcctctga ygaggcagcc c 21 1112 21 DNA Homo sapiens 1112 cttcaaaaga raataacgtt t 21 1113 21 DNA Homo sapiens 1113 acagaatgtt yaacttcaag c 21 1114 21 DNA Homo sapiens 1114 tgttttgtgg yaaaagattc a 21 1115 21 DNA Homo sapiens 1115 agcagctcac rgaggaactg a 21 1116 21 DNA Homo sapiens 1116 ccagcacgcc stcgcccccc g 21 1117 21 DNA Homo sapiens 1117 tgcacagcga rgggaagccc t 21 1118 21 DNA Homo sapiens 1118 tgttcggacc rgaagcaccc a 21 1119 21 DNA Homo sapiens 1119 atcctagacg scttcgagga g 21 1120 21 DNA Homo sapiens 1120 tgagcgacac rgtggcgctg t 21 1121 21 DNA Homo sapiens 1121 tgcacagcac rtgcggaccg g 21 1122 21 DNA Homo sapiens 1122 ttctgctcat yctagacgcc t 21 1123 21 DNA Homo sapiens 1123 tactctagag ragcctgttg g 21 1124 21 DNA Homo sapiens 1124 gaaactccag ktcaaagact t 21 1125 21 DNA Homo sapiens 1125 ctgcttgaat ycatgtatga r 21 1126 21 DNA Homo sapiens 1126 ccaacttcga ygctataaga g 21 1127 21 DNA Homo sapiens 1127 ttgaccttgt rcaaataaaa c 21 1128 21 DNA Homo sapiens 1128 gtcagaagtc rgccctaatt g 21 1129 21 DNA Homo sapiens 1129 cccgacagct yattaagaaa g 21 1130 21 DNA Homo sapiens 1130 acttctgtga ygtccagcgc t 21 1131 21 DNA Homo sapiens 1131 tgtgaatgcc ygcctggcca t 21 1132 21 DNA Homo sapiens 1132 agatagctcc ktcctgtggc t 21 1133 21 DNA Homo sapiens 1133 gatctgcaat matggacgct g 21 1134 21 DNA Homo sapiens 1134 gaactgcaca sacattgacg a 21 1135 21 DNA Homo sapiens 1135 tctgcatgaa ygggcgttgc g 21 1136 21 DNA Homo sapiens 1136 gcaaacacaa yggaatgtgg c 21 1137 21 DNA Homo sapiens 1137 aagccagaca wtcagccctt t 21 1138 21 DNA Homo sapiens 1138 ccactattgc ycatgtcctg c 21 1139 21 DNA Homo sapiens 1139 gcccaaagac rttctcataa t 21 1140 21 DNA Homo sapiens 1140 gtgcctgggc ygcagaagtg a 21 1141 21 DNA Homo sapiens 1141 cctgggggtg yctgggctgc a 21 1142 21 DNA Homo sapiens 1142 ttctttggcc rtggtgcgga g 21 1143 21 DNA Homo sapiens 1143 tatccagaga ytctttggcc a 21 1144 21 DNA Homo sapiens 1144 cttggtcctg rgtgtcagca g 21 1145 21 DNA Homo sapiens 1145 ctgaccttca ycaagagcgc c 21 1146 21 DNA Homo sapiens 1146 tatgcccgga maccatgaac a 21 1147 21 DNA Homo sapiens 1147 gttcatgctc rgcttcctcc g 21 1148 21 DNA Homo sapiens 1148 ccataaaaag yataagccag c 21 1149 21 DNA Homo sapiens 1149 cagcctggac ragagcccca t 21 1150 21 DNA Homo sapiens 1150 gggcatcagc wtctatgagg a 21 1151 21 DNA Homo sapiens 1151 actttgccaa ygtgcaggag c 21 1152 21 DNA Homo sapiens 1152 gggcggtgct rcagaacacg t 21 1153 21 DNA Homo sapiens 1153 gttcttgctg raatggtcct t 21 1154 21 DNA Homo sapiens 1154 aaggccaaca yagctgcagg c 21 1155 21 DNA Homo sapiens 1155 cagcaacatt rtcaagactg a 21 1156 21 DNA Homo sapiens 1156 gggtgcagtt rgtctatgtg t 21 1157 21 DNA Homo sapiens 1157 tttttgtgga yttccgtgag a 21 1158 21 DNA Homo sapiens 1158 caggccagga ratcactgaa a 21 1159 21 DNA Homo sapiens 1159 tcaacaacct ygtgaacgcc a 21 1160 21 DNA Homo sapiens 1160 agaagcacgt ktgccacatc c 21 1161 21 DNA Homo sapiens 1161 tgtggtgaag ytgacaggtg g 21 1162 21 DNA Homo sapiens 1162 cccactcccg yggcagcatg a 21 1163 21 DNA Homo sapiens 1163 tcggatgcaa rtccaggccc a 21 1164 21 DNA Homo sapiens 1164 aaagagtttc rgtcagagtt c 21 1165 21 DNA Homo sapiens 1165 aaactcttac rgccattgca g 21 1166 21 DNA Homo sapiens 1166 tagatgtagt saacaaccca g 21 1167 21 DNA Homo sapiens 1167 atttgcggga sggcaacatc a 21 1168 21 DNA Homo sapiens 1168 acagccggcc ractttggag g 21 1169 21 DNA Homo sapiens 1169 tcttggatca sctgaactat g 21 1170 21 DNA Homo sapiens 1170 caaaaagcct scatcagagc t 21 1171 21 DNA Homo sapiens 1171 ccacaatggt rtcagaggag g 21 1172 21 DNA Homo sapiens 1172 agaggattta saggaagatg a 21 1173 21 DNA Homo sapiens 1173 acctgagccc ygaggagaag g 21 1174 21 DNA Homo sapiens 1174 tacattggcc mcaagacaaa g 21 1175 21 DNA Homo sapiens 1175 tcacagccct ycggccaggg t 21 1176 21 DNA Homo sapiens 1176 cccagatgaa ygggaaaccc t 21 1177 21 DNA Homo sapiens 1177 ggctggccca rtgagaacct g 21 1178 21 DNA Homo sapiens 1178 gtgagaccga yttccgccga t 21 1179 21 DNA Homo sapiens 1179 tgtcactgtc rgaactcagt t 21 1180 21 DNA Homo sapiens 1180 agtggaaatg rcatccagtg c 21 1181 21 DNA Homo sapiens 1181 gcagtgccca yggcgagctg g 21 1182 21 DNA Homo sapiens 1182 gagcagtatg mcagcaaggt t 21 1183 21 DNA Homo sapiens 1183 caccaggtga yggtacagaa a 21 1184 21 DNA Homo sapiens 1184 gaagagccac kttcgtaccc a 21 1185 21 DNA Homo sapiens 1185 agctgtggaa rggcctttgc c 21 1186 21 DNA Homo sapiens 1186 agctgtcgca ytcggacgag a 21 1187 21 DNA Homo sapiens 1187 ttcgattttc yaaagaacaa c 21 1188 21 DNA Homo sapiens 1188 ggcgtgctga stgccctggg a 21 1189 21 DNA Homo sapiens 1189 ttataacgtt katgtagctg a 21 1190 21 DNA Homo sapiens 1190 ctcggaactg rgactgaggc c 21 1191 21 DNA Homo sapiens 1191 tctcacggat rgcaccatca c 21 1192 21 DNA Homo sapiens 1192 atctaatgac maaaagtgac a 21 1193 21 DNA Homo sapiens 1193 gatgatgaac rgtttgtccc a 21 1194 21 DNA Homo sapiens 1194 tcagcaagtc ycttttatgg t 21 1195 21 DNA Homo sapiens 1195 gactggaagg saaagtcaaa c 21 1196 21 DNA Homo sapiens 1196 ttacctcctg racatggacc g 21 1197 21 DNA Homo sapiens 1197 tcccagattt ycagtctgat a 21 1198 21 DNA Homo sapiens 1198 ctggaaggca ragtcaaaca g 21 1199 21 DNA Homo sapiens 1199 agagcatgtc maatgttcca t 21 1200 21 DNA Homo sapiens 1200 atctcaatcg rcacaagctc t 21 1201 21 DNA Homo sapiens 1201 aaaggagaca kgacggcagg a 21 1202 21 DNA Homo sapiens 1202 tgaagctcac wctttataat c 21 1203 21 DNA Homo sapiens 1203 ctcaacagac rgcttccttg a 21 1204 21 DNA Homo sapiens 1204 agagccagag ytctacctcg a 21 1205 21 DNA Homo sapiens 1205 gctcagacag rgaaccctga g 21 1206 21 DNA Homo sapiens 1206 aaaagcctta ygtgtgccgg g 21 1207 21 DNA Homo sapiens 1207 ctggggatcc rggcccaggg g 21 1208 21 DNA Homo sapiens 1208 gggaaaagcc ktatgtgtgc c 21 1209 21 DNA Homo sapiens 1209 cagctctaat yacacacaag c 21 1210 21 DNA Homo sapiens 1210 agcattgtat rtggagaagt c 21 1211 21 DNA Homo sapiens 1211 cacagctcct ygctcagcca g 21 1212 21 DNA Homo sapiens 1212 tcagccagca ygaaaggacg c 21 1213 21 DNA Homo sapiens 1213 agtcacagct ygtccctcac c 21 1214 21 DNA Homo sapiens 1214 gcgaatccac rctggggaga a 21 1215 21 DNA Homo sapiens 1215 caggagagaa rccctatgaa t 21 1216 21 DNA Homo sapiens 1216 aaagccgtat sggtgcaatg a 21 1217 21 DNA Homo sapiens 1217 caccaaacat yagcgaatcc a 21 1218 21 DNA Homo sapiens 1218 cctatgggcc rttcaccacg g 21 1219 21 DNA Homo sapiens 1219 tccccaagtg ractcgcccc g 21 1220 21 DNA Homo sapiens 1220 gagctggcct rtactttagc a 21 1221 21 DNA Homo sapiens 1221 tgctgtgggc rtaagcaccc t 21 1222 21 DNA Homo sapiens 1222 tgagtcctct ktttcatcag c 21 1223 21 DNA Homo sapiens 1223 aaacatcatt ygattgaaca c 21 1224 21 DNA Homo sapiens 1224 agatattcca waagagtagt t 21 1225 21 DNA Homo sapiens 1225 agagaaggga mtgctaagaa c 21 1226 21 DNA Homo sapiens 1226 tgccaacaga ycagacagtg t 21 1227 21 DNA Homo sapiens 1227 ataactttag ytgctccctg t 21 1228 21 DNA Homo sapiens 1228 cagttttacc rgtgggatca a 21 1229 21 DNA Homo sapiens 1229 cttgccaaca rtccaaaata g 21 1230 21 DNA Homo sapiens 1230 acaagtatct statgccatg c 21 1231 21 DNA Homo sapiens 1231 tgacgatgtc rgaaaccatg c 21 1232 21 DNA Homo sapiens 1232 gccattccca ygccaaaatg t 21 1233 21 DNA Homo sapiens 1233 agagtaccag stgttggtgg a 21 1234 10 DNA Homo sapiens 1234 attgttcccs 10 1235 21 DNA Homo sapiens 1235 tgctggcaga rtcagatgaa t 21 1236 21 DNA Homo sapiens 1236 tggccaaggc maaagctgtg a 21 1237 21 DNA Homo sapiens 1237 aactgcctga rtgtcttaaa t 21 1238 21 DNA Homo sapiens 1238 tcgaaatgga scgtgcgttc c 21 1239 21 DNA Homo sapiens 1239 actgccccac sgtcattaac a 21 1240 21 DNA Homo sapiens 1240 ctgccccacc rtcattaaca g 21 1241 21 DNA Homo sapiens 1241 aagagactat yacagccctc t 21 1242 21 DNA Homo sapiens 1242 ccgccaccag yagtaccggg t 21 1243 21 DNA Homo sapiens 1243 ggagcgcaga stcggcaggc a 21 1244 21 DNA Homo sapiens 1244 gccctcaagg rctgaaaata a 21 1245 21 DNA Homo sapiens 1245 atgagtacga ygagcttcca g 21 1246 21 DNA Homo sapiens 1246 tcatgggtct rgatggggcc a 21 1247 21 DNA Homo sapiens 1247 ctcagatcca ytggacactt t 21 1248 21 DNA Homo sapiens 1248 cgcaggctga rgtgggagta c 21 1249 21 DNA Homo sapiens 1249 aggccttgtc ycctttctat t 21 1250 21 DNA Homo sapiens 1250 cttctaacga raccactttt g 21 1251 21 DNA Homo sapiens 1251 gcttacattc kgaattactt a 21 1252 21 DNA Homo sapiens 1252 tggctcacta ygacaccacc g 21 1253 21 DNA Homo sapiens 1253 tcatccccac rgtgctggac a 21 1254 21 DNA Homo sapiens 1254 ggcacccaat rgaagccatg c 21 1255 21 DNA Homo sapiens 1255 tcatgggcct rgcagtggtg c 21 1256 21 DNA Homo sapiens 1256 cgtcacgcag saaagggacg a 21 1257 21 DNA Homo sapiens 1257 aggcctatgg saatggctac t 21 1258 21 DNA Homo sapiens 1258 cactctctgg rtatgaagag c 21 1259 21 DNA Homo sapiens 1259 gcagaaacta ycagaggccg t 21 1260 21 DNA Homo sapiens 1260 gcctccttca yggcctacag c 21 1261 21 DNA Homo sapiens 1261 agatccagac rgagaggagg g 21 1262 21 DNA Homo sapiens 1262 gcatcatcga ygtaatcaca c 21 1263 21 DNA Homo sapiens 1263 atcatccata ygacgcagca c 21 1264 21 DNA Homo sapiens 1264 aaaattctcc rttgaaggat t 21 1265 21 DNA Homo sapiens 1265 tcaccaagtg yttctctagc a 21 1266 21 DNA Homo sapiens 1266 caatatcaag ygaaatattc a 21 1267 21 DNA Homo sapiens 1267 cagagaataa ycttcaattc c 21 1268 21 DNA Homo sapiens 1268 ttctgacaag ygttgggtct a 21 1269 21 DNA Homo sapiens 1269 ctatgaaaaa sgagaaaaat g 21 1270 21 DNA Homo sapiens 1270 tcatctactc sagcccaggc g 21 1271 21 DNA Homo sapiens 1271 ggagaactgg ytgtctgagt g 21 1272 21 DNA Homo sapiens 1272 tggagctcca magaaggatg t 21 1273 21 DNA Homo sapiens 1273 cacctcccac rtcccggagg t 21 1274 21 DNA Homo sapiens 1274 ctggacaggg ygacccgaga g 21 1275 21 DNA Homo sapiens 1275 caagagctac rtcatcgctg g 21 1276 21 DNA Homo sapiens 1276 tggcacacat yctgggcatc c 21 1277 21 DNA Homo sapiens 1277 ggggcatcaa ygtcctgctg a 21 1278 21 DNA Homo sapiens 1278 acatggccca rgggaagcac a 21 1279 21 DNA Homo sapiens 1279 ggacccggct yccgtccgtg a 21 1280 21 DNA Homo sapiens 1280 cacctttgtg rtgataccaa c 21 1281 21 DNA Homo sapiens 1281 tctacctgga yggcaggtgt g 21 1282 21 DNA Homo sapiens 1282 ggcaggatgc rtgtggttcc a 21 1283 21 DNA Homo sapiens 1283 gcgtgcccac ragtccggag g 21 1284 21 DNA Homo sapiens 1284 agcagcgggc raggctcccc c 21 1285 21 DNA Homo sapiens 1285 atgacagtgc rggaaagcag c 21 1286 21 DNA Homo sapiens 1286 atcacagaca stctggttgc a 21 1287 21 DNA Homo sapiens 1287 cactctccag sagctccgtg c 21 1288 21 DNA Homo sapiens 1288 gctgctgccg scaacctaca a 21 1289 21 DNA Homo sapiens 1289 ctccagaaat rctgaggaac a 21 1290 21 DNA Homo sapiens 1290 ttgctcgtgc sgtggacaca c 21 1291 21 DNA Homo sapiens 1291 aggacctgga sgtgattctc c 21 1292 21 DNA Homo sapiens 1292 gcccctgaga rcaaggcctt c 21 1293 21 DNA Homo sapiens 1293 tggcctcaac ygccaccaat g 21 1294 21 DNA Homo sapiens 1294 actgtaccat ragtggagtc c 21 1295 21 DNA Homo sapiens 1295 gctcgagtgt rccaaaacgt g 21 1296 21 DNA Homo sapiens 1296 gccagaacta ygacctggag t 21 1297 21 DNA Homo sapiens 1297 tctcggaacc rccgttgcac g 21 1298 21 DNA Homo sapiens 1298 aactttgtcc rctacgtcca g 21 1299 21 DNA Homo sapiens 1299 gccctaatgc yaacgtgcag g 21 1300 21 DNA Homo sapiens 1300 ttaccagtga ygtcttccag g 21 1301 21 DNA Homo sapiens 1301 acatggtgac ygtggagtac c 21 1302 21 DNA Homo sapiens 1302 caggagcaag ragttcatgg a 21 1303 21 DNA Homo sapiens 1303 cctgcagcgg ktgcgagaga t 21 1304 21 DNA Homo sapiens 1304 tcagcgaggc mcagtccaaa g 21 1305 21 DNA Homo sapiens 1305 aaacaaggag yaggacctgg a 21 1306 21 DNA Homo sapiens 1306 tcaccttggt yacatcttca c 21 1307 21 DNA Homo sapiens 1307 caggtgtgca rccagctgga g 21 1308 21 DNA Homo sapiens 1308 accaaccaca ytgtgatgac c 21 1309 21 DNA Homo sapiens 1309 tcactgccga ycagctcagg a 21 1310 21 DNA Homo sapiens 1310 catctacaac wtgataggat a 21 1311 21 DNA Homo sapiens 1311 tgaagaagct rgtatacctc t 21 1312 21 DNA Homo sapiens 1312 ttcttggcgg yggccttgac a 21 1313 21 DNA Homo sapiens 1313 aggtccacgc rccactcagc c 21 1314 21 DNA Homo sapiens 1314 gaggcaccac yatgtaccct g 21 1315 21 DNA Homo sapiens 1315 cgaggctgac ygagagcgag g 21 1316 21 DNA Homo sapiens 1316 ggtgcccagc ygtgaccaga c 21 1317 21 DNA Homo sapiens 1317 acaccgtcta yagcatggag c 21 1318 21 DNA Homo sapiens 1318 gatcttggca rgagacaaga a 21 1319 21 DNA Homo sapiens 1319 ggctgctctc rgagatccgg c 21 1320 21 DNA Homo sapiens 1320 tgctgctgcc kgatgactac c 21 1321 21 DNA Homo sapiens 1321 tgtactaccg yggtgccaac c 21 1322 21 DNA Homo sapiens 1322 agctggtctc ygaagccaag g 21 1323 21 DNA Homo sapiens 1323 agagtgtcat yggcagcgtg c 21 1324 21 DNA Homo sapiens 1324 acgccagtga ygacggcagc g 21 1325 21 DNA Homo sapiens 1325 cttgccaacc wggccgacct g 21 1326 21 DNA Homo sapiens 1326 tcatgggtga yggcctggcc a 21 1327 21 DNA Homo sapiens 1327 gacctctgcg sccggaaggt c 21 1328 21 DNA Homo sapiens 1328 gtgacgacgg yagcggctcg g 21 1329 21 DNA Homo sapiens 1329 tgacctctgc rgccggaagg t 21 1330 21 DNA Homo sapiens 1330 tctggcactt ygccgacaac c 21 1331 21 DNA Homo sapiens 1331 gctccgtggc ycaggttgtg c 21 1332 21 DNA Homo sapiens 1332 ccctcatcct sgtgatgttt g 21 1333 21 DNA Homo sapiens 1333 tgtgtgccca ygaggagctc c 21 1334 21 DNA Homo sapiens 1334 ccatacacag kccttgcaaa c 21 1335 21 DNA Homo sapiens 1335 ggagatctgt kttcgtacag t 21 1336 21 DNA Homo sapiens 1336 tggctgctgt ycatgccgaa a 21 1337 21 DNA Homo sapiens 1337 cccggggcag yggtgtcaat g 21 1338 21 DNA Homo sapiens 1338 acgagctgat rgtgcgccgc g 21 1339 21 DNA Homo sapiens 1339 gctggaggtg wcagtcactt a 21 1340 21 DNA Homo sapiens 1340 ggtggcagtc mcagaatgat g 21 1341 21 DNA Homo sapiens 1341 cttcatctac ytgtggactg a 21 1342 21 DNA Homo sapiens 1342 gaggctactg yaatcgctac c 21 1343 21 DNA Homo sapiens 1343 gaccaggcag wtgattaggg c 21 1344 21 DNA Homo sapiens 1344 tttctccgag yttcatctac c 21 1345 21 DNA Homo sapiens 1345 cacggccatg ytgatcgctg c 21 1346 21 DNA Homo sapiens 1346 agtgtgatcc rgatggggca g 21 1347 21 DNA Homo sapiens 1347 ctatggagac rtggccacag g 21 1348 21 DNA Homo sapiens 1348 ggctgtgaac ygtgtgcctg c 21 1349 21 DNA Homo sapiens 1349 cctgacagga ytggagaagc g 21 1350 21 DNA Homo sapiens 1350 tgctgcgctc rgcggacctg a 21 1351 21 DNA Homo sapiens 1351 tggagcagga kaagcaccgg c 21 1352 21 DNA Homo sapiens 1352 cgtttggcag rgcagccagg c 21 1353 21 DNA Homo sapiens 1353 ggtcccaatg rgcaaggagc c 21 1354 21 DNA Homo sapiens 1354 ccacagagat ycctgacttc a 21 1355 21 DNA Homo sapiens 1355 tttgggatga ytccagctgc c 21 1356 21 DNA Homo sapiens 1356 ttcaggctta yggtatgaag c 21 1357 21 DNA Homo sapiens 1357 agattgacaa rttcgagttt g 21 1358 21 DNA Homo sapiens 1358 gcaaagtcgg ygggcgctgg a 21 1359 21 DNA Homo sapiens 1359 ggagctctgg sagaccctgc a 21 1360 21 DNA Homo sapiens 1360 gattctcctc rggcatcaca g 21 1361 21 DNA Homo sapiens 1361 ttgagttcca ytgtgctgtg c 21 1362 21 DNA Homo sapiens 1362 aatgctatga yagctcccca t 21 1363 21 DNA Homo sapiens 1363 tggctgtgcc ygaggaaacc g 21 1364 21 DNA Homo sapiens 1364 gtgccgctgg yggccagcat c 21 1365 21 DNA Homo sapiens 1365 ggacagccac rcggtgctgc a 21 1366 21 DNA Homo sapiens 1366 caaagaaatc rattcagtcg g 21 1367 21 DNA Homo sapiens 1367 atctaaacag yctgcctcac a 21 1368 21 DNA Homo sapiens 1368 ctaaggttgt rtctcagtat c 21 1369 21 DNA Homo sapiens 1369 tacagcgtgg ygaagacgga t 21 1370 21 DNA Homo sapiens 1370 attattgctg mccggaagca g 21 1371 21 DNA Homo sapiens 1371 agatgtcctt rctggctaca a 21 1372 21 DNA Homo sapiens 1372 agagagttaa kgccctggag g 21 1373 21 DNA Homo sapiens 1373 aacttcacca raacatggca a 21 1374 21 DNA Homo sapiens 1374 tcgatgtggc rggcaacctg g 21 1375 21 DNA Homo sapiens 1375 ttcaccatgt ytctgaacct g 21 1376 21 DNA Homo sapiens 1376 gaggtggacc rgatgttcca g 21 1377 21 DNA Homo sapiens 1377 tcgagaacct rcggcggcga t 21 1378 21 DNA Homo sapiens 1378 tcgctggcat rctggcagta g 21 1379 21 DNA Homo sapiens 1379 aacccaacac rccatttgcc g 21 1380 21 DNA Homo sapiens 1380 actcgtactc sttccgggtc t 21 1381 21 DNA Homo sapiens 1381 agagagggag sctcggagtg g 21 1382 21 DNA Homo sapiens 1382 ctgtcgacga yccctacgcc a 21 1383 21 DNA Homo sapiens 1383 gaaagatgag ytttgccgtc a 21 1384 21 DNA Homo sapiens 1384 atgacttggc ytccctcagt g 21 1385 21 DNA Homo sapiens 1385 aagatcctaa yctggtgaat g 21 1386 21 DNA Homo sapiens 1386 gctgctactt ygacatcgag t 21 1387 21 DNA Homo sapiens 1387 gaaatatacc rtaagtatgg a 21 1388 21 DNA Homo sapiens 1388 gtataataaa ytcctggagt t 21 1389 21 DNA Homo sapiens 1389 agcagcctta rgcatcttgg a 21 1390 21 DNA Homo sapiens 1390 tcaaccagct ktctgtgcct t 21 1391 21 DNA Homo sapiens 1391 aaaaaggcaa wactgttcct g 21 1392 21 DNA Homo sapiens 1392 tttttaatta yatttactcc a 21 1393 21 DNA Homo sapiens 1393 ttagtaaaac yggagctgaa g 21 1394 21 DNA Homo sapiens 1394 gctcattggc rtcaacctga t 21 1395 21 DNA Homo sapiens 1395 ctgtccatgt kccagttcag c 21 1396 21 DNA Homo sapiens 1396 actacaacac rtccagcaaa g 21 1397 21 DNA Homo sapiens 1397 ctggtcccca rgggcattgg t 21 1398 21 DNA Homo sapiens 1398 cagcctcctc rgagacctcc a 21 1399 21 DNA Homo sapiens 1399 aatccaccga yggaagccgc a 21 1400 21 DNA Homo sapiens 1400 ccggcaaacc ygacagccag t 21 1401 21 DNA Homo sapiens 1401 tctcggacac ygtggctttt g 21 1402 21 DNA Homo sapiens 1402 gctgcgttct yttccgcact c 21 1403 21 DNA Homo sapiens 1403 ctggattacg ytgcgttctc t 21 1404 21 DNA Homo sapiens 1404 gagtgcactt ycctatcccg c 21 1405 21 DNA Homo sapiens 1405 agaagacgtt yaccaagccc c 21 1406 21 DNA Homo sapiens 1406 aatttctcca ycaattttcc a 21 1407 21 DNA Homo sapiens 1407 tgtgtgaact ktcacctgtc a 21 1408 21 DNA Homo sapiens 1408 ctgatgagct yctgtttagc c 21 1409 21 DNA Homo sapiens 1409 agctacggat yctgctggac c 21 1410 21 DNA Homo sapiens 1410 tcttgaagtg maaaaagtct g 21 1411 21 DNA Homo sapiens 1411 cctcctgagc yacggatcct g 21 1412 21 DNA Homo sapiens 1412 atgttgaggt rtctgttact a 21 1413 21 DNA Homo sapiens 1413 ctctgcgcgg ytttttgagc g 21 1414 21 DNA Homo sapiens 1414 agacagcgat ygcctcggag g 21 1415 21 DNA Homo sapiens 1415 accttctgga rtggattgaa c 21 1416 21 DNA Homo sapiens 1416 agctcgaggc ygagaattac c 21 1417 21 DNA Homo sapiens 1417 acatcaagaa ygagatcgac a 21 1418 21 DNA Homo sapiens 1418 ccaagcacat ygcggaagag g 21 1419 21 DNA Homo sapiens 1419 aaggccagac katgccccta t 21 1420 21 DNA Homo sapiens 1420 ccaacaaagc kgttaagggc a 21 1421 21 DNA Homo sapiens 1421 ctatggagtc ytcagatgag g 21 1422 21 DNA Homo sapiens 1422 gggtccattg mccatgcatc t 21 1423 21 DNA Homo sapiens 1423 atgaccacac rtcagaaaag t 21 1424 21 DNA Homo sapiens 1424 tccatccagc rtctcctccc c 21 1425 21 DNA Homo sapiens 1425 agggtgaaca yataagggaa a 21 1426 21 DNA Homo sapiens 1426 ccatcctgaa rgaggagggt g 21 1427 21 DNA Homo sapiens 1427 tgatcctaaa saaagagatg a 21 1428 21 DNA Homo sapiens 1428 ccatctcccc ratggtgatg g 21 1429 21 DNA Homo sapiens 1429 gggatgaaga ygcctgggcc a 21 1430 21 DNA Homo sapiens 1430 aagcacagcg rtggattgat a 21 1431 21 DNA Homo sapiens 1431 gccagggtgg ytacaaagat a 21 1432 21 DNA Homo sapiens 1432 gaattcttca rtccttaaaa c 21 1433 21 DNA Homo sapiens 1433 ttagacctgc mgaaatcctg a 21 1434 21 DNA Homo sapiens 1434 agtgttctag mtattctgaa a 21 1435 21 DNA Homo sapiens 1435 cttttggcaa ygtggagcct g 21 1436 21 DNA Homo sapiens 1436 ctctggaaca rctcctaatt c 21 1437 21 DNA Homo sapiens 1437 aaccttatta ytttatgtga g 21 1438 21 DNA Homo sapiens 1438 attagatgac yttgttgaaa c 21 1439 21 DNA Homo sapiens 1439 gtggtcccag rtgcacttcc t 21 1440 21 DNA Homo sapiens 1440 cagacaagtg yaatatgatt a 21 1441 21 DNA Homo sapiens 1441 agatgacttt rttgaaacgg g 21 1442 21 DNA Homo sapiens 1442 atgcctccaa raaagatggg g 21 1443 21 DNA Homo sapiens 1443 ggaactttgc rtactgggct g 21 1444 21 DNA Homo sapiens 1444 ccgaggaggc yactggcgtc g 21 1445 21 DNA Homo sapiens 1445 gctgctgctg ytcttcgtag g 21 1446 21 DNA Homo sapiens 1446 ccataacctg mtgacatttc a 21 1447 21 DNA Homo sapiens 1447 agctggaggt raagatccgt g 21 1448 21 DNA Homo sapiens 1448 acaggacaat ygaggagctg c 21 1449 21 DNA Homo sapiens 1449 ggaggaggcc racactgagc t 21 1450 21 DNA Homo sapiens 1450 ctggctgctg mtgacttccg c 21 1451 21 DNA Homo sapiens 1451 atcgattgca stcagagcct g 21 1452 21 DNA Homo sapiens 1452 gtcctatcag yactgagagg c 21 1453 21 DNA Homo sapiens 1453 acacccggga rctgtttctc a 21 1454 21 DNA Homo sapiens 1454 acctgaagag ygtgatgctg c 21 1455 21 DNA Homo sapiens 1455 tcgaggagaa stctggcatg g 21 1456 21 DNA Homo sapiens 1456 agttccacag raaataccgg a 21 1457 21 DNA Homo sapiens 1457 cctccttcct rcgggcaccc a 21 1458 21 DNA Homo sapiens 1458 ccagccgcct ytttgaccag t 21 1459 21 DNA Homo sapiens 1459 ggatcccagc ygatgtagac c 21 1460 21 DNA Homo sapiens 1460 tagagttggc rttggaaaca t 21 1461 21 DNA Homo sapiens 1461 tatttagtag ygaaaccaaa t 21 1462 21 DNA Homo sapiens 1462 tcattatcac rcaaggtaac t 21 1463 21 DNA Homo sapiens 1463 cggtcagtgg yttccagcca g 21 1464 21 DNA Homo sapiens 1464 catgctgatg rtcacacacc t 21 1465 21 DNA Homo sapiens 1465 agcctcctga wgctgatggt g 21 1466 21 DNA Homo sapiens 1466 tacatcaact ytttggagat g 21 1467 21 DNA Homo sapiens 1467 gctttgccta yattgcccgc c 21 1468 21 DNA Homo sapiens 1468 gtcactggga ytgctgtagc g 21 1469 21 DNA Homo sapiens 1469 gggagtacac rtgccagact g 21 1470 21 DNA Homo sapiens 1470 tacacgctgt wctcatccaa g 21 1471 21 DNA Homo sapiens 1471 ttacgtccat rctttatcat c 21 1472 21 DNA Homo sapiens 1472 gagtgtcctg rctcctttta c 21 1473 21 DNA Homo sapiens 1473 gccagcaagg wcttctctcc g 21 1474 21 DNA Homo sapiens 1474 ccagggaaag rcgcttactt g 21 1475 21 DNA Homo sapiens 1475 accgtgtgtg rctgcaggaa g 21 1476 21 DNA Homo sapiens 1476 ttattggagt raaaaccttt t 21 1477 21 DNA Homo sapiens 1477 tgctaaagct ragagggctg c 21 1478 21 DNA Homo sapiens 1478 caggctgcag rcagttcagc g 21 1479 21 DNA Homo sapiens 1479 tgcccagctc yaggagggac a 21 1480 21 DNA Homo sapiens 1480 gaacaacatt rcttatgggc t 21 1481 21 DNA Homo sapiens 1481 aaggggctga ygtttaccct a 21 1482 21 DNA Homo sapiens 1482 tgcacttggg kgtgcagatg c 21 1483 21 DNA Homo sapiens 1483 gtacctgctc rtaaggaggg t 21 1484 21 DNA Homo sapiens 1484 tgctcagcaa ygtgggagct g 21 1485 21 DNA Homo sapiens 1485 cccgcctggt kcagcagcgg c 21 1486 21 DNA Homo sapiens 1486 tgataaggtg rtggcggctg c 21 1487 21 DNA Homo sapiens 1487 gccaatcaaa kgagggctca c 21 1488 21 DNA Homo sapiens 1488 ccgcccaccc rggcccggag t 21 1489 21 DNA Homo sapiens 1489 accgccacgt ygcagatggg g 21 1490 21 DNA Homo sapiens 1490 acaaaaaact yatcatgtat t 21 1491 21 DNA Homo sapiens 1491 atcacatgaa ragagcaact c 21 1492 21 DNA Homo sapiens 1492 agaattgtca kaattgtccc t 21 1493 21 DNA Homo sapiens 1493 gtgcccggct sctgaaagcc g 21 1494 21 DNA Homo sapiens 1494 ggctgtctgt rgagaccctg g 21 1495 21 DNA Homo sapiens 1495 acacagtctt ygctcccaca a 21 1496 21 DNA Homo sapiens 1496 gtaatagcct ytgcattgag a 21 1497 21 DNA Homo sapiens 1497 gctgaccaat raggccaccc t 21 1498 21 DNA Homo sapiens 1498 tgcccgagac ygaggacgag a 21 1499 21 DNA Homo sapiens 1499 gcaaaacaag rgcatcagtg c 21 1500 21 DNA Homo sapiens 1500 tgacctggcg ygctgccatg c 21 1501 21 DNA Homo sapiens 1501 tcattatatt ygagcagatt c 21 1502 21 DNA Homo sapiens 1502 tttcagttcc ytattttctg t 21 1503 21 DNA Homo sapiens 1503 ttttctgttt saacattggc g 21 1504 21 DNA Homo sapiens 1504 ggggttatgt ygctatgaag t 21 1505 21 DNA Homo sapiens 1505 tccagccaac ratgaccagt c 21 1506 21 DNA Homo sapiens 1506 ttcagtcctc rgcctctcca g 21 1507 21 DNA Homo sapiens 1507 gctaaataaa racatgacct a 21 1508 21 DNA Homo sapiens 1508 ccagcctctc raatgggcac a 21 1509 21 DNA Homo sapiens 1509 caactcgacg rtccaggcct c 21 1510 21 DNA Homo sapiens 1510 gatttctgga ytccactgtt g 21 1511 21 DNA Homo sapiens 1511 acctgaagaa rtttatagaa a 21 1512 21 DNA Homo sapiens 1512 gatgtctgca rtgggaagag t 21 1513 21 DNA Homo sapiens 1513 aatttacaaa yttcaatctt t 21 1514 21 DNA Homo sapiens 1514 ctccaggtca rcccctgcca c 21 1515 21 DNA Homo sapiens 1515 cacatcgacc rggctctgga t 21 1516 21 DNA Homo sapiens 1516 tcatcgtgcc rctgctgatc a 21 1517 21 DNA Homo sapiens 1517 gccatggact yctcaagatt c 21 1518 21 DNA Homo sapiens 1518 atggagagtg rcagctttga a 21 1519 21 DNA Homo sapiens 1519 gctatgccag yccggagatg t 21 1520 21 DNA Homo sapiens 1520 atggcggcag ytgtggctgt g 21 1521 21 DNA Homo sapiens 1521 agcttgacaa ratggtgaca g 21 1522 21 DNA Homo sapiens 1522 tggtcaacct rcccttggtg a 21 1523 21 DNA Homo sapiens 1523 tctggagaca ytacttccag a 21 1524 21 DNA Homo sapiens 1524 cgagatcttt ktcataatcc t 21 1525 21 DNA Homo sapiens 1525 tcctcataaa rtacaggagg c 21 1526 21 DNA Homo sapiens 1526 gcaagaagat mctgctgccc g 21 1527 21 DNA Homo sapiens 1527 tagaagggca ygtggtgatt c 21 1528 21 DNA Homo sapiens 1528 ccctgctcaa rcccaacatg g 21 1529 21 DNA Homo sapiens 1529 tgaagccttc scatgtaatt t 21 1530 21 DNA Homo sapiens 1530 ttttctcaac rcattacttc c 21 1531 21 DNA Homo sapiens 1531 tgcaaggtaa rgccaattgg a 21 1532 21 DNA Homo sapiens 1532 ctcctcgcca sgtctctgca a 21 1533 21 DNA Homo sapiens 1533 gtggagcaga ratcttcgtt g 21 1534 21 DNA Homo sapiens 1534 agttcccacg saaatgagag g 21 1535 21 DNA Homo sapiens 1535 ggtgacttgg sagcctccca g 21 1536 21 DNA Homo sapiens 1536 tctaaactgg stacggagtc g 21 1537 21 DNA Homo sapiens 1537 ccagtgtccc ygagctggtc g 21 1538 21 DNA Homo sapiens 1538 acaacaacac yaagctcgca a 21 1539 21 DNA Homo sapiens 1539 gctgaaagtg magaaagtca t 21 1540 21 DNA Homo sapiens 1540 gaagaaatat rtccgcaggg a 21 1541 21 DNA Homo sapiens 1541 ttcaagccac rgagcttgcc a 21 1542 21 DNA Homo sapiens 1542 acaaactggc ygagtcctgt g 21 1543 21 DNA Homo sapiens 1543 gcctcaatga kcctggtcca t 21 1544 21 DNA Homo sapiens 1544 tggatgtgca ygcggacagg a 21 1545 21 DNA Homo sapiens 1545 cactttccat ygctttgaca a 21 1546 21 DNA Homo sapiens 1546 tgcgggaggt ytttgagagc a 21 1547 21 DNA Homo sapiens 1547 gtaccaaggg ycagctggcc a 21 1548 21 DNA Homo sapiens 1548 cctggggagt ygctccaaca a 21 1549 21 DNA Homo sapiens 1549 aggccatcat ygactgcctg g 21 1550 21 DNA Homo sapiens 1550 tccaaattta ytctgctgac a 21 1551 21 DNA Homo sapiens 1551 aaggctatga ygtcattgcc t 21 1552 21 DNA Homo sapiens 1552 ggccctgcat ygcccgcaaa c 21 1553 21 DNA Homo sapiens 1553 aatcccagac rctatgtcca g 21 1554 21 DNA Homo sapiens 1554 tggacacctc stgcatcctc g 21 1555 21 DNA Homo sapiens 1555 agtttgtgga rgagttcatc t 21 1556 21 DNA Homo sapiens 1556 aggcactgaa rcttggggcc a 21 1557 21 DNA Homo sapiens 1557 ccagtccagc rcactgtatg a 21 1558 21 DNA Homo sapiens 1558 tgtcccacgg ygccacagga a 21 1559 21 DNA Homo sapiens 1559 gaattctaca rccggttcaa g 21 1560 21 DNA Homo sapiens 1560 ttctcgagat ygagttcaaa a 21 1561 21 DNA Homo sapiens 1561 atgctcattt rgacatcgag g 21 1562 21 DNA Homo sapiens 1562 cagttttcca ygagcaacat c 21 1563 21 DNA Homo sapiens 1563 ttcagtggaa ygcaggctca g 21 1564 21 DNA Homo sapiens 1564 ggtttcttct stgtctccgc g 21 1565 21 DNA Homo sapiens 1565 ccacgagtgc rttcctgggg a 21 1566 21 DNA Homo sapiens 1566 cgagtgattg ragagcccac g 21 1567 21 DNA Homo sapiens 1567 gggtgctccc rgccggccga g 21 1568 21 DNA Homo sapiens 1568 agccgtgctg yggacatttc c 21 1569 21 DNA Homo sapiens 1569 gcaagaatct ygcagcagca t 21 1570 21 DNA Homo sapiens 1570 acaacaccac ytctaacatg g 21 1571 21 DNA Homo sapiens 1571 aagttgatta yccccgggat g 21 1572 21 DNA Homo sapiens 1572 catcatttca rtgaaggaaa a 21 1573 21 DNA Homo sapiens 1573 accctgctac rtttatctga t 21 1574 21 DNA Homo sapiens 1574 acccaggtca rcacgcaggc c 21 1575 21 DNA Homo sapiens 1575 acacgcaggc ygagcagctg c 21 1576 21 DNA Homo sapiens 1576 ctcaattgct rttgacacaa t 21 1577 21 DNA Homo sapiens 1577 atctttcatt kctgcaagga a 21 1578 21 DNA Homo sapiens 1578 tccatcgcag ygaacgccga c 21 1579 21 DNA Homo sapiens 1579 ctgccgccca ygctgctggg g 21 1580 21 DNA Homo sapiens 1580 ttttgccttt raagtggatg g 21 1581 21 DNA Homo sapiens 1581 agccggagcc rgagctggaa c 21 1582 21 DNA Homo sapiens 1582 cagggcctgg kcgtcacacc c 21 1583 21 DNA Homo sapiens 1583 agctgacact sgttcgcgtg a 21 1584 21 DNA Homo sapiens 1584 accccaaacc ygaggttgct g 21 1585 21 DNA Homo sapiens 1585 tttggcagaa raagccacgt t 21 1586 21 DNA Homo sapiens 1586 gttacatgat ygacaacgtg a 21 1587 21 DNA Homo sapiens 1587 taaaggtttc yaacaccctg g 21 1588 21 DNA Homo sapiens 1588 tcactaccaa yctgatcaat t 21 1589 21 DNA Homo sapiens 1589 aggtatacgg yattgaaggt c 21 1590 21 DNA Homo sapiens 1590 atcacagcaa ragagaggtt c 21 1591 21 DNA Homo sapiens 1591 tgccctggac rcccaccagc a 21 1592 21 DNA Homo sapiens 1592 cgcaatgtct ytgacggcat c 21 1593 21 DNA Homo sapiens 1593 gcactatctg ygtggcctac c 21 1594 21 DNA Homo sapiens 1594 caggaccatg wtgaagaaca t 21 1595 21 DNA Homo sapiens 1595 tgcactgacc yagattaatg t 21 1596 21 DNA Homo sapiens 1596 atgtcacgct yatcatcctg g 21 1597 21 DNA Homo sapiens 1597 agctgcgttc ragggatgca c 21 1598 21 DNA Homo sapiens 1598 tgatccaagg raatgatctg a 21 1599 21 DNA Homo sapiens 1599 tactagcact rttgaaggaa a 21 1600 21 DNA Homo sapiens 1600 cctggcggct kcgccggtcc a 21 1601 21 DNA Homo sapiens 1601 cagaccgtga raatagatgc c 21 1602 21 DNA Homo sapiens 1602 tgaaaggcaa kccctccaga g 21 1603 21 DNA Homo sapiens 1603 cgaggctgct rttacggctc a 21 1604 21 DNA Homo sapiens 1604 cagtgacggg racaaaggtc t 21 1605 21 DNA Homo sapiens 1605 accgccgagg mtgctgttac g 21 1606 21 DNA Homo sapiens 1606 tttccccagg ygaatgggct g 21 1607 21 DNA Homo sapiens 1607 tgcctcatgc rtacgtccca c 21 1608 21 DNA Homo sapiens 1608 acaaatctct yactgaagaa g 21 1609 21 DNA Homo sapiens 1609 ccagtgtcag yttgtgattc a 21 1610 21 DNA Homo sapiens 1610 tgagcctttg saggccccag a 21 1611 21 DNA Homo sapiens 1611 ctgtactcac yctttgggaa a 21 1612 21 DNA Homo sapiens 1612 cggacaacct kacgctgcgg t 21 1613 21 DNA Homo sapiens 1613 cggcctccgg stacctcttg c 21 1614 21 DNA Homo sapiens 1614 tgccacaaga ragcaggagt t 21 1615 21 DNA Homo sapiens 1615 aactacaact kgtcacttac a 21 1616 21 DNA Homo sapiens 1616 agggctgagc mttcaggcag c 21 1617 21 DNA Homo sapiens 1617 agtatgatct rtctgacatg c 21 1618 21 DNA Homo sapiens 1618 atttctttaa yaactacaag a 21 1619 21 DNA Homo sapiens 1619 gtgcagaaga mtatctatcc g 21 1620 21 DNA Homo sapiens 1620 aagactatct mtccgtggtc c 21 1621 21 DNA Homo sapiens 1621 ttgttgagct ygtgaaacac a 21 1622 21 DNA Homo sapiens 1622 cagggcggac yttgccaagt a 21 1623 21 DNA Homo sapiens 1623 tatctatccg wggtcctgaa c 21 1624 21 DNA Homo sapiens 1624 ccagaatgcg ytattagttc g 21 1625 21 DNA Homo sapiens 1625 cctaggaaaa rtgggcagca a 21 1626 21 DNA Homo sapiens 1626 accagccctt yctcatcgag g 21 1627 21 DNA Homo sapiens 1627 gctagccact sctcagtaat g 21 1628 21 DNA Homo sapiens 1628 tgttcttcac yaccttcatg c 21 1629 21 DNA Homo sapiens 1629 agaatgggca ygtggatata g 21 1630 21 DNA Homo sapiens 1630 aaagtatgaa rttcctgaag g 21 1631 21 DNA Homo sapiens 1631 aagaaaagta ygtgaacagg a 21 1632 21 DNA Homo sapiens 1632 tcgtacccga ygtctcctac g 21 1633 21 DNA Homo sapiens 1633 aggatggcca rgcctctgga g 21 1634 21 DNA Homo sapiens 1634 tgctgcagaa rgagctggcc a 21 1635 21 DNA Homo sapiens 1635 tctactgcca ygagtacttc a 21 1636 21 DNA Homo sapiens 1636 acggggtcca ygccactaag c 21 1637 21 DNA Homo sapiens 1637 ggaggccata ytggacataa t 21 1638 21 DNA Homo sapiens 1638 cagacacacc yagtggagac a 21 1639 21 DNA Homo sapiens 1639 aaggaggact rtcacaagtc c 21 1640 21 DNA Homo sapiens 1640 tggtggagaa rtcagtgaca g 21 1641 21 DNA Homo sapiens 1641 attggctacc yagtgatgat c 21 1642 21 DNA Homo sapiens 1642 tggagaagtc mgtgacaggt t 21 1643 21 DNA Homo sapiens 1643 gacaccattg rctacccagt g 21 1644 21 DNA Homo sapiens 1644 agcctgtttt kaatatcaca a 21 1645 21 DNA Homo sapiens 1645 cacaaaggcc yttgctatga c 21 1646 21 DNA Homo sapiens 1646 aaagctacca mcattacatc a 21 1647 21 DNA Homo sapiens 1647 gtgccaacgt ycctcaaccg t 21 1648 21 DNA Homo sapiens 1648 agcagtgccc rccaggcctg c 21 1649 21 DNA Homo sapiens 1649 ttttgttccg matgtctgag g 21 1650 21 DNA Homo sapiens 1650 ggccatcgcc yggactccga g 21 1651 21 DNA Homo sapiens 1651 tcgcctggac wccgagactc c 21 1652 21 DNA Homo sapiens 1652 ttcgtgactt ygctggccgc a 21 1653 21 DNA Homo sapiens 1653 tgcgccgccg yccgcccggc c 21 1654 21 DNA Homo sapiens 1654 tctgttgatc mgaacctgtg g 21 1655 21 DNA Homo sapiens 1655 tggtggccac rcagcaggag a 21 1656 21 DNA Homo sapiens 1656 tctggggcca sccccaaaga g 21 1657 21 DNA Homo sapiens 1657 acgacctcgc ygggctcggc a 21 1658 21 DNA Homo sapiens 1658 gatggtggcc ytattgacgg g 21 1659 21 DNA Homo sapiens 1659 ataagcggag rcggagcgtg a 21 1660 21 DNA Homo sapiens 1660 agagccccat ygcgccctgt a 21 1661 21 DNA Homo sapiens 1661 aaatccaaac mgatcggcag a 21 1662 21 DNA Homo sapiens 1662 tatagcctga wttttgtgtt g 21 1663 21 DNA Homo sapiens 1663 aaggatgcag yggtgtcctt t 21 1664 21 DNA Homo sapiens 1664 tgtgttgggc ytcagcggga a 21 1665 21 DNA Homo sapiens 1665 aaaatagctg yagccttggt g 21 1666 21 DNA Homo sapiens 1666 tctgagaact mccctaacaa g 21 1667 21 DNA Homo sapiens 1667 aggctgagga mccgggccaa g 21 1668 21 DNA Homo sapiens 1668 gatggttgag rtctatctgc t 21 1669 21 DNA Homo sapiens 1669 atgagcctgg rcaagtacct g 21 1670 21 DNA Homo sapiens 1670 cagggccggg ytttaaaaat a 21 1671 21 DNA Homo sapiens 1671 ttccagatgt kaccagtcaa c 21 1672 21 DNA Homo sapiens 1672 tccaccccag yggggccata g 21 1673 21 DNA Homo sapiens 1673 ttcctaacac rgtgactgtg g 21 1674 21 DNA Homo sapiens 1674 cctgccctat yaccgacgcc c 21 1675 21 DNA Homo sapiens 1675 atattgtcca yaagcatgga g 21 1676 21 DNA Homo sapiens 1676 gggacagaag yacatgaccg c 21 1677 21 DNA Homo sapiens 1677 tggtgaagct sttcgggccc t 21 1678 21 DNA Homo sapiens 1678 tgaagtacta yaccctagag g 21 1679 21 DNA Homo sapiens 1679 agaatttcgt mgttgggaag t 21 1680 21 DNA Homo sapiens 1680 ctgttgatcc ygatgaacct g 21 1681 21 DNA Homo sapiens 1681 tggatttcaa kaatatacca t 21 1682 21 DNA Homo sapiens 1682 acacttactc rgagtggcac a 21 1683 21 DNA Homo sapiens 1683 gggaaagtgc rtgtgagcgg c 21 1684 21 DNA Homo sapiens 1684 ctggcaaaag ktggcctatt g 21 1685 21 DNA Homo sapiens 1685 gttattttct ycttaccctg g 21 1686 21 DNA Homo sapiens 1686 aatgaaacca matccgtggt t 21 1687 21 DNA Homo sapiens 1687 ccctgcacca ygccttggaa c 21 1688 21 DNA Homo sapiens 1688 ctgacgtctt yctggaggca t 21 1689 21 DNA Homo sapiens 1689 ccttcccgac rtgaacaaga t 21 1690 21 DNA Homo sapiens 1690 cgagctggcc rtgatggtga t 21 1691 21 DNA Homo sapiens 1691 ttaccagcat kccagacacc t 21 1692 21 DNA Homo sapiens 1692 gtttttcatt mtgcctgcca a 21 1693 21 DNA Homo sapiens 1693 gcttgaatgt kaagaaattt t 21 1694 21 DNA Homo sapiens 1694 catcacagtg rtggtgtttt t 21 1695 21 DNA Homo sapiens 1695 gaaaagtttg raaaaaaact c 21 1696 21 DNA Homo sapiens 1696 tgagagatac ratgaggaag a 21 1697 21 DNA Homo sapiens 1697 tacttaggca satattacca g 21 1698 21 DNA Homo sapiens 1698 cttacggtat ytacatcgtt g 21 1699 21 DNA Homo sapiens 1699 gcgctcacgt sttcaccacg g 21 1700 21 DNA Homo sapiens 1700 tgcaatcagc ygactaagtt t 21 1701 21 DNA Homo sapiens 1701 catcaaagtg rttggcaatg g 21 1702 21 DNA Homo sapiens 1702 aacccgggaa yaaatccgag a 21 1703 21 DNA Homo sapiens 1703 aagaagtggc rgcacaagtc g 21 1704 21 DNA Homo sapiens 1704 atggcgagcc ytccggagag c 21 1705 21 DNA Homo sapiens 1705 agaaaccatt rtcatcaccc t 21 1706 21 DNA Homo sapiens 1706 cgcgctggtg ktggccacca t 21 1707 21 DNA Homo sapiens 1707 gaccctgccg ygggcgcggc a 21 1708 21 DNA Homo sapiens 1708 aggtgctgac rtgctcctgg t 21 1709 21 DNA Homo sapiens 1709 cgggagcaac ktgctggaga c 21 1710 21 DNA Homo sapiens 1710 cttataggta ytttcagcca t 21 1711 21 DNA Homo sapiens 1711 tgaaagccat yctcgttaca c 21 1712 21 DNA Homo sapiens 1712 cgattccacg ygaagacatt g 21 1713 21 DNA Homo sapiens 1713 attggtgaga ragacataaa g 21 1714 21 DNA Homo sapiens 1714 attgcaaagc rccctaatgt t 21 1715 21 DNA Homo sapiens 1715 tccctgccac rgtctgagag c 21 1716 21 DNA Homo sapiens 1716 cccctgaacc rtccgcagct c 21 1717 21 DNA Homo sapiens 1717 catgatcagc ygggccaaga a 21 1718 21 DNA Homo sapiens 1718 ggaagtgtta ygaagtggga a 21 1719 21 DNA Homo sapiens 1719 aggcctgccg rcttcggaag t 21 1720 21 DNA Homo sapiens 1720 gctttgaagg rctatagcat g 21 1721 21 DNA Homo sapiens 1721 gcaacatcaa rcaagtgcag g 21 1722 21 DNA Homo sapiens 1722 gaggacatac rtcatgatgg t 21 1723 21 DNA Homo sapiens 1723 cctgtatgaa mttcgattaa a 21 1724 21 DNA Homo sapiens 1724 cactgttggc rtgtacaatg g 21 1725 21 DNA Homo sapiens 1725 ccaatgtcaa rgagatcaag g 21 1726 21 DNA Homo sapiens 1726 ccaacatgat ygtggaggag t 21 1727 21 DNA Homo sapiens 1727 cttattttcc rgagatggaa g 21 1728 21 DNA Homo sapiens 1728 cagcttgcat kgctgacttt g 21 1729 21 DNA Homo sapiens 1729 ctgactttgg sttggcctta a 21 1730 21 DNA Homo sapiens 1730 tctcttggaa ygaactgtgt c 21 1731 21 DNA Homo sapiens 1731 tgagcgggaa ygcgtgtgtg c 21 1732 21 DNA Homo sapiens 1732 tctggcagaa yttgcggctc a 21 1733 21 DNA Homo sapiens 1733 tggacagcct rccccaggca g 21 1734 21 DNA Homo sapiens 1734 aagccactgt sgcttctggc a 21 1735 21 DNA Homo sapiens 1735 ccagcgaccc rgcaggacct a 21 1736 21 DNA Homo sapiens 1736 tatgcagctg ytaccctcca g 21 1737 21 DNA Homo sapiens 1737 gggatcccag ytttgaggag g 21 1738 21 DNA Homo sapiens 1738 aaccccaacc rcgttcgcat g 21 1739 21 DNA Homo sapiens 1739 gcttcctcaa yggggaggtg c 21 1740 21 DNA Homo sapiens 1740 agcagagcca rggcacctgc a 21 1741 21 DNA Homo sapiens 1741 atgctcttcg sgtgcctcca c 21 1742 21 DNA Homo sapiens 1742 atgaggagga rgaagagcca c 21 1743 21 DNA Homo sapiens 1743 gcctggccaa ygctgctgcc t 21 1744 21 DNA Homo sapiens 1744 gcagcagagt ygccacatca t 21 1745 21 DNA Homo sapiens 1745 gacgcttgtg yttgccctgg c 21 1746 21 DNA Homo sapiens 1746 acagggaggt rgccgagatc c 21 1747 21 DNA Homo sapiens 1747 tcatgctggc ygtgggagga g 21 1748 21 DNA Homo sapiens 1748 ccatcgcgct rgcactgctg g 21 1749 21 DNA Homo sapiens 1749 agtgaagatc magaagacaa g 21 1750 21 DNA Homo sapiens 1750 atgatcgttt ycttagtcag t 21 1751 21 DNA Homo sapiens 1751 tagtagcagt yttagaatac a 21 1752 21 DNA Homo sapiens 1752 ctcagccccg magtgcttca g 21 1753 21 DNA Homo sapiens 1753 gttgtaatga rtttataatg g 21 1754 21 DNA Homo sapiens 1754 atttataatg raaggaactc t 21 1755 21 DNA Homo sapiens 1755 aagcaggaac yggccaagta c 21 1756 21 DNA Homo sapiens 1756 agtattgtcc rtatcagacc t 21 1757 21 DNA Homo sapiens 1757 ccattgacat sgccacggaa a 21 1758 21 DNA Homo sapiens 1758 gctacattgc ygagcagaac a 21 1759 21 DNA Homo sapiens 1759 gctgcagcaa rtgctcgccg g 21 1760 21 DNA Homo sapiens 1760 tctgcacctg yaggcccggc t 21 1761 21 DNA Homo sapiens 1761 gatctgtaac rtggtggcca t 21 1762 21 DNA Homo sapiens 1762 aatgcaagca kggatgcagt c 21 1763 21 DNA Homo sapiens 1763 ccaagcacct ycttcctgct c 21 1764 21 DNA Homo sapiens 1764 gccgctgccc rctcatgctg a 21 1765 21 DNA Homo sapiens 1765 cgcgctacag ycagcgccca g 21 1766 21 DNA Homo sapiens 1766 tcggcctcta ygactccgtc a 21 1767 21 DNA Homo sapiens 1767 tgcaccacag ragccatggc g 21 1768 21 DNA Homo sapiens 1768 tacgggaatc rccgttttga a 21 1769 21 DNA Homo sapiens 1769 atcctgacca yggtgcggac t 21 1770 21 DNA Homo sapiens 1770 actgtggcat mgagatatac t 21 1771 21 DNA Homo sapiens 1771 atattaactt satggctgca a 21 1772 21 DNA Homo sapiens 1772 cctgtagtga mtcggccgct g 21 1773 21 DNA Homo sapiens 1773 cgctgcagcg mctggtggag g 21 1774 21 DNA Homo sapiens 1774 ggaccgctac stggccgtgg t 21 1775 21 DNA Homo sapiens 1775 tggccgtggt rcatcccatc a 21 1776 21 DNA Homo sapiens 1776 tgcagctggt yaacgtgttt g 21 1777 21 DNA Homo sapiens 1777 gccacggagc ygcgtccaga c 21 1778 21 DNA Homo sapiens 1778 acgtgtcggc rggcccaagc c 21 1779 21 DNA Homo sapiens 1779 ccacccgctc rgcccgctgg c 21 1780 21 DNA Homo sapiens 1780 agctgaatga yactcaccct c 21 1781 21 DNA Homo sapiens 1781 agctgatcac ytcagtggca g 21 1782 21 DNA Homo sapiens 1782 tgtacaaccg yattaagaaa g 21 1783 21 DNA Homo sapiens 1783 aagcaagttg raagtcatct t 21 1784 21 DNA Homo sapiens 1784 gatgtggacc stctgagaag g 21 1785 21 DNA Homo sapiens 1785 ccggggaagc kgccgtctaa a 21 1786 21 DNA Homo sapiens 1786 ggacgactcc ragctgccta c 21 1787 21 DNA Homo sapiens 1787 tgggaggcac rgtgattgga a 21 1788 21 DNA Homo sapiens 1788 tgattggaag ygcccggtgc a 21 1789 21 DNA Homo sapiens 1789 cgtgggatca scaatctctg t 21 1790 21 DNA Homo sapiens 1790 cactgtggat rcctggccct t 21 1791 21 DNA Homo sapiens 1791 atggcagcct yacaggtgcc a 21 1792 21 DNA Homo sapiens 1792 cagcgttctt ygtgacgtta g 21 1793 21 DNA Homo sapiens 1793 aatatctcgc ygtggagtcc c 21 1794 21 DNA Homo sapiens 1794 acttcaaacg katgacagca c 21 1795 21 DNA Homo sapiens 1795 cctcacatac saggcctcca t 21 1796 21 DNA Homo sapiens 1796 tccgggatct yagtaagcca g 21 1797 21 DNA Homo sapiens 1797 aagtatatca ktttcaaata t 21 1798 21 DNA Homo sapiens 1798 gtagccatgc ytacgcaaat c 21 1799 21 DNA Homo sapiens 1799 cacgagcact rtaaaatcca c 21 1800 21 DNA Homo sapiens 1800 ccatgcttac rcaaatcttg g 21 1801 21 DNA Homo sapiens 1801 tgccattcag sgattgtatg t 21 1802 21 DNA Homo sapiens 1802 attctgcatc rtgggactct a 21 1803 21 DNA Homo sapiens 1803 ttgtgaaatc wattcgaagt a 21 1804 21 DNA Homo sapiens 1804 cgaagtaatg ytcagcgcca g 21 1805 21 DNA Homo sapiens 1805 attgcttcaa sgacacctga a 21 1806 21 DNA Homo sapiens 1806 gagtagtcgc yatggcacag g 21 1807 21 DNA Homo sapiens 1807 gtaatgctca scgccaggaa a 21 1808 21 DNA Homo sapiens 1808 tgcaagatta yaggctgttg c 21 1809 21 DNA Homo sapiens 1809 ccctcagtca ygattcttta a 21 1810 21 DNA Homo sapiens 1810 gttggcagtt wccagctccc a 21 1811 21 DNA Homo sapiens 1811 gcagtactca rtctgaaaag c 21 1812 21 DNA Homo sapiens 1812 tcctgaacca kggctttctg g 21 1813 21 DNA Homo sapiens 1813 actatattac rtgcttcaaa a 21 1814 21 DNA Homo sapiens 1814 acaatagcca yatgggaaat a 21 1815 21 DNA Homo sapiens 1815 atcaaatgga rttccccacc a 21 1816 21 DNA Homo sapiens 1816 atttgtcccc rcacagaagt a 21 1817 21 DNA Homo sapiens 1817 tgcggtccat yttggtcaag g 21 1818 21 DNA Homo sapiens 1818 accaacctgc mcttccaggc c 21 1819 21 DNA Homo sapiens 1819 ccatctcata macgggcgac g 21 1820 21 DNA Homo sapiens 1820 gggacctatg ytgataaact g 21 1821 21 DNA Homo sapiens 1821 cctgttaata ytaggagtaa g 21 1822 21 DNA Homo sapiens 1822 ggtaatgaag kcacgtgtgt t 21 1823 21 DNA Homo sapiens 1823 gtacctttgt yatccaggcc a 21 1824 21 DNA Homo sapiens 1824 ccaggcagat sgaggcctta c 21 1825 21 DNA Homo sapiens 1825 gagtaatcat wgaagatgtg g 21 1826 21 DNA Homo sapiens 1826 tccaataatc wgtcaacttt a 21 1827 21 DNA Homo sapiens 1827 ttcaaaagca wttcaatcaa a 21 1828 21 DNA Homo sapiens 1828 tattcagctc rtccgtatcc t 21 1829 21 DNA Homo sapiens 1829 atctttacct yggtgctatg a 21 1830 21 DNA Homo sapiens 1830 gtggaaatcc rtactacctg t 21 1831 21 DNA Homo sapiens 1831 ttgtggcatt sctagcagac a 21 1832 21 DNA Homo sapiens 1832 atccatctat ygtaaatggc a 21 1833 21 DNA Homo sapiens 1833 ctatggacct yagataactg t 21 1834 21 DNA Homo sapiens 1834 accatcacag rgatgtgcca g 21 1835 21 DNA Homo sapiens 1835 ccctttacga rgcagcatta t 21 1836 21 DNA Homo sapiens 1836 tatgtgggag rcacccattg c 21 1837 21 DNA Homo sapiens 1837 aagagctcct ytgggagaat a 21 1838 21 DNA Homo sapiens 1838 gtctttgcaa ygatgtcatt c 21 1839 21 DNA Homo sapiens 1839 gctcattgcg rtatcttctt g 21 1840 21 DNA Homo sapiens 1840 tatcttcttg watggataga a 21 1841 21 DNA Homo sapiens 1841 agaagtcagc rttcacacgg t 21 1842 21 DNA Homo sapiens 1842 cctgtgtgtt wgacatggaa g 21 1843 21 DNA Homo sapiens 1843 ggggttctct yttcggcaga t 21 1844 21 DNA Homo sapiens 1844 cagctcagca wctcgtgcgc a 21 1845 21 DNA Homo sapiens 1845 ctttgttgta rcacaggccc t 21 1846 21 DNA Homo sapiens 1846 agaactgtct scctgaccct g 21 1847 21 DNA Homo sapiens 1847 ttaaaccaca ytttggcagt g 21 1848 21 DNA Homo sapiens 1848 acgtggacaa ygccgagggc t 21 1849 21 DNA Homo sapiens 1849 attccccatt ygccggggca c 21 1850 21 DNA Homo sapiens 1850 ggcaaggtga rgcagcagca g 21 1851 21 DNA Homo sapiens 1851 atgctcccat ygtctccgaa a 21 1852 21 DNA Homo sapiens 1852 tccagaggaa yaggacactg c 21 1853 21 DNA Homo sapiens 1853 cactcctcaa ytggataaat g 21 1854 21 DNA Homo sapiens 1854 tggagaacca rgtgctggta a 21 1855 21 DNA Homo sapiens 1855 gtaaatggac rgttaataga g 21 1856 21 DNA Homo sapiens 1856 agcatatcat stcccgagtg g 21 1857 21 DNA Homo sapiens 1857 agtcatcagc yttgtgccac c 21 1858 21 DNA Homo sapiens 1858 ctcagtacca ygatcctgat g 21 1859 21 DNA Homo sapiens 1859 ccgagccata ygatgagagc g 21 1860 21 DNA Homo sapiens 1860 aaatctcctc rgaacacgcc c 21 1861 21 DNA Homo sapiens 1861 gccccagaag racctgagca g 21 1862 21 DNA Homo sapiens 1862 tcctggttta ycagctgctg c 21 1863 21 DNA Homo sapiens 1863 tttgcatgca ragaacatca t 21 1864 21 DNA Homo sapiens 1864 gacagtctaa rgaaagcact g 21 1865 21 DNA Homo sapiens 1865 ccaaacagag rattttagtc t 21 1866 21 DNA Homo sapiens 1866 aggaagaggc rtccttagca g 21 1867 21 DNA Homo sapiens 1867 aagaagacaa kaggtttctt c 21 1868 21 DNA Homo sapiens 1868 gcatatacct sgagtatgtg a 21 1869 21 DNA Homo sapiens 1869 ataacaatta yggctgtgtc c 21 1870 21 DNA Homo sapiens 1870 tgaaattcag rgaattgacc c 21 1871 21 DNA Homo sapiens 1871 gaagctcaac ytggactcga t 21 1872 21 DNA Homo sapiens 1872 aagacggcta ygagttcttt g 21 1873 21 DNA Homo sapiens 1873 cattgaacca mcacagttca a 21 1874 21 DNA Homo sapiens 1874 atcagaaatt ygtacaacag c 21 1875 21 DNA Homo sapiens 1875 aggagtacct stcctttcgt t 21 1876 21 DNA Homo sapiens 1876 aaaactgtct yttgaaagga a 21 1877 21 DNA Homo sapiens 1877 agcacggaca ygcaggcccg g 21 1878 21 DNA Homo sapiens 1878 tgaccctcac rtgagtagta a 21 1879 21 DNA Homo sapiens 1879 ttctggggaa raagctgaag c 21 1880 21 DNA Homo sapiens 1880 taagcattgc rgagacgcca a 21 1881 21 DNA Homo sapiens 1881 ccctgaaagc mctgaggctc t 21 1882 21 DNA Homo sapiens 1882 tggtgttccc rcctggactg g 21 1883 21 DNA Homo sapiens 1883 tgaggctctc ycgtcagcgg t 21 1884 21 DNA Homo sapiens 1884 gacgccaagt ktgaaggaac t 21 1885 21 DNA Homo sapiens 1885 tctggagatg rtactgacta t 21 1886 21 DNA Homo sapiens 1886 tgatcttgga ygaaggacac a 21 1887 21 DNA Homo sapiens 1887 ctaacatatc ygtaaatgat g 21 1888 21 DNA Homo sapiens 1888 gggcacctgc rggaagcttc t 21 1889 21 DNA Homo sapiens 1889 tatcatggaa wtagatgaca c 21 1890 21 DNA Homo sapiens 1890 cctcatgtta sacggcgcac c 21 1891 21 DNA Homo sapiens 1891 ttttatgatg ratgtctgcg a 21 1892 21 DNA Homo sapiens 1892 ttcatggaca rtatacagat t 21 1893 21 DNA Homo sapiens 1893 cattctggag rattactagc a 21 1894 21 DNA Homo sapiens 1894 aggggtatga wcacaaagca a 21 1895 21 DNA Homo sapiens 1895 ccaattattg yggagagttt g 21 1896 21 DNA Homo sapiens 1896 gatcttatat ktagagccca t 21 1897 21 DNA Homo sapiens 1897 aaagatgcag rtctgaactc t 21 1898 21 DNA Homo sapiens 1898 cgatgggaac kccccatcct t 21 1899 21 DNA Homo sapiens 1899 cgccccatcc yttggtttac t 21 1900 21 DNA Homo sapiens 1900 acttaaagga yattgcagga g 21 1901 21 DNA Homo sapiens 1901 taaagatgtg yttggacatc t 21 1902 21 DNA Homo sapiens 1902 atgttcaggg ytgcaggggg a 21 1903 21 DNA Homo sapiens 1903 attatggcag yaacttacag a 21 1904 21 DNA Homo sapiens 1904 caaagatgca ratctgaact c 21 1905 21 DNA Homo sapiens 1905 acctttgtct yatagaaact c 21 1906 21 DNA Homo sapiens 1906 tgcaagtggc yaacaccacc a 21 1907 21 DNA Homo sapiens 1907 gtcatgcaag yggccaacac c 21 1908 21 DNA Homo sapiens 1908 acaaggacgt rgagcccggc a 21 1909 21 DNA Homo sapiens 1909 tccacgacgg mgagtgcatg c 21 1910 21 DNA Homo sapiens 1910 cttctgctca satgctccaa g 21 1911 21 DNA Homo sapiens 1911 agaaggagca ratgacattc c 21 1912 21 DNA Homo sapiens 1912 aagtggccgg macctgagaa t 21 1913 21 DNA Homo sapiens 1913 ctccaccacc wcgtcgaaga a 21 1914 21 DNA Homo sapiens 1914 caccacgtcg ragaatcgca t 21 1915 21 DNA Homo sapiens 1915 cccctgacta yagggatctc a 21 1916 21 DNA Homo sapiens 1916 tctgcagact yttcaggaga g 21 1917 21 DNA Homo sapiens 1917 aagcattaga rgccttacag a 21 1918 21 DNA Homo sapiens 1918 caaatatcca ygtggactaa a 21 1919 21 DNA Homo sapiens 1919 ttctgctgtg kcgctccatc c 21 1920 21 DNA Homo sapiens 1920 cttgcccaga kcatgcaact t 21 1921 21 DNA Homo sapiens 1921 gcaccaagca rtggacagtt g 21 1922 21 DNA Homo sapiens 1922 tgaagacgtg ratgaatgtg c 21 1923 21 DNA Homo sapiens 1923 ttactattgc rcttgcaaac a 21 1924 21 DNA Homo sapiens 1924 tcaccagcag sgtctgccct g 21 1925 21 DNA Homo sapiens 1925 ctcagcaaat rtcactccgg c 21 1926 21 DNA Homo sapiens 1926 acactggcat ytttttggaa a 21 1927 21 DNA Homo sapiens 1927 gacaacaaga ygggctgcgc c 21 1928 21 DNA Homo sapiens 1928 tgcctcccta ygccttcttc t 21 1929 21 DNA Homo sapiens 1929 aacgtgagcc rggagcagcg t 21 1930 21 DNA Homo sapiens 1930 attgttttta rggtgagaaa t 21 1931 21 DNA Homo sapiens 1931 ctcgccgaac raccctgtca c 21 1932 21 DNA Homo sapiens 1932 tcctgccgct ygatttctcc a 21 1933 21 DNA Homo sapiens 1933 ggccatgggc rtgaagcggg a 21 1934 21 DNA Homo sapiens 1934 gacaaacagc ytttcaccct g 21 1935 21 DNA Homo sapiens 1935 aggagaaagc yctcaaagca t 21 1936 21 DNA Homo sapiens 1936 ccttcagcaa ygggaggaaa a 21 1937 21 DNA Homo sapiens 1937 cctatcctta mcctcggtac a 21 1938 21 DNA Homo sapiens 1938 tttctgctgc ygccaacaac a 21 1939 21 DNA Homo sapiens 1939 tctatgacct yggagatgtg c 21 1940 21 DNA Homo sapiens 1940 ccttcatgac kcagagctcc c 21 1941 21 DNA Homo sapiens 1941 ttcatgactc rgagctcccc t 21 1942 21 DNA Homo sapiens 1942 tcacccagga ygcccagctg a 21 1943 21 DNA Homo sapiens 1943 cgccacgcgc rcctgcggcc t 21 1944 21 DNA Homo sapiens 1944 ggccgcgcca scgaggtccc c 21 1945 21 DNA Homo sapiens 1945 tcgatgccta maaacaggtg a 21 1946 21 DNA Homo sapiens 1946 tgcctacaaa maggtgaaat t 21 1947 21 DNA Homo sapiens 1947 tgtctccagt rcagaaggag g 21 1948 21 DNA Homo sapiens 1948 cgagcctggg ragccccggg g 21 1949 21 DNA Homo sapiens 1949 ggctcgccga wttgcccaga t 21 1950 21 DNA Homo sapiens 1950 actgccaggc rttcagtggc a 21 1951 21 DNA Homo sapiens 1951 ttggaaaaac wctaggagaa g 21 1952 21 DNA Homo sapiens 1952 cgagtgagct kcgagacctg c 21 1953 21 DNA Homo sapiens 1953 tcggctggaa wgaatggata a 21 1954 21 DNA Homo sapiens 1954 ctgtggagca rtggaaagcc c 21 1955 21 DNA Homo sapiens 1955 tgtgactgct scatgcactg t 21 1956 21 DNA Homo sapiens 1956 agcacctact ycatgctggg c 21 1957 21 DNA Homo sapiens 1957 aggaaatgat ygaggaactc c 21 1958 21 DNA Homo sapiens 1958 aagtgcacac yataccagcc a 21 1959 21 DNA Homo sapiens 1959 gtttatcagg kgctccagga g 21 1960 21 DNA Homo sapiens 1960 aggtgctcca rgagcacttg g 21 1961 21 DNA Homo sapiens 1961 ggctggctgg kgtttgacat c 21 1962 21 DNA Homo sapiens 1962 ggcctgcagc kctcggtgga g 21 1963 21 DNA Homo sapiens 1963 atctacaagg rctacatccg g 21 1964 21 DNA Homo sapiens 1964 gccactagct yctccgagaa t 21 1965 21 DNA Homo sapiens 1965 gttcccttta kgattatctg a 21 1966 21 DNA Homo sapiens 1966 gctaaatcaa ygctgaagtt a 21 1967 21 DNA Homo sapiens 1967 tatcagacag kgttgatgag g 21 1968 21 DNA Homo sapiens 1968 tccttatcat racctagtgc c 21 1969 21 DNA Homo sapiens 1969 gttacgcccc kcattcccaa a 21 1970 21 DNA Homo sapiens 1970 tgttggacga ragcttgaac a 21 1971 21 DNA Homo sapiens 1971 aaatttggca rcaagcacaa a 21 1972 21 DNA Homo sapiens 1972 tggagttgcc wagatgaata c 21 1973 21 DNA Homo sapiens 1973 atgatcagga yggcaatgga t 21 1974 21 DNA Homo sapiens 1974 gggcacaatt scagctgatg a 21 1975 21 DNA Homo sapiens 1975 tacctgtgga yacctttctg a 21 1976 21 DNA Homo sapiens 1976 ttacggatat yctacaatgt g 21 1977 21 DNA Homo sapiens 1977 cctacaatgt ktacttagca g 21 1978 21 DNA Homo sapiens 1978 ggagagggct yttcaccaat g 21 1979 21 DNA Homo sapiens 1979 tacggatatc ytacaatgtg t 21 1980 21 DNA Homo sapiens 1980 tcgtgctctg yatctcatgc a 21 1981 21 DNA Homo sapiens 1981 tgtcctcctg rtgtttgagg c 21 1982 21 DNA Homo sapiens 1982 tctcccgcaa scggtccagc a 21 1983 21 DNA Homo sapiens 1983 tcctattcat wttggagtag c 21 1984 21 DNA Homo sapiens 1984 cattccagcc katgccagca c 21 1985 21 DNA Homo sapiens 1985 agggatatct rcatcgactt c 21 1986 21 DNA Homo sapiens 1986 gatatttgcc rtagaggaga t 21 1987 21 DNA Homo sapiens 1987 ttctggtcca rtgagaacca c 21 1988 21 DNA Homo sapiens 1988 agctggagga ygagatcatc t 21 1989 21 DNA Homo sapiens 1989 tcagcaactc sacggcgcgc a 21 1990 21 DNA Homo sapiens 1990 cggcgccctg ytagtcaacg c 21 1991 21 DNA Homo sapiens 1991 gcggctccct rctattcatt g 21 1992 21 DNA Homo sapiens 1992 aacgatgttg magcaggaac t 21 1993 21 DNA Homo sapiens 1993 tggacaaatt wtacccagtg t 21 1994 21 DNA Homo sapiens 1994 aggcattcca rgattccctg g 21 1995 21 DNA Homo sapiens 1995 tgccaaccag sgggtaacag g 21 1996 21 DNA Homo sapiens 1996 cataccacgt scatgtgaaa g 21 1997 21 DNA Homo sapiens 1997 agtcatgcct sagggtttta t 21 1998 21 DNA Homo sapiens 1998 agaagaaaac wgtgacaatg a 21 1999 21 DNA Homo sapiens 1999 tgacaatgat wgttgattgt a 21 2000 21 DNA Homo sapiens 2000 tagtccagac wgtgactctt c 21 2001 21 DNA Homo sapiens 2001 agactgtgac wcttcagcac c 21 2002 21 DNA Homo sapiens 2002 tgacgggaag wggcatcggg t 21 2003 21 DNA Homo sapiens 2003 tggcatcggg wagcaatcag c 21 2004 21 DNA Homo sapiens 2004 cgtcctggct yaccaggggc t 21 2005 21 DNA Homo sapiens 2005 tgggtttcca rgtgccaatg g 21 2006 21 DNA Homo sapiens 2006 gtccagaagg wcttcggggc a 21 2007 21 DNA Homo sapiens 2007 gaaaaaggtg wccgagggct c 21 2008 21 DNA Homo sapiens 2008 gctaaggggg magcaggtgc a 21 2009 21 DNA Homo sapiens 2009 agacatactg raggcatgca a 21 2010 21 DNA Homo sapiens 2010 aacaagacat ygagcatatg a 21 2011 21 DNA Homo sapiens 2011 aagcactaga ktttcacaat t 21 2012 21 DNA Homo sapiens 2012 gggagcctgg scctccaggt c 21 2013 21 DNA Homo sapiens 2013 aattgatcaa rtacctattg t 21 2014 21 DNA Homo sapiens 2014 ggagttcaag rtcctgttgg t 21 2015 21 DNA Homo sapiens 2015 gagatgtcct wtgacaataa t 21 2016 21 DNA Homo sapiens 2016 tcccctgaga ytccgtgggg c 21 2017 21 DNA Homo sapiens 2017 caatggcgct ratggcccac a 21 2018 21 DNA Homo sapiens 2018 gcctggctca racggacccc c 21 2019 21 DNA Homo sapiens 2019 gcctctcctc ytgcagagac c 21 2020 21 DNA Homo sapiens 2020 tgttggacaa raaatgacaa c 21 2021 21 DNA Homo sapiens 2021 gcttgttgca wgctgtggca a 21 2022 21 DNA Homo sapiens 2022 attccaccag mccgggatgt a 21 2023 21 DNA Homo sapiens 2023 aagaagtaaa racattattt t 21 2024 21 DNA Homo sapiens 2024 tggctcctat wgcattggga t 21 2025 21 DNA Homo sapiens 2025 attacttgga ytcaagctcc a 21 2026 21 DNA Homo sapiens 2026 cagataagat rgagaccatc t 21 2027 21 DNA Homo sapiens 2027 gagcccatgg wagcctttgt t 21 2028 21 DNA Homo sapiens 2028 ccaggatgag rtcaagaagg c 21 2029 21 DNA Homo sapiens 2029 acctcggggg stgcctgggc c 21 2030 21 DNA Homo sapiens 2030 tcgggggctg yctgggcccc c 21 2031 21 DNA Homo sapiens 2031 ccccctggcc rtcctggaaa c 21 2032 21 DNA Homo sapiens 2032 cagtatttgc macttacagc a 21 2033 21 DNA Homo sapiens 2033 tgtgactgta sttcccgttt a 21 2034 21 DNA Homo sapiens 2034 aggaaacaag kgctccatgg g 21 2035 21 DNA Homo sapiens 2035 tccagggact ycagggaatg a 21 2036 21 DNA Homo sapiens 2036 tgtgggtcca rgcagtgaag a 21 2037 21 DNA Homo sapiens 2037 atattccaat rtactccttt g 21 2038 21 DNA Homo sapiens 2038 ccatttgcaa katctgtcca c 21 2039 21 DNA Homo sapiens 2039 ccagcagcac ycgtggtggc g 21 2040 21 DNA Homo sapiens 2040 aaggcgacca rggagcccag g 21 2041 21 DNA Homo sapiens 2041 ggcgaccagg ratttcaagg c 21 2042 21 DNA Homo sapiens 2042 ccatgaaaac yatgaagggg c 21 2043 21 DNA Homo sapiens 2043 ccaaaggtga maaaggggac a 21 2044 21 DNA Homo sapiens 2044 gcccacgcga mgagtattcc c 21 2045 21 DNA Homo sapiens 2045 ggggtctccc rgaggagttt g 21 2046 21 DNA Homo sapiens 2046 ctcatgaaga mgtctgccat c 21 2047 21 DNA Homo sapiens 2047 cctggtcctc ygggattgcc a 21 2048 21 DNA Homo sapiens 2048 tcctggctgt kttgggagcc c 21 2049 21 DNA Homo sapiens 2049 acctcatcca ycgactcagc c 21 2050 21 DNA Homo sapiens 2050 acaggcgaga rgggccagaa a 21 2051 21 DNA Homo sapiens 2051 gtcaggagct ytgggaccct c 21 2052 21 DNA Homo sapiens 2052 tcctggtgaa saaggtccct c 21 2053 21 DNA Homo sapiens 2053 atgaggagac yggcaacctg a 21 2054 21 DNA Homo sapiens 2054 ggtgcaatcg rcagtccagg a 21 2055 21 DNA Homo sapiens 2055 ggtgtcaagg rtgaaagtgg g 21 2056 21 DNA Homo sapiens 2056 tcttggtcag ycctatgcgg a 21 2057 21 DNA Homo sapiens 2057 ctggacctca rggaccccca g 21 2058 21 DNA Homo sapiens 2058 tagaggtgga rctggtcccc c 21 2059 21 DNA Homo sapiens 2059 gggattggag rtgaaaaagc t 21 2060 21 DNA Homo sapiens 2060 gagattggcg ygactggtga t 21 2061 21 DNA Homo sapiens 2061 ctcgtggaaa raaaggtccc c 21 2062 21 DNA Homo sapiens 2062 gaaaggacca rtgggattcc c 21 2063 21 DNA Homo sapiens 2063 atgatgtggg rccacctggt c 21 2064 21 DNA Homo sapiens 2064 accaggaaag matggtgcct c 21 2065 21 DNA Homo sapiens 2065 ctgtttgcca ytgtgttcct g 21 2066 21 DNA Homo sapiens 2066 tccaggggat satgaagatg c 21 2067 21 DNA Homo sapiens 2067 gccttcccgt rtttagcacg c 21 2068 21 DNA Homo sapiens 2068 ctggaccacc rgggtgccca g 21 2069 21 DNA Homo sapiens 2069 ggagcatccg sagagcaggg c 21 2070 21 DNA Homo sapiens 2070 ctggtcttcc rggtcccaga g 21 2071 21 DNA Homo sapiens 2071 gccacttttt mgcaaataag t 21 2072 21 DNA Homo sapiens 2072 gacttgcctg ygatgtggtc t 21 2073 21 DNA Homo sapiens 2073 ttcaaggttt wctgcaactt c 21 2074 21 DNA Homo sapiens 2074 aacagggtat yactggtcct t 21 2075 21 DNA Homo sapiens 2075 tcggtcctcc sggtgaacag g 21 2076 21 DNA Homo sapiens 2076 acggcctggc wgggttgcca g 21 2077 21 DNA Homo sapiens 2077 gtgaccctgg yccttccggc c 21 2078 21 DNA Homo sapiens 2078 cgggcagaaa rgtgatgaag g 21 2079 21 DNA Homo sapiens 2079 atggactgga rccagatact g 21 2080 21 DNA Homo sapiens 2080 tatcctggcg rccactcaga g 21 2081 21 DNA Homo sapiens 2081 gactcggtga ytttggcctg g 21 2082 21 DNA Homo sapiens 2082 cggactatga kgtgaccgtg a 21 2083 21 DNA Homo sapiens 2083 ccaagtgact ktgattgccc t 21 2084 21 DNA Homo sapiens 2084 cgccgggagc yggaaactcc a 21 2085 21 DNA Homo sapiens 2085 gcttagctac wctgtgcggg t 21 2086 21 DNA Homo sapiens 2086 tgtccgccgg ragccggaaa c 21 2087 21 DNA Homo sapiens 2087 gggccctgct rcagtcatcg t 21 2088 21 DNA Homo sapiens 2088 gagccagata ytgagtatac g 21 2089 21 DNA Homo sapiens 2089 tcatctgtca ycattacctg g 21 2090 21 DNA Homo sapiens 2090 accaggagag ygtggtatgg c 21 2091 21 DNA Homo sapiens 2091 gggtgaccga kgctttgacg g 21 2092 21 DNA Homo sapiens 2092 cgccatccgt ragcttagct a 21 2093 21 DNA Homo sapiens 2093 aggatccgtg wcatgcccta c 21 2094 21 DNA Homo sapiens 2094 acggagaacc yggggaccct g 21 2095 21 DNA Homo sapiens 2095 tgccagggcc scgaggcgag a 21 2096 21 DNA Homo sapiens 2096 gcttggatgg ygacaaagga c 21 2097 21 DNA Homo sapiens 2097 accgtggttc ycactggacc a 21 2098 21 DNA Homo sapiens 2098 tcctagggcc rgctggagaa g 21 2099 21 DNA Homo sapiens 2099 ccagggagat yctggagagg a 21 2100 21 DNA Homo sapiens 2100 atcttgcaaa rgatccgtga c 21 2101 21 DNA Homo sapiens 2101 atgggcaagg ragccgttcc c 21 2102 21 DNA Homo sapiens 2102 caggcgggac rgcccggaag t 21 2103 21 DNA Homo sapiens 2103 aagggagaga ygggccctca t 21 2104 21 DNA Homo sapiens 2104 aagtgggtga yccaggggtg g 21 2105 21 DNA Homo sapiens 2105 ccaccagggc stagcgggtg t 21 2106 10 DNA Homo sapiens 2106 tgctccctgk 10 2107 21 DNA Homo sapiens 2107 atggagagct raagtccaag a 21 2108 21 DNA Homo sapiens 2108 gcgccgaggg rccaaatgag a 21 2109 21 DNA Homo sapiens 2109 tgctgaagtt rtggaaacat c 21 2110 21 DNA Homo sapiens 2110 gtatcagaag ytatttttag a 21 2111 21 DNA Homo sapiens 2111 ccctggagac mctcgagacc a 21 2112 21 DNA Homo sapiens 2112 ctcagcaaga rgccctgcct g 21 2113 21 DNA Homo sapiens 2113 ccttcaggga yggaggcaat g 21 2114 21 DNA Homo sapiens 2114 ccgcgctgat ygaggccatc c 21 2115 21 DNA Homo sapiens 2115 ttgaccggaa ygtgccccgg a 21 2116 21 DNA Homo sapiens 2116 atcacctcac wcatggaaag c 21 2117 21 DNA Homo sapiens 2117 aagatgatga rgaccatgtg g 21 2118 21 DNA Homo sapiens 2118 ccattgactc raacgactct g 21 2119 21 DNA Homo sapiens 2119 taaacaggct rattctggaa g 21 2120 21 DNA Homo sapiens 2120 ccaggacctg macgcgcctt c 21 2121 21 DNA Homo sapiens 2121 catacaaggc matccccgtt g 21 2122 21 DNA Homo sapiens 2122 gacagcagtc sggatgccgc c 21 2123 21 DNA Homo sapiens 2123 cggccattga rgcagagctg g 21 2124 21 DNA Homo sapiens 2124 ggacaaccgg racagttcca t 21 2125 21 DNA Homo sapiens 2125 gtacaatgcc rtgtccaacg c 21 2126 21 DNA Homo sapiens 2126 cagttcctcc rcctgtcctc t 21 2127 21 DNA Homo sapiens 2127 cctgcaggcc mccaacatct t 21 2128 21 DNA Homo sapiens 2128 gaactgaatt yggcctgaag t 21 2129 21 DNA Homo sapiens 2129 tcatcgactt ygtgtggatc a 21 2130 21 DNA Homo sapiens 2130 aagcagctca scatcagaaa a 21 2131 21 DNA Homo sapiens 2131 gatgcttcac sagcagaggt c 21 2132 21 DNA Homo sapiens 2132 acctgcattg kcatgtgcaa g 21 2133 21 DNA Homo sapiens 2133 cgggaaccca ygtcggccga g 21 2134 21 DNA Homo sapiens 2134 cctctttgag ygtcactggc a 21 2135 21 DNA Homo sapiens 2135 atggcgtctg racagctcag c 21 2136 21 DNA Homo sapiens 2136 cgtggaggtg sagctgctac a 21 2137 21 DNA Homo sapiens 2137 taggagctgg yttgctaatg g 21 2138 21 DNA Homo sapiens 2138 agaagaaagt raccttggaa a 21 2139 21 DNA Homo sapiens 2139 caaatcatca kgtggcctag a 21 2140 21 DNA Homo sapiens 2140 gaagattcca ycagatccca t 21 2141 21 DNA Homo sapiens 2141 ctgggccctt ycctgatgaa c 21 2142 21 DNA Homo sapiens 2142 tgccatcact yctgctgttg g 21 2143 21 DNA Homo sapiens 2143 tgtttgaact yaaacatatg a 21 2144 21 DNA Homo sapiens 2144 ccccgttact ktctctttgg g 21 2145 21 DNA Homo sapiens 2145 gagcgccaag ygctcatgct c 21 2146 21 DNA Homo sapiens 2146 gtccccgtgg ragcctgcag g 21 2147 21 DNA Homo sapiens 2147 gctggcacaa rgctgcgggc a 21 2148 21 DNA Homo sapiens 2148 tgatggccac rtcccggaaa t 21 2149 21 DNA Homo sapiens 2149 cccactgcac magtgtgaca t 21 2150 21 DNA Homo sapiens 2150 tccccttcag ytacctcgtc g 21 2151 21 DNA Homo sapiens 2151 tcaggtactt ygtcagcttc a 21 2152 21 DNA Homo sapiens 2152 agcccctcta yctgaacctc c 21 2153 21 DNA Homo sapiens 2153 tcagcagcag ygtgtcctca g 21 2154 21 DNA Homo sapiens 2154 cctttgtgct rctcatgttg c 21 2155 21 DNA Homo sapiens 2155 ctagcaagat ygactttgtg c 21 2156 21 DNA Homo sapiens 2156 tcgtcatcct sgcctgggcc a 21 2157 21 DNA Homo sapiens 2157 tgtttgggag yggcctgcct g 21 2158 21 DNA Homo sapiens 2158 ccttgttctc yggtatcggc t 21 2159 21 DNA Homo sapiens 2159 tagaagacct yatcaaacct c 21 2160 21 DNA Homo sapiens 2160 gattgttgtg stgggacctc g 21 2161 21 DNA Homo sapiens 2161 ggcttttcct rgcctgtgct t 21 2162 21 DNA Homo sapiens 2162 atacaatatc rgccagcctg g 21 2163 21 DNA Homo sapiens 2163 ctgagctggg yaagccgcgg c 21 2164 21 DNA Homo sapiens 2164 agagccccct racctatgag g 21 2165 21 DNA Homo sapiens 2165 ctcgtgagat ygccaagtcc c 21 2166 21 DNA Homo sapiens 2166 atctcgtctc ygaagacatc t 21 2167 21 DNA Homo sapiens 2167 atgtgaacga yggtgcgatg c 21 2168 21 DNA Homo sapiens 2168 gtatctcaat ktgttcatcc c 21 2169 21 DNA Homo sapiens 2169 atgggcctcc ygagcaggtc t 21 2170 21 DNA Homo sapiens 2170 aggatgtcca rtgcttttcc g 21 2171 21 DNA Homo sapiens 2171 ctagtggtat sccagcaact a 21 2172 21 DNA Homo sapiens 2172 gcctggcagt ragctggaca a 21 2173 21 DNA Homo sapiens 2173 ctctgaggcc yggagtacca a 21 2174 21 DNA Homo sapiens 2174 ccaacgactc yggcccccgc c 21 2175 21 DNA Homo sapiens 2175 gaaaattata yttagaacga g 21 2176 21 DNA Homo sapiens 2176 cagctggaac rtgaagaggg c 21 2177 21 DNA Homo sapiens 2177 ggaagctttt saaagaatgt t 21 2178 21 DNA Homo sapiens 2178 gcgtgtgcac rgaagctggc a 21 2179 21 DNA Homo sapiens 2179 ctcacggagg rttccccaac a 21 2180 21 DNA Homo sapiens 2180 ggttgtgatc ytagggaaac a 21 2181 21 DNA Homo sapiens 2181 gctactggaa ygagtatgaa a 21 2182 21 DNA Homo sapiens 2182 tcttttccta rtcagcaggt t 21 2183 21 DNA Homo sapiens 2183 gctacaacgt rtatggaaca g 21 2184 21 DNA Homo sapiens 2184 ctcagcatta rgaacgcctg t 21 2185 21 DNA Homo sapiens 2185 tgcagacgac raccatgtgc a 21 2186 21 DNA Homo sapiens 2186 cacagactgc rcctcaacag g 21 2187 21 DNA Homo sapiens 2187 gtggtcttgg sctgtttgtt t 21 2188 21 DNA Homo sapiens 2188 atcctgtttc raccccagaa g 21 2189 21 DNA Homo sapiens 2189 acacccttgg ycaaagcatc g 21 2190 21 DNA Homo sapiens 2190 ccctgctgac yaagacaaac t 21 2191 21 DNA Homo sapiens 2191 gcgccaatgc ytccttcacc t 21 2192 21 DNA Homo sapiens 2192 caacaaatgc ytggaactgg c 21 2193 21 DNA Homo sapiens 2193 agggtatact ycaaggatgc a 21 2194 21 DNA Homo sapiens 2194 gcgtggccca yggatgcacc a 21 2195 21 DNA Homo sapiens 2195 agctgatggc rtcttcgacc c 21 2196 21 DNA Homo sapiens 2196 cctcatggaa yaaataacac t 21 2197 21 DNA Homo sapiens 2197 tttacctgct rgcggtgctg g 21 2198 21 DNA Homo sapiens 2198 ctgggcctgg rgggtggagg t 21 2199 21 DNA Homo sapiens 2199 tcactgatgg kcacataaaa g 21 2200 21 DNA Homo sapiens 2200 gcaagccact sgaggttaat t 21 2201 21 DNA Homo sapiens 2201 acactacccg ragaattggt c 21 2202 21 DNA Homo sapiens 2202 accaaaatca rtgatggcca g 21 2203 21 DNA Homo sapiens 2203 ctctgtgact rcttcctccc t 21 2204 21 DNA Homo sapiens 2204 gtcagtcctc rggtggaaga t 21 2205 21 DNA Homo sapiens 2205 tgtgagagcc ytggatggac c 21 2206 21 DNA Homo sapiens 2206 aagtaacagc rgtgttgcca a 21 2207 21 DNA Homo sapiens 2207 ggcgaggaac yctacatcat c 21 2208 21 DNA Homo sapiens 2208 gccgtcaggg matctcccct a 21 2209 21 DNA Homo sapiens 2209 ttggagttcc rgccatgtct a 21 2210 21 DNA Homo sapiens 2210 tgaccttcgc ygaggcccag g 21 2211 21 DNA Homo sapiens 2211 gaggtgacag rtgttgtgtt c 21 2212 21 DNA Homo sapiens 2212 acaggatatc rccgatgcca g 21 2213 21 DNA Homo sapiens 2213 agcgcagccc sagatgcccc t 21 2214 21 DNA Homo sapiens 2214 gctttgcccg rgagctgggg g 21 2215 21 DNA Homo sapiens 2215 acattgatga ytgcctctgc a 21 2216 21 DNA Homo sapiens 2216 gccaagcgca rcccgagatg c 21 2217 21 DNA Homo sapiens 2217 atgaaaacac rtggatcggc c 21 2218 21 DNA Homo sapiens 2218 ccagggcaga sttcagagaa a 21 2219 21 DNA Homo sapiens 2219 atatcaccga kgccagcgaa a 21 2220 21 DNA Homo sapiens 2220 acaggacttg yccatcctgg t 21 2221 21 DNA Homo sapiens 2221 gcatgagcaa rccagccgga t 21 2222 21 DNA Homo sapiens 2222 ataaggatac macaagaagg a 21 2223 21 DNA Homo sapiens 2223 ggcagcaaat katgacatgg t 21 2224 21 DNA Homo sapiens 2224 cagacgaagg kcaatgctgg c 21 2225 21 DNA Homo sapiens 2225 atctcccaga mactgaatgt t 21 2226 21 DNA Homo sapiens 2226 gaagcctgaa racagtgaat g 21 2227 21 DNA Homo sapiens 2227 taccggaaaa wtccagggga c 21 2228 21 DNA Homo sapiens 2228 aactttttga rtccggaaaa a 21 2229 21 DNA Homo sapiens 2229 tcgagactat rttgtgacca a 21 2230 21 DNA Homo sapiens 2230 gaggaagcct saaaacagtg a 21 2231 21 DNA Homo sapiens 2231 aagtaaaaga yttgaaaaag a 21 2232 21 DNA Homo sapiens 2232 tccatgaata wcagcatttg g 21 2233 21 DNA Homo sapiens 2233 cctggagcta rgtccatgaa t 21 2234 21 DNA Homo sapiens 2234 tgaccaagac rtatgccact g 21 2235 21 DNA Homo sapiens 2235 accttctacc ycaatcacaa a 21 2236 21 DNA Homo sapiens 2236 cgtcagtgtc wgggaactgg a 21 2237 21 DNA Homo sapiens 2237 catgtctgac rgatacaagc t 21 2238 21 DNA Homo sapiens 2238 tgtccaacgc rgtcaagcag a 21 2239 21 DNA Homo sapiens 2239 ttaaagtaga rcaggccgaa t 21 2240 21 DNA Homo sapiens 2240 ccaaccccga ygagaagacg a 21 2241 21 DNA Homo sapiens 2241 tacacgacat kttcatggac a 21 2242 21 DNA Homo sapiens 2242 tatgacagag racagaggat g 21 2243 21 DNA Homo sapiens 2243 gcatccacat sgtgacaggt c 21 2244 21 DNA Homo sapiens 2244 ctaactggtc kggattacag a 21 2245 21 DNA Homo sapiens 2245 gaaatgaaac rgattgttga g 21 2246 21 DNA Homo sapiens 2246 gagtttttca ytgcactcaa t 21 2247 21 DNA Homo sapiens 2247 tgtgagacac rgttcagatc c 21 2248 21 DNA Homo sapiens 2248 tataatccat mtacacggag t 21 2249 21 DNA Homo sapiens 2249 gattacctgc maacaggaat g 21 2250 21 DNA Homo sapiens 2250 ccttctatac yccagagcca g 21 2251 21 DNA Homo sapiens 2251 tcctgaaaga yaccaagagc a 21 2252 21 DNA Homo sapiens 2252 cagacggaaa ktgctcacac c 21 2253 21 DNA Homo sapiens 2253 tggtgggaca yggataaagc t 21 2254 21 DNA Homo sapiens 2254 gaaaagcttt ytatcgaaac a 21 2255 21 DNA Homo sapiens 2255 aatgactacg ycaacggctt c 21 2256 21 DNA Homo sapiens 2256 actgggcaga yggaaagtgc t 21 2257 21 DNA Homo sapiens 2257 actacgccaa mggcttcatg g 21 2258 21 DNA Homo sapiens 2258 gctcagatac yagcagcctg g 21 2259 21 DNA Homo sapiens 2259 tctttgacaa rtcctgcagc g 21 2260 21 DNA Homo sapiens 2260 cttgattggg sagaacgaga a 21 2261 21 DNA Homo sapiens 2261 gatggctatg rcctggagat c 21 2262 21 DNA Homo sapiens 2262 cctgagacca raagaaacgc a 21 2263 21 DNA Homo sapiens 2263 ccgcagggat ytactgagac t 21 2264 21 DNA Homo sapiens 2264 agattaccaa rcccaacgtg t 21 2265 21 DNA Homo sapiens 2265 tgtcctgcag kgacaagatt g 21 2266 21 DNA Homo sapiens 2266 gggttggagg yccgtgactg c 21 2267 21 DNA Homo sapiens 2267 atgatgaccc rtctcttgaa g 21 2268 21 DNA Homo sapiens 2268 aagctggtct rccagatctt c 21 2269 21 DNA Homo sapiens 2269 aaatccacag rtttctgatg a 21 2270 21 DNA Homo sapiens 2270 aattccgact ygacctatga g 21 2271 21 DNA Homo sapiens 2271 gggccacgtc rgaccctctg g 21 2272 21 DNA Homo sapiens 2272 gttcttcctc ytggagaatg t 21 2273 21 DNA Homo sapiens 2273 aggacctgat maacaagatc g 21 2274 21 DNA Homo sapiens 2274 agacattcac wggacacaga g 21 2275 21 DNA Homo sapiens 2275 cctctggctc mgtgttccga g 21 2276 21 DNA Homo sapiens 2276 actcactttg wtgagctcca g 21 2277 21 DNA Homo sapiens 2277 gaaccttcac rccatctatg a 21 2278 21 DNA Homo sapiens 2278 tgaccaggag wtggaggagc t 21 2279 21 DNA Homo sapiens 2279 aacgacgtgg rcggccagcg c 21 2280 21 DNA Homo sapiens 2280 gtcctgccca ytggggggcg c 21 2281 21 DNA Homo sapiens 2281 cgcagctggg rcccaagctc t 21 2282 21 DNA Homo sapiens 2282 caggcagctg rtctgcaacg t 21 2283 21 DNA Homo sapiens 2283 ctcaggcaaa yggagtaagc c 21 2284 21 DNA Homo sapiens 2284 accgtctgaa sttgtaggga g 21 2285 21 DNA Homo sapiens 2285 caagggtacc rcgtcgatgc t 21 2286 21 DNA Homo sapiens 2286 ttttggcttc stggcctttg g 21 2287 21 DNA Homo sapiens 2287 cccagttcat kgatggtgcc c 21 2288 21 DNA Homo sapiens 2288 ctgtgagtgg satttgtttt g 21 2289 21 DNA Homo sapiens 2289 ggtctgcagt kgccacctga a 21 2290 21 DNA Homo sapiens 2290 gtgtaacaga mgacgggggt t 21 2291 21 DNA Homo sapiens 2291 aggccatcaa satggggcag t 21 2292 21 DNA Homo sapiens 2292 gtcaacagta rcctggtgtg c 21 2293 21 DNA Homo sapiens 2293 ccttcactta ygaggatccc a 21 2294 21 DNA Homo sapiens 2294 acctgtgtgg ytcatgcaga g 21 2295 21 DNA Homo sapiens 2295 ctttgggata ytcatgtggg a 21 2296 21 DNA Homo sapiens 2296 gagaccttca ycctttacta c 21 2297 21 DNA Homo sapiens 2297 tttgaggtgc maggctcagc a 21 2298 21 DNA Homo sapiens 2298 ctatgaccag rcagaagacg a 21 2299 21 DNA Homo sapiens 2299 ggggctttgg scttcctcct g 21 2300 21 DNA Homo sapiens 2300 ggccatccag rccctgtggg c 21 2301 21 DNA Homo sapiens 2301 ggaggtcatt sggacaggct c 21 2302 21 DNA Homo sapiens 2302 ttcctcaggc rgcgggaggg c 21 2303 21 DNA Homo sapiens 2303 agccattgga ytggagtgct a 21 2304 21 DNA Homo sapiens 2304 agctgaacct sctgacagag t 21 2305 21 DNA Homo sapiens 2305 tttggtgttc ratagcatat t 21 2306 21 DNA Homo sapiens 2306 tgaagcaaat scagatactt c 21 2307 21 DNA Homo sapiens 2307 gcatcagcca ygatggtaga a 21 2308 21 DNA Homo sapiens 2308 tacagaacag rctactcggg t 21 2309 21 DNA Homo sapiens 2309 cagcaatggg yatcccctcg g 21 2310 21 DNA Homo sapiens 2310 aaatcccgta rtgaatccaa g 21 2311 21 DNA Homo sapiens 2311 taacaggaaa ygtgcagttt a 21 2312 21 DNA Homo sapiens 2312 agatcagcag kgtagcccgt g 21 2313 21 DNA Homo sapiens 2313 cagaagagtc sttcacagct g 21 2314 21 DNA Homo sapiens 2314 ctagagaaat wctactttgc t 21 2315 21 DNA Homo sapiens 2315 aagtcagtac rgtggatgcc a 21 2316 21 DNA Homo sapiens 2316 gaacatgaca raagagtcct t 21 2317 21 DNA Homo sapiens 2317 ggaagatcat rgaagttgaa g 21 2318 21 DNA Homo sapiens 2318 ttctcttaac saagccatca t 21 2319 21 DNA Homo sapiens 2319 tgttggctta ytcattcacg c 21 2320 21 DNA Homo sapiens 2320 ggctgccatt ktcattgctc a 21 2321 21 DNA Homo sapiens 2321 aaacccttgg rtttttattg g 21 2322 21 DNA Homo sapiens 2322 ctgttggagc maccattaac a 21 2323 21 DNA Homo sapiens 2323 gactttgtgc ycaacgtcaa g 21 2324 21 DNA Homo sapiens 2324 cttctatgtc rcctccagtg a 21 2325 21 DNA Homo sapiens 2325 atgcaagtat kttgggctcg c 21 2326 21 DNA Homo sapiens 2326 cccagtttgt ycccactgtt t 21 2327 21 DNA Homo sapiens 2327 acaggtggcc rtctgcctgg c 21 2328 21 DNA Homo sapiens 2328 gtgcttggct kcctctttgc g 21 2329 21 DNA Homo sapiens 2329 cctcttccag ycgcagaaga a 21 2330 21 DNA Homo sapiens 2330 agcccgacct kggcacctgc t 21 2331 21 DNA Homo sapiens 2331 ggacctgtcg ytcatctgcc t 21 2332 21 DNA Homo sapiens 2332 accagcggac rctcgacccc c 21 2333 21 DNA Homo sapiens 2333 atcgcaaatg macaggacag g 21 2334 21 DNA Homo sapiens 2334 tcctgtcttc ytggcaatgt t 21 2335 21 DNA Homo sapiens 2335 tgtgcacact rccatgtaag c 21 2336 21 DNA Homo sapiens 2336 tgtgctgact wccggggtgt c 21 2337 21 DNA Homo sapiens 2337 aagccagagg rgttctcaag t 21 2338 21 DNA Homo sapiens 2338 tcatagacta ygatgaacac a 21 2339 21 DNA Homo sapiens 2339 cgaactcttg mcaataatcg a 21 2340 21 DNA Homo sapiens 2340 aaacaaaccg yatccaccga a 21 2341 21 DNA Homo sapiens 2341 gagggcttca rgacgcgaac t 21 2342 21 DNA Homo sapiens 2342 attagtccag satctcagct g 21 2343 21 DNA Homo sapiens 2343 ttttctctgt kattcaatca c 21 2344 21 DNA Homo sapiens 2344 ttaccatgta yaccacctgc a 21 2345 21 DNA Homo sapiens 2345 aactcaggcc mcagcagagc c 21 2346 21 DNA Homo sapiens 2346 gaagtcgctc wacaactgcc g 21 2347 21 DNA Homo sapiens 2347 gtctgagaat raaattccca c 21 2348 21 DNA Homo sapiens 2348 gcgtgtccaa ygatgtctgc a 21 2349 21 DNA Homo sapiens 2349 tgggcaatcc rtttacatgc t 21 2350 21 DNA Homo sapiens 2350 ggatcaagac wctccaagag g 21 2351 21 DNA Homo sapiens 2351 gcaaatctgg ycgcacctaa c 21 2352 21 DNA Homo sapiens 2352 ctccaagttt rgcatgaaag g 21 2353 21 DNA Homo sapiens 2353 gtcggtggcc rcacaatgct g 21 2354 21 DNA Homo sapiens 2354 tccttaagga yaactaacat t 21 2355 21 DNA Homo sapiens 2355 aggatgccag ygacaatgca c 21 2356 21 DNA Homo sapiens 2356 ggacctcaac magttcctca g 21 2357 21 DNA Homo sapiens 2357 agcatgggga yctcaacaag t 21 2358 21 DNA Homo sapiens 2358 gtaatgaaat yccttccaca g 21 2359 21 DNA Homo sapiens 2359 tactaaaata yatgttacca a 21 2360 21 DNA Homo sapiens 2360 catttgttca scacatcaag c 21 2361 21 DNA Homo sapiens 2361 cacgcaagga yttccaccgt g 21 2362 21 DNA Homo sapiens 2362 ctgtcattat yggaatgacc a 21 2363 21 DNA Homo sapiens 2363 attggaatga scaagatccc t 21 2364 21 DNA Homo sapiens 2364 ccagtacttt kgcatcacca a 21 2365 21 DNA Homo sapiens 2365 gacataacat kgttctgaaa a 21 2366 21 DNA Homo sapiens 2366 aaatctggcc kcacctaacc t 21 2367 21 DNA Homo sapiens 2367 tgctgcccat ycgctggatg c 21 2368 21 DNA Homo sapiens 2368 gatgctgcat wtagcccagc a 21 2369 21 DNA Homo sapiens 2369 cgtcccagca mttcgtgcac c 21 2370 21 DNA Homo sapiens 2370 cccattcgct rgatgcctcc a 21 2371 21 DNA Homo sapiens 2371 tttggccacc mggaactgcc t 21 2372 21 DNA Homo sapiens 2372 ggagaacttg ytggtgaaaa t 21 2373 21 DNA Homo sapiens 2373 gggatgtcgt yctggataag g 21 2374 21 DNA Homo sapiens 2374 tgtattggga ygttggtaac c 21 2375 21 DNA Homo sapiens 2375 ggtataagag ycgccctgtc g 21 2376 21 DNA Homo sapiens 2376 ccggagctgc rggaggccta c 21 2377 21 DNA Homo sapiens 2377 tgcaattcaa ygcagtccga a 21 2378 21 DNA Homo sapiens 2378 tgcacacagt rgaccacgtg g 21 2379 21 DNA Homo sapiens 2379 acgtccggaa maaactgaag a 21 2380 21 DNA Homo sapiens 2380 agcaagccct yagtgagatt g 21 2381 21 DNA Homo sapiens 2381 gctgaattaa ragtggccta a 21 2382 21 DNA Homo sapiens 2382 attgaggaaa ytcggcttaa c 21 2383 21 DNA Homo sapiens 2383 cagctgacac rggatgatga t 21 2384 21 DNA Homo sapiens 2384 ccggaagaaa ytgataatta t 21 2385 21 DNA Homo sapiens 2385 tacagtatca ytctctctgc a 21 2386 21 DNA Homo sapiens 2386 acttccagtc wgtcacctcc a 21 2387 21 DNA Homo sapiens 2387 atttcgtgag rgccaagggc a 21 2388 21 DNA Homo sapiens 2388 tccagatcaa ygttatcccc a 21 2389 21 DNA Homo sapiens 2389 attctggcct wgatgaagtg g 21 2390 21 DNA Homo sapiens 2390 agtccctgtc sccttcagga t 21 2391 21 DNA Homo sapiens 2391 aagggaagaa rgtctggata g 21 2392 21 DNA Homo sapiens 2392 gggagagcct rcgacaggga a 21 2393 21 DNA Homo sapiens 2393 gcccaaatac kggaaataaa a 21 2394 21 DNA Homo sapiens 2394 tcgtgcgcaa ygtgccctgg g 21 2395 21 DNA Homo sapiens 2395 ctggggccac rtgccccaca g 21 2396 21 DNA Homo sapiens 2396 gcagtgctgc maagctaaag a 21 2397 21 DNA Homo sapiens 2397 ttaccttggt rttcccattg t 21 2398 21 DNA Homo sapiens 2398 acagcttgtt raaaaaaagc t 21 2399 21 DNA Homo sapiens 2399 gagcagtttt yggaggccag c 21 2400 21 DNA Homo sapiens 2400 cggaggagtt sgtgccccag g 21 2401 21 DNA Homo sapiens 2401 gagctcagaa ygtctctaag g 21 2402 21 DNA Homo sapiens 2402 agagccagcg rgttgtgctg c 21 2403 21 DNA Homo sapiens 2403 gaccacttaa ytgagcgact a 21 2404 21 DNA Homo sapiens 2404 ctgcaaggca rcctggaaac t 21 2405 21 DNA Homo sapiens 2405 tggtggtgat ycctgcagag g 21 2406 21 DNA Homo sapiens 2406 gctggagcca statctggcc t 21 2407 21 DNA Homo sapiens 2407 aaggatgaga rggaccactt a 21 2408 21 DNA Homo sapiens 2408 actgcgcacc ygaaattctt a 21 2409 21 DNA Homo sapiens 2409 agagccacaa rgctagccga g 21 2410 21 DNA Homo sapiens 2410 catgttcagg wgaattctga a 21 2411 21 DNA Homo sapiens 2411 tggcctcttc scgcctggga a 21 2412 21 DNA Homo sapiens 2412 atgacattcc ygatcgtcca g 21 2413 21 DNA Homo sapiens 2413 atagccttcc ytaatccata c 21 2414 21 DNA Homo sapiens 2414 cattggagcg rtcgcaggaa g 21 2415 21 DNA Homo sapiens 2415 atattttccg raagctggga c 21 2416 21 DNA Homo sapiens 2416 gccattgaag yttcgaagca t 21 2417 21 DNA Homo sapiens 2417 tcccttagct ktcctgacac a 21 2418 21 DNA Homo sapiens 2418 catcatcaga rgttacttgg g 21 2419 21 DNA Homo sapiens 2419 agtagtaaca ytaacaggat t 21 2420 21 DNA Homo sapiens 2420 caatggagat ygtggtggat a 21 2421 21 DNA Homo sapiens 2421 gagaggttga ycaggaaata c 21 2422 21 DNA Homo sapiens 2422 ccctcccagg ytaagctgcg g 21 2423 21 DNA Homo sapiens 2423 ctcacgcaag scgaagacca g 21 2424 21 DNA Homo sapiens 2424 tcaacacctc ytccttgctg g 21 2425 21 DNA Homo sapiens 2425 gagctaagcc rgggcaagct c 21 2426 21 DNA Homo sapiens 2426 ctaagccggg kcaagctcta t 21 2427 21 DNA Homo sapiens 2427 tcttcacggg rtactacggg a 21 2428 21 DNA Homo sapiens 2428 gggtcatgag ygtctgtctg c 21 2429 21 DNA Homo sapiens 2429 tgctgcccat ycgctggatg g 21 2430 21 DNA Homo sapiens 2430 aagatctggt yagtcttgat t 21 2431 21 DNA Homo sapiens 2431 taccaggagc yccggcctcg t 21 2432 21 DNA Homo sapiens 2432 cgccccactc ygctccctgt g 21 2433 21 DNA Homo sapiens 2433 tggagaacgg ygacctcaac c 21 2434 21 DNA Homo sapiens 2434 tgaaagcttt kacctggagc c 21 2435 21 DNA Homo sapiens 2435 ccacgcgatt satcaggatc t 21 2436 21 DNA Homo sapiens 2436 gaccttctgg yatcacatgt c 21 2437 21 DNA Homo sapiens 2437 ttcccaagct kacgaaaatc a 21 2438 21 DNA Homo sapiens 2438 ttttttacac ygacagcgcg a 21 2439 21 DNA Homo sapiens 2439 acttgggcct yctgcgcttt g 21 2440 21 DNA Homo sapiens 2440 gaaatctggg mtggattccc t 21 2441 21 DNA Homo sapiens 2441 cagaatggag stgctgggct g 21 2442 21 DNA Homo sapiens 2442 ttgtctttgc rccaaagatg t 21 2443 21 DNA Homo sapiens 2443 tgggtcccac rtcggcacac t 21 2444 21 DNA Homo sapiens 2444 ggattgctaa ygaacagatc a 21 2445 21 DNA Homo sapiens 2445 atgacacccc kgacatccga a 21 2446 21 DNA Homo sapiens 2446 tggcactcag rtatcgccct c 21 2447 21 DNA Homo sapiens 2447 atggctacta ygtcaaatcc t 21 2448 21 DNA Homo sapiens 2448 gttcatcgac rgggatcctc t 21 2449 21 DNA Homo sapiens 2449 gcaacctcag kgtctggcgc c 21 2450 21 DNA Homo sapiens 2450 gctatatcac ytctcccggt t 21 2451 21 DNA Homo sapiens 2451 cttttgcagt kgacatccca g 21 2452 21 DNA Homo sapiens 2452 ttgcagtgga satcccagaa a 21 2453 21 DNA Homo sapiens 2453 aaggatatga rgatgaaatt g 21 2454 21 DNA Homo sapiens 2454 agatgaaatt katgatgaat a 21 2455 21 DNA Homo sapiens 2455 tcgttcatcg wcggggatcc t 21 2456 21 DNA Homo sapiens 2456 atggcggtgg ycaaggatgg c 21 2457 21 DNA Homo sapiens 2457 acaatgggaa raaatcagta g 21 2458 21 DNA Homo sapiens 2458 actggttcat rgccgtctgt t 21 2459 21 DNA Homo sapiens 2459 tgtcagcaag rttgacaaaa t 21 2460 21 DNA Homo sapiens 2460 caaaagaaag rcatcaaagc c 21 2461 21 DNA Homo sapiens 2461 agaacaaatg mtttggttca c 21 2462 21 DNA Homo sapiens 2462 aattacgatg yttcagctgc a 21 2463 21 DNA Homo sapiens 2463 aaggctatga yattcgtctg a 21 2464 21 DNA Homo sapiens 2464 ctctgggtgc ytgataccta t 21 2465 21 DNA Homo sapiens 2465 ctggatggaa sctacagtga g 21 2466 21 DNA Homo sapiens 2466 accaccatca ycacgggcgt g 21 2467 21 DNA Homo sapiens 2467 cgtctcctac rtcaaggccg t 21 2468 21 DNA Homo sapiens 2468 gtcctgctcc mgttcaccac t 21 2469 21 DNA Homo sapiens 2469 gataacagca mgccacattt g 21 2470 21 DNA Homo sapiens 2470 ctgggtagtg yaacgtgcaa g 21 2471 21 DNA Homo sapiens 2471 ctggcctctt yaccgtggag a 21 2472 21 DNA Homo sapiens 2472 ctaccccaac mcagaaacta c 21 2473 21 DNA Homo sapiens 2473 gtgtgcccca ragtccgagc c 21 2474 21 DNA Homo sapiens 2474 atcagcttct rcatgctctg t 21 2475 21 DNA Homo sapiens 2475 accacctgga ygagtttaaa a 21 2476 21 DNA Homo sapiens 2476 ccggctccaa ygccaacatc a 21 2477 21 DNA Homo sapiens 2477 cttcacatag yccttttggt a 21 2478 21 DNA Homo sapiens 2478 aagaggaccc wgctccatgt g 21 2479 21 DNA Homo sapiens 2479 gctggacaga ygtgctctac t 21 2480 21 DNA Homo sapiens 2480 ggcaagttta wttttgatga a 21 2481 21 DNA Homo sapiens 2481 tgctgagcag ygctgccctg g 21 2482 21 DNA Homo sapiens 2482 ttgaagatga yaacttttgg a 21 2483 21 DNA Homo sapiens 2483 actgggttac yttgactatg c 21 2484 21 DNA Homo sapiens 2484 tgcctctcaa yagtgacggg a 21 2485 21 DNA Homo sapiens 2485 tgctttggtt ygaacggctc t 21 2486 21 DNA Homo sapiens 2486 cagatatcgt rgctgaagag g 21 2487 21 DNA Homo sapiens 2487 accaagcgga kcacctttga c 21 2488 21 DNA Homo sapiens 2488 tcaccttttt ycgtcttttc c 21 2489 21 DNA Homo sapiens 2489 gctacagcga ygaagagcca g 21 2490 21 DNA Homo sapiens 2490 cccgagccaa yggggatgtg g 21 2491 21 DNA Homo sapiens 2491 tacatcgagc rtgcttcatg a 21 2492 21 DNA Homo sapiens 2492 gccactacat ygtgaacctg c 21 2493 21 DNA Homo sapiens 2493 atgtagatca ygagaaaaac a 21 2494 21 DNA Homo sapiens 2494 agaacgagaa ygaacgctgc g 21 2495 21 DNA Homo sapiens 2495 tatggacccc rccgatgacg g 21 2496 21 DNA Homo sapiens 2496 atgacggaca kttccaagaa c 21 2497 21 DNA Homo sapiens 2497 gctggcagga rgccttgatg a 21 2498 21 DNA Homo sapiens 2498 ccctcctttc ytacagctcc c 21 2499 21 DNA Homo sapiens 2499 aacgctttgg saaccaacaa a 21 2500 21 DNA Homo sapiens 2500 tgacttcatc rccgtgattg g 21 2501 21 DNA Homo sapiens 2501 ttgatgccct ytgatgaggc c 21 2502 21 DNA Homo sapiens 2502 tggacaggat yttcacagcg t 21 2503 21 DNA Homo sapiens 2503 aggctctctt ygacttcctc a 21 2504 21 DNA Homo sapiens 2504 catgcggcct rtggtgctgg t 21 2505 21 DNA Homo sapiens 2505 actctgccta ygtagagcca a 21 2506 21 DNA Homo sapiens 2506 catttgactc rgaaacccag g 21 2507 21 DNA Homo sapiens 2507 ccaattgaaa racgaagtct a 21 2508 21 DNA Homo sapiens 2508 ggagcaggtt kaaaagatcc g 21 2509 21 DNA Homo sapiens 2509 acacttacaa rccccatagg a 21 2510 21 DNA Homo sapiens 2510 tcctgcacgg ygggcaaccc c 21 2511 21 DNA Homo sapiens 2511 acacacacca ycgctcaccc a 21 2512 21 DNA Homo sapiens 2512 aagattttta yagaagacat t 21 2513 21 DNA Homo sapiens 2513 acacttcaga ygtggtgatt g 21 2514 21 DNA Homo sapiens 2514 ctggaacccc rctgattttg g 21 2515 21 DNA Homo sapiens 2515 aagttatacg ygttccttca g 21 2516 21 DNA Homo sapiens 2516 ccattagata matttcgaga c 21 2517 21 DNA Homo sapiens 2517 gatactactc rgcgctgcga c 21 2518 21 DNA Homo sapiens 2518 gaaaacgatc yagcccagag a 21 2519 21 DNA Homo sapiens 2519 gcgactgggg ytgtccggac t 21 2520 21 DNA Homo sapiens 2520 tggtcttcat ygtcacttcc t 21 2521 21 DNA Homo sapiens 2521 tgatgtgtgt ractgtgagg c 21 2522 21 DNA Homo sapiens 2522 gccgctgacc kccgtctaca c 21 2523 21 DNA Homo sapiens 2523 tggaggagtc rgagcatctg c 21 2524 21 DNA Homo sapiens 2524 cctccacctg ygtcaaccca t 21 2525 21 DNA Homo sapiens 2525 agttcctggc rgataaggtg g 21 2526 21 DNA Homo sapiens 2526 gggcttcatc ytggtctgtt a 21 2527 21 DNA Homo sapiens 2527 catctaccgg ygcctgcaga g 21 2528 21 DNA Homo sapiens 2528 gtgatggtgg wggcctttgc c 21 2529 21 DNA Homo sapiens 2529 tggcctttgc ygtgctctgg c 21 2530 21 DNA Homo sapiens 2530 caacagcctg raagactggc a 21 2531 21 DNA Homo sapiens 2531 ccatctgcca ygggaacctc a 21 2532 21 DNA Homo sapiens 2532 tgactcatgc ytactggggc a 21 2533 21 DNA Homo sapiens 2533 accacccagc rtctaataca a 21 2534 21 DNA Homo sapiens 2534 gagcccttcc rcaacctctc t 21 2535 21 DNA Homo sapiens 2535 aaggtacttg ygttcagaaa a 21 2536 21 DNA Homo sapiens 2536 tccacactct kcctgtgtca g 21 2537 21 DNA Homo sapiens 2537 taaggaccag raagacaagg c 21 2538 21 DNA Homo sapiens 2538 gggcctattc kcattgccgg a 21 2539 21 DNA Homo sapiens 2539 cttagatggc racctgtccg a 21 2540 21 DNA Homo sapiens 2540 atgtatgaga kttgggtgcc a 21 2541 21 DNA Homo sapiens 2541 gacaggatgt rgcccggttt a 21 2542 21 DNA Homo sapiens 2542 tggaggagga rtttaactac c 21 2543 21 DNA Homo sapiens 2543 caaataagac mtactccttc c 21 2544 21 DNA Homo sapiens 2544 caatctgggc katgagatca a 21 2545 21 DNA Homo sapiens 2545 cagaattact rgcctcgatc c 21 2546 21 DNA Homo sapiens 2546 ctggtcgaag mattggaatc c 21 2547 21 DNA Homo sapiens 2547 gacttggaga wgtggaccag c 21 2548 21 DNA Homo sapiens 2548 aataagaagt saggctgaaa c 21 2549 21 DNA Homo sapiens 2549 taagaagtca rgctgaaact g 21 2550 21 DNA Homo sapiens 2550 aggctgaaac ygggcgaatc t 21 2551 21 DNA Homo sapiens 2551 gaaactgggc raatctacag a 21 

What is claimed is:
 1. A method for predicting the likelihood that a human will have myocardial infraction, comprising: determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 in a nucleic acid sample obtained from a human, wherein presence of a C at nucleotide position 1186 is indicative of increased likelihood of a myocardial infraction in the human as compared with a human having a G at nucleotide position 1186, thereby predicting the likelihood that a human will have myocardial infraction.
 2. A method for predicting the likelihood that a human will have coronary revascularization, comprising: determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 from a nucleic acid sample obtained from a human, wherein presence of a C at nucleotide position 1186 is indicative of increased likelihood of a coronary revascularization in the human as compared with a human having a G at nucleotide position 1186, thereby predicting the likelihood that a human will have coronary revascularization.
 3. A method for predicting the likelihood that a human will have myocardial infraction, comprising: determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 in a nucleic acid sample obtained form a human, wherein presence of a G at nucleotide position 1186 is indicative of decreased likelihood of a myocardial infraction in the human as compared with a human having a C at nucleotide position 1186, thereby predicting the likelihood that a human will have myocardial infraction.
 4. A method for predicting the likelihood that a human will have coronary revascularization, comprising: determining the nucleotide present at nucleotide position 1186 of the thrombospondin-4 gene having the nucleotide sequence of SEQ ID NO: 3 from a nucleic acid sample obtained from a human, wherein presence of a G at nucleotide position 1186 is indicative of decreased likelihood of a coronary revascularization in the human as compared with a human having a C at nucleotide position 1186, thereby predicting the likelihood that a human will have coronary revascularization. 